close
【王修含醫師演講公告】
演講主題：以雷射治療活躍性的青春痘(痤瘡)
演講日期：2015年5月3日
主辦單位：臺灣皮膚科醫學會Taiwanese Dermatological Association
(註：本次演講會議語言為英語，現場有中文同步口譯，請詳見下列資訊)
3rd Taiwan Dermatology Aesthetic Conference
Taiwanese Dermatological Association Spring Meeting 2015
2 May- 3 May 2015, Kaohsiung Exhibition Center
第三屆臺灣皮膚科美容醫學學術研討會
2015年臺灣皮膚科醫學會春季學術研討會
2 May- 3 May 2015, 高雄展覽館
Speaker: WANG, Shiou-Han (王修含) MD
Moderators:
YANG, Li-Cheng (楊麗珍) MD
HUANG, Po-Han (黃柏翰) MD
Adjunct Staff, Department of Dermatology, NTUH(台大醫院), Taipei, Taiwan
EDUCATION
Doctor of Medicine (MD), College of Medicine, National Taiwan University
Master of Science in Electrical Engineering (MSEE), Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University
Bachelor of Science in Mechanical Engineering (BSME), College of Engineering, National Taiwan University
PROFESSIONAL CERTIFICATE & LICENSE
Medical License of the National Examination for Physician
Board Certification of the National Specialist Examination for Specialist of Dermatology
Certificate for special competence in Cosmetic Dermatology
POSTGRADUATE TRAINING & OCCUPATIONAL HISTORY
Resident, Department of Surgery, National Taiwan University Hospital(NTUH), Taipei, Taiwan
Resident, Department of Dermatology, NTUH, Taipei, Taiwan
Chief Resident, Department of Dermatology, NTUH, Taipei, Taiwan
Adjunct Staff, Department of Dermatology, NTUH, Taipei, Taiwan
Specialist in Dermatological Surgery & Laser, Department of Dermatology, NTUH, Taipei, Taiwan
Specialist in Acne & Scar Treatment, Department of Dermatology, NTUH, Taipei, Taiwan
Specialist in Dermatologic Ultrasound, Department of Dermatology, NTUH, Taipei, Taiwan
Doctor Shiou-Han Wang(王修含), MD MSEE is the Director of Skin168 Institute of Dermatology(王修含皮膚科診所) and on the Adjunct Staff at National Taiwan University Hospital(台大醫院) in Taipei.
He graduated with Academic Excellence Award from Department of Mechanical Engineering and received his MD degree from College of Medicine of National Taiwan University. He also received his MSEE from National Taiwan University Graduate Institute of Biomedical Electronics and Bioinformatics.
Dr. Shiou-Han Wang's area of research interest in biomedical engineering (laser, radiofrequency and ultrasound) and aesthetic dermatology. He has served as a specialist in Dermatological Surgery & Laser, Acne & Scar Treatment, and High-Frequency Ultrasound in Department of Dermatology, NTUH, Taipei, Taiwan.
Dr. Wang was awarded Best Annual Paper Award(年度最佳論文獎) from Taiwanese Society of Biomedical Engineering(中華民國生物醫學工程學會) and Enginnering Paper Award (工程論文獎) from Chinese Institute of Engineers(中國工程師學會). He serves a reviewer for Archives of Dermatology and International Journal of Dermatology. He delivered professional oral presentations and has been invited to speak at national and international aesthetic and dermatologic conferences, including International Conference on Behçet's Disease (ICBD), The International Society for Optical. Engineering (SPIE), International Master Course on Aging Skin (IMCAS), Asian Dermatological Congress (ADC), Global Chinese Dermatologist Summit (GCDS) and Minimal invasive plastic and aesthetic and dermatology (MIPASD).
附錄：
以下會議相關資訊，由台灣皮膚科醫學會提供，歡迎有興趣者報名參與盛會。
會議手冊資料引用自 http://www.tdmt.org/TDAC2015/AgendaInfo/?AgendaInfoSID=11
3rd Taiwan Dermatology Aesthetic Conference
Taiwanese Dermatological Association Spring Meeting 2015
2 May- 3 May 2015, Kaohsiung Exhibition Center
第三屆臺灣皮膚科美容醫學學術研討會
2015年臺灣皮膚科醫學會春季學術研討會
2 May- 3 May 2015, 高雄展覽館
SCIENTIFIC PROGRAM
理事長的話 WELCOME MESSAGE
會長、各位貴賓、先進、同仁：
「Glocalization」全球在地化，是全球化 (globalization)與在地化 (localization)兩字的結合，具有「思考全球化，行動在地化」的意涵。醫學的領域，與「人」息息相關，必須因地制宜，配合在地的風土民情，適情適性。
2015年台灣皮膚科醫學會春季學術研討會暨第三屆台灣皮膚科美容醫學學術研討會，承襲前兩屆傳統，結合皮膚科學與美容醫學，提供一個台灣與國際交流的平台，在皮膚科學部份：「痤瘡、酒糟性皮膚炎、異位性皮膚炎、蕁麻疹」，在美容醫學部份：「針劑注射、溶脂與自體脂肪移植、多汗症治療」，是本屆研討會的重點。每場研討會，都有一位國際與台灣代表，台上講者與台下會員共同參與，群策群力，以示本次會議「全球在地化」之宗旨。
感謝遠道而來的貴賓，以及籌辦委員會，與所有幕後工作人員的辛勞。
最後敬祝 大會圓滿成功!
各位貴賓、先進、同仁 身體健康、萬事如意!
臺灣皮膚科醫學會理事長
楊志勛
Distinguished Guests and Fellow Colleagues:
"Glocalization" is a combination of globalization and localization, which implies "globalized thinking and localized action." Medical practice should be customized to accommodate local culture to achieve better outcomes.
Adopting tradition from previous meetings, the 3rd Taiwan Dermatology Aesthetic Conference (TDAC) and the Taiwanese Dermatological Association (TDA) Spring Meeting 2015, integrates Dermatology Science and Aesthetic medicine, meanwhile, offers a platform for ideas exchange between Taiwan and the world. The key discussion to this meeting features "acne, rosacea, atopic dermatitis, urticaria"for dermatology, and "injectables, liposuction and fat autograft, hyperhydrosis/osmidrosis"for aesthetic medicine. Both International and Taiwanese representatives will be allocated in each sessions, while audience were encouraged to fully participate in the discussion to demonstrate the objective of "Glocalization".
We value and appreciate the attendance of all participants and I wish to thank the organizers, and the staff who has dedicated their hard work for this event.
Finally, best wishes for a successful meeting.
President of Taiwanese Dermatological Association
Chih-Hsun Yang, M.D.
TABLE OF CONTENTS
即時口譯服務
大會禮聘蔣希敏老師之專業團隊全程即時口譯 請在會議室入口處索取耳機
01
理事長的話 WELCOME MESSAGE
籌備委員會 ORGANIZING COMMITTEE
編輯室報告 EDITORIAL
會議緣由 ABOUT TDAC
贊助單位 SPONSORS & EXHIBITORS
報到需知 GENERAL INFORMATION
免費接駁巴士 FREE SHUTTLE BUS
交通資訊 TRANSPORTATION
高雄展覽館 MEETING VENUE
平面圖 3F FLOOR PLAN
議程一覽 PROGRAM AT A GLANCE
演講摘要 SCIENTIFIC SESSIONS
SATURDAY, MAY 2
10:00-12:00 MERZ Forum (Preconference Meeting)
13:30-15:00 Toxins Forum (I)
UV, inflammation and Cancer Forum
Hair Forum
Cosmeceuticals Symposium
15:30-18:00
Toxin Forum (II)
Wound Care Forum
Face Sculpting and Lifting Symposium
IMCAS Session
Satellite Speeches
18:00-19:30
Welcome Reception and Gala Dinner
19:30-21:00
Injectable Workshop:
Liposculpting Symposium
Satellite Speeches: HIFU
SUNDAY, MAY 3
08:30-10:00
Anatomy Workshop
Acne and Rosacea Symposium (I)
Non-invasive Body Contouring
Skin Tumor Experts Meeting
Satellite Speeches: Intense Pulse Light and Pulsed Dye Laser
10:30-12:00
Injectable Workshop: How to Make an Elegant Nose
Acne and Rosacea Symposium (II)
Emerging Energy Based Devices Symposium:
Satellite Speeches: Body Contouring (I)
12:00-13:30
Lunch Symposia
13:30-15:00
Injectable Workshop: How to Make Charming Eyes
Urticaria Symposium
Osmidrosis Workshop
Special Lecture
Satellite Speeches
Pearl of Injectable Treatment -Tips and Tricks
Dye Laser and Picosecond laser
Toxin Forum (II)
Wound Care Forum
Face Sculpting and Lifting Symposium
IMCAS Session
Satellite Speeches
18:00-19:30
Welcome Reception and Gala Dinner
19:30-21:00
Injectable Workshop:
Liposculpting Symposium
Satellite Speeches: HIFU
SUNDAY, MAY 3
08:30-10:00
Anatomy Workshop
Acne and Rosacea Symposium (I)
Non-invasive Body Contouring
Skin Tumor Experts Meeting
Satellite Speeches: Intense Pulse Light and Pulsed Dye Laser
10:30-12:00
Injectable Workshop: How to Make an Elegant Nose
Acne and Rosacea Symposium (II)
Emerging Energy Based Devices Symposium:
Satellite Speeches: Body Contouring (I)
12:00-13:30
Lunch Symposia
13:30-15:00
Injectable Workshop: How to Make Charming Eyes
Urticaria Symposium
Osmidrosis Workshop
Special Lecture
Satellite Speeches
15:30-17:00
Injectable Workshop: How to Make Sexy Lips
Psoriasis Symposium
診所經營管理者論壇
Satellite Speeches: Body Contouring (II) and Injectable
特邀嘉賓 Invited Faculty
Pearl of Injectable Treatment -Tips and Tricks
Dye Laser and Picosecond laser
TABLE OF CONTENTS
8
ORGANIZING COMMITTEE
臺灣有超過半數的皮膚科專科醫師在基層執業，他們不但提供了舉世最佳的基層皮膚醫療服務，也運用最新的醫療技術，造福具有美容醫學需求的民眾。
這將是臺灣再次由基層皮膚科醫師，根據第一線醫師的臨床需求，設計議程與邀請國外貴賓，共同為提升臺灣臨床醫療品質而舉辦。我們期望在會議籌辦的過程，各位皮膚科先進能不吝提出建議，讓這次會議能因為專題演講、示範教學與會場展覽，更加提升臺灣皮膚科醫師執業能力。
我們選擇由高雄出發，結合許多本地的基層執業醫師的想法與力量，呈現臨床與美容皮膚醫學的最新學術新知。
謹代表籌備委員會，我們期待並歡迎您在2015年初夏到訪高雄。
臺灣皮膚科醫學會2015年春季學術研討會
第三屆臺灣皮膚科美容醫學學術研討會
籌備委員會 曾忠仁 許乃仁 王昭欽 王銘燦 黃柏翰 蔡仁雨
敬 邀
籌備委員會：
主辦單位：臺灣皮膚科醫學會
委員：王銘燦、黃柏翰、曾忠仁、蔡仁雨
秘書長兼財務長：許乃仁
副秘書長：王昭欽
編輯委員會：王昭欽、林尚宏、謝其娟
晚會主持：李建儀、高珮菡
醫學會理事長：楊志勛
醫學會秘書長：王偉銘
顧問：王正坤、王德華、朱家瑜、吳介山、吳育弘、李婉若、林長熙、張英睿、張雅菁、張雲亭、陳怡如、陳國熏、黃禎憲、彭賢禮、楊國材、趙曉秋、蔡呈芳、蔡秀欣、 蔡高頌
會務秘書：林佳蓉、羅敏君、邵盈嘉、鄭雅方
ORGANIZING COMMITTEE
Organizing Committee
Organizer: Taiwanese Dermatological Association
Chair: Ming-Tsan Wang MD MOH, Po-Han Huang MD, Chung-Jen Tseng MD, Ren-Yeu Tsai MD
Secretary-Treasurer: Nai-Jen Hsu MD
Deputy Secretary General: Chao-Chin Wang MD
Program Editors: Chao-Chin Wang MD, Shang-Hong Lin MD, Chi-Chuan Hsieh MD
Gala Dinner Hostess: Jennifer C.Lee MD, Pei-Han Kao MD
President of TDA: Chih-Hsun Yang MD
Secretary General of TDA: Wei-Ming Wang MD PhD
Consultants: Cheng-Kun Wang MD, Tak-Wah Wong MD, Chia-Yu Chu MD PhD, Chieh-Shan Wu MD, Yu-Hung Wu
MD, Woan-Ruoh Lee MD PhD, Chrang-Shi Lin MD, Ying-Jui Chang MD PhD, Ya-Ching Chang MD,
Yun-Ting Chang MD PhD, Yi-Ju Chen MD PhD, Gwo-Shing Chen MD PhD, Jhen-Sian Huang MD,
Hsien-Li Peng MD, Kuo-Chia Yang MD, Sheau- Chiou Chao MD, Tsen-Fang Tsai MD, Hsiou-Hsin
Tsai MD,Kao Sung Tsai MD
Conference Secretaries: Chia-Jung Lin, Min-Jyun Luo, Yin-Chia Shao,Ya-Fang Cheng
There has been more than half of dermatologists running their own clinics in Taiwan. They offer one of the best dermatology care services in the world for local community. In addition, they are also practicing with newest techniques for patients with aesthetic demands.
Local practicing dermatologists are proud to support Kaohsiung to act as host city for the staging of the Taiwanese Dermatological Association Spring Meeting in 2015 and the 3rd Taiwan Dermatology Aesthetic Conference (TDAC) to present the latest information on medical and aesthetic dermatology.
On behalf of the Organizing committee, we look forward to welcoming you to Kaohsiung in 2015.
TDA Spring Meeting 2015 and the 3rd TDAC Organizing Committee:
Chung-Jen Tseng MD, Director, Beautyland Medical Cosmetic Center
Nai-Jen Hsu MD, Director, Hsu Nai-Jen Dermatological Clinic
Chao-Chin Wang MD, Director, Tainan Vigor Dermatological Clinic
Ming-Tsan Wang MD MOH, Director, Taiwanese Dermatological Association
Po-Han Huang MD, Executive Director, Taiwanese Dermatological Association
Ren-Yeu Tsai MD, Associate Professor, Taipei Medical University
ORGANIZING COMMITTEE
10
EDITORIAL
自己的會議，自己打造！
一本去年的初衷，我們堅信一個成功的會議，不該是單方面的聽講，而是由各方與會精英一同成就的。
大會提供最頂尖的講者、最深入的主題、最高水準的場地，另一方面還需要更多與會者的加入，讓知識成為真正的力量。今年大會更向前邁進一步，提出「「自己的會議，自己打造」的概念，在大會臉書粉絲團與討論區中廣徵各方意見，希望透過與會者好的想法、腦力激盪，一起打造一個屬於大家的理想會議。
籌備委員會廣邀國際級講者來台，今年共有68位國內外講者，近百場專題演講，為台灣醫界帶來最尖端的醫學新知。希望這個會議在作為一個知識傳遞的媒介之外，還能作為台灣醫界跨科別的交流、與國際專家接軌、與業界共存共榮的平台。本次大會手冊有充分的留白，讓它同時成為您的筆記本。會議期間還是會有不同的驚喜活動與大獎，敬請期待，也歡迎您的參與。會後全課程的線上評量讓您為台上的講者打分數；您會後的心得可以讓更多的朋友一起分享感動，還有機會把大獎贏回家。
「...會議曲終人散時，我們不只行囊滿滿，資訊滿滿，心中的暖意也和高雄的氣溫一樣，溫熱融融。」我們很開心去年與會的鄭愷平醫師為她去年的參與留下了這一段註腳。您可以用各種不同的角度來看待這場春季的盛宴：是學術的交會、是老友情感的交流、是業界資訊的匯集，甚至可以是闔家出遊的機會。
我們堅信這場國際級的會議讓您在學術上不需要捨近求遠。至於享用這場春季盛宴的方式，由您來決定。在溫暖的南臺灣，我們期待您的參與，激起更璀璨的火花。
It is not the speakers but the attendees who play the leading role of a conference. The organizing committee works hard to organize the world-class faculty and to create the best harmony between science and art, academics and professionals. And we believe that the faculty will bring up the most cutting-edge knowledge of their specialties for all the attendees. However, the conference won’t succeed without you taking part. We invite you to join us for the lively events during the conference and meet the experts and colleagues through the networking opportunity. You may also follow us on Facebook for the most updated news. Wish you a fantastic meeting experience in Kaohsiung.
Facebook page: https://www.facebook.com/tdacmeeting for all the ongoing events of TDAC Facebook group: http://goo.gl/ZR9b5T join for all the prize-winning opportunities
Chao-Chin Wang MD, Chi-Chuan Hsieh MD, Shang-Hong Lin MD
Editors, 3rd TDAC Publishing
Chih-Hsun Yang MD
President of Taiwanese Dermatological Association
Conference Secretary: Yin-Chia Shao
EDITORIAL
臉書粉絲團 https://www.facebook.com/tdacmeeting
好康好玩的都在這裡，記得按讚
臉書討論區 http://goo.gl/ZR9b5T
想拿大獎，加入就對了
第三屆臺灣皮膚科美容醫學學術研討會
編輯委員 王昭欽 謝其娟 林尚宏
理事長 楊志勛
會務秘書 邵盈嘉 謹識
11
EDITORIAL
12
美容皮膚醫學，乃是植基於皮膚生理學、皮膚病理學、臨床診斷學、皮膚治療學、皮膚外科學，將科學與美學結合的產物。由於嚴格的專科醫師訓練制度，讓皮膚科醫師能輕易地診斷皮膚的狀態，再利用最新的治療技術，完美地與型態美學結合，讓皮膚科專科醫師擁有與其他科別醫師更全面而獨特的增進皮膚的健康與美感的能力。
然而隨著醫療科技的進展，更精確的評估方法、創新的生物醫材與先進的治療儀器的發明，皮膚科醫師雖早已能善用自己對於皮膚狀態診治的優勢，提供更好的醫療服務，但臺灣皮膚科醫學會身為國內最大美容醫學領域之署定專科醫學會，有責無旁貸的義務，提供除了皮膚科醫師以外有志於美容醫學領域的醫界同仁進修的管道，全面提升臺灣美容醫學水準。除將提升國人皮膚健康與型態美學醫療水準外，也希望導正國內非專業當道的"醫美亂象"，因此舉辦臺灣皮膚科美容醫學學術研討會，讓有志於此新興領域的各界同好能齊聚一堂進行研習與討論。
臺灣皮膚科美容醫學學術研討會將提供國際頂尖專家互動交流、現場示範教學、臨床醫學美容醫學兼具的自由選擇多元教育課程，以提升國內與區域國家皮膚美容醫學水準，貢獻醫學繼續教育，提供臨床研究與專家經驗的交流園地。
About TDAC
Aesthetic dermatology is a combination of skin physiology, skin pathology, clinical diagnosis, skin therapeutics and skin surgery. It is a marriage of science and aesthetics. Doctors can easily diagnose the status of skin and its problems due to the intensive and strict training programs for specialized dermatologists. By combining the most advanced
therapeutic technique with precise aesthetic concept it allows dermatologists to enhance the health of skin and its beauty.
A dermatologist can achieve his/her best skin care medical practice by combining the progress of medical technology along with more precise diagnostic methods, innovative biological medical device and invention of advanced therapeutic equipment. However, Taiwanese Dermatological Association, the largest and prestigious aesthetic
medical society in Taiwan, has the obligation to provide the physicians other than dermatologists to pursuit the knowledge of the aesthetic medicine in order to enhance the quality of care to a higher level. Not only do we hope to elevate the health of skin and the aesthetic standard of our people but we also hope to correct the chaos of other
non-specialized doctors who are taking charge of most of the aesthetic medicine in Taiwan.
Therefore, conducting a Taiwan Dermatology Aesthetic Conference (TDAC) will allow physicians who are interested in this new medical field further learning and discussion. This symposium will provide the best international experts with interactions, live demonstrations and varies choices of clinical aesthetic dermatology learning courses. It is our goal to enhance the standard of our national aesthetic dermatology as well as to contribute
to the continuation and the growth of medical education and to become an exchange corner of clinical researches and expert experiences.
ABOUT TDAC
About TDAC
13
LOGO Designer
Prof Wang I-Hsuan Cindy
TDAC Logo Design Concept
Line : 線條 代表臺灣各地皮膚專科精英
Red Dot : 紅點 臺灣皮膚科美容醫學學術研討會
Vision : 科技 / 美學 / 提升臺灣美容醫學水準
Vision is positioned ourselves as the market leader for aesthetic dermatology
and cosmetic procedures. It's characterized as a simple and humble solution to
maintaining good health; hopes to bring joy and improve lifestyle.
School of Art, Design and Media, College of Humanities, Arts, & Social Sciences, Nanyang Technological
University, Singapore
1.2010年獲7項國際最具指標性視覺設計競賽類大獎
2.亞洲最具影響力設計金獎
3.美國ADC
4.One Show Design
5.德國紅點Reddot
6.德國 iF
7.台灣金蝶獎
Prof Cindy Wang is currently in the School of Art, Design and Media; she joined as an Assistant Professor of Visual Communication in 2007. Cindy holds a BFA from the School of Visual Art and a MA in New York University (NYU), Dept. of Graphic Communication Management & Technology.
Cindy's research focuses on use various principles and elements of graphic design, and combining with modern printing techniques to enhance visual communications. One of the key findings of her research was how to use illusions to further stimulate the visual expression of an artwork. The research revolves around the utilization of illusions and modern printing technologies to create new, innovative and unique illustration of visual presentation.
On the other hand, Cindy also research on type forms that combines elements of Asia and Western typography is innovative from as Asian perspective and meaningful as bridge between East and West. This fusion typography is gathering tremendous interest across the globe and her work in this area establishes her as a pioneer in this exciting
new area of design research. She has been successful in securing research grants to support her work.
Cindy's reputation is more and more well known on both international and national level. She has been prolific in publishing five books on her research themes, won numerous international awards and with numerous of exhibitions locally and internationally. All these awards are only honored to highly talented designer from Hong Kong, New York, and Germany. This explains that Cindy's creativity, talents, and ability are recognized throughout
the continents of Asia, North America, and Europe.
About TDAC
14
鑽石級贊助商
新加坡商莫氏亞太有限公司台灣分公司
法國高德美大藥廠
台灣諾華股份有限公司
博而美國際股份有限公司
沃醫學有限公司
德瑪凱股份有限公司
白金級贊助商
海喬國際股份有限公司
新加坡商美納里尼醫藥有限公司台灣分公司
裕利股份有限公司
欣美生醫股份有限公司
曜亞國際股份有限公司
友華生技醫藥股份有限公司
博士倫股份有限公司
慶安生醫科技股份有限公司
聯發生技美學有限公司
金級贊助商
臺灣萊雅股份有限公司
愛迪亞生醫股份有限公司
森田生醫股份有限公司
八億實業股份有限公司
萊亞實業股份有限公司
優擎科技有限公司
億鑫國際股份有限公司
恆旺國際有限公司
綺麗生技有限公司
妮傲絲翠股份有限公司
傑出美國際有限公司
泰合生技藥品股份有限公司
美商思爾提克 Zeltiq
永信藥品工業股份有限公司
惠民製藥股份有限公司
澳洲意高大藥廠
巴爾桑波有限公司
美商亞培股份有限公司台灣分公司
嬌生股份有限公司
一般贊助商
膠原科技股份有限公司
杏輝藥品工業股份有限公司
德實科技有限公司
德星有限公司
奇瑩國際有限公司
傳羚國際貿易有限公司
晨欣國際有限公司
長杏股份有限公司
美科實業有限公司
呈汝生物科技有限公司
衡奕精密工業股份有限公司
可若夫生物科技有限公司
力大圖書有限公司
高一藥品股份有限公司
IMCAS
台灣資生堂股份有限公司
科懋生物科技股份有限公司
歐強國際有限公司
SPONSORS & EXHIBITORS
報名截止日:
1.優先註冊費：即日起至4/19
2.4/19線上報名截止，請至大會現場報名。
報到作業事項:
1.請持使用身份證, 健保卡或其他有相片之證件進行
報到作業。
5/2報到時間 : 09:00~19:00
5/3報到時間 : 08:00~13:30
2.報到地點：高雄展覽館(806高雄市前鎮區成功二
路39號)一樓大會報到櫃檯。
出入管制:
出入會場一律配掛識別證。 與會者依身份別與是否
預訂活動，於進入各講堂或活動地點前，以識別證
確認身份，始得進入。
各項繼續教育學分：
參加證明需於會後上網填寫課後問卷完成後，得自
行列印。
皮膚科專科繼續教育積分：二十四點
台灣整形外科醫學會積分：B類積分15分
公務人員終身學習護照：十二小時
美容醫學教育訓練聯合委員會認證時數：申請中
用餐須知:
大會迎賓晚宴訂於5/2星期六下午18:00-19:30，地點
位於三樓301B會議室。 晚宴後仍有學術演講緊接著
登場。
5/3星期日午餐時間，除了有四場學術午餐活動同時
進行外(詳情請見會議議程)，本次特於大會會場三
樓增設用餐交誼專區。
費用:
1.因辦理會議之必要成本，若為個人因素不克前往
會議者，恕不退費。
2.若因天災等不可抗力因素取消會議，已繳費之與
會者，將由主辦單位臺灣皮膚科醫學會辦理全額
退費。
大會禁止事項:
演講進行時，全程禁止錄影、攝影、錄音。
會議設備:
會議期間，開放Wi-Fi免費無線上網。
17
General Information
Welcome to TDA Spring Meeting 2015 and 3rd TDAC!
Here are some important notices for you.
Please keep your badge at hand throughout the conference.
Attendees without registration badges will not be granted entry.
Pre-registration is strongly recommended as space is limited.
Those who have not completed advanced registration online may proceed to the On-Site Registration Desk at KEC
for registration.
The On-Site Registration Desk locate on the first floor of KEC (near the East Gate).
Office hour:
May 2 (Sat): 09:00~19:00
May 3 (Sun): 08:00~13:30
Photo identification will be required for registration.
Official Language
The official languages of TDAC 2015 are English and Mandarin. All seminars are in English unless otherwise
specified.
Simultaneous interpretation is available for all but satellite sessions.
Lunch and Dinner
The Gala Dinner will be held in Room 301B from 18:00 to 19:30 on May 2. Night sessions ensue after the Gala
Dinner. In addition to the luncheon symposia from 12:00-13:30 on May 3, the attendees who do not attend the
luncheon symposia may enjoy Chinese lunch boxes in the dining area. Vegetarian lunch boxes are also available.
Please specify your lunch option during registration.
Speaker Ready Room
The Speaker Ready Room will be open during the meeting.
Free Wi-Fi Service
Complimentary Wi-Fi service is available at KEC during the meeting.
No Photo Policy
Any form of photographing, video or audio recording is prohibited during the lectures.
Staff
The conference is organized by Taiwan Dermatological Association. For further information, please feel free to
contact the Office of TDA by
Phone at +886-2-25185127
Email at derma.email@msa.hinet.net
18
免費接駁專車（20人座中巴）
上車地點:展覽館東門入口
接駁路線
高雄展覽館 →捷運三多商圈站3號出口（靠中山路）（停５分鐘） → 漢來飯店 （新田路側門）
→ 國賓飯店 （大門慢車道處）→ 高雄展覽館（停５分鐘）
Route：Meeting Venue (KEC) → MRT R8 Sanduo Shopping District (Exit No 3) (stop 5 mins)
→ Grand Hi-Lai Hotel → Ambassador Hotel Kaohsiungl → Meeting Venue (KEC) (stop 5 mins)
FREE SHUTTLE BUS
Free Shuttle Bus
日期接駁時間發車頻率
末班車21:30
(高雄展覽館發車)
每15分鐘
每20-30分鐘
5/2 (六)
尖峰時段
離峰時段
5/3 (日)
09:30-21:30
09:30-11:30
13:00-15:00
19:30-21:30
末班車18:00
(高雄展覽館發車)
每15分鐘
每20-30分鐘
尖峰時段
離峰時段
07:30-18:00
07:30-09:30
11:30-13:30
15:00-18:00
Date / Day
May 2, Sat
Peak
Off-peak
May 3, Sun
Hours of Service Frequency
Last departure
from KEC at 21:30
15 min
20-30 min
Peak
Off-peak
Last departure
from KEC at 18:00
15 min
20-30 min
09:30-21:30
09:30-11:30
13:00-15:00
19:30-21:30
07:30-18:00
07:30-09:30
11:30-13:30
15:00-18:00
19
FREE SHUTTLE BUS
Free Shuttle Bus
KEC
展覽館
R8 MRT
Hi-Lai
Ambassador
漢
國
20
高雄展覽館座落亞洲新灣區樞紐位置，交通便捷，四通八達。
飛機-高雄小港國際機場
小港國際機場 → 轉乘捷運至三多商圈站 → 步行約10分鐘即可抵達
高鐵
台北至高雄僅需 1.5 小時
1.自左營高鐵站開車約20分鐘即可抵達
2.自左營高鐵站轉乘捷運至三多商圈站(15分鐘) → 步行約10分鐘即可抵達
火車
高雄火車站轉乘捷運至三多商圈站 (5分鐘) → 步行約10分鐘即可抵達
捷運
三多商圈站.3 號出口→步行約10分鐘即可抵達
自行開車-中山高速公路
北上：中山高國道一號→中正交流道下→沿中正路直行至中華路左轉→中華四路直行至四維路右轉→
四維四路直行至成功路左轉→直行成功二路→抵達
南下：中山高國道一號→高雄端/中山路出口下交流道→右轉中山四路直行至新光路左轉→成功二路左轉→抵達
市區公車
1. 168(環狀幹線) 至高雄展覽館站
2. 紅21(建軍站←→新光路口) 至高雄展覽館站
停車資訊
高雄展覽館B1停車場：汽車：40元 / 小時 機車：40元 / 每次
新光公有停車場：小型車30元 / 小時、大型車 60 元 / 小時
大會接駁車
三多捷運站→漢來飯店→國賓飯店→高雄展覽館 (定時循迴接駁)
KEC is located at the hub of the Kaohsiung Asian New Bay Zone and is easily reachable by air, sea, and land
transportation, including high-speed rail from Taipei and other cities in North Taiwan. Free shuttle transportation
will be provided during the meeting.
Kaohsiung International Airport
Direct flights from over 40 major Asian cities.
High Speed Rail
High Speed Rail connects from Taipei in 1 and half hour. Terminal stop is Kaohsiung is Zuoying Station:
(1) Taxi ride: 20 min to KEC
(2) Kaohsiung Rapid Transit to Sanduo Shopping District: 10 min walk to KEC
Kaohsiung Rapid Transit
Sanduo Shopping District Station (Exit No.3) : 10 min walk to KEC
National Freeway
10 minutes drive from National Freeway No.1.
Kaohsiung Buses
1. 168
2. Red 21
Shuttle
MRT R8 Sanduo Shopping District→ Grand Hi-Lai Hotel→ Ambassador Hotel Kaohsiung→Meeting Venue (KEC)
TRANSPORTATION
TRANSPORTATION
21
MEETING VENUE
高雄展覽館
806高雄市前鎮區成功二路39號
於2014年4月全新落成的高雄展覽館(KEC)位於高雄港亞洲新灣區中心，交通位置優越，氣候舒適怡人。
展覽館的整體造型設計結合了河流、海洋、船帆與港灣的意象，塑造波浪的屋頂造型，與城市的自然美景緊
密相容，表現出高雄特有的水色山光、優雅的港灣和海洋的波浪，是高雄水岸的新地標。
展覽空間包含室內與戶外展場，會議空間大小皆備，最多可容納4,000人，約1,500個標準攤位。
Kaohsiung Exhibition Center (KEC)
No.39, Chenggong 2nd Rd, Qianzhen District, Kaohsiung 806, Taiwan
Kaohsiung Exhibition Center (KEC) is nestled in Kaohsiung, Taiwan. This business exhibition center opened
in April 2014. The center has a total floor area of 67,000m2, which can accommodate 1,424 exhibition booths
and different meeting room sizes suitable for up to 4,000 people. It provides a place for holding international
conferences and trade shows. The exhibition center boasts of its multifunctional and flexible areas and of its
capability to host different kinds of events, making it a perfect venue to host 3rd TDAC and TDA Spring Meeting
2015.
MEETING VENUE
Scientfic Program 22
3F FLOOR PLAN
3F FLOOR PLAN
Scientfic Program
23
Scientfic Program 24
SCIENTIFIC SESSIONS
SATURDAY, MAY 2
10:30-12:00
MERZ Forum (Preconference Meeting)
Physician Only
Lecturing in English
Lecturing in Chinese
Simultaneous Interpreting
Medical Dermatology
Dermatological Surgery
Engergy-based Devices
Injectables
Staff Training
SCIENTIFIC SESSIONS 28
MF1 Pharmacology and Immunlogy of
Botulinum Toxin
Speakers FREVERT, Jürgen PhD
Moderator CHANG, Li-Yen (張立言) MD
TSENG, Chung-Jen (曾忠仁) MD
Botulinum neurotoxin injections are a valuable
treatment modality for many therapeutic indications
and have revolutionized the field of aesthetic
medicine so that they are the leading cosmetic
procedure performed worldwide. Studies show that
onabotulinumtoxinA (Botox), abobotulinumtoxinA
(Dysport) and incobotulinumtoxinA (Xeomin)
are comparable in terms of clinical efficacy and
safety. Differences between the products relate to
the botulinum neurotoxin protein composition
(complexes), specific biological potency, and their
immunogenicity. Protein complex size and molecular
weight have no effect on biological activity, stability,
spread of the neurotoxin in the body or side effect
profile. Complexing proteins can activate dendritic
cells and increase the risk of neutralizing antibody
formation, which can cause secondary treatment
failure. These attributes could lead to differences in
therapeutic outcomes, and given their widespread
aesthetic use physicians should be aware of how the
three neurotoxin products differ to ensure their safe
and effective use.
SATURDAY, MAY 2
MERZ Forum
Sat. May 2, 10:00~12:00
Room 301A
Moderator CHANG, Li-Yen (張立言) MD
TSENG, Chung-Jen (曾忠仁) MD
MF1 Pharmacology and Immunlogy of
Botulinum Toxin
10:00 / FREVERT, Jürgen PhD
MF2 Crafting Predictable Aesthetic
Outcomes with HA Filler Technology
10:35 / PRASETYO, Adri Dwi MD
MF3 Combination Therapy Using
Ulthera and Radiesse
11:10 / CHAO, Yates Yen-Yu (趙彥宇) MD
11:45 Discussion
SCIENTIFIC SESSIONS
29
MF2 Crafting Predictable Aesthetic
Outcomes with HA Filler Technology
Speaker PRASETYO, Adri Dwi MD
Moderator CHANG, Li-Yen (張立言) MD
TSENG, Chung-Jen (曾忠仁) MD
The use of injectable fillers for soft tissue
augmentation has gain worldwide popularity. With
regards of the value of volumetric enhancement in
achieving a more aesthetic appearance, as well as the
minimal downtime and predictable results, a new
hyaluronic acid (HA) filler technology is introduced.
As there is no single injectable filler that has all of the
desired characteristics, understanding the advantages
and disadvantages of one filler over another is
extremely helpful in guiding the patient to an informed
decision. Knowledge of the specific properties of HA
fillers may help physicians in choosing the appropriate
HA filler for facial rejuvenation and beautification.
This, together with appropriate injection training and
experience, should lead to results that ultimately will
benefit patients.
MF3 Combination Therapy Using Ulthera
and Radiesse
Speaker CHAO, Yates Yen-Yu (趙彥宇) MD
Moderator CHANG, Li-Yen (張立言) MD
TSENG, Chung-Jen (曾忠仁) MD
This section of lecture covers the subjects of
1.Principles of facial reshaping.
2.Advanced Ultherapy treatment technique.
3.Noval concepts of Radiesse skin boosting.
4.Different roles of Radiesse filler and Ulthera for
rejuvenation.
5.Different roles of Radiesse filler and Ulthera for
recontouring.
6.Practical combination of Radiesse and Ultherapy.
Coffee Break
Coffee Break
May 2, Sat 15:00-15:30
May 3, Sun 10:00-10:30
May 3, Sun 15:00-15:30
RM305
and Exhibit Hallway
14
SCIENTIFIC SESSIONS SCIENTIFIC SESSIONS
SATURDAY, MAY 2
Physician Only
Lecturing in English
Lecturing in Chinese
Simultaneous Interpreting
Medical Dermatology
Dermatological Surgery
Engergy-based Devices
Injectables
Staff Training
13:30-15:00
Toxin Forum (I)
UV, inflammation and Cancer Forum
Hair Forum
Cosmeceuticals Symposium
15:30-18:00
Toxin Forum (II)
Wound Care Forum
Face Sculpting and Lifting Symposium
IMCAS Session
Satellite Speeches
SCIENTIFIC SESSIONS
31
SATURDAY, MAY 2
Toxin Forum (I)
Sat. May 2, 13:30-15:00
Room 301A
Moderator HUANG, Po-Han (黃柏翰) MD
CASSUTO, Daniel MD
TF1 Facial Danger Zones During Toxin
Injection
13:30 / JUNG, Wonsug MD, PhD
/ MOON, Hyoung-Jin MD
TF2 The Solution of Dilemma Injection
in Toxin Treatments
14:30 / CASSUTO, Daniel MD
TF1 Facial Danger Zones During Toxin
Injection
Speaker JUNG, Wonsug MD, PhD
MOON, Hyoung-Jin MD
Moderator HUANG, Po-Han (黃柏翰) MD
CASSUTO, Daniel MD
Botulinum toxin, which has seen increasing popularity
in the field of esthetic surgery over the years, is a
neurotoxin secreted by bacteria called Clostridium
botulinum and is found in canned foods. Botulinum
toxin paralyzes the muscle by blocking the secretion of
a neurotransmitter called acetylcholine at the terminal
part of neuromuscular synapse. There are many types
of botulinum toxin such as A, B, C, D, E, F, G etc.,
but the ones for medical use are types A and B, and in
particular, type A is most commonly used. Botulinum
toxin is used for the treatment of muscular diseases
such as torticollis, strabismus, spastic dysphonia etc
but it is also widely used for esthetic purposes such as
treatment of wrinkles and square jaw. Botulinum toxin
can only be successfully performed if the surgeon has
a good understanding of facial anatomy and is able to
select the appropriate product for his purposes.
Anatomically, the face is the most complicated
structure of the human body. Especially, the structure
of facial muscles including nerves and vessels is very
variable and has the racial differences. Recently,
the importance on the facial anatomy has been
reconsidered as the interest on the facial aesthetics is
increasing. The aesthetic physicians should understand
the anatomy of the facial musculature. So I want
to introduce the anatomy oriented technique with
botulinum injection.
SCIENTIFIC SESSIONS 32
TF2 The Solution of Dilemma Injection
in Toxin Treatments
Speaker CASSUTO, Daniel MD
Moderator HUANG, Po-Han (黃柏翰) MD
CASSUTO, Daniel MD
.
高爾夫球賽
SATURDAY, MAY 2
GOLF Tournament
Time：Registration： 9：10 AM Tee-off：9:30 AM
Venue: Kaohsiung Golf Course
270, Qiu-Chang Rd. Da-Hua Li, Niao-Song District, Kaohsiung City
Tel：07-370-1101
Fee：Green fee and caddy fee on own.
Qualification：Members of TDA, and the attendee of 3rd TDAC
Registration：(Due April 25th, 2015)
Organizer：Mark Ming-Long Hsu
Tel：+886 921-290-364
E-mail：molly19790829@gmail.com (黃小姐 Miss Huang)
比賽時間：上午9時10分報到 9時30分開球（四人一組）
地點：高雄高爾夫球場(高雄市鳥松區大華里球場路270號 )
召集人：許明隆醫師
08
SATURDAY, MAY 2
Toxin Forum (I)
Sat. May 2, 13:30-15:00
SCIENTIFIC SESSIONS
33
SATURDAY, MAY 2
UV, Inflammation and Cancer Forum
Sat. May 2, 13:30-15:00
Room 301B
Moderator CHANG, Chung-Hsing (張中興) MD, PhD
LIU, Fu-Tong (劉扶東) MD, PhD
UV1 UV Pathways and Responses in Skin
Physiology and Carcinogenesis
13:30 / FISHER, David MD, PhD
UV2 At the Crossroad of Inflammation,
Senescence and Cancer
14:15 / BEN-NERIAH, Yinon MD, PhD
UV1 UV Pathways and Responses in Skin
Physiology and Carcinogenesis
Speaker FISHER, David MD, PhD
Moderator CHANG, Chung-Hsing (張中興) MD, PhD
LIU, Fu-Tong (劉扶東) MD, PhD
Skin cells are notable for their extensive intercellular
communication, which regulates numerous
physiologic aspects of skin as an organ. The control
of pigmentation represents one of the most important
regulators of skin carcinogenesis as well as photoaging.
Recent studies have helped to elucidate fundamental
processes which regulate melanocyte development
as well as molecular pathways controlling adaptive
pigmentary responses. The induction of pigment by
UV radiation (“tanning”) has been found to involve
cross-talk between keratinocytes and melanocytes.
This pathway involves the induced synthesis of
multiple biologically active peptides, some of which
appear to stimulate behavioral effects, such as sunseeking
(UV-seeking) behaviors via cutaneous
synthesis of beta-endorphin. Additionally, the roles of
certain pigments, particularly red/blond pheomelanins,
has suggested several mechanisms through which
they increase skin cancer risk. Pathways regulating
their synthesis as well as the molecular mechanisms
through which they modulate melanoma risk, will be
discussed.
SCIENTIFIC SESSIONS 34
UV2 At the Crossroad of Inflammation,
Senescence and Cancer
Speaker BEN-NERIAH, Yinon MD, PhD
Moderator CHANG, Chung-Hsing (張中興) MD, PhD
LIU, Fu-Tong (劉扶東) MD, PhD
Inflammation has many faces, most commonly
observed as an acute reaction in response to pathogen
or another insult, or a chronic phase, accompanying
chronic infection and chronic remittent inflammatory
disease, such as inflammatory bowel disease. Yet,
there is another type of smoldering inflammation,
which is harder to notice or monitor; it is called
parainflammation and appears to underlie some
of the major human diseases, cancer, diabetes type
2 and certain neurodegenerative diseases1. We
have developed mouse models of cancer based on
inducible CKI knockout, which exhibit smoldering
inflammation, and demonstrate how a low grade,
infiltrate-free inflammatory reaction to persistent
DNA damage response translates to an aberrant
growth2. To that end we determined the inflammatory
repertoire of the knockout mice, demonstrated its
association with cellular senescence and showed how
in the absence of p53, a senescence-inflammatory
response (SIR) is converted from a growth inhibitory
to growth promoting mechanism, both in vitro
and in vivo3. Anti-inflammatory reagents capable
of blocking SIR prevent carcinogenesis in mutant
mice. Our studies may explain the anti-carcinogenic
effects of non-steroidal anti-inflammatory drugs in
human cancer patients4. We will discuss mechanisms
and potential therapeutic effect of inducing
parainflammation in cancer, including melanoma.
1.Medzhitov, R. Origin and physiological roles of
inflammation. Nature 454, 428-35 (2008).
2.Elyada, E. et al. CKIalpha ablation highlights a
critical role for p53 in invasiveness control. Nature
470, 409-13 (2011).
3.Pribluda, A. et al. A senescence-inflammatory
switch from cancer-inhibitory to cancer-promoting
mechanism. Cancer Cell 24, 242-56 (2013).
4.Chan, A.T., Ogino, S. & Fuchs, C.S. Aspirin use and
survival after diagnosis of colorectal cancer. JAMA
302, 649-58 (2009).
SATURDAY, MAY 2
UV, Inflammation and Cancer Forum
Sat. May 2, 13:30-15:00
SCIENTIFIC SESSIONS
35
SATURDAY, MAY 2
Hair Forum
Sat. May 2, 13:30~15:00
Room 304A
Moderator CHEN, Chien-Hsun (陳建勳) MD
TSAI, Ren-Yeu (蔡仁雨) MD
HF1 Patient Selection for Hair
Transplantation and Training a Hair
Transplant Team
13:30 / AVRAM, Marc R. MD
HF2 Robotic Follicular Unit Extraction
14:15 / AVRAM, Marc R. MD
HF1 Patient Selection for Hair
Transplantation and Training a Hair
Transplant Team
Speaker AVRAM, Marc R. MD
Moderator CHEN, Chien-Hsun (陳建勳) MD
TSAI, Ren-Yeu (蔡仁雨) MD
The risk/benefit of elliptical donor harvesting vs.
robotic follicular unit extraction will be discussed and
reviewed. Appropriate candidate selection, anesthesia,
hairline design for men and women, instrumentation,
corrective surgery and future trends will be discussed.
Pre-conference: MERZ Forum May 2, Sat 10:00-12:00
Perhaps You Missed the Special Events!
03(2014手冊P.104是海喬的廣告)
SCIENTIFIC SESSIONS 36
HF2 Robotic Follicular Unit Extraction
Speaker AVRAM, Marc R. MD
Moderator CHEN, Chien-Hsun (陳建勳) MD
TSAI, Ren-Yeu (蔡仁雨) MD
Over the past twenty years, there has been
revolutionary changes in techniques in hair
transplantation. Men and women should consistently
receive naturally appearing transplanted hair. This
session will provide an overview of state of the art
techniques.
SATURDAY, MAY 2
Hair Forum
Sat. May 2, 13:30~15:00
SCIENTIFIC SESSIONS
37
SATURDAY, MAY 2
Cosmeceuticals Symposium
Sat. May 2, 13:30-15:00
Room 304B
Moderator CHIU,Pin-Chi (邱品齊) MD, MBA
SCHWARZ, Thomas MD, PhD
CS1 Whitening Cosmetic Development
and Claim Substantiation
13:30 / SATO, Kyoshi M Agr Sc
CS2 Claim Substantiation within Sun
Protection Products
14:00 / SCHWARZ, Thomas MD, PhD
CS3 我國化粧品管理現況與未來方向
14:30 / Yie, Mon-I (葉孟宜) Phar D
CS1 Whitening Cosmetic Development
and Claim Substantiation
Speaker SATO, Kyoshi M Agr Sc
Moderator CHIU,Pin-Chi (邱品齊) MD, MBA
SCHWARZ, Thomas MD, PhD
Skin lightening products which give lighter skin tone
or an even skin complexion are very popular especially
in Asian countries. In Japan, skin lightening products
are categorized in quasi-drugs which are defined as
cosmetic products that have moderate pharmacological
activity and contain active ingredients approved by
Japanese Ministry of Health, Labor and Welfare. Now
approximately twenty ingredients are used as active
skin lightening ingredients in Japanese cosmetic
market.
Skin lightening ingredients having different types of
mechanisms exist. The most common target of skin
lightening ingredients is tyrosinase in melanocytes.
Arbutin is known as a tyrosinase inhibitor. It inhibits
tyrosinase by competing with L-tyrosine, which
is a substrate of tyrosinase, at the active biding site
of tyrosinase. Kojic acid, which is also known as
a tyrosinase inhibitor, chelates copper needed for
tyrosinase to exert its activity. Magnolignan controls
tyrosinase activity inside melanocytes in a different
way. It inhibits the maturation of tyrosinase and
reduces the amount of tyrosinase in melanosomes.
Tranexiamic acid and chamomilla extract are
the different type of skin lightening ingredients.
Melanogenesis in melanocytes is much influenced by
mediators released from keratinocytes. The ingredients
reduce melanogenesis by controlling keratinocytederived
mediators to stimulate melanogenesis.
In my presenation, active skin lightening ingredients
approved in Japan will be introduced and their results
of human test will be shown.
SCIENTIFIC SESSIONS 38
CS2 Claim Substantiation within Sun
Protection Products
Speaker SCHWARZ, Thomas MD, PhD
Moderator CHIU,Pin-Chi (邱品齊) MD, MBA
There is no doubt about the benefit of sun protection.
Sunscreens are not the only but certainly a very
important tool to limit the adverse effects of UV rays.
The major aim of UV protection is the prevention
of DNA damage since DNA damage is the major
molecular mediator of chronic sun damage which
includes development of skin cancer, premature skin
ageing and pigment disorders. The most frequently
used method to measure the UVB filtering capacity
is the determination of the minimal erythema dose.
This method is quite well standardized (application
volume: 2 mg/cm²). UVB-induced erythema is
used as a surrogate marker for UVB-induced DNA
damage, since the erythema action spectrum and
the DNA damage action spectrum are quite similar.
However, they are not identical. Hence, methods are
developed which allow the direct measurement of
DNA damage. This, however, cannot be done in vivo
since biopsies would be required. An alternative is
the in vitro exposure of cultured keratinocytes or skin
equivalents to UV radiation in the absence or presence
of filter substances. In this setting DNA damage can
be directly measured. In addition, with this method
other read out systems can be utilized which includes
immunofluorescence, FACS analysis, multiplex
ELISA and PCR. P53 is another read-out candidate
since the increase in the expression of p53 correlates
quite well with the amount of DNA damage. P53
has been recently shown to play a crucial role in UVinduced
pigmentation by inducing the release of alpha
melanocyte stimulating hormone in keratinocytes
which activates melanocytes in a paracrine fashion to
produce melanin. However, with this method also
reactive oxygen species which are mostly induced by
UVA can be measured. The same applies for matrix
metalloproteinases which contribute to premature
skin aging. There is some evidence the infrared
irradiation also induces reactive oxygen species and
matrix metalloproteinases. Although the biologic
relevance of these findings is not yet clear, there are
substances available which absorb infrared radiation.
The respective capacity can also be measured with
these in vitro methods which certainly will contribute
to improve the quality and the accurate labeling of
filter substances. However, one has to be aware that a
filter substance can only be as good in daily practice as
it is applied. The major mistake by the vast majority
of consumers is the application of too small amounts.
The filtering capacity correlates strongly with the
amounts, however not in a linear but exponential
regression. Repeated application of sunscreens is
beneficial but cannot replace the application of the
required amounts. Hence, the consumers have to
better informed how to use sunscreens correctly.
大會花藝設計15
SATURDAY, MAY 2
Cosmeceuticals Symposium
Sat. May 2, 13:30-15:00
SCIENTIFIC SESSIONS
39
CS3 我國化粧品管理現況與未來方向
Speaker Yie, Mon-I (葉孟宜) Phar D
Moderator CHIU,Pin-Chi (邱品齊) MD, MBA
SCHWARZ, Thomas MD, PhD
簡報內容主要是說明目前國內化粧品主管機關重要
之管理規定及未來修法後之管理方向及重點。
籌備委員會製作海報
至IMCAS PARIS and IMCAS ASIA
我們努力讓
台灣看見世界
更希望
世界看見台灣
18
SCIENTIFIC SESSIONS 40
Room 301A
Moderator HUANG, Po-Han (黃柏翰) MD
SUNDARAM, Hema MD
TF3 Functional Facial Rebalancing
and Reshaping by Toxin-Concept,
Diagnosis and Advanced Approach
15:30 / HUANG, Chi-Ching DDS
TF4 Image Changing: Lifting Techniques
& Facial Reshaping Using Botulinum
Toxin and Fillers
16:20 / AN, Kyung-Chun MD
TF3 Functional Facial Rebalancing and
Reshaping by Toxin-Concept,
Diagnosis and Advanced Approach
Speaker HUANG, Chi-Ching (黃奇卿) DDS
Moderator HUANG, Po-Han (黃柏翰) MD
SUNDARAM, Hema MD
Functional facial rebalancing and reshaping by toxinconcept,
diagnosis and advanced approach.
Orofacial myofunctional disorders (OMD) refer to
abnormal resting posture of the orofacial musculature,
atypical chewing and swallowing patterns, dental
malocclusions, blocked nasal airways, and speech
problems (Hanson,1988). OMD are patterns involving
oral and/orofacial musculature that interferes
with normal growth, development, or function of
structures, or calls attention to itself (ASHA, 1993).[1]
OMD are found in both children and adults.
Mouth breathing is the most common problem of
OMD.
Open mouth posture
The adaptation from nasal to mouth breathing
takes pace when changes such as chronic middle ear
infections, sinusitis, allergic rhinitis, upper airway
infections, and sleep disturbances (e.g., snoring) take
place. In addition, mouth breathing is often associated
with a decrease in oxygen intake into the lungs.
Mouth breathing can particularly affect the growing
face, as the abnormal pull of these muscle groups
on facial bones slowly deforms these bones, causing
misalignment. The earlier in life these changes take
place, the greater the alterations in facial growth, and
ultimately an open mouth posture is created where the
upper lip is raised and the lower jaw is maintained in
an open posture.
Causes
1. Upper airway constrictions (e.g., deviated nasal
septum) or obstructions (e.g., enlarged tonsils) or
infections (e.g., rhinitis)
2. Imbalance in dental growth
3. Inadequate development of facial and cranial bones,
Long face, short face, wide face, narrow face or jaw
reduction, chin is too long, the flat of midface
4. Inappropriate development of muscles in the head
and neck areas
5. Facial asymmetry
Toxin-concept, diagnosis and advanced approach
SATURDAY, MAY 2
Toxin Forum (II)
Sat. May 2, 15:30-16:50
SCIENTIFIC SESSIONS
41
Goals/benefits of therapy
In accordance with Functional matrix theory, muscles
tend to dominate and determine the skeletal form
and function. This is the Toxin concept to reduce the
muscle strength to change the muscle function and
form in functional reconstruction & muscle training.
TF4 Image Changing: Lifting Techniques
& Facial Reshaping Using Botulinum
Toxin and Fillers
Speaker AN, Kyung-Chun MD
Moderator HUANG, Po-Han (黃柏翰) MD
Botulinum toxin and fillers have been friends for many
doctors and patients around the world for more than
15 years. Many techniques have been discussed by
the experts. Various techniques concerning injection
of the botulinum toxin concerns with the paralysing
target muscles of the face alone and injection of
the toxin is usually somewhat deep directly to the
muscles. In ‘lifting botulinum toxin technique,’ The
target for injection varies from epidermal area to deep
muscles. Very diluted solutions are used in small
amounts and the main purpose of this technique is
to achieve natural lookin appearance after the toxin
injection. This technique provides changes of image
of the patients. Serial procedures, 7 to 10 days apart
for 3-6 sessions will change the facial contours and
acquire desired look.
Using this technique will be very useful procedure in
outpatient clinics with short down time or almost no
down time.
SCIENTIFIC SESSIONS 42
SATURDAY, MAY 2
Wound Care Forum
Sat. May 2, 15:30~16:20
Room 301B
Moderator CWONG, Tak-Wah (王德華) MD
LEE, Chih-Hung (李志宏) MD, PhD
WC1 The Role of Hyperbaric Oxygen
Therapy in Chronic Wound
Management
15:55 / PAN, Shin-Chen (潘信誠) MD, PhD
WC2 Diabetic Wound Care Education in
Asia – Perspective of an Orthopaedic
Surgeon and Foot & Ankle Specialist
15:55 / CHAN, Samson Chi-Fai (陳智輝) MB,
B Ch, FRCSE, FHKAM, FHKCOS
WC1 The Role of Hyperbaric Oxygen
Therapy in Chronic Wound
Management
Speaker PAN, Shin-Chen (潘信誠) MD, PhD
Moderator CWONG, Tak-Wah (王德華) MD
LEE, Chih-Hung (李志宏) MD, PhD
Chronic wounds included diabetic foot ulcers and
others are still extremely difficult to heal. Therefore,
therapeutic options to improve healing rates are
continuously being explored. Optimal management
of chronic wounds is best offered by multidisciplinary
clinics. Revascularization to restore adequate blood
flow as needed and aggressive infection control are the
cornerstones of treatment. Other emerging therapy
such as systemic hyperbaric oxygen (HBO) may also
be helpful for improvement of healing of wounds.
HBO has been used in addition to standard
treatment of difficult wounds foot for more than
20 years. Evidence suggests that HBO reduces
amputation rates and increases the likelihood of
healing in infected diabetic foot ulcers, in association
with improved tissue oxygenation, resulting in better
quality of life. HBO therapy is a medical treatment
in which a patient breathes 100% oxygen (O2) inside
a pressurized treatment chamber. Intermittent HBO
may help in salvaging marginally perfused tissues. It
also improves (a) infection control due to enhanced
mobility and bacteria killing ability of leukocytes, (b)
granulation tissue formation due to stimulation of
fibroblast proliferation and collagen synthesis, and
(c) microcirculation due to edema reduction and
angiogenesis. We present our experience about the role
of HBO in management of chronic wounds.
SCIENTIFIC SESSIONS
43
WC2 Diabetic Wound Care Education
in Asia – Perspective of an
Orthopaedic Surgeon and Foot &
Ankle Specialist
Speaker CHAN, Samson Chi-Fai (陳智輝) MB,
B Ch, FRCSE, FHKAM, FHKCOS
Moderator CWONG, Tak-Wah (王德華) MD
LEE, Chih-Hung (李志宏) MD, PhD
Diabetes has an increasing proportion in health care
cost worldwide, due to its increasing prevalence
and persistence complications, countries in Asia
are battered with increasing incidence in younger
population and longer survival. The impact of diabetic
wound care drives wound care worker searching for
better and more effective wound healing technologies
and advances. Diabetic wound burdens the
orthopaedic care for the limbs and especially for the
Foot and Ankle specialist. We in Hong Kong formed
the Hong Kong Society of Diabetic Limb Care about
ten years ago and missioned to improve the Diabetic
Wound Care, education, research, and coordination
among wound care workers, including wound
specialist, wound nurses, podiatrist, and prosthetist
and orthotist. We have organized local health care
worker conference, public education, community
care activities, as well as regional and international
conferences, and have fostered and networked with the
Asia Pacific Association for Diabetic Limb Problems,
the World Union of Wound Healing Societies, and the
Asian Academy of Wound Technology collaboration.
The impact of our activities historically have aroused
awareness of the problem and importance of diabetic
limb care for the public, also disseminate knowledge
to health professionals and ancillary medical personnel
through medical seminars, various types of symposia
and educational exhibits, as well as attracted attention
of the health administrators and health care budgetholders,
political ministers in our local community
have been our strong support of our activities, after
all we are non-profit making, professional voluntary
group.
We can share some of our experience in success in
educating a mixed audience in this area of difficult
common clinical problems when so many advances
are made in recent years, in the coming future we shall
strive to provide practitioner who have a dedicated
interest in diabetic limbs care with new knowledge,
skill and techniques to optimize patient care.
SCIENTIFIC SESSIONS 44
SATURDAY, MAY 2
Face Sculpting and Lifting Symposium
Sat. May 2, 15:30-18:00
Room 304A
Moderator CHANG, Li-Yen (張立言) MD
WANG, Chao-Chin (王昭欽) MD
FSL1 Cog Thread Lifting Using ‘Curved
Cannula Technique’ for Easy and
Parallel Insertion of the Thread,
and ‘Temporal Loop Technique’ for
Strong Anchoring of the Threads
15:30 / AN, Kyung-Chun MD
FSL2 Combination Therapy of Fillers and
Noninvasive Face-Lift Modalities
with Monopolar RF and HIFU for
Facial Rejuvenation
16:00 / CHANG, Kao-Jung (張高榮) MD
FSL3 Facial Sculpting with Injectables and
Energy-Based Devices
16:30 / CHAO, Yates Yen-Yu (趙彥宇) MD
FSL4 The Application of
Micro-Autologous Fat
Transplantation(MAFT)
with Thread Lifting in Facial
Rejuvenation
17:00 / LIN, Tsai-Ming (林才民) M.D, Ph.D
FSL5 Minimally Invasive Face Lift with
Cone Sutures-Personal Experience
17:30 / LI, Kuan-Ying (李冠穎) MD
FSL1 Face Sculpting and Lifting: Cog
Thread Lifting Using ‘Curved
Cannula Technique’ for Easy and
Parallel Insertion of the Thread,
and ‘Temporal Loop Technique’ for
Strong Anchoring of the Threads
Speaker AN, Kyung-Chun MD
Moderator CHANG, Li-Yen (張立言) MD
WANG, Chao-Chin (王昭欽) MD
Cog thread lifting has been replacing the face lifting
surgeries because they are convinient and simple. Cog
threads not only elevates the drooping middle and
lower face but also stimulates the colagen production
around the inserted threads.
The ‘curved cannula technique ‘ keeps the thread in
parallel with the skin. Thus, preventing the ends of
the threads coming out near the perioral areas. With
proper execution of this technique, one can easily
place the threads in parallel with the curved facial skin.
The pulling force distributed among the entire cogs
of the thread will be dispersed through out the whole
length of the thread, thus sustaining length of period
by the PDO threads will be longer because lesser
force will be added at each cogs. This helps to prevent
unwanted dimpling effects by the cog threads.
In many procedures for uplifting the middle and
lower face, temporal fascia has been used. However,
the thread which also bites the temporal muscle
produces trigger points which makes unbarable pain
in many patients, for many months. ‘Temporal loop
technique’ utilizes the properties of the cogs which
will be embeded at the dermis of the temporal area in
figure of ‘U’ or ‘O’ loop form. This technique will
hold the threads, strongly, the lower face, especially.
However, this technique will be well utilized only if
the threads have good cogs, and the threads should be
long enough to make the loops.
SCIENTIFIC SESSIONS
45
FSL2 Combination Therapy of Fillers and
Noninvasive Face-Lift Modalities
with Monopolar RF and HIFU for
Facial Rejuvenation
Speaker CHANG, Kao-Jung (張高榮) MD
Moderator CHANG, Li-Yen (張立言) MD
WANG, Chao-Chin (王昭欽) MD
Nowadays, the rapid evolution and advance of
machines with radiofrequency and highly-intensified
focused ultrasound makes it easier for rejuvenation
of face without much downtime and much suffering
than the surgical intervention. In addition to the above
mentioned, any kind of fillers can also provide the
possibility of the volumizing effect and augument the
lift. We use these two combination therapy for years
and share these experience to all .
FSL3 Facial Sculpting with Injectables and
Energy-Based Devices
Speaker CHAO, Yates Yen-Yu (趙彥宇) MD
Moderator CHANG, Li-Yen (張立言) MD
WANG, Chao-Chin (王昭欽) MD
This section of lecture covers the subjects of
1.Principles of facial reshaping.
2.Intensive focused ultrasound in facial reshaping.
3.Radiofrequency devices in facial reshaping.
4.Volumizing fillers in facial reshaping.
5.Activating fillers in facial reshaping.
6.Practical combination of different modalities for
facial sculpting.
SCIENTIFIC SESSIONS 46
FSL4 The Application of Micro-Autologous
Fat Transplantation(MAFT) with
Thread Lifting in Facial Rejuvenation
Speaker LIN, Tsai-Ming (林才民) MD, PhD
Moderator CHANG, Li-Yen (張立言) MD
WANG, Chao-Chin (王昭欽) MD
Introduction
Aging process oN human face involves not only
the ptosis of skin (sagging or redundancy) but also
the deficiency of soft tissue under-beneath the skin.
Therefore both lifting and filling procedures for
rejuvenation of face are equally important. To evaluate
the effect of the thread-lift procedure with fat graft for,
we retrospectively reviewed our experience in applying
the concept of micro- autologous fat transplantation
(MAFT) to re-contour the deficient tissues combined
with simultaneous lifting with barbed suture.
Materials and Methods
The autologous fat was harvested from lower abdomen
then refined and processed at 3 min 3000 rpm by
centrifuge. There were 88 patients (79 female/9 male)
with average age 47.5 receiving micro- autologous fat
transplantation (MAFT) as a primary strategy for aging
face from Jan 2009 to Dec. 2014. Immediate after fat
grafting, barbed sutures were applied as an adjunctive
lifting procedure. An averaged 0.9 ml (ranging from 0.5
to 2.3 ml) of refined fat graft was micro-transplanted
evenly and precisely for each thread limb and related
uneven appearance with the MAFT-Gun®.
Results
Total procedural time of applying MAFT and placing
thread lift in was 28.5 minutes. Mild swelling and
ecchymosis but no other major morbidities were
noted. The final touch-up MAFT after thread-lift
alleviated the dimpling of the barbed suture and
avoided the temporal stretching line or plane should
the sutures placed superficially. In follow-up period,
patients all were satisfied with the result and longterm
(>6 months) outcome was appreciated as well.
Conclusion
MAFT concept has been introduced by Lin et al., and
applied for facial rejuvenation since 2006. Clinical
results for facial rejuvenation are satisfactory in longterm
follow up. By application of the innovative
medical device, surgeons seem to turn a used-to-be
inaccurate, labor demanding, and unpredictable fat
grafting into a micro-, precise, reliable, and confident
procedure. The consistency of each delived parcel
from 1/60 ~1/240 mL has also demonstrated its
reliable feasibility clinically.
More documents have also demonstrated the longterm
effect of barbed suture lifting in facial areas.
However, the immediately morbidities and most
embarrassed complications such as superficial
stretching marks and exit-dimple often frustrated both
surgeons and patients. With the immediate applying of
MAFT after thread-lifting, the embarrassed situations
have been effectively diminished. Therefore, thread
lift with micro- autologous fat transplantation (MAFT)
might be a better strategy for facial rejuvenation.
SATURDAY, MAY 2
Face Sculpting and Lifting Symposium
Sat. May 2, 15:30-18:00
SCIENTIFIC SESSIONS
47
FSL5 Minimally Invasive Face Lift with
Cone Sutures-Personal Experience
Speaker LI, Kuan-Ying (李冠穎) MD
Moderator
Surgical management of the aging face has
incorporated a wide range of new techniques over
thepast few years. Traditional face-lifting procedures
have employed historically more aggressive methods.
Because of the recent shift in the population’s interest
in less invasive procedures, the newer surgical
techniques have approached the reversal of senescent
changes of the face in a different fashion. Ultimately,
patients are seeking out procedures that
have little downtime coupled with longer-lasting
results and a favorable side-effect profile. For this
reason, facial plastic surgeons are continually adapting
newer and safer approaches to reversing ptotic changes
of the maturing face
Suture lifting over the early aging face are now
adaptive method and are better alternative to the
less invasive methods, such as toxin, fillers and
radiofrequence device.
My suture material is cones suture that have better
suspension effect and evenly hold the tissue. Limited
period and experience of the suture lifting for facial
rejuvenation in early aging, I also combined with some
rejuvenation techniques for whole face to get better
result.
SATURDAY, MAY 2
Satellite Speeches
Sat. May 2, 17:30-18:00
Position / 卡麥拉攝影咖啡館商業企劃攝影師 photographer
Website / http://www.wretch.cc/blog/wangdavid
http://www.flickr.com/photos/cameracoffee
WORKING EXPERIENCE /
Grand Hi Lai Hotel 漢來大飯店
Kaohsiung Howard hotel 高雄福華大飯店
CHATEAU de CHINE 翰品高雄
Dream mall 夢時代購物中心
BOZEN SANITARYWARE &
KITCHENWARE BOUTIQUE, Kaohsiung 柏正衛廚
David Wang is devoted to the integration of
photography with different aspects of life and the
promotion of esthetic sensibilities among the
general public. He established Camera Coffee in
2006,which is the first theme coffee shop that
focuses on photographic imaging. He is
currently a commercial project photographer.
PHOTOGRAPHER
王大衛
大會攝影師
致力於影像生活化並積極推廣市民美學的提升，
2006年創辦高雄第一間以生活攝影為主題的影像
咖啡館CAMERA COFFEE，並擔任CAMERA
COFFEE 商業企劃攝影師。
05
SCIENTIFIC SESSIONS 48
Room 304A
Moderator ASCHER, Benjamin MD
IS1 Presentation of IMCAS
17:00 / ASCHER, Benjamin MD
IS2 What's New in Anatomy- Injection
on Cadaver? Avoiding Face
Complications
17:05 / ASCHER, Benjamin MD
IS3 What's New in Anatomy- Injection
on Cadaver? Injectables
17:17 / PRASETYO, Adri Dwi MD
IS4 The New Science of Fillers and
Asian Aesthetics
17:29 / SUNDARAM, Hema MD
IS5 What's New in Lasers for Scars and
Pigmentation?
17:41 / CASSUTO, Daniel MD
Questions and Answers
17:53 / All
SATURDAY, MAY 2
IMCAS Session
Sat. May 2, 17:00-18:00
IS1 The Application of Micro-Autologous
Fat Tranvenation
Speaker ASCHER, Benjamin MD
Moderator ASCHER, Benjamin MD
SCIENTIFIC SESSIONS
49
IS2 What's New in Anatomy- Injection
on Cadaver? Avoiding Face
Complications
Speaker ASCHER, Benjamin MD
Moderator ASCHER, Benjamin MD
IS3 What's New in Anatomy- Injection
on Cadaver? Injectables
Speaker PRASETYO, Adri Dwi MD
Moderator ASCHER, Benjamin MD
學會在會議籌備期間發文至
國際知名會議組織IMCAS，
告知會議資訊，併邀請參加本次盛會。
台灣與
國際組織的合作
SCIENTIFIC SESSIONS 50
IS4 The New Science of Fillers and Asian
Aesthetics
Speaker SUNDARAM, Hema MD
Moderator ASCHER, Benjamin MD
IS5 What's New in Lasers for Scars and
Pigmentation?
Speaker CASSUTO, Daniel MD
Moderator ASCHER, Benjamin MD
SATURDAY, MAY 2
IMCAS Session
Sat. May 2, 17:00-18:00
SCIENTIFIC SESSIONS
51
SATURDAY, MAY 2
Satellite Speeches
Sat. May 2, 15:30-18:00
Room 304B
Moderator WU, Ching-Ying (吳青穎) MD
SS1 New Perspective for Skin Barrier
Repairer
15:30 / MEDINA-LAVADIA, Angela MD
Moderator LEE, Woan-Ruoh (李婉若) MD, PhD
SS2 A New Trend in Laser Treatment:
Mixed Technology. Combined CO2
10600nm and GaAs 1540nm for
Fractional Skin Resurfacing
16:00 / LU, Ching-I (盧靜怡) MD
Moderator Tseng, Chung-Ren (曾忠仁) MD
SS3 eTWO : Advanced Fractional
Radiofrequency for Rejuvenation
and Scar Treatment in Asian and
Other Pigmented Skin
16:30 / SUNDARAM, Hema MD
Moderator TSENG, Ming-Yi (曾銘儀) MD
SS4 Clinical Experiences of the Next
Generation Sculpturing System-
Maximus
17:00 / YU, Jonathan Nevin MD
Moderator Tseng, Chung-Ren (曾忠仁) MD
SS5 Evaluation of RF v.s. HIFU in Skin
Tightening: A Split Face Study
17:30 / TSENG, Fang-Wen (曾繁聞) MD
SS1 New Perspective for Skin Barrier
Repairer
Speaker MEDINA-LAVADIA, Angela MD
Moderator WU, Ching-Ying (吳青穎) MD
SCIENTIFIC SESSIONS 52
SS2 A New Trend in Laser Treatment:
Mixed Technology. Combined CO2
10600nm and GaAs 1540nm for
Fractional Skin Resurfacing-
Speaker LU, Ching-I (盧靜怡) MD
Moderator LEE, Woan-Ruoh (李婉若) MD, PhD
Fractional ablative and non-ablative lasers are useful
tools for facial rejuvenation and to treat acne scars.
However, each laser has its own advantages and
limitations. The ablative laser requires a period of
downtime during re-epithelialization and has a higher
risk of PIH, esp. on Asian skin. The non-ablative laser
needs more sessions to show the result and has less
fading-out effect for the scar border. A procedure that
combines both ablative and non-ablative fractional
lasers, which I had used for 6 more years, can deliver
good cosmetic results and reduce some side effects
of only using each one laser. Now, a novel technique
can deliver these two kinds of lasers at the same time.
We will discuss about the advantages of this technique
over the past and the possible side effects in this
session.
S S 3 e Two: Advanced Fr a c t i o n a l
Radiofrequency for Rejuvenation
and Scar Treatment in Asian and
Other Pigmented Skin
Speaker SUNDARAM, Hema MD
Moderator Tseng, Chung-Ren (曾忠仁) MD
Asian patients have individual patterns of aging,
and may also express different treatment aims
and objectives. Selection of laser and light energy
technologies for enhancement and rejuvenation of
Asian skin is based on the balance between treatment
needs, safety and efficacy. Each patient's tolerance
for post-procedural recovery time must also be
considered. The trend for patients in Asia and globally
is a preference for treatments that offer as little
recovery time as possible.
In this lecture, Dr. Hema will discuss the science
and clinical applications of eTwo, an advanced,
light energy device that combines fractionated
bipolar radiofrequency resurfacing (Sublative)
with bipolar radiofrequency plus broad band light
(Sublime). Because the light energies of eTwo are
non-chromophore-specific and therefore “colorblind”,
they offer excellent safety and efficacy for
all Fitzpatrick skin phototypes, including skin types
III and above. Dr. Hema will present the results she
has achieved with eTwo on Asian patients, and other
patients with pigmented skin. She will also discuss her
study data, which demonstrate the safety, efficacy and
tolerability of eTwo and the minimal recovery time.
The eTwo technology is well-suited to Asian
skin because it diminishes epidermal ablation to
sufficient extent that the risk of post-inflammatory
hyperpigmentation or hypopigmentation is minimized
or eliminated. The combined light energies of eTwo
target both superficial and deep tissue planes below the
epidermis, to achieve multi-level energy delivery. This
provides improvement in hyperpigmentation, skin
reflectance and rhytides, and volumetric improvement
in skin laxity and facial contours.
Since facial aging is recognized as a multi-level
pathology, layered rejuvenation with lasers and light
energy technologies such as eTwpo is logical and can
deliver optimal results.
SATURDAY, MAY 2
Satellite Speeches
Sat. May 2, 15:30-18:00
SCIENTIFIC SESSIONS
53
SS4 Clinical Experiences of the Next
Generation Sculpturing System-
Maximus
Speaker YU, Jonathan Nevin MD
Moderator TSENG, Ming-Yi (曾銘儀) MD
Non-invasive aesthetic procedures for body shaping
are constantly demanded worldwide. Currently
existing non- invasive procedures are limited in term
of efficacy and safety and practitioners often tend
to combine a few technologies and complementary
treatment modalities in order to improve results.
The Maximus platform is a unique device which
uses Tripolar RF to stimulate the release of fat with
collagen remodeling of the dermal layer. At the same
time it synergistically uses low frequency pulsed
current to stimulate muscle to remove the fat via
enhanced lymphatic drainage.
Clinical evaluations of the technology demonstrated
safety and efficacy of the Maximus treatment in
circumference reduction, improvement of cellulite
appearance and skin tightening.
Patients and practitioners benefit from the use of
multiple technologies at once, in a significantly shorter
treatment time as compared to other commonly used
combination protocols applying separate devices or
technologies.
Aside from body contouring, other treatment
modalities like facial tightening, acne and acne scar
treatments using the Maximus will be presented.
SS5 Evaluation of RF v.s. HIFU in Skin
Tightening: A Split Face Study
Speaker TSENG, Fang-Wen (曾繁聞) MD
Moderator Tseng, Chung-Ren (曾忠仁) MD
Monopolar radiofrequency (RF) and high-intensity
focused ultrasound (HIFU) are two of the moststudied
non-invasive skin tightening procedures. Both
technologies deliver heat to the dermis and deeper
layers of skin, causing thermally induced collagen
contraction, remodeling, and later neocollagenesis.
Although the effectiveness and safety of RF and HIFU
had been demonstrated separately in the literature,
there is controversy about direct comparison of
these two procedures. In order to improve our
understanding of patient selection for non-invasive
skin tightening procedures, we conducted a splitface
study on patients with different degree of facial
sagging and soft tissue volume. Monopolar RF with a
“total tip” (Thermage CPT Inc., Hayward, CA) was
used on one side of the face and neck of each patient,
while HIFU (Ulthera LLC, Mesa, AZ) was used on
the other. Clinical results and adverse events will be
presented.
May 2, Sat, 18:00-19:30
RM 301B
Gala Dinner, Opening and
Networking
Extensive Banquet-style Dining with
Self-select Buffet
雞尾酒會式精緻自助餐點
大會晚宴
13
SCIENTIFIC SESSIONS 54
SCIENTIFIC SESSIONS
SATURDAY, MAY 2
Physician Only
Lecturing in English
Lecturing in Chinese
Simultaneous Interpreting
Medical Dermatology
Dermatological Surgery
Engergy-based Devices
Injectables
Staff Training
19:30-21:00
Injectable Workshop: Pearl of Injectable Treatment -Tips and Tricks
Liposculpting Symposium
Satellite Speeches: HIFU
SCIENTIFIC SESSIONS
55
SATURDAY, MAY 2
Injectable Workshop: Pearl of Injectable Treatment-Tips and Tricks
Sat. May 2, 19:30-21:00
Room 301A
Moderator CHAO, Yates Yen-Yu (趙彥宇) MD
CASSUTO, Daniel MD
PIT1 To Treat Tear Trough with
Confidence
19:30 / MOON, Hyoung-Jin MD
PIT2 Upper and Lower Asian Eyelid
Volumetry to Achieve Holistic
Periorbital Augmentation
19:45 / PRASETYO, Adri Dwi MD
PIT3 Treatment of Skin Necrosis After
Filler Injection
20:00 / CHANG, Geun-Uck MD
PIT4 How can Science Predict and Perfect
our Filler Results?
20:15 / SUNDARAM, Hema MD
PIT5 Tips and Tricks of Injectables
20:30 / CASSUTO, Daniel MD.
PIT1 To Treat Tear Trough with Confidence
Speaker MOON, Hyoung-Jin MD
Moderator CHAO, Yates Yen-Yu (趙彥宇) MD
CASSUTO, Daniel MD
The deflated infraorbital hollow gives an impression
of tiredness, age, and depression. It is one of the
most challenging areas of the face to treat, with
far less tissue between bone and skin than in the
cheek. Recently, the use of dermal fillers to correct
infraorbital hollows has evolved as a rapid nonsurgical
option. Overcorrection, too-superficial injections,
and choice of an inappropriate filler may lead to
unacceptable aesthetic results. By placing the filler at
the deepest
level of the hollow, the filler is covered by multilayer.
This multilayer covering
the product, allows for ease of manipulation if there
are irregularities detected.
Selection of appropriate patients, filler material,
and injection techniques are critical for successful
treatment outcomes. Three-dimensional volume
augmentation is an essential to correct the infraorbital
hollow. Doctors must thoroughly understand threedimensional
facial anatomy. And also requires
knowledge of the properties of each filler , as well
as an understanding of the patient's major aesthetic
concerns.
SCIENTIFIC SESSIONS 56
PIT2 Upper and Lower Asian Eyelid
Volumetry to Achieve Holistic
Periorbital Augmentation
Speaker PRASETYO, Adri Dwi MD
Moderator CHAO, Yates Yen-Yu (趙彥宇) MD
CASSUTO, Daniel MD
The typical characteristics of an aging periorbital
region are complex 3-dimensional volume loss, change
of contours, and thin skin with laxity. Rejuvenation
treatment is based on these holistic understandings.
The volumetric injection using hyaluronic acid (HA)
fillers brings substantial enhancement to both upper
and lower eyelid. To achieve smooth contours, a
layered, diffuse feathered threading technique was
used, placing the filler deep and superficial to the
orbicularis oculi muscle. Despite the relatively small
volume required, the upper and lower periorbital
aesthetics are significantly improved. Thin skin in
aging periorbital requires volumetric under laxitybased
sequential sessions, which is safer, less risk
of over-correction, and effectively integrate to
produce a more natural appearance of rejuvenation.
Individualized planning and evaluation during
procedural injection are essential in patients with very
thin skin, preexisting color problems, or preexisting
fat bulge for periorbital augmentation with hyaluronic
acid fillers.
PIT3 Treatment of Skin Necrosis After
Filler Injection
Speaker CHANG, Geun-Uck MD
Moderator CHAO, Yates Yen-Yu (趙彥宇) MD
CASSUTO, Daniel MD
The use of fillers in the face for augmentation is
a popular procedure in aesthetic practice. In nose
case, it can be used for augmentation of the radix,
dorsum, and tip. Although generally safe, disastrous
complications can occur if filler is inadvertently
injected into a terminal artery, resulting in
thromboembolism, skin ischemia, and necrosis. This
occurs most commonly in the region of the nasal
tip, columella, and alar region. Injections in these
sitesshould be avoided.
In the event of skin ischemia, initial treatment
consists of regular dressing, hyperbaric oxygen therapy,
and prostaglandin injections. If skin necrosis occurs
despite initial attempts at salvage, reconstruction
must be performed. Local flap and regional flapssuch
as the subnasal flap, nasolabial flap, and paramedian
forehead flaps can be used, often in conjunction with
autologous cartilage.
The paramedian forehead flap remains a workhorse
for nasal reconstruction. Based on the supratrochlear
artery, it can be designed for soft tissue cover of the
nasal dorsum, tip and alar regions, with good skin
matching. Closure of the donor site can usually be
performed primarily.
SATURDAY, MAY 2
Injectable Workshop: Pearl of Injectable Treatment-Tips and Tricks
Sat. May 2, 19:30-21:00
SCIENTIFIC SESSIONS
57
PIT4 How can Science Predict and Perfect
our Filler Results?
Speaker SUNDARAM, Hema MD
Moderator CHAO, Yates Yen-Yu (趙彥宇) MD
CASSUTO, Daniel MD
Hyaluronic acid (HA) fillers products that are
currently available for aesthetic use including Belotero
(Esthélis, Fortélis and Modélis), Juvéderm, Voluma,
Restylane and Teosyal. Another commonly used filler
is calcium hydroxylapatite (CaHA) which is known
as Radiesse. All are safe, efficacious and predictable.
In recent years, interest has focused on the rheology
(flow-related properties) of these products and
how they are relevant to clinical behavior. In this
lecture, Dr. Hema will provide an overview of the
physical properties of HA and CaHA fillers, some key
rheologic studies including important methodological
considerations, and a discussion of how the results can
guide the use of different filler products. The primary
rheologic parameters that have been investigated are
cohesivity, elastic modulus (G prime), and viscosity.
Recently, a new 5-point scale for HA filler cohesivity
has been developed and validated. Previous studies of
HA and CaHA fillers reveal that they can be broadly
divided into three groups based on their G prime
and viscosity and their resultant physical properties.
Group 1 fillers have high elasticity and high viscosity
and therefore are firm and non-spreading. Group 2
fillers have medium to high elasticity and viscosity
and are intermediate in firmness and tendency to
spread. Group 3 fillers are soft, spreading fillers. Filler
rheology is an exciting and rapidly advancing field.
It is of value in selecting the most appropriate filler
products and injection techniques to achieve the best
outcomes. The lecture concludes with a look into the
future – at new scientific investigations, and how they
will shape our future use of fillers.
REFERENCES
Sundaram H, Rohrich R, Liew S et al. Cohesivity
of hyaluronic acid fillers: Development and clinical
implications of a novel assay, pilot validation with a
5-point grading scale, and evaluation of six US FDAapproved
fillers Plast Reconstr Surg – in press.
Sundaram H, Cassuto D. Biophysical characteristics
of hyaluronic acid soft tissue fillers and their relevance
to aesthetic applications. Plast Reconstr Surg. (2013)
Ascher B, Rzany B, Sundaram H. (Chairs). “Fillers:
From Characteristics to Recommendations.”
Consensus panel discussion, IMCAS 2013 Annual
Meeting, Paris, France.
Stocks D, Sundaram H, et al. Rheological evaluation
of the physical properties of hyaluronic acid dermal
fillers. J Drugs Dermatol. (2011).
Sundaram H, Voigts B et al. Comparison of the
rheological properties of viscosity and elasticity in two
categories of soft tissue fillers: calcium hydroxylapatite
and hyaluronic acid. Dermatol Surg. (2010).
Kablik J, Monheit GD et al. Comparative physical
properties of hyaluronic acid dermal fillers. Dermatol
Surg. (2009).
SCIENTIFIC SESSIONS 58
PIT5 Tips and Tricks of Injectables
Speaker CASSUTO, Daniel MD
Moderator CHAO, Yates Yen-Yu (趙彥宇) MD
SATURDAY, MAY 2
Injectable Workshop: Pearl of Injectable Treatment-Tips and Tricks
Sat. May 2, 19:30-21:00
SCIENTIFIC SESSIONS
59
SATURDAY, MAY 2
Liposculpting Symposium
Sat. May 2, 19:30-21:00
Room 304A
Moderator YANG, Hung-Hsu (楊弘旭) MD
WANG, Chao-Huei (王朝輝) MD
LS1 Comprehensive Surgeries of the
Trunk for ‘Trunk Contouring’ vs.
Regional Liposuction
19:30 / AN, Kyung-Chun MD
LS2 How to Become a Successful
Liposuctionist Detailed Techniques
20:00 / WANG, Chao-Huei (王朝輝) MD
LS3 Body Sculpture : Surgical and Nonsurgical
Choices
20:30 / CHOU, Erh-Kang (周爾康) MD
LS1 Comprehensive Surgeries of the
Trunk for ‘Trunk Contouring’ vs.
Regional Liposuction
Speaker AN, Kyung-Chun MD
Moderator YANG, Hung-Hsu (楊弘旭) MD
WANG, Chao-Huei (王朝輝) MD
A massive number of patients are looking for
liposuction. Their need for liposuction used to be
to discard unwanted fatty tissue around their belly,
arms, and thighs, mostly. However, the expectations of
patients seeking for liposuction are high. They want
to become healthy looking with perfect body contour.
They don’t want to have any loose skin around their
waist with many stretch marks.
When designing the patients before liposuction, who
want to have perfect body like the celebrities, the
whole problem has to be taken into consideration
for the surgeons. Laxity of the skin and abdominal
muscles, stretch marks on the abdomen, diastasis of
the rectus abdominis, hernias, etc. must be taken into
consideration. Likewise the smooth contour between
the suctioned area and the area without liposuction
must also be harmonized. The whole figure of the
body should coninside with the look of other parts.
Thus, giving perfect shape of the patients. As the
technologies of the surgical devices advance, shaping
of the fatty tissue is more precisely done. Devices
using radiofrequencies, ultrasound, LASERs, and
vibration are helpful aids for sculpting the fatty tissues
and for skin retraction. The shape of the abdominal
muscles are emphasized on the surface of the
abdomen, thus acquiring a much wanted athletic look
for both male and female patients.
SCIENTIFIC SESSIONS 60
LS2 How to Become a Successful
Liposuctionist Detailed Techniques
Speaker WANG, Chao-Huei (王朝輝) MD
Moderator YANG, Hung-Hsu (楊弘旭) MD
The liposuction had developed since 1970. Too much
complications and incredible high mortalities were
noted. The wetting methods improved with time. Till
tumescent solution by Dr Klein had greatly success.
The complication rate and mortality rate lower down
thereafter. The concepts included with vascular
constriction, swellen fat tissue, diluted lidocaine,
controlled systemic toxicity of lidocaine. So we can
avoid bleeding, fat emboli, thumbus and lidocaine
toxicity. The evolution of techniques developed with
time as well. According to different equipement and
machine, different kinds of liposuction style marked.
There were SAL, UAL, PAL, LAL, WAL and RFAL.
Each technique contained different function and
benefit, so did the complications and drawbacks.
Basically, from skin to muscle, there contained
different layers, including epidermis, dermis, apical
layer, superficial fat, superficial fascia, deep fat and
deep fascia. Acknowledging the structure, we are able
to draw more fat, naming ultratumescent liposuction,
than before without skin complication. With event
wetting distribution, we can expect smooth skin
performance.
For satisfactory success, multiple factories must
be considered. Such as proper custom selection,
anethesia, positions, incisions, techniques and skills,
we should take more into consideration. Patient
complained with localized or refractory fat part.
Neither major comorbidity nor unrealistic expectation
should be taken place. Unlike foreign sugery
performance with multiple entries, we try to hide the
entry point in fold and hair. For the different purpose,
we use different techniques and skills. To draw out
the fat or to shaping the muscular texture was totally
different thinking process and doing.
With proceeding from tumescent liposuction by
Dr Klein, we revised something to improve the
performance. At very beginning, drawing fat safely was
the first consideration and stage. In the tumescent era,
the total complication lowered to acceptable result.
The mortality became extremely rare at a large-scaled
study for decades. Then, by knowing the structure,
we drawed more fat than before. Following stage, to
persuing excent result, we shaping and contouring
the muscular texture. At final stage, we shall devote
our knowledge and skills to treat the complication. By
learning and teaching, the liposuction performance
can achieve more satisfactory boundary.
SATURDAY, MAY 2
Liposculpting Symposium
Sat. May 2, 19:30-21:00
SCIENTIFIC SESSIONS
61
LS3 Body Sculpture : Surgical and Nonsurgical
Choices
Speaker CHOU, Erh-Kang (周爾康) MD
Moderator YANG, Hung-Hsu (楊弘旭) MD
WANG, Chao-Huei (王朝輝) MD
In recent years, body contouring project is receiving
increasing attention in the medical beauty items.
Plastic items inside the United States, liposuction and
breast augmentation surgery is the highest ranking in
the top three. Generalized body contouring surgery
also includes lifting surgery after massive weight
loss. Several years before, autologous fat graft as one
method for breast augmentation bring the liposuction
surgery to another peak in cosmetic market. Today we
will talk about the body curve beauty, from the ancient
standard, evolution of body pretty, then latest scientific
selection appreciate treatment tools for better results.
國內會議宣傳
FB粉絲專頁
https://www.facebook.com/tdacmeeting
11
SCIENTIFIC SESSIONS 62
Room 304B
Moderator HSU, Nai-Jen (許乃仁) MD
SS7 Safety and Efficacy of Ulthera in
the Rejuvenation of Aging Lower
Eyelids: A Pivotal Clinical Trial
19:30 / PAK, Chang-Sik MD
Moderator CHAO, Sheau-Chiou (趙曉秋) MD
SS8 Double Micro Focused Ultrasound
System for Non Invasive Skin Lifting
20:00 / CHEN, Ya-Hui (陳雅惠) MD
Moderator LIN, Chrang-Shi (林長熙) MD
SS9 My Experience for Combined
Therapy in HIFU Treatment with
Toxin, Derma Filler and PDO
Thread
20:30 / KIM, Beom-Joon MD, PhD
SS10 The Potential Risk of Combined
Therapy in HIFU Treatment and
how to Handle it
20:40 / SU, Chen-Wei (蘇承偉) MD
SS11 HIFU for skin tightening and lifting
using Ultraformer
20:50 / ASCHER, Benjamin MD
SS7 Safety and Efficacy of Ulthera in
the Rejuvenation of Aging Lower
Eyelids: A Pivotal Clinical Trial
Speaker PAK, Chang-Sik MD
Moderator HSU, Nai-Jen (許乃仁) MD
The changes in the periorbital region are among the
most prominent features of the aging process in the
lower eyelids. Intense focused ultrasound (IFUS),
known as the Ulthera System, was designed to correct
this process. The current study assessed the safety and
efficacy of the Ulthera System. This study enrolled
seven adult patients who presented from March 2011
to May 2012 for correction of lower eyelid aging by
Ulthera. The subjects were treated using Ulthera
1.5 and 3.0 mm probes. The 1.5 mm probe is used
to tighten of loose eyelid skin and the deep dermis,
whereas the 3.0 mm probe is used to tighten the
orbicularis oculi muscle and the orbital septum. The
patients were evaluated for allergic reactions and other
side effects. The subjects' satisfaction with clinical
photographs and the degree of pain were evaluated.
Moreover, orbital computed tomography (CT) and
ophthalmologic examinations were performed. The
study used CT both as a research tool and as a clinical
score system for evaluating aging lower eyelids and
performed statistical analysis. Based on the CT images,
the difference between the pre- and postoperative
distances from the baseline (line between the most
inferior point of the supraorbital rim and the most
superior point of the infraorbital rim) to the most
protruding point of the orbital septum was 0.51 +/- A
0.23 for the right eye (p < 0.001) and 0.54 +/- A 0.17
for the left eye (p < 0.001). The subjective score for
patient satisfaction was 3.85 +/- A 0.69. The objective
satisfaction scores reported by two blinded researchers
were respectively 3.45 +/- A 1.69 and 3.25 +/- A
1.43. During the study period, no adverse events and
no suspected serious adverse reactions were noted.
Tightening of infraorbital laxity and skin can be
achieved using the Ulthera System. Patients showed
a minimal pain level during treatment, and topical
analgesic cream was able to manage pain during the
procedure.
SATURDAY, MAY 2
Satellite Speeches: HIFU
Sat. May 2, 19:30-21:00
SCIENTIFIC SESSIONS
63
SS8 Double Micro Focused Ultrasound
System for Non Invasive Skin
Lifting
Speaker CHEN, Ya-Hui (陳雅惠) MD
Moderator CHAO, Sheau-Chiou (趙曉秋) MD
Skin laxity is a common complaint from patients who
request a skin rejuvenation procedure.
Microfocused ultrasound (MFU), a novel treatment
modality for skin laxity, produces thermal effects at
various depths while sparing overlying epidermis.
The transducer can concentrate ultrasound energy
with very high intensity at specific locations below
the epidermis and specifically target the dermis or
superficial musculoaponeurotic system, a fibrous
network consisting of collagen fibers, elastic fibers,
and fat cells that connects the facial muscles with the
dermis, which is supposed to be tightened during a
facelift. The goal is to produce a deeper wound healing
response at multiple levels with robust collagen
remodeling and thus a more durable clinical response.
MFU combined with visual monitoring can be
applied to the skin with higher degree of precision
to lift and tighten the dermis and subdermal tissues
noninvasively. Common adverse events include
momentary discomfort during the treatment session,
transient erythema and edema, and occasional
bruising.
The patients in our institute were first treated with a
4.5-mm, 4-MHz HIFU probe, from 1.5 to 1.8J/cm2,
followed by a 3.0-mm, 7-MHz HIFU probe, from
0.7 to 0.9J/cm2. The improvement after treatment as
compared to the pre-treatment photography, patient
satisfaction and adverse events will be presented and
discussed in our report.
In conclusion, MFU is a useful nonablative method
for lifting lax facial and neck skin.
SS9 My Experience for Combined Therapy
in HIFU Treatment with Toxin,
Derma Filler and PDO Thread
Speaker KIM, Beom-Joon M.D, PhD
Moderator LIN, Chrang-Shi (林長熙) MD
The demand for noninvasive techniques of facial
contouring has experienced exponential growth over
the last decade because younger looking face raises
one's competitiveness. Moreover, there is a particular
interest in safe and effective ways to decrease skin
laxity and smooth irregular contours and texture
without downtime. Also, aesthetic clinicians have
a constantly expanding range of treatment options
in facial contoruing and tightening at their disposal.
In addition to surgical interventions, cosmetic
rejuvenation procedures may involve injectable fillers,
botulinum toxin, ablative and nonablative resurfacing,
phototherapy, and radiofrequency treatments. Over
the past decade, radiofrequency and infrared laser
devices have been popularized owing to their ability
to deliver controlled heat to the dermis, stimulate
neocollagenesis, and effect modest tissue tightening
with minimal recovery. However, these less invasive
approaches are historically associated with inferior
efficacy so that surgery still remains the treatment of
choice to address moderate to severe tissue laxity.
High intensity focused ultrasound (HIFU) has
recently been evaluated as a method for transcutaneous
heat delivery that reaches the deeper subdermal
connective tissue in tightly focused zones at consistent
programmed depths and selective destruction of
adipose tissue. HIFU has been adapted specifically for
skin tightening and contouring with little recovery or
risk of complications.
This topic covers the principles and clinical
applications of HIFU to facial contouring for
enhanced efficacy and consistency of clinical
improvement.
SCIENTIFIC SESSIONS 64
SS10 The Potential Risk of Combined
Therapy in HIFU Treatment and
how to Handle
Speaker SU, Chen-Wei (蘇承偉) MD
Moderator LIN, Chrang-Shi (林長熙) MD
High intensity focused ultrasound (HIFU) is a one
of noninvasive treatments for facelift, it directly
delivers heat energy to skin and subcutaneous tissue
that can stimulate and renew the skin's collagen
and thus consequently improving the texture and
reducing sagging of the skin. There are still some
common and severe complications which need serious
consideration. Skin burns and pain in the treatment
region; the next common complication was severe
edema or neurapraxia of the designated area to variable
degrees.
Injectable soft tissue fillers/toxin and HIFU
treatments are frequently combined or performed
soon after one another to literally achieves the great
results. The treating physician should keep in mind
that the potential exists for injection complications.
Fortunately, most complications are minor and
transient in nature, although the patient may consider
them aesthetically displeasing and unacceptable.
Major complications are rare, but they can produce
permanent, disfiguring damage.
Skin thickness varies among facial areas, which affects
optimal injection or targeting depth. The appropriate
depth of placement is dependent on the combined
product selected and strongly influences the end
result. In order of depth, hyaluronic acid products,
calcium hydroxyapatite (Radiesse) and poly-L-lactic
acid (Sculptra) should be injected into the different
depth. In addition, the areas have minimal collateral
circulation and are at increased risk of vascular
compromise.
Complications are best prevented with careful
planning. Thorough knowledge of both pertinent
facial anatomy and the specific characteristics of each
filler/HIFU machine is critical. In addition, managing
patient expectations is an important element in the
pretreatment preparation.
SS11 HIFU for skin tightening and lifting
using Ultraformer
Speaker ASCHER, Benjamin MD
Moderator LIN, Chrang-Shi (林長熙) MD
SATURDAY, MAY 2
Satellite Speeches: HIFU
Sat. May 2, 19:30-21:00
SCIENTIFIC SESSIONS
65
SCIENTIFIC SESSIONS
MEMO
SCIENTIFIC SESSIONS 68
SCIENTIFIC SESSIONS
69
SCIENTIFIC SESSIONS
SUNDAY, MAY 3
08:30-10:00
Anatomy Workshop
Acne and Rosacea Symposium (I)
Non-invasive Body Contouring
Satellite Speeches: Intense Pulse Light and Pulsed Dye Laser
Physician Only
Lecturing in English
Lecturing in Chinese
Simultaneous Interpreting
Medical Dermatology
Dermatological Surgery
Engergy-based Devices
Injectables
Staff Training
SCIENTIFIC SESSIONS 70
SUNDAY, MAY 3
Anatomy Workshop
Sun. May 3, 8:30-10:00
Room 301A
Moderator TSENG, Chung-Jen (曾忠仁) MD
SUNDARAM, Hema MD
CASSUTO, Daniel MD
AW1 Overview of Key Anatomical
Structures - An Asian Perspective
(video demo)
8:30 / JUNG, Wonsug MD, Ph.D
/ MOON, Hyoung-Jin MD
AW1 Overview of Key Anatomical
Structures - An Asian Perspective
(video demo)
Speaker JUNG, Wonsug MD, PhD
MOON, Hyoung-Jin MD
Moderator TSENG, Chung-Jen (曾忠仁) MD
SUNDARAM, Hema MD
CASSUTO, Daniel MD
It has already been passed 10 years since cosmetic
surgical procedures, using fillers has been introduced
to Asia. The concept itself of ‘filler’ was unfamiliar,
but the advantage that it is safer and effective gradually
became well-known. Thus, it has recently become a
representative procedure in the cosmetic surgery area.
Filler is any material that can augment volume when
injected into the body, and is usually an injectable
material. Well-known fillers include hyaluronic acid
products, collagen, paraffin, liquid silicon etc. Fillers
are usually classified by their components. Fillers can
be classified by their longevity, fillers with duration of
less than 2 years are called temporary fillers, those with
duration of 2 to 5 years are called semi-permanent
fillers, and those lasting no less than 5 years after
injection are called permanent fillers. Fillers can also
be divided based on the mechanism of action, such as
volumizing fillers and stimulatory fillers. Collagen
and hyaluronic fillers in which the injected material
itself constitute the augmented volume are classified as
volumizing fillers, and those which augment volume
by stimulating fibroblasts to synthesize collagen or
depositing fibrous tissues through inflammatory
response are called stimulatory fillers.
Most of the fillers introduced in Asia have a good
safety profile. However, serious side effects such
as granuloma formation or inflammation due to
tissue reaction have been reported with several filler
products, so it is necessary to select the desirable filler
by understanding the characteristics of each product.
The ideal filler should have no tissue reaction, is longlasting,
safe and easy to use, be, and have no intratissue
migration or allergic reaction.
Facial cosmetic surgery using filler can only be
successfully performed if the surgeon has a good
understanding of anatomy and is able to select the
appropriate product for his purposes.
Anatomically, the face is the most complicated
structure of the human body. Especially, the structure
SCIENTIFIC SESSIONS
71
of facial muscles including nerves and vessels is very
variable and has the racial differences. Recently,
the importance on the facial anatomy has been
reconsidered as the interest on the facial aesthetics is
increasing. The aesthetic physicians should understand
the anatomy of the facial musculature. Through
this lecture, I would like to show the anatomical
characteristics and the individual variations of the face
related to the filler injection for the safe and efficient
clinical applications.
Meet and Dine with Experts
SUNDAY, MAY 3 18:30~20:30
與大師有約
Dr. ACQUILLA, Raj
Dr. CHAN,Samson Chi-Fai (陳智輝)
Dr. PRASETYO, Adri
Dr. SATO, Kiyoshi
Dr. SUNDARAM, Hema
會員/準會員限定！
與大師共進晚餐的難得經驗
若您尚未登記與大師見面的機會，
請速洽大會秘書處預約繳費(1500元/人)
高雄漢來飯店12F東方樓
19
SCIENTIFIC SESSIONS 72
Room 301B
Moderator YANG, Li-Cheng (楊麗珍) MD
HUANG, Po-Han (黃柏翰) MD
AR1 Taiwan Acne Consensus Report
8:30 / HUI, Rosaline Chung-Yao (許仲瑤) MD, PhD
AR2 What does 30 years of Isotretinoin
Usage Tell Us?
8:40 / YANG,Chia-Yi (楊佳懿) MD
AR3 How I Treat Active Lesion with
Lasers
9:00 / WANG, Shiou-Han (王修含) MD
AR4 How I Treat Acne Scars?
9:20 / CHAO, Yates Yen-Yu (趙彥宇) MD
AR5 Evidence for Treating Early to
Prevent Scar
9:40 / HAYASHI, Nobukazu MD, PhD
10:00 Discussion
AR1 Taiwan Acne Consensus Report
Speaker HUI, Rosaline Chung-Yao (許仲瑤) MD, PhD
Moderator YANG, Li-Cheng (楊麗珍) MD
HUANG, Po-Han (黃柏翰) MD
I will present the conclusion from consensus meeting
on treatment of Acne vulgaris, which covers patient
education and recommendation on the use of topical
and systemic antibiotics, hormone, and isotretinoin;
as well as adjuvant physical therapies and laser/ light
treatment. Special highlight is on the use of topical
maintenance therapy and agreement on limiting the
use of antibiotics.
SUNDAY, MAY 3
Acne and Rosacea Symposium (I)
Sun. May 3, 8:30-10:00
SCIENTIFIC SESSIONS
73
AR2 What does 30 years of Isotretinoin
Usage Tell Us?
Speaker YANG,Chia-Yi (楊佳懿) MD
Moderator YANG, Li-Cheng (楊麗珍) MD
HUANG, Po-Han (黃柏翰) MD
With 30 years of clinical use, it is appropriate to review
the use of isotretinoin. We now understand that
retinoids influence cellular growth, differentiation,
morphogenesis and apoptosis, inhibit tumour
promotion and malignant cell growth, exert immunomodulatory
actions and alter cellular cohesiveness.
This has expanded the indications of isotretinoin from
just acne and rosacea to a wide range of inflammatory
and malignant skin disorders. While the standard dose
has served us well in the management of acne vulgaris,
there is emerging evidence that much lower dosages
are just as effective but have significantly fewer adverse
effects. Important changes in the use of isotretinoin
include using a lower daily dose for a longer period of
time. The frequency of depressive disorders during
isotretinoin treatment varies in different studies, and it
is unclear whether this is a consequence of isotretinoin
therapy. Teratogenicity however,remains a very
significant concern. Relapse of acne vulgaris continues
to be a problem but we are beginning to recognise
that this is related less to the cumulative dose and
more to the length of sebaceous gland suppression.
New indications continue to emerge, particularly as
a potential treatment for both intrinsic and extrinsic
(photo) aging.
AR3 How I Treat Active Lesion with
Lasers
Speaker WANG, Shiou-Han (王修含) MD
Moderator YANG, Li-Cheng (楊麗珍) MD
HUANG, Po-Han (黃柏翰) MD
Acne treatment is an important issue for the daily
practice of dermatologist. Topical and oral agents
are essential in traditional medical therapy. Laser
and energy based methods can provide adjuvant
therapeutic effects. In several studies, light-emitting
diode (LED), intense pulsed light (IPL), lasers and
radiofrequency (RF) are advocated to take into
consideration for the treatment of acne. For most
modalities, such as infrared/KTP lasers, blue/red
lights, IPL and RF, they can kill Propionibacterium
acnes, the causitive bacteria of acne and destruct the
sebaceous glands with either or both photochemical
and photothermal effects. Besides suppression of
sebaceous glands and bactericidal activity, pulsed dye
laser (PDL) can induce keratinocyte growth arrest
and have anti-inflammatory property. Although both
IPL and PDL can treat acne effectively, PDL has a
more sustained effect. TGF-beta is an substantial antiinflammatory
cytokine related to PDL. Combination
therapy can get the most significant result if several
laser modalities are combined with traditional medical
treatment.
SCIENTIFIC SESSIONS 74
AR4 How I Treat Acne Scars?
Speaker CHAO, Yates Yen-Yu (趙彥宇) MD
Moderator YANG, Li-Cheng (楊麗珍) MD
HUANG, Po-Han (黃柏翰) MD
The section of lecture covers the subjects of
1.Review of present environments of acne scar
treatment.
2.The good, the bad and the ugly of what we do.
3.The mechanism of acne scar formation.
4.The principle of acne scar treatment.
5.Operational acne scar treatment.
6.The combination with light-based procedures.
7.Prevention is better than cure.
AR5 Evidence for Treating Early to
Prevent Scar
Speaker HAYASHI, Nobukazu MD, PhD
Moderator YANG, Li-Cheng (楊麗珍) MD
HUANG, Po-Han (黃柏翰) MD
Prevention of scar is one of the most important
concern for acne patients, but classification of acne
scars has not yet been established, and there have been
very few studies on the prevalence and severity of acne
scars. We investigated the prevalence of acne scars and
their impact on the quality of life (QOL) in Japanese
acne patients with our classification for acne scars.
Acne scars were classified as mini-scars (atrophic
scars 0.5-2 mm in diameter), atrophic scars (≥2 mm
in diameter), and hypertrophic scars. The severity of
acne and acne scars were evaluated. The background
of patients and their QOL in relation to acne were
assessed. Of 240 subjects, 90.8% had scars. All patients
with scars had mini-scars; 61.2% and 14.2% of 240
had atrophic scars and hypertrophic scars, respectively.
Severe scarring was found in patients who had
experienced severe acne symptoms, although 15.0%
of patients with scars had experienced only mild acne
symptoms. The total Dermatology Life Quality Index
score was significantly higher in patients with scars
than in patients without scars (5.9 ± 4.4 vs. 4.2 ± 4.1)
.The onset age of acne was similar but acne patients
with scar got initial treatment at the significantly elder
age than ones without acne scar. (19.9±6.4 and 16.8
±4.3 years, respectively; P < 0.01).
Our results confessed that approximately 90% of
patients who visited dermatologists have some scars,
and mild acne symptoms may cause acne scar which
had a negative inpact on patients’ QOL. Comparison
of the background between acne patients with scar
and without scar suggested that earlier treatments by
dermatologists may avoid scar formation.
In conclusion, early intervention by dermatologists is
recommended to prevent acne scar.
SUNDAY, MAY 3
Acne and Rosacea Symposium (I)
Sun. May 3, 8:30-10:00
SCIENTIFIC SESSIONS
75
SUNDAY, MAY 3
Non invasive Body Contouring Devices
Sun. May 3, 8:30-10:00
Room 304A
Moderator CHEN, Yi-Ju (陳怡如) MD
CHENG, Teh-Yang (莊德揚) MD
NB1 Monopolar Radiofrequency for Body
Contouring
8:30 / PENG, Hsien-Li (彭賢禮) MD
NB2 Side Effects and Adipocytic Changes
after Cryolipolysis
8:42 / WANG, Cheng-Kun (王正坤) M.D., EMBA
NB3 Non-invasive Fat Reduction by
Using Cryolipolysis
8:54 / LU, Ching-I (盧靜怡) MD
NB4 Thermal Effect Focused Ultrasound
for Body Contouring
9:06 / IN, Sung-il MD
NB5 Non-thermal Effect Focused
Ultrasound for Body Contouring
9:18 / CHANG, Shyue-Luen (張學倫) MD
NB6 Combined Techniques of
Radiofrequency and Dynamic
muscle Activation in Body
Contouring
9:30 / YU, Jonathan Nevin MD
NB7 Selective Radiofrequency Therapy
As A Non-Invasive Approach For
Contactless Body Contouring
9:42 / FUJIMOTO, Takahiro MD, PhD, MBA
NB1 Monopolar Radiofrequency for Body
Contouring
Speaker PENG, Hsien-Li (彭賢禮) MD
Moderator CHEN, Yi-Ju (陳怡如) MD
CHENG, Teh-Yang (莊德揚) MD
Body contouring is one of the fastest growing
treatments of the global aesthetic field. Monopolar
radiofrequency uses volumetric bulk heating to induce
new collagen formation and tighten skin. It not only
treats the facial and neck skins, but also that of the
hands and the body. In this session, I will present
clinical experience using monopolar RF for body
contouring and tightening.
SCIENTIFIC SESSIONS 76
NB2 Side Effects and Adipocytic Changes
after Cryolipolysis
Speaker WANG, Cheng-Kun (王正坤) M.D., EMBA
Moderator CHEN, Yi-Ju (陳怡如) MD
CHENG, Teh-Yang (莊德揚) MD
Cryolipolysis is a contemporary method for localized
natural fat reduction while sparing injury to skin
and other structures. The proposed mechanisms,
which result in immediate fat cell demise and gradual
apoptosis, are associated with lipid-ice crystallization,
inflammatory panniculitis, phagocytic process, and
then gradual clearance.
Most adipocytes cooled to 7°C demonstrated necrotic
injury and some apoptotic injury. Adipocytes cooled to
temperatures of 14°C, 21°C, and 28°C resulted in no
necrotic injury but had the same degree of apoptotic
injury after 48 hours as those cooled to 7°C. There
is supportive evidence that intracellular “lipid ice” is
formed at around 10.0°C (compared to water ice at
0°C). The presence of lipid ice may contribute to the
immediate death or delayed apoptosis of fat cells.
The side effects of cryolipolysis includes cold injury
and blister formation. The wound may present with
blisters that do not appear to be deep. There is often
progression of the wounds over days because of injury
to the microvasculature.
NB3 Cryolipolysis for Body Contouring
Speaker LU, Ching-I (盧靜怡) MD
Moderator CHEN, Yi-Ju (陳怡如) MD
CHENG, Teh-Yang (莊德揚) MD
CryolipolysisTM is developed according to the
concept: the fat cells are more susceptible to cold
than the skin, nerve and muscle. The efficacy and
safety of CryolipolysisTM depends on the suitable
temperature and treatment duration. Here, we will
discuss about the advantages of this technique over the
other noninvasive treatment of fat reduction and the
advantages of “DualSculpting”.
SUNDAY, MAY 3
Non invasive Body Contouring Devices
Sun. May 3, 8:30-10:00
SCIENTIFIC SESSIONS
77
NB4 Thermal Effect Focused Ultrasound
for Body Contouring
Speaker IN, Sung-il MD
Moderator CHEN, Yi-Ju (陳怡如) MD
CHENG, Teh-Yang (莊德揚) MD
Non-invasive body contouring is often challenging
topic in aesthetic dermatology field. There have been
various non-invasive methods to reduce body fat,
including radiofrequency, laser/light, cryolipolysis,
ultrasound and etc.
HIFU is a one of the cutting edge technology that
passing through skin and superficial tissue without
causing injury. Liposonix® is a significant advance
in non-invasive body contouring that patients are
looking for. Liposonix® automatically aims transducer
to create continuous thermal lesion lines at focal
depth, and produce predictable, reproducible, uniform
lesion matrix. The temperature within the focal zone
causes rapid cell death. It reduces fat and provides
tightening of collagen within the subcutaneous layer.
Average circumferential waist reduction after a single
Liposonix treatment is at least 2.5 cm.
NB5 Non-thermal Effect Focused
Ultrasound for Body Contouring
Speaker CHANG, Shyue-Luen (張學倫) MD
Moderator CHEN, Yi-Ju (陳怡如) MD
CHENG, Teh-Yang (莊德揚) MD
Wider social acceptances of cosmetic procedures
have resulted in increased demands for procedures
that will improve body image and the quality of life.
Current available options for body contouring do not
necessarily satisfy all of the patient’s needs.A novel
non-invasive therapeutic ultrasound system that uses
non-thermal focused ultrasound to reduce adipose
tissue has been developed to improve the removal
of unwanted fat deposits without the drawbacks of
invasive techniques. Previous studies have shown
that single or multiple treatments by this device are
effective and safe.
We conduct a study that include thirty-two Asian
patients receiving 3 sequential treatments every
2 weeks in the abdominal region. Two patients
underwent MRI study randomly. There was a mean
reduction in circumference of 3.91±1.8 cm (p≤0.001).
In MRI measurement, the average in fat thickness
reduction was 21.4 and 25 % on the upper and lower
abdomen, respectively. There were three mild and
self-limited localized adverse events. Although the
change is minor compared to traditional surgical
procedure, it is real and effective.
SCIENTIFIC SESSIONS 78
NB6 Combined Techniques of
Radiofrequency and Dynamic
muscle Activation in Body
Contouring
Speaker YU, Jonathan Nevin MD
Moderator CHEN, Yi-Ju (陳怡如) MD
CHENG, Teh-Yang (莊德揚) MD
Non-invasive aesthetic procedures for body shaping
are constantly demanded worldwide. Currently
existing non- invasive procedures are limited in term
of efficacy and safety and practitioners often tend
to combine a few technologies and complementary
treatment modalities in order to improve results.
The Maximus platform is a unique device which uses
Tripolar RF to stimulate the release of fat with collagen
remodeling of the dermal layer. At the same time it
synergistically uses low frequency pulsed current
to stimulate muscle to remove the fat via enhanced
lymphatic drainage.
Clinical evaluations of the technology demonstrated
safety and efficacy of the Maximus treatment in
circumference reduction, improvement of cellulite
appearance and skin tightening.
Patients and practitioners benefit from the use of
multiple technologies at once, in a significantly shorter
treatment time as compared to other commonly used
combination protocols applying separate devices or
technologies.
Aside from body contouring, other treatment
modalities like facial tightening, acne and acne scar
treatments using the Maximus will be presented.
NB7 Selective Radiofrequency Therapy
As A Non-Invasive Approach For
Contactless Body Contouring
Speaker FUJIMOTO, Takahiro MD, PhD, MBA
Moderator CHEN, Yi-Ju (陳怡如) MD
CHENG, Teh-Yang (莊德揚) MD
Noninvasive body contouring treatment is an everexpanding
category in aesthetics, and today there is
an array of technologies that promise to help freeze,
emulsify, or damage fat cells and tame trouble spots.
Vanquish from BTL Aesthetics utilizes a Selective
RF™ field system designed for no contact deep tissue
energy application. This system automatically tunes
the tissue-applicator generator circuitry to selectively
deliver RF energy to adipose tissue layer with specific
impedance, shaping the energy field to optimize
penetration and maximize the treatment area. The
adipose tissue layer is heated faster than other tissue
layers such as skin and muscle. However, these layers
cool down much more rapidly than adipose tissue
because of the circulating blood. In addition, skin
can be cooled by air circulation due to the no contact
applicator.
Vanquish provides a safe and effective procedure that
treats a large surface area with virtually no patient
discomfort and no consumables. Numerous published
studies confirm that the clinical end point of body
contouring is to achieve adipocyte apoptosis.This has
been documented to occur when the temperature
of fat cells rises above 44C. Vanquish emits highfrequency
radio waves that penetrate through
the tissue layers to heat the fat cells to 46C with
extraordinary selectivity due to its software.
During the procedure, the client lies down in a
comfortable position and the Vanquish panel is
positioned over the intended areas of the body. Sensors
within the device will almost instantaneously measure
the impedance and adjust the energy delivery. Patients
describe a feeling of warmth that is similar to a heating
pad. They often use the 30-minute treatment time to
relax, nap, or listen to music because of the easy and
pain-free nature of treatment.
The average patient typically undergoes one treatment
a week for approximately 4 to 6 weeks. Most of
our patients report a visible change after the third
SUNDAY, MAY 3
Non invasive Body Contouring Devices
Sun. May 3, 8:30-10:00
SCIENTIFIC SESSIONS
79
treatment.
Patients can return to their normal routines and
activities immediately after the treatment. To ensure
the proper elimination of the fat cells, patients
are advised to drink lots of water before and after
Vanquish treatment, as well as to stay active by walking
or exercising.
SCIENTIFIC SESSIONS 80
SUNDAY, MAY 3
Skin Tumor Experts Meeting
Sun. May 3, 9:20-10:20
Room 303B
Moderator CHANG, Chun-Hsing (張中興) MD PhD
C HENG, Shih-Tsung (鄭詩宗) MD
ST1 The Melanoma Revolution:
Breakthroughs in Therapeutics
and Understanding Molecular
Pathogenesis
8:30 / FISHER, David MD, PhD
Discussion
10:00 / All
ST1 The Me l anoma R e v o l u t i o n :
Breakthroughs in Therapeutics
and Understanding Molecular
Pathogenesis
Speaker FISHER, David MD, PhD
Moderator CHANG, Chun-Hsing (張中興) MD PhD
C HENG, Shih-Tsung (鄭詩宗) MD
Melanoma has emerged as a malignancy whose
molecu l a r underpinnings and thera p e u t i c
opportunities stand at the forefront of recent progress
in the world of oncology. Several key oncogenic driver
events were identified through genomic analyses,
one of which (BRAF(V600E)) provides a drugable
opportunity. In deed small molecule targeting of the
BRAF/MEK/MAPK pathway has produced a high
fraction of significant clinical responses in patients
harboring mutant BRAF. Emergence of treatment
resistance, however, is a common event, and represents
a key challenge to ultimate success of this therapeutic
approach. Simultaneously, major breakthroughs have
occurred in the application of immunotherapies to
the treatment of advanced melanoma. Most successful
among these are the “immune checkpoint” blockade
therapies. These treatments consist of humanized
“blocking” antibodies which prevent “tolerance”
receptors from functioning, thereby triggering
reactivation and anti-tumor immunity. This lecture
will review these important treatment paradigms as
well as molecular aspects of melanoma which are
thought to underlie both the successes and limitations
of these new therapeutic approaches.
SCIENTIFIC SESSIONS
81
SUNDAY, MAY 3
Satellite Speeches: Intense Pulse Light and Pulsed Dye Laser
Sun. May 3, 8:30- 10: 00
Room 304B
Moderator CHEN, Po-Hung (陳柏宏) MD
SS12 Clinical Applications on Optimal
Pulse Technology (OPT) and
Fractional Non-Ablative Skin
Resurfacing
8:30 / CHAN, Hau-Ngai (陳厚毅) MD
Moderator CHEN,Chien-Hsun (陳建勳) MD
SS13 Novel Treatment of Acne Vulgaris
(Biostimulation)
9:00 / TSE, Ian Chi-Tat (謝志達)
MBBS,MRCP,FHKCP,FHKAM,FRCP
Moderator WU, Chwen-Huey (吳純慧) MD
SS14 Versatile Clinical Application of
Cynergy MPX Laser
9:30 / PENG, Hsien-Li (彭賢禮) MD
SS12 Clinical Applications on Optimal
Pulse Technology (OPT) and
Fractional Non-Ablative Skin
Resurfacing
Speaker HAN, Hau-Ngai (陳厚毅) MD
Moderator CHEN, Po-Hung (陳柏宏) MD
SCIENTIFIC SESSIONS 82
SS13 Novel Treatment of Acne Vulgaris
(Biostimulation)
Speaker TSE, Ian Chi-Tat (謝志達)
MBBS,MRCP,FHKCP,FHKAM,FRCP
Moderator CHEN,Chien-Hsun (陳建勳) MD
Pulsed dye laser is one of the standard treatment
modalities for vascular lesions. A novel use of the
pulsed dye laser, biostimulation, is achieved by
585nm-pulsed dye laser with pulse duration 0.35ms.
The microcapillaries of diameter <15micron are
injured rather than damaged. This up-regulates TGFbeta
(transforming growth factor) by up to 15 times
in 24 hours following a single treatment. Fibroblast
activity is stimulated and dermal collagen is enhanced.
This presentation will examine the evidence of
biostimulation in treatment of inflammatory acne
lesion, acne scar and facial rhytides.
SS14 Versatile Clinical Application of
Cynergy MPX Laser
Speaker PENG, Hsien-Li (彭賢禮) MD
Moderator WU, Chwen-Huey (吳純慧) MD
Dye lasers have long been the gold standard of
vascular lesion treatment such as port wine stain (PWS)
and telangiectasia (up to about 2 mm in diameter),
while Long pulsed Nd Yag laser showed success in
hair removal and dilated vessels (up to 3-4mm in
diameter).Cynergy laser combines dye laser and long
pulsed Nd Yag laser on the same station. Sequential
firing of dye laser and long pulsed Nd Yag can induce
methemoglobin formation, and allow the physician
to use lower energies when targeting different sizes
of unwanted vessels.Aside from vascular implications,
there are many conditions reported to be treatable
by Cynergy MPX laser, such as rosacea, acne scars
,psoriasis and dark circles.In this session, I will
present and review the versatile clinical applications of
Cynergy MPX laser treatments.
SUNDAY, MAY 3
Satellite Speeches: Intense Pulse Light and Pulsed Dye Laser
Sun. May 3, 8:30- 10: 00
SCIENTIFIC SESSIONS
83
SUNDAY, MAY 3
Satellite Speeches
Sun. May 3, 10:00-10:30
Room 303A
Moderator LIN, Cythia (林亭如)
SS15 經營診所如何擴大非醫療的毛利效益
10:00 / LIN, Cythia (林亭如)
SS15 經營診所如何擴大非醫療的毛利效益
Speaker CHOU, Chunhsu (周俊旭) MD
Moderator LIN, Cythia (林亭如)
消費者對於美容需求概分為手術、注射整形、
鐳射以及美容保養，醫療美容院所（醫院附設醫美
中心、醫美診所）競爭亦日趨激烈，如何在既有營
業項目下擴大營業額，最重要是擴大毛利，將外在
市場既有消費行為導入院所，是未來醫療美容院所
所必須思考的方向。
SCIENTIFIC SESSIONS 84
SCIENTIFIC SESSIONS
SUNDAY, MAY 3
10:30-12:00
Injectable Workshop: How to Make an Elegant Nose
Acne and Rosacea Symposium (II)
Emerging Energy Based Devices Symposium:
Dye Laser and Picosecond laser
Satellite Speeches: Body Contouring (I)
Physician Only
Lecturing in English
Lecturing in Chinese
Simultaneous Interpreting
Medical Dermatology
Dermatological Surgery
Engergy-based Devices
Injectables
Staff Training
SCIENTIFIC SESSIONS
85
Room 301A
Moderator MOON, Hyoung-Jin MD
CHAO, Yates Yen-Yu (趙彥宇) MD
SW1 Asian Rhinoplasty and Preference of
Asian Nasal Aesthetics
10:30 / CHANG, Geun-Uck MD
SW2 Dual Anatomic Layer Concept of
Nasal Augmentation
11:00 / PRASETYO, Adri Dwi MD
SW3 Surgical Removal and Aestheic
Restoration of Nasal Granulomatosis
after Filler Injection (Surgical
Treatment of Paraffinoma)
11:30 / CHANG, Geun-Uck MD
SW1 Asian Rhinoplasty and Preference of
Asian Nasal Aesthetics
Speaker CHANG, Geun-Uck MD
Moderator MOON, Hyoung-Jin MD
CHAO, Yates Yen-Yu (趙彥宇) MD
Cosmetic doctors should have knowledges of standard
aesthetics and features of Asian nose for the best result
when they consult with patients.
Ideal nasal shape is important, but most of all,
harmony with face is more important.
Asian nose vs Western nose
Many Asians have poorly projected tip with weak
support and somewhat bulbous nasal tip with little
definition. The weak lower lateral cartilages and the
caudal septum as well as thick skin and soft tissues
contribute to this phenomenon.
Ideal nasal shape
1. Nasion area
Nasofrontal angle is the most important element in
deciding the nasal height. the ideal nasofrontal angle
for Westerns is 134 degrees(woman) and 130(man),
but 135 degrees was preferred by Asians. The nasion
is the lowest part of the nose. Generally, nasal height
at nasion in the lateral view is about 6mm visible
from the cornea to the nasion was recommended,
but the elevation and shape of the forehead should be
considered.
2. Nasal dorsum
It's ideal if there are 2 parallel lines as a pair on the
nasal dorsum when seen from the front. The ideal
width between the lines in Westerns resulted as
6-8mm(woman), 8-10mm(man). But 8-10mm is ideal
for Asians; however, the shape of the face, distance
between the eyes, and the patient's preference should
be considered in this numerical value. In lateral face
view, the nasal dorsal line from nasion to nasal tip is
more natural when the line is little bit curved rather
than going straight.
3. Nasal tip
The beauty of the nasal tip decides the entire nose's
beauty. In case of Asians, the cartilage is weak and the
SUNDAY, MAY 3
Injectable Workshop: How to Make an Elegant Nose
Sun. May 3, 10:30-12:00
SCIENTIFIC SESSIONS 86
skin is thick so the nasal tip does not get defined too
well, however, the tip defining point should be visible
if possible. In lateral view, 90-95 degrees is appropriate
for Asian nasolabial angle. The doctor should be able
to present the ideal aesthetic standard for the patient
before procedues or operation.
SW2 Dual Anatomic Layer Concept of
Nasal Augmentation
Speaker PRASETYO, Adri Dwi MD
Moderator MOON, Hyoung-Jin MD
CHAO, Yates Yen-Yu (趙彥宇) MD
The nose is a central feature of the face and in
contemporer socio-psychology is highly rewarded
aesthet i c a l l y. Des c r iption of nasal anatomy
corresponds to various skin lining thickness,
specific subcutaneous adipose tissue, layers of
superficial musculoaponeurotic system (SMAS),
dermocartilaginous ligaments, bone and cartilage.
Skin quality with various thickness supported by
underneath tissues creates the border outline and
three-dimensional contour. Interdomal fat pad
and other specific subcutaneous adipose tissue
provides useful space for augmentation. The nasal
SMAS consists of unique layers and has medial
and lateral components. The dermocartilaginous
ligament corresponds to the deep medial expansion.
Supraperiosteum and supraperichondrium provide the
deep spacial place for safe and volumic filler injection.
These detailed anatomy provide rational for dual
anatomic layers of safe and effective augmentation to
establish the aesthetic trends of the nose.
SUNDAY, MAY 3
Injectable Workshop: How to Make an Elegant Nose
Sun. May 3, 10:30-12:00
SCIENTIFIC SESSIONS
87
SW3 Surgical Removal and Aestheic
Restoration of Nasal Granulomatosis
after Filler Injection (Surgical
Treatment of Paraffinoma)
Speaker CHANG, Geun-Uck MD
Moderator MOON, Hyoung-Jin MD
CHAO, Yates Yen-Yu (趙彥宇) MD
Injection of foreign materials, such as paraffin oil, is
an old and obsolete procedure used since the 19th
century to fill anatomic or surgical cavities or to
improve body appearance aesthetically. Some of the
more commonly used liquids are paraffin (mineral
oil), and polydimethyl siloxane (injectable silicone).
Direct injection of liquid paraffin has been used for
soft tissue augmentation throughout the world during
the first half of the 20th century. The use of injectable
liquids for nasal augmentation has been described
by numerous clinicians informing the public of its
destructive consequences. Many patients are suffering
from complications such as paraffinoma, or sclerosing
lipogranulomatosis defined as a granulomatous foreign
body reaction, a well-recognized late complication of
foreign material injection. Although this practice was
abandoned in many countries because of numerous
complications, it continued to be performed by
unqualified practitioners. Most patients are initially
asymptomatic after injection. Gradually, however,
complications such as foreign body granulomatous
reaction develop. It usually manifest as irregular
plaque-like indurations of the skin. Microscopically,
there is granulomatous inflammation with multiple
clear vacuoles.
The goal in treating patients with nasal sclerosing
lipogranulomatosis after injection is radical
debridement of affected areas preserving nasal skin,
and dermofat grafting. Affected soft tissue and foreign
material can be excised between nasal skin and nasal
bone. Only thin skin can be remained after removal,
so blood supply could be poor. That’s why dermofat
graft can be recommended, and hard implants cannot
be used for dorsal augmentation. Dermofat can be
harvested from buttocks area, epidermis is removed,
and inserted into nasal dorsum. If patients don’t want
skin scar or dermofat harvest is not available due to
other reasons, donated dermis such as Alloderm® can
be used. Complete surgical excision is desired because
it can reduce the incidence of recurrence. Surgeons
should be careful not to perforate skin during removal.
SCIENTIFIC SESSIONS 88
SUNDAY, MAY 3
Acne and Rosacea Symposium (II)
Sun. May 3, 10:30-12:30
Room 301B
Moderator CHEN, Wen-Chieh (陳文杰) MD
AR6 Antibiotic Resistance in Asia
Antibiotic Stewardship in Acne
10:30 / LEYDEN, James MD
Moderator LEE, Julia Yu-Yun (李玉雲) MD
AR7 Facial Flushing: Update on
Pathogenesis and Treatment
11:20 / CHEN, Wen-Chieh (陳文杰) MD
Moderator LEE, Woan-Ruoh (李婉若) MD, PhD
AR8 Topical Brimonidine Gel
Introduction
11:50 / TSENG, Jonathan Te-Peng (曾德朋) MD
Moderator LEE, Julia Yu-Yun (李玉雲) MD
AR9 Therapeutic Effects of Topical
Brimonidine Gel on Facial Erythema
of Rosacea - A Preliminary
Observation on Taiwanese Patients
12:10 / LEE, Chaw Ning (李兆甯) MD
/ LEE, Julia Yu-Yun (李玉雲) MD
AR6 Antibiotic Resistance in Asia
Antibiotic Stewardship in Acne
Speaker LEYDEN, James MD
Moderator CHEN, Wen-Chieh (陳文杰) MD
Antimicrobial resistance is a major health issue.
Good antibiotic stewardship is a commitment to help
reduce the spread of antibiotic resistance by using
the right dose of the right antibiotic at the right time
and for the right duration. In many Asian countries,
the consumption of antibiotics is high and antibiotic
resistance is rising so a review of current practice is
urgently needed.
The sensitivity of Propionibacterium acnes (P. acnes)
to antibiotics has decreased rapidly, resulting in less
sensitive strains of P. acnes being found worldwide.
Decreased sensitivity can affect clinical outcomes.
Topical clindamycin is prescribed based on in-vitro
data demonstrating its anti-inflammatory properties,
not in-vivo studies. Two in three patients will have
P. acnes strains for which clindamycin will not work
as an antibiotic. P. acnes sensitivity is greatest to
minocycline.
The Global Alliance to Improve Outcomes in Acne
group recommends the combination of a topical
retinoid with an antimicrobial agent as first-line
therapy for almost all patients with acne. If the
addition of an antibiotic to this regimen is required, its
use should be limited in duration and co-prescribed
with benzoyl peroxide (BPO). Antibiotics should not
be used as monotherapy.
Treatment of acne with adapalene/BPO, a retinoid/
antimicrobial combination, provides both shortterm
efficacy and long-term control. In addition,
clinical improvements resulting from the use of this
combination product with an oral antibiotic for 12
weeks are maintained without continued antibiotic
use.
BPO, the most potent bactericidal agent against P.
acnes, reduces the likelihood of antibiotic resistant P.
acnes emerging. In addition, clinical data demonstrate
that treatment with adapalene/BPO effectively reduces
skin colonization by both antibiotic-sensitive and
antibiotic-resistant P. acnes strains.
SCIENTIFIC SESSIONS
89
AR7 Fa c i a l F l u s h i n g : U p d a t e o n
Pathogenesis and Treatment
Speaker CHEN, Wen-Chieh (陳文杰) MD
Moderator LEE, Julia Yu-Yun (李玉雲) MD
Flush/flash can be defined as transient recurrent
erythema of rapid onset due to paroxismal arteriolar
dilatation localized to face and anterior chest. Clinical
variations may include behavior-dependent flushes
(alcohol consumption, sport or emotional stress),
menopausal hot flushes, hypersentivity reactionmediated
flushes, neoplasm-associated flushes,
drug-induced flushes and rosacea. Menopausal hot
flush is an exaggerated heat dissipation response,
accompanied with profuse sweating, peripheral
vasodilation and feelings of intense internal heat.
Flushes can occur in the presence of tumors, such as
neuroendocrine tumors, medullary thyroid cancer,
renal cell carcinoma, pheochromocytoma or mast
cell activation disorders. Drugs inducing flushes may
include androgen or estrogen deprivation therapy,
niacin, prostacyclin analogues, phosphodiesterase
type 5 inhibitors, dimethyl fumarate, pentoxyfylline,
and infusions with steroid, adenosine or intravenous
immunoglobulin.
The pathophysiologic mechanisms of different
flushes are incompletely understood. Cutaneous
circulation is controlled by a complex interplay of
reflex thermoregulatory control and local heating/
cooling control involving vascular endothelia,
adrenergic and sensory systems. The arterioles
constitute the major resistance in vessels and play a
key role in regulating regional blood flows. Factors
that can influence neurogenic constriction of vascular
beds include the density of sympathetic innervation,
density and subtype of adrenergic receptors,
differences in norepinephrine kinetics, release of
cotransmitters, and local factors such as the degree
of basal tone, the concentrations of vasoactive tissue
metabolites, as well as vessel size and structure. The
sympathetic nerves innervating the vasculature, like
the autonomic nerves innervating the heart, also
display tonic activity, which sets a background level
of vasoconstriction. Withdrawing sympathetic tone
causes less vasoconstriction, resulting in vasodilation.
Understanding of the sympathetic control of blood
vessels in modulating arteriolar resistance and
venous capacitance is expanded upon molecular
characterization of nine subtypes of adrenergic
receptors ( 1A, 1B, 1D, 2A/D, 2B, 2C, 1, 2, and 3)
located on vascular smooth muscles. Whereas both
postjunctional 1- and 2-adrenergic receptors (
1A-, 1D-, 2A/D-, and 2B- subtypes) have been implicated
in sympathetic vasoconstriction, activation of
prejunctional neural adrenergic receptors (mainly
2A/D- and 2C- receptor subtypes) reduces sympathetic
vasoconstriction. In many blood vessels expressing
-adrenergic receptors, - is the predominant
subtype and is activated mainly by circulating
catecholamines to cause vasodilation. Binding of
norepinephrine to adrenergic receptors increases
intracellular Ca2+ leading to contraction of the smooth
muscle.
Elevations in core body temperature occur prior to
menopausal hot flushes, which acts within a greatly
narrowing thermoneutral zone mainly due to estrogen
withdrawl and elevated brain norepinephrine. The
precise etiopathogenesis of rosacea is still unclear. A
progressive central facial erythema is the hallmark,
which usually begins at the age between 20s and 40s.
An increased size of blood and lymphatic vessels has
been demonstrated but the existence of angiogenesis
and/or lymphangiogenesis is debating. Involvement
and activation of mast cells is observed in flushes
associated with hypersensitivity reactions, certain drug
side effects and rosacea.
Topical use of selective -adrenergic receptor agonists
has been demonstrated to be an effective symptomatic
treatment for facial erythema of rosacea. Brimonidine
is highly selective for the 2A-, whereas oxymetazoline
highly selective for the 1A- and partially selective
for 2A- receptor. Brimonidine tartrate 0.33% gel,
approved by the US FDA in August 2013, is indicated
for persistent facial erythema of rosacea. Effect on
erythema severity is observed within 30 minutes of
application after the first application in 1/3 of the
treated patients. The durability of the effect can
be maintained at month 12, with no tachyphylaxis
observed. Rebound erythema can be observed in
approximately 10 to 20% of the patients treated.
Systemic administration of carvedilol, a nonselective
-adrenergic blocker, at 3.125-6.25 mg twice daily
has also been demonstrated to be effective in a small
series of patients. Whether these drugs also possess
an intrinsic anti-inflammatory capacity remains to be
determined.
SCIENTIFIC SESSIONS 90
Systemic hormone therapy with low-dose estrogen
(< 0.5 mg/day) or estrogen plus progestin is the
most effective treatment for menopausal vasomotor
symptoms including hot flushes. Conjugated
estrogens/bazedoxifene (selective estrogen receptor
modulator) represents a new, progestin-free treatment.
Paroxetine mesylate is the first non-hormonal therapy
approved by FDA. Gabapentin and venlafaxine
demonstrate significant efficacy in improving hot
flushes in patients of breast cancer or prostate cancer
undertaking estrogen or androgen-deprivation
therapies. Clonidine can reduce hot flushes associated
with menopause or hormone-deprivation therapy, but
its efficacy in rosacea is weakly evidenced.
AR8 Topical Brimonidine Gel Introduction
Speaker TSENG, Jonathan Te-Peng (曾德朋) MD
Moderator LEE, Woan-Ruoh (李婉若) MD, PhD
Rosacea is a common inflammatory skin disorder
affecting a significant amount of population. Persistent
erythema is the primary feature of rosacea, in addition,
other cutaneous signs such as telangiectasia, papules,
and pustules may also be present. Several medications
are currently approved for the treatment of rosacea
in papules and pustules forms, however, treatment
of erythema is limited. Brimonidine tartrate, a highly
selective alpha2-adrenergic receptor agonist, was
recently shown to be an effective medication in
reducing the erythema of Rosacea with good safety
profile. (J Drugs Dermatol. 2014;13(1):56-61)
SUNDAY, MAY 3
Acne and Rosacea Symposium (II)
Sun. May 3, 10:30-12:30
SCIENTIFIC SESSIONS
91
AR9 Therapeutic Effects of Topical
Brimonidine Gel on Facial
Erythema of Rosacea - A
Preliminary Observation on
Taiwanese Patients
Speaker LEE, Chaw Ning (李兆甯) MD
LEE, Julia Yu-Yun (李玉雲) MD
Moderator LEE, Julia Yu-Yun (李玉雲) MD
Rosacea is a common, chronic inflammatory
skin condition worldwide, including Taiwan.
It has a significant negatively impacts patients'
quality of life. Treatment of moderate to severe
erythematotelangiectatic rosacea (ETR) subtype is
often not satisfactory. Brimonidine is a α2 adrenergic
receptor agonist. Topical brimonidine tartrate gel (TB)
is newly approved for treating moderate to severe
erythema of rosacea. Recent studies showed that oncedaily
application resulted in a 2-grade improvement
of facial erythema in 22% patients at 12h on day 29,
and that BT is safe and consistently effective for longterm
treatment, even in the presence of concomitant
therapies for the inflammatory lesions of rosacea.
(Moore et al JDD 2014).
TB has just become available to a small number of our
patients with ETR in March this year. We shall report
our preliminary clinical observation of the treatment
effects in these patients.
SCIENTIFIC SESSIONS 92
SUNDAY, MAY 3
Emerging Energy Based Devices Symposium Dye Laser and Picosecond Laser
Sun. May 3, 10:30-12:00
Room 304A
Moderator YANG, Chia-Yi (楊佳懿) MD
CHUANG, Shyh-Dyi (莊士迪) MD
EE1 New Applications of Pulsed-dye
Laser: “Biostimulation”
10:30 / TSE, Ian Chi-Tat MBBS, MRCP, FHKCP,
FHKAM, FRCP
EE2 Versatile Clinical Applications of
MPX Pulsed Dye Laser
10:45 / PENG, Hsien-Li (彭賢禮) MD
EE3 Picoseconed Laser
Picosure: From Science to Clinical
Applications
11:00 / PENG, Hsien-Li (彭賢禮) MD
EE4 Dual Wavelength Picosecond Laser
11:15 / CHAN, Henry MD, PhD.
EE5 The Therapeutic Strategy and
Clinical Experiences in Scar
Remodeling by Laser Treatment
11:30 / TAN, Jun (譚軍) MD
EE6 Combination of Infrared Light and
Bi-polar Radio Frequency Energies
for Facial Rejuvenation
11:45 / SUNDARAM, Hema MD
EE1 New Applications of Pulsed-dye
Laser: “Biostimulation”
Speaker TSE, Ian Chi-Tat MBBS, MRCP, FHKCP,
FHKAM, FRCP
Moderator YANG, Chia-Yi (楊佳懿) MD
CHUANG, Shyh-Dyi (莊士迪) MD
Pulsed dye laser is one of the standard treatment
modalities for vascular lesions. A novel use of the
pulsed dye laser, biostimulation, is achieved by
585nm-pulsed dye laser with pulse duration 0.35ms.
The microcapillaries of diameter <15micron are
injured rather than damaged. This up-regulates TGFbeta
(transforming growth factor) by up to 15 times
in 24 hours following a single treatment. Fibroblast
activity is stimulated and dermal collagen is enhanced.
This presentation will examine the evidence of
biostimulation in treatment of inflammatory acne
lesion, acne scar and facial rhytides.
SCIENTIFIC SESSIONS
93
EE2 Versatile Clinical Applications of
MPX Pulsed Dye Laser
Speaker PENG, Hsien-Li (彭賢禮) MD
Moderator YANG, Chia-Yi (楊佳懿) MD
CHUANG, Shyh-Dyi (莊士迪) MD
Dye lasers have long been the gold standard of
vascular lesion treatment such as port wine stain (PWS)
and telangiectasia (up to about 2 mm in diameter),
while Long pulsed Nd Yag laser showed success in
hair removal and dilated vessels (up to 3-4mm in
diameter).
Cynergy laser combines dye laser and long pulsed
Nd Yag laser on the same station. Sequential firing
of dye laser and long pulsed Nd Yag can induce
methemoglobin formation, and allow the physician
to use lower energies when targeting different sizes of
unwanted vessels.
Aside from vascular implications, there are many
codition which the Cynergy laser can treat, such as
rosacea and dark circles.
In this session, I will present clinical experience
on Cynergy laser treatments for different clinical
conditions.
EE3 Picosure: From Science to Clinical
Applications
Speaker PENG, Hsien-Li (彭賢禮) MD
Moderator YANG, Chia-Yi (楊佳懿) MD
CHUANG, Shyh-Dyi (莊士迪) MD
The use of Q-switching lasers in the 1980s
revolutionized the way tattoos and pigmented
lesions were treated and became the gold standard
for tattoo removal. However, treatments and results
remain far from perfect, and doctors are looking
for new technologies to reduce the pain during
treatments and get better results. To achieve selective
photothermolysis, sufficient energy to damage the
target needs to be delivered with a pulse duration that
is less than the thermal relaxation time (TRT) of the
target, which is itself defined by the size and shape of
the target. The TRT of tattoo pigment particles and
melanocyte is less than 10 nanoseconds, suggesting
that energy delivery in the picosecond range (10−12
seconds) should be effective. Picosecond laser
treatments cause significant photomechanical effects
and lead to mechanical breakup of the ink or pigment
particles. Using picosecond pulses allows lower
laser fluences to be used, which should decrease
adverse side effects that are typically produced with
nanosecond QS lasers. Using the Picosecond laser we
can break up smaller particles of tattoo and pigmented
lesions, and less treatments are needed to achieve
better results.
The new picosecond 755 / 532 nm laser ranging from
550 to 750 picosecond is avalible on the aesthetic
market. 755nm provides better photoselective effect in
malanin, while 532nm provides better tattoo clearance
in red and yellow tatoo ink.
Furthermore, an innovative optical focus lens has
been developed that gauges distribution of energy to
the treatment area. The focus lens can enhance focal
fluence up to 20 times energetically campared to the
standard handpiece, and only less than 10% of the
tissue is exposed to ultra high fluence. When using
the fractional focus lens, the epidermis will experience
damage called laser induced optical breakdown
(LIOB). By using this special focus lens, removal of
pigmentation, pore size reduction, and improvement
of wrinkles can be done at the same time.
SCIENTIFIC SESSIONS 94
EE4 Dual Wavelength Picosecond Laser
Speaker CHAN, Henry MD, PhD.
Moderator YANG, Chia-Yi (楊佳懿) MD
CHUANG, Shyh-Dyi (莊士迪) MD
EE5 The Therapeutic Strategy and Clinical
Experiences in Scar Remodeling by
Laser Treatment
Speaker TAN, Jun (譚軍) MD
Moderator YANG, Chia-Yi (楊佳懿) MD
CHUANG, Shyh-Dyi (莊士迪) MD
傳統的疤痕修復技術，總是無法有效的幫助病人消
除疤痕。隨著雷射技術的成熟發展，譚軍教授利用
二氧化碳飛梭雷射技術在整形外科、美容及燒燙傷
領域建立了多個全新的治療理論：疤痕原位再生皮
膚理論、疤痕早期干預治療概念與雷射聯合治療疤
痕概念。而譚軍教授發明的「人工點陣技術」及
「雷射穿孔技術與濕式醫療技術結合的皮膚原位再
生技術」更是突破了傳統疤痕修復的技術限制，有
效幫助病人重獲美麗的肌膚。
SUNDAY, MAY 3
Emerging Energy Based Devices Symposium Dye Laser and Picosecond Laser
Sun. May 3, 10:30-12:00
SCIENTIFIC SESSIONS
95
EE6 Combination of Infrared Light and
Bi-polar Radio Frequency Energies
for Facial Rejuvenation
Speaker SUNDARAM, Hema MD
Moderator YANG, Chia-Yi (楊佳懿) MD
CHUANG, Shyh-Dyi (莊士迪) MD
SCIENTIFIC SESSIONS 96
Room 304B
Moderator WANG, Chao-Huei (王朝輝) MD
SS15 Vanquish: Selective Radiofrequency
Therapy As A Non-Invasive
Approach For Contactless Body
Contouring
10:30 / FUJIMOTO, Takahiro MD,PhD, MBA
Moderator CHANG, Kao-Jung (張高榮) MD
SS16 A Review of Non-Invasive Fat
Reduction Treatments in Korea-
Focusing on High Intensity Focused
Ultrasound
11:00 / IN, Sung-Il MD
Moderator CHIU,Pin-Chi (邱品齊) MD, MBA
SS17 Managing Seborrheic Dermatitis
with Herbal Cosmeceuticals
11:30 / HUANG, Po-Han (黃柏翰) MD
SUNDAY, MAY 3
Satellite Speeches: Body Contouring I
Sun. May 3, 10:30-12:00
SS15 Vanquish: Selective Radiofrequency
Therapy As A Non-Invasive
Approach For Contactless Body
Contouring
Speaker FUJIMOTO, Takahiro MD,PhD, MBA
Moderator WANG, Chao-Huei (王朝輝) MD
Noninvasive body contouring treatment is an everexpanding
category in aesthetics, and today there is
an array of technologies that promise to help freeze,
emulsify, or damage fat cells and tame trouble spots.
Vanquish from BTL Aesthetics utilizes a Selective
RF™ field system designed for no contact deep tissue
energy application. This system automatically tunes
the tissue-applicator generator circuitry to selectively
deliver RF energy to adipose tissue layer with specific
impedance, shaping the energy field to optimize
penetration and maximize the treatment area. The
adipose tissue layer is heated faster than other tissue
layers such as skin and muscle. However, these layers
cool down much more rapidly than adipose tissue
because of the circulating blood. In addition, skin
can be cooled by air circulation due to the no contact
applicator.
Vanquish provides a safe and effective procedure that
treats a large surface area with virtually no patient
discomfort and no consumables. Numerous published
studies confirm that the clinical end point of body
contouring is to achieve adipocyte apoptosis.This has
been documented to occur when the temperature
of fat cells rises above 44C. Vanquish emits highfrequency
radio waves that penetrate through
the tissue layers to heat the fat cells to 46C with
extraordinary selectivity due to its software.
During the procedure, the client lies down in a
comfortable position and the Vanquish panel is
positioned over the intended areas of the body. Sensors
within the device will almost instantaneously measure
the impedance and adjust the energy delivery. Patients
describe a feeling of warmth that is similar to a heating
pad. They often use the 30-minute treatment time to
relax, nap, or listen to music because of the easy and
pain-free nature of treatment.
The average patient typically undergoes one treatment
a week for approximately 4 to 6 weeks. Most of
our patients report a visible change after the third
treatment.
SCIENTIFIC SESSIONS
97
Patients can return to their normal routines and
activities immediately after the treatment. To ensure
the proper elimination of the fat cells, patients
are advised to drink lots of water before and after
Vanquish treatment, as well as to stay active by walking
or exercising.
SS16 A Review of Non-Invasive Fat
Reduction Treatments in Korea –
Focusing on High Intensity Focused
Ultrasound
Speaker IN, Sung-Il MD
Moderator CHANG, Kao-Jung (張高榮) MD
Non-invasive body contouring is often challenging
topic in aesthetic dermatology field. There have been
various non-invasive methods to reduce body fat,
including radiofrequency, laser/light, cryolipolysis,
ultrasound and etc.
HIFU is a one of the cutting edge technology that
passing through skin and superficial tissue without
causing injury. Liposonix® is a significant advance
in non-invasive body contouring that patients are
looking for. Liposonix® automatically aims transducer
to create continuous thermal lesion lines at focal
depth, and produce predictable, reproducible, uniform
lesion matrix. The temperature within the focal zone
causes rapid cell death. It reduces fat and provides
tightening of collagen within the subcutaneous layer.
Average circumferential waist reduction after a single
Liposonix treatment is at least 2.5 cm.
SCIENTIFIC SESSIONS 98
SS17 Body Contouring I: Managing
Seborrheic Dermatitis with Herbal
Cosmeceuticals
Speaker HUANG, Po-Han (黃柏翰) MD
Moderator CHIU,Pin-Chi (邱品齊) MD, MBA
Dandruff and seborrheic dermatitis are common and
troublesome scalp conditions with the primary signs
and symptoms being presence of skin flakes, pruritus,
and sometimes erythema. The first line treatment for
patients with mild severity consists of prescription
and cosmeceutical products, such as zinc pyrithione,
ketoconazole and tar shampoo. Herbal medicine is
traditionally used in many diseases by most Asian
population. The botanical agents reported to be useful
in seborrheic dermatitis are extracts of herbs with antiinflammatory
and anti-fungal effects.
However, p r e p a r a t i o n o f b o t a n i c a l - b a s ed
cosmeceuticals is complex. Very few of these products
are supported by evidence-based science. Therefore,
we conducted a clinical observation using a novel
bio-herbal scalp lotion containing Rheum Palmatum
Extract (Da Huang), Portulaca Oleracea Extract (Ma
Chi Xian), Phellodendron Amurense Bark Extract
(Huang Bai), Angelica Polymorpha Sinensis Root
Extract (Dang Gui), Sapindus Mukorossi Fruit Extract
(You Huang Zi) and Indigofera Tinctoria Extract (Qing
Dai) once daily. Patients also used semi-herbal antidandruff
shampoo containing zinc pyrithione, salicylic
acid and Sapindus Mukorossi Fruit Extract every other
day. Patients who were not satisfied with previously
used shampoo were enrolled in this observation.
Based on Global Severity Score of Scalp, Scalp Surface
Area, Patient and Physician Global Assessments of
Severity, we found the bio-herbal skin treatment is a
safe, well-tolerated and efficacious option in managing
patients with mild seborrheic dermatitis. For those who
have poor response to ketoconazole or zinc pyrithione
shampoo, this herbal cosmeceutical combination will
be one of the options before dermatologists prescribe
topical steroid preparations. In addition, since more
and more botanicals are marketed in cosmeceutical
formulations, dermatologists need to obtain working
knowledge of the major botanicals.
SUNDAY, MAY 3
Satellite Speeches: Body Contouring I
Sun. May 3, 10:00- 17: 00
SCIENTIFIC SESSIONS
99
SCIENTIFIC SESSIONS
SUNDAY, MAY 3
12:00-13:30
Lunch Symposia
Physician Only
Lecturing in English
Lecturing in Chinese
Simultaneous Interpreting
Medical Dermatology
Dermatological Surgery
Engergy-based Devices
Injectables
Staff Training
SCIENTIFIC SESSIONS 100
SUNDAY, MAY 3
Lunch Symposium: MERZ
Sun. May 3, 12:00- 13:30
Room 301A
Moderator WU, Ying-Chin (吳英俊) MD
LS1 From Complex to Neurotoxin : the
Development of Incobotulinum
Toxin A
12:00 / FREVERT, Jürgen MD
LS2 The Science of Total Facial
Rejuvenation with New Generation
HA Filler Technology
12:40 / PRASETYO, Adri Dwi MD
13:20 Discussion
LS1 From Complex to Neurotoxin : the
Development of Incobotulinum
Toxin A
Speaker FREVERT, Jürgen MD
Moderator WU, Ying-Chin (吳英俊) MD
SCIENTIFIC SESSIONS
101
LS2 The Science of Total Fa c i a l
Rejuvenation with New Generation
HA Filler Technology
Speaker PRASETYO, Adri Dwi MD
Moderator WU, Ying-Chin (吳英俊) MD
Aging process decrease facial aesthetics by ongoing
soft-tissue and structural remodeling. The objective
of aesthetic treatments is to challenge this process and
create a more youthful and appearance. Most injectable
fillers are indicated for the reduction of facial folds,
but the current aesthetic paradygm is toward volume
replacement, structural support and beautification
in multiple areas, known as total facial approach.
Successful outcomes incorporate artistic principles,
anatomically rational techniques, and modern
hyaluronic acid filler technology. A novel technology
comprising cohesivity, elasticity, and plasticity provides
complete restoration and structural augmentation
in multilayers fashion, from supraperiosteal deep
injections of volume-depleted fat pads to subdermal
injections for panfacial treatment. The combination of
these new generation fillers helps to forestall the facial
aging process, to beautify, and provide more natural
outcome.
SCIENTIFIC SESSIONS 102
SUNDAY, MAY 3
Lunch Symposium: Galderma
Sun. May 3, 12:30- 13:30
Room 301B
Moderator CHIU,Pin-Chi (邱品齊) MD, MBA
LS3 Innovation in Sun Protection :
Daylong
12:30 / SCHWARZ, Thomas MD, PhD
/ ROHNER, Sonja Andrea eidg. dipl. pharm., dipl.
pharm. med. SwAPP
LS3 Innovation in Sun Protection :
Daylong Lunch Symposium
Speaker SCHWARZ, Thomas MD, PhD
Moderator CHIU,Pin-Chi (邱品齊) MD, MBA
SCIENTIFIC SESSIONS
103
LS3 Innovation in Sun Protection :
Daylong Lunch Symposium
Speaker ROHNER, Sonja Andrea eidg. dipl. pharm., dipl.
pharm. med. SwAPP
Moderator CHIU,Pin-Chi (邱品齊) MD, MBA
Sun protection is the central most powerful tool
available to prevent the development of skin cancer
and avoid premature skin aging. .
However, optimal sun protection is dependent on
multiple factors including the amount of sunscreen
applied, the frequency of application, and the type of
sunscreen utilized. Without consideration of these
critical measures, even the most effective sunscreen
will provide inadequate protection, and result in poor
consumer compliance.
Innovative galenic formulations are the solution
to achieve these critical measures in optimal sun
protection. By creating formulations that have superior
photoprotection, offer application convenience, and
reach high cosmetic acceptance will ultimately support
compliant, frequent, and recommended application
amounts.
Daylong’s passion is to stay at the forefront of
innovation in sun protection, applying the latest
scientific findings to deliver the best sun protection
solutions possible:
-A combination of high quality ingredients in an
innovative galenic formulation.
SCIENTIFIC SESSIONS 104
SUNDAY, MAY 3
Lunch Symposium: TBMS
Sun. May 3, 12:10- 13:30
Room 304A
Moderator PENG, Hsien-Li (彭賢禮) MD
CHENG, Kuo Liang (鄭國良) MD
LS5 The Picosecond Revolution
12:10 / PENG, Hsien-Li (彭賢禮) MD
LS6 New Revolutionary Revitalization
Technique with Improvement of
Pigmentation, Pore Size and Fine
Wrinkle Simultaneously by 755 nm
Picosecond Laser with Focus Lens
Array in Asia Skin—A Preliminary
Report
12:50 / CHENG, Kuo Liang (鄭國良) MD
LS5 The Picosecond Revolution
Speaker PENG, Hsien-Li (彭賢禮) MD
Moderator CHENG, Kuo Liang (鄭國良) MD
Picosecond laser is one of the most important
advances in laser technology in recent years. Picosure,
the first commercially available picosecond laser, has
a pulse length 90 times shorter than the nanosecond
Alexandrite 755nm .
Picosure sees success in treating tattoos of different
colors, pigmented lesions, and the revitalizing of skin.
Through the unique focus lens design, the picosecond
755 laser can also treat fine wrinkles, melasma,
reduced pore size and atrophic acne scars, etc.
In this session, I will present clinical experience about
the picosecond 755nm laser.
SCIENTIFIC SESSIONS
105
LS6 New Revolutionary Revitalization
Technique with Improvement of
Pigmentation, Pore Size and Fine
Wrinkle Simultaneously by 755 nm
Picosecond Laser with Focus Lens
Array in Asia Skin—A Preliminary
Report
Speaker CHENG, Kuo Liang (鄭國良) MD
Moderator PENG, Hsien-Li (彭賢禮) MD
New breakingthrough laser technology with much
shorter pulse width of 755 nm ranged from 550 to 750
picosecond was recently introduced in the aesthetic
market. With picosecond pulse duration, theoretically
more photomechanical effect was involved to destroy
targets with less thermal damage, fluence and sessions
of treatment compared to covnentional photothermal
effect by nanosecond system. We report a new method
of revitalization in treating aging skin for 3 months
with 755 nm picosecond laser.
SCIENTIFIC SESSIONS 106
SUNDAY, MAY 3
Lunch Symposium: Menarini
Sun. May 3, 12:00- 13:30
Room 304B
Moderator HO, Ji-Chen (何宜承) MD
LS7 A Novel Topical Therapy for
Seborrheic Dermatitis
12:00 / CHEONG, Wai-Kwong MD
LS8 Handling Seborrheic Dermatitis
with a Non-Steroid Topical Agent –
Patient Experience Sharing
12:40 / SHIH, I-Hsin (施一新) MD
13:20 Questions & Answers
L S 7 A Novel Topical Therapy for
Seborrheic Dermatitis
Speaker CHEONG, Wai-Kwong MD
Moderator HO, Ji-Chen (何宜承) MD
Seborrhoeic dermatitis (SD) affects 1 – 5% of the
overall population. Infants and adults between the
ages of 30 and 60 years are most commonly affected.
In Asian skin, SD presents in a similar manner to
that seen in Western skin. However, milder forms of
the clinical lesions are often not recognized by the
patient as SD, but regarded as dry skin and therefore
left untreated. SD is a multifactorial skin disease that
is dependent on 3 factors: sebaceous gland secretions,
Malassezia infection and genetic susceptibility; M.
restricta appears to be the predominant species seen in
Korean patients.
It has been observed that patients in Asia tend to selftreat
SD. This could be related to lack of awareness
among the public that SD is a chronic skin condition
that can worsen without effective medical treatment.
This situation is compounded by a limitation in
effective treatments available to physicians. The most
commonly prescribed topical treatments contain
corticosteroids which are associated with potential
side effects with prolonged usage. Steroid-free topical
agents include calcineurin inhibitors and anti-fungals
such as ketoconazole.
A new non-steroidal cream, Sebclair™ has been
proven to be an effective SD treatment with superior
relapse prevention rates. It has anti-inflammatory and
anti-fungal activities, the latter attributed to Piroctone
olamine. The presentation will discuss this novel
therapy in SD
SCIENTIFIC SESSIONS
107
LS8 Handling Seborrheic Dermatitis with
a Non-Steroid Topical Agent –
Patient Experience Sharing
Speaker SHIH, I-Hsin (施一新) MD
Moderator HO, Ji-Chen (何宜承) MD
Seborrheic dermatitis (SD) is a very common skin
problem and dermatologists encounter SD in their
practice almost everyday. Since SD is a chronic,
relapsing, inflammatory skin disease, It bothers many
patients. We tried to use a non-steroid topical agent on
SD patient and observe its clinical response.
We have conducted an open label clinical study on SD:
Inclusion criteria:
1.Age > 12 years of age
2.Diagosed SD patient for at least 3 months
3.Willing to participate and follow-up at weeks 2 and 4
sfter first consultation
4.Agreeable to patient consent/release form
Exclusion criteria:
1.Age < 12 years of age
2.Pregnant or lactaing patients
3.Using SD preparations from either physicians
(prescribed) or from pharmacies
4.Frequent, unavoidable sun exposure over majority of
skin
5.Non-compliance
Clincal pictures taken at week 0, week 2 and week 4
for assessment.
SCIENTIFIC SESSIONS 108
SCIENTIFIC SESSIONS
SUNDAY, MAY 3
13:30-15:00
Injectable Workshop: How to Make Charming Eyes
Urticaria Symposium
Osmidrosis Workshop
Special Lecture
Satellite Speeches
Physician Only
Lecturing in English
Lecturing in Chinese
Simultaneous Interpreting
Medical Dermatology
Dermatological Surgery
Engergy-based Devices
Injectables
Staff Training
SCIENTIFIC SESSIONS
109
SUNDAY, MAY 3
Injectable Workshop: How to Make Charming Eyes
Sun. May 3, 13:30-15:00
Room 301A
Moderator PENG, Hsien-Li (彭賢禮) MD
ACQUILLA, Raj MBChB MRCGP MBCAM
HM4 Peri-orbital Beautification – a 6
Point Approach Using HA Filler
13:30 / ACQUILLA, Raj MBChB MRCGP MBCAM
HM5 The Ideal Shapes and Positions of
Eyebrows
14:00 / HSU, Nai-Jen (許乃仁) MD
HM6 Restorative Approach to the
Periorbital Region
14:30 / SUNDARAM, Hema MD
HM4 Peri-orbital Beautification – a 6 Point
Approach Using HA Filler
Speaker ACQUILLA, Raj MBChB MRCGP MBCAM
Moderator PENG, Hsien-Li (彭賢禮) MD
Peri-orbital beautification
The eye and peri-orbital area is the aesthetic centre of
the face and the first area to show the signs of ageing.
It is often perceived as the area through which people
estimate age and mood. This region is a 360 degree
complex which deteriorates through ageing and can be
summarised as follows:
1) Frontal elongation and brow ptosis
2) Fat accumulation and skin excess in the upper
eyelid
3) Crows feet lines
4) Lateral lower lid cheek junction
5) Infraorbital fat prolapse
6) Tear trough
After treating the upper face with Botulinum toxin we
can optimise the peri-orbital region by injecting low
molecular weight HA in the following 6 points:
1) Zygomatic arch - to lift the lateral cheek
2) Beautification point - to optimise the Ogee curve
3) Malar groove - to correct concavity in the cheek
and tear trough
4) Anatomical tear trough
5) Lateral lid cheek junction
6) Temple, brow and forehead to support the eyebrow
Sequential treatment in low to high risk areas allows
safe injection using low volumes and optimising
aesthetic outcomes in this sensitive and delicate
anatomical region.
SCIENTIFIC SESSIONS 110
HM5 The Ideal Shapes and Positions of
Eyebrows
Speaker HSU, Nai-Jen (許乃仁) MD
Moderator PENG, Hsien-Li (彭賢禮) MD
ACQUILLA, Raj MBChB MRCGP MBCAM
Eyebrows are the important frames of the eyes. Their
main function is hypothesized to prevent sweat, water,
and other debris from falling down into the eye socket,
but they are also important to human communication
and facial expression.The popular shapes and positions
of eyebrows changed in different times.In this leture,
I will talk about the ideal position of eyebrows; the
aging process of eyebrows and the methods which can
change the shapes and positions of eyebrows.
HM6 Restorative Approach to the
Periorbital Region
Speaker SUNDARAM, Hema MD
Moderator PENG, Hsien-Li (彭賢禮) MD
ACQUILLA, Raj MBChB MRCGP MBCAM
If the eyes are the window to the soul, as the poets
say, then the periorbital area is the all-important
frame for that window. When periorbital rejuvenation
is performed well, it can profoundly improve the
appearance of the eyes, and also positively impact the
whole face by restoring prominence to the upper face
in comparison to the lower face and re-establishing
more youthful facial proportions.
This lecture discusses the rationale for combined
nonsurgical treatments to the "periorbital frame" and
presents some novel paradigms for rejuvenating it
by combining fractional bipolar radiofrequency (RF)
and infrared (IR) energy with soft tissue fillers and
botulinum toxin neuromodulators. These treatments
can be applied directly within the periorbital frame.
They can also be applied outside the frame for
secondary vectoring effects. These two approaches
will be compared and contrasted. The combination
of volumetric RF and IR technologies that stimulate
collagenesis and elastogenesis with fillers results in
a restorative approach to periorbital rejuvenation
via synergistic improvement of tissue quality. This
approach is well-suited to Asian patients because RF
and IR are non-chromophore-specific (“color-blind)
and thus can be used safely for pigmented skin.
References
Sundaram H and Kiripolsky M. Clinics in Plastic
Surgery (2013)
Sundaram H and Carruthers J. in Procedures in
Cosmetic Dermatology: Soft Tissue Augmentation
(2013)
SUNDAY, MAY 3
Injectable Workshop: How to Make Charming Eyes
Sun. May 3, 13:30-15:00
SCIENTIFIC SESSIONS
111
SUNDAY, MAY 3
Urticaria Symposium
Sun. May 3, 13:30-15:00
Room 301B
Moderator LEE, Woan-Ruoh (李婉若) MD, PhD
SCHMID-GRENDELMEIER, Peter MD, PhD
UT1 Classification, Diagnosis, Disease
Burden of Chronic Spontaneous
Urticaria (CSU)
13:30 / KULTHANAN, Kanokvalai MD
UT2 Chronic Urticarial and Its
Management: The Humanized IgE
Antibody Omalizumab as a Novel
Treatment of Chronic Spontaneous
Urticaria: MoA and Phase III Data
14:00 / SCHMID-GRENDELMEIER, Peter MD, PhD
UT3 Overview of International and Local
CSU Treatment Guideline, and
Clinical Experience
14:30 / CHU, Chia-Yu (朱家瑜) MD, PhD.
UT1 Classification, Diagnosis, Disease
Burden of Chronic Spontaneous
Urticaria (CSU)
Speaker KULTHANAN, Kanokvalai MD
Moderator LEE, Woan-Ruoh (李婉若) MD, PhD
SCHMID-GRENDELMEIER, Peter MD, PhD
Urticaria is defined by the occurrence of transient
pruritic wheals and/or angioedema. Episodes lasting for
longer than 6 weeks are regarded as chronic urticaria.
The current classification distinguishes spontaneous
from inducible urticarial forms. Symptoms of chronic
spontaneous urticaria (CSU) appear spontaneously. In
most cases, there is no identifiable exogenous stimulus
for hive production.
Diagnostic approach in patients with CSU requires a
thorough history, including possible eliciting factors
and comorbid disorders. Routine laboratory testing
in the absence of a clinical history is rarely helpful
in determining an etiology. The extended diagnostic
procedures should be considered on an individual
basis in patients with long-standing, severe or
persistent urticaria.
The quality of life (QoL) impairment of CSU
patients is comparable with that of patients with
ischemic heart disease. The common impact issues are
pruritus, wheals, embarrassment from urticarial sighs
on body, feeling nervous, swelling of eyes and lips,
embarrassment in going to public places, bad mood,
interfere with sleep, eating, work and spot activities.
CSU poses a high socioeconomic burden for patients.
It is burdensome in terms of both direct medical
costs and indirect costs to society. Dealing with
CSU patients who have a frustrating, unpredictable
condition is challenging and time consuming for
physicians. The patients often have impaired QoL, a
significant emotional burden and high expectations.
SCIENTIFIC SESSIONS 112
UT2 Chroni c U r t i c a r i a l a n d I t s
Management: The Humanized IgE
Antibody Omalizumab as a Novel
Treatment of Chronic Spontaneous
Urticaria: MoA and Phase III Data
Speaker SCHMID-GRENDELMEIER, Peter MD, PhD
Moderator Woan-Ruoh (李婉若) MD, PhD
Urticaria is a very common skin disease with
heterogenous background of causes. A diagnostic
approach is based on the duration of the disease and
a variety of other aspects such angioedeme, duration
of wheals and possible inducing factors such as
physical factors. The diagnsotic algorhytm suggested
revised Urticaria guidelines 2014 elaborated by
EAACI/WAO/GA2LEN will be discussed. Also the
suggested sequentilal therapeutic management by
increased doses of H1-blockers up to fourfold doses
and as a new 3rd step the use of omalizumab will be
presented. Data from the several phase III studies with
Omalizumab will be presented. Also indication and
practical use of Omalizumab in chronic spontaneous
urticaria willl be extensively shwon, based onn the
litarature and experience with mor than 40 own cases.
UT3 Overview of International and Local
CSU Treatment Guideline, and
Clinical Experience
Speaker CHU, Chia-Yu (朱家瑜) MD, PhD
Moderator LEE, Woan-Ruoh (李婉若) MD, PhD
SCHMID-GRENDELMEIER, Peter MD, PhD
Chronic idiopathic urticaria (also called chronic
spontaneous urticarial; CSU) is defined as itchy
hives that last for at least 6 weeks, with or without
angioedema, and that have no apparent external
trigger. CSU has a significant effect on patients’
quality of life both physically and psychologically.
CSU is a common dermatosis, with a prevalence of
1% and a peak incidence between 20 and 40 years of
age. This disease affects women more frequently than
men and it may persist for 3-5 years in 50% of patients
and for over 10 years in 20%. The EAACI/GA2LEN/
EDF/WAO/ guideline provides recommendations for
diagnostic and therapeutic approaches in urticaria.
This guideline recommended first-line treatment
is monotherapy with a second-generation H1-
antihistamine. If symptoms persist after 2 weeks,
recommended second-line therapy is a secondgeneration
H1-antihistmamine at up to four times the
licensed dose. If symptoms persist after one to four
further weeks, the third-line add-on therapies would
be omalizumab, cyclosporine A, or montelukast. The
international EAACI/GA2LEN/EDF/WAO/ guideline
states that the aim of therapy for urticarial should
be complete symptom control. The presentation
will cover the 2014 Taiwanese Dermatological
Association (TDA) consensus regarding the definition,
classification, diagnosis, and management of urticaria.
TDA urticaria treatment consensus recommended
the Urticaria Activity Score (UAS) system or UAS7
(Urticaria Activity Score for 7 days) system to be the
method for assessing disease activity in spontaneous
urticaria. With regard to the treatment algorithm,
it should be noted that the time between each line
of defense was shortened from the original EAACI
guidelines upon which the TDA consensus is based.
Clinicians should also be aware that H1 antihistamines
and omalizumab are the only medications licensed for
treating chronic urticaria by the FDA (US Food and
Drug Administration) and EMA (European Medicines
Agency). Finally, the practical use of omalizumab in
chronic spontaneous urticaria will be shown based on
my own experience.
SUNDAY, MAY 3
Urticaria Symposium
Sun. May 3, 13:30-15:00
SCIENTIFIC SESSIONS
113
SUNDAY, MAY 3
Osmidrosis Workshop
Sun. May 3, 13:30-15:00
Room 304A
Moderator TSAI, Ren-Yeu (蔡仁雨) MD
OW1 Toxin for Hyperhidrosis
13:30 / CASSUTO, Daniel MD
OW2 Noninvasive Treatment of
Bromidrosis by Microwave-based
Device --the Correlation between
clinical and Histologic Study
14:00 / YANG, Chih-Hsun (楊志勛) MD
OW1 Toxin for Hyperhidrosis
Speaker CASSUTO, Daniel MD
Moderator TSAI, Ren-Yeu (蔡仁雨) MD
SCIENTIFIC SESSIONS 114
OW2 Noninvasive Treatment of Bromidrosis
by Microwave-based Device --the
Correlation between clinical and
Histologic Study
Speaker YANG, Chih-Hsun (楊志勛) MD
Moderator TSAI, Ren-Yeu (蔡仁雨) MD
Microwave-based devices target sweat glands through
energy delivery at the dermal-subcutaneous interface.
These devices have been approved by the Food and
Drug Administration as a noninvasive treatment for
axillary hyperhidrosis. We conducted a prospective
study using miraDry® system in treating axillary
osmidrosis. Seven patients with axillary osmidrosis
were recruited and received two consecutive treatment
sessions with a 3-month interval. Overall, six out
of seven (85.7%) participants were satisfied with
the procedure. Skin biopsy specimens reveled 93%
reduction of apocrine glands. Histopathological
changes include dermal fibrosis, necrosis of sweat
glands, and subcutaneous fat necrosis. Transient
swelling, bruise, numbness, lumps, and hypotrichosis
were observed, but no patient reported disabling side
effects. Microwave-based devices are noninvasive and
a potential alternative therapeutic modality for axillary
osmidrosis treatment.
SUNDAY, MAY 3
Osmidrosis Workshop
Sun. May 3, 13:30-15:00
SCIENTIFIC SESSIONS
115
SUNDAY, MAY 3
Special Lecture
Sun. May 3, 14:20-15:00
Room 304A
Moderator HUANG, Po-Han (黃柏翰) MD
CL1 What's Hot in Aesthetic Procedures
Concerning: Lipolysis, Morphotypes
and Neck Rejuvenation
14:20 / ASCHER, Benjamin MD
CL1 What's Hot in Aesthetic Procedures
Concerning: Lipolysis, Morphotypes
and Neck Rejuvenation
Speaker ASCHER, Benjamin MD
Moderator HUANG, Po-Han (黃柏翰) MD
SCIENTIFIC SESSIONS 116
SUNDAY, MAY 3
Satellite Speeches
Sun. May 3, 13:30-15:00
Room 304B
Moderator TSENG, Chung-Jen (曾忠仁) MD
SS18 The Efficacy of a 532nm & 1064nm
Picoseconds Laser for the Treatment
of Tattoo Removal and Benign
Pigmented Lesions
13:30 / CHAN, Henry MD, PhD
Moderator CHAO, Yates Yen-Yu (趙彥宇) MD
SS19 Nonsurgical Modalities to Treat the
Aging Face with Princess ha -based
Fillers
14:00 / RAPPL, Thomas MD
Moderator WANG, Chao-Chin (王昭欽) MD
SS20 EnerJet: Dermal remodeling system
for immediate and long lasting
aesthetic results, by incorporating
Jet Volumetric Remodeling (JVR)
Technology.
14:30 / CASSUTO, Daniel MD
SS18 The Efficacy of a 532nm & 1064nm
Picoseconds Laser for the Treatment
of Tattoo Removal and Benign
Pigmented Lesions
Speaker CHAN, Henry MD, PhD
Moderator TSENG, Chung-Jen (曾忠仁) MD
Improved tattoo clearance by picosecond pulses in
humans was first reported in the literature in 1998.
The study treated designated parts of the same tattoo
with 35-picosecond and 10-nanosecond pulses
from 2 neodymium:YAG lasers and reported that
picosecond pulses are more efficient than nanosecond
pulses in clearing black tattoos. Recently, commercial
picosecond lasers were introduced.
A new (2014) mult i - c e n t e r s t u dy u s ing a
450-picosecond pulses dual-wavelength picosecond
laser to treat 60 patients at 3 sites (Tina Alster, MD,
Arielle Kauvar, MD, & Eric Bernstein, MD) had
interim results which reported that 89% of the subjects
had at least 50% clearance, and 54% of the subjects had
at least 75% clearance of the tattoo. For patients who
had at least 75% clearance, the clearance was achieved
in an average of 4 treatments.
Laser treatment of benign pigmented lesions have
been studied widely. Q-switched laser for pigmented
lesions in Asians reported a 25% post inflammatory
hyperpigmentation risk. Long pulsed Nd:YAG was
reported to have a lower PIH risk.
We recently conducted a study using the dualwavelength
picosecond device to assess the safety
and efficacy of picosecond laser for the treatment
of benign pigmented lesions among Asian. Interim
result reported that 72.7% of subjects had at least 50%
clearance after 3-month follow-up and 3.2% of blister
and PIH.
Preliminary results support the effectiveness and
safety. Updated data from the study will be presented.
SCIENTIFIC SESSIONS
117
SS19 Nonsurgical Modalities to Treat the
Aging Face with Princess HA -based
Fillers
Speaker RAPPL, Thomas MD
Moderator CHAO, Yates Yen-Yu (趙彥宇) MD
Over the past two decades, soft tissue augmentation
using injectable fillers, has become a standard clinical
approach for correcting age-related facial defects.
HA-based fillers appear to be ideal due to their low
immunogenic potential and relatively long-lasting
effect.
The Princess® family (Princess® FILLER, Princess®
VOLUME, Princess® RICH) of dermal fillers,
based on bio fermentative HA, was introduced to the
European market in 2009. It is indicated to correct
deeper wrinkles and folds, increase or restore facial
volume to the face and remodel facial contours.
SS20 EnerJet: Dermal remodeling system
for immediate and long lasting
aesthetic results, by incorporating
Jet Volumetric Remodeling (JVR)
Technology. .
Speaker CASSUTO, Daniel MD
Moderator WANG, Chao-Chin (王昭欽) MD
Using non-thermal kinetic energy to deliver
hyaluronic acid (or other beneficial solutions) for
immediate skin hydration and long term effect which
initiate wound healing process resulting in collagen
regeneration. The treatment is painless and with
minimum downtime. The EnerJet offers various
treatments such as lifting, acne scars, stretch marks
and overall skin regeneration. Improvement can be
seen as early as 1 month and as long as 18 months after
the treatment series.
I have been using the technology since 2009.It’s the
most effective treatment I can provide to my patients
for old stretch marks. It’s also the first line treatment
for deep acne scars, that would not show such an
improvement with any other kind of technology.
In both cases, the atrophic areas are regenerated
without any risk of side effects.
SCIENTIFIC SESSIONS 118
SCIENTIFIC SESSIONS
SUNDAY, MAY 3
15:30-17:00
Injectable Workshop: How to Make Sexy Lips
Psoriasis Symposium
診所經營管理者論壇
Satellite Speeches: Body Contouring (II) and Injectable
Physician Only
Lecturing in English
Lecturing in Chinese
Simultaneous Interpreting
Medical Dermatology
Dermatological Surgery
Engergy-based Devices
Injectables
Staff Training
SCIENTIFIC SESSIONS
119
SUNDAY, MAY 3
Injectable Workshop: How to Make Sexy Lips
Sun. May 3, 15:30-17:00
Room 301A
Moderator PENG, Hsien-Li (彭賢禮) MD
ACQUILLA, Raj MBChB MRCGP MBCAM
IW7 Lip & Peri-oral Rejuvenation – A 6
Point Technique Using HA Filler
15:30 / ACQUILLA, Raj MBChB MRCGP
MBCAM
IW8 Lips Sculpture in Asian
16:00 / PENG, Hsien-Li (彭賢禮) MD
IW9 Anatomic Subdivision Unit Concept
of Lip Augmentation
16:30 / PRASETYO, Adri Dwi MD
IW7 Lip & Peri-oral Rejuvenation – A 6
Point Technique Using HA Filler
Speaker ACQUILLA, Raj MBChB MRCGP MBCAM
Moderator PENG, Hsien-Li (彭賢禮) MD
Peri-oral rejuvenation
The lips are the most dynamic, sensitive and sensual
part of the face. During ageing the lip tissue inverts
causing loss of vertical height and projection, the
philtrum flattens and elongates whilst peri-oral rhytids
deepen. Meanwhile the oral commisure descends
giving the mouth a sad appearance. Injecting in a
sequential manner over 6 points from lateral to medial
can optimise the beauty of the lips and peri-oral
region:
1)Oral commisure – to promote a positive mouth
2)Vermillion border – to enhance eversion and
musocal show
3)Glogau-Klein points – to sharpen the cupids bow
4)Philtral columns – to strengthen the peri-oral frame
5) Peri-oral rhytids – injected superficially and
perpendicularly
6)Volumetry – to achieve the harmony and balance of
PHI
Injection methodology of HA filler at specific depths
allows restoration of the anatomical detail of the lip
and conformity towards the aesthetic ideal.
SCIENTIFIC SESSIONS 120
IW8 Lips Sculpture in Asian
Speaker PENG, Hsien-Li (彭賢禮) MD
Moderator ACQUILLA, Raj MBChB MRCGP MBCAM
The lips is very important for feminine beauty. The
aging signs in lips may include volume loss, wrinkles
on the lips or the perioral skin, dryness, dark color,
and a downturn at the corners of the mouth. A full
pair of beautiful lips makes a face young and attractive.
Just as Asian skin differs from Caucasian skin, so do
the lips. Asian lips are generally fuller than Caucasian
ones, with thicker upper vermilion lips. As a result, lip
sculpting for Asians may differ from in Caucasians.
In this presentation, I will introduce my way to do
aesthetic lip sculpting in Asians .
IW9 Anatomic Subdivision Unit Concept
of Lip Augmentation
Speaker PRASETYO, Adri Dwi MD
Moderator PENG, Hsien-Li (彭賢禮) MD
ACQUILLA, Raj MBChB MRCGP MBCAM
Lip filler augmentation is performed to achieve the
goals of universally accepted standards for ‘ideal’
shapes and proportions, trends, and harmony
with the patient’s overall facial structure. These
objectives lead to specific technical implications in
filler injection by using the concept of anatomic
subdivision unit. Sixteen anatomic subdivision
units for lip augmentation are defined. Videos of
injection technique using this concept are displayed
and practical cases are explained. Lip shapes and
proportions vary between individuals. Aesthetic goals
have to be addressed by using universally accepted
standards, trends regarding attractiveness, and how
it can be applied aesthetically to the patient’s overall
facial structure. These objectives have the implication
of injecting specific target of augmentation in the
anatomic subdivision units of the lips. Regarding lip
augmentation, there are overlapping rules of aesthetic
proportions and trends. Anatomic subdivision unit
concept of lip augmentation is important for achieving
specific results guided by the patient's aesthetic
indication and demand.
SUNDAY, MAY 3
Injectable Workshop: How to Make Sexy Lips
Sun. May 3, 15:30-17:00
SCIENTIFIC SESSIONS
121
SUNDAY, MAY 3
Psoriasis Symposium
Sun. May 3, 15:30-17:00
Room 301B
Moderator TSAI, Tsen-Fang (蔡呈芳) MD
HUANG, Po-Han (黃柏翰) MD
PS1 Selective Targeting of IL-17 in
Psoriasis: the State of the Art
15:30 / FOLEY, Peter BMedSc, MB BS,MD,FACD
PS2 Challenging the Standard of Care
with IL 17 Inhibition: the Evidence
16:00 / FOLEY, Peter BMedSc, MB BS,MD,FACD
PS3 Fresh Perspectives on Maximizing
Psoriasis Patient
16:30 / HUANG, Yu-Huei (黃毓惠) MD
PS1 Selective Targeting of IL-17 in
Psoriasis: the State of the Art
Speaker FOLEY, Peter BMedSc, MB BS,MD,FACD
Moderator TSAI, Tsen-Fang (蔡呈芳) MD
HUANG, Po-Han (黃柏翰) MD
Psoriasis is a chronic relapsing disease of the skin
characterized by variable clinical features. The lesions
are classified as erythrosquamous, which indicates that
both the vasculature (erythema) and the epidermis
(increased scale formation) are involved. Infiltration
of T-helper Type 1 (Th1) cells into regions of affected
skin has long been recognised as a major component
of the immunopathogenesis of psoriasis. More
recently, the Th17 cell was identified; so named
because IL-17 is the key cytokine it produces. The
identification of IL-17 inhibition could be important
in the management of psoriasis. Current treatments,
such as ustekinumab (a IL-23 inhibitor), act upstream
to the generation of IL-17.
In synergy with other cytokines such as TNFα and
IFNγ, IL-17A directly activates keratinocytes and
dermal fibroblasts to produce cytokines (e.g. IL-6,
TNFα, IL-1β) and chemokines. This leads to the
recruitment of inflammatory cells such as neutrophils
and lymphocytes (e.g. Th17 cells) into the psoriatic
lesion thereby maintaining and amplifying local
inflammation. Furthermore, IL-17A released from
Th17 cells induces keratinocyte hyperproliferation.
IL-17A is highly expressed in psoriatic skin lesions. To
target IL-17 effectively, it should be recognised that its
expression in psoriatic skin does not depend entirely
on the activation of Th17 cells, and that mast cells
and neutrophils also release IL-17. Thus, IL-17A is a
rational target for inhibition as therapy for psoriasis.
SCIENTIFIC SESSIONS 122
PS2 Challenging the Standard of Care
with IL 17 Inhibition: the Evidence
Speaker FOLEY, Peter BMedSc, MB BS,MD,FACD
Moderator TSAI, Tsen-Fang (蔡呈芳) MD
HUANG, Po-Han (黃柏翰) MD
Wi th the development of treatments such as
adalimumab (an antitumour necrosis factor
alpha mAb) and ustekinumab (anti-IL-12/23),
dermatologists began to be able to achieve higher %
of PASI 75 and further explore possibility of PASI 90
response in psoriasis patients. Psoriasis treatments are
now at a stage where it is possible to extend treatment
expectations further using the new generation of anti-
IL-17 medications. Secukinumab is the first of the IL-
17 agents that has been assessed in several 52-week
Phase III studies, of which the two pivotal trials were
recently reported in the New England Journal of
Medicine.
Secukinumab at 150 mg and 300 mg (administered at
Baseline, Weeks 1, 2, 3 and then every 4 weeks starting
from Week 4) was compared with placebo in the
ERASURE trial, or etanercept (at the indicated dose of
50 mg twice weekly, followed by 50 mg once weekly)
in the FIXTURE trial. The proportion of patients who
met the criterion for PASI 75 at week 12 was higher
with each secukinumab dose than with placebo or
etanercept: in the ERASURE study, the rates were
81.6% with 300 mg of secukinumab, 71.6% with 150
mg of secukinumab, and 4.5% with placebo; in the
FIXTURE study, the rates were 77.1% with 300 mg
of secukinumab, 67.0% with 150 mg of secukinumab,
44.0% with etanercept, and 4.9% with placebo. At 16
weeks the benefit was even greater, with 76% (150
mg) and 87% (300 mg) of patients achieving PASI 75.
Furthermore, Clinical response (i.e., a 50% reduction
in the mean PASI score) occurred more rapidly with
each secukinumab dose (median, 3.0 weeks with 300
mg and 3.9 weeks with 150 mg) than with etanercept
(median, 7.0 weeks) in the FIXTURE study. Most
importantly, the improvements seen at 16 weeks were
maintained throughout the full 52 weeks of the study,
suggesting that the efficacy of secukinumab is both
rapid and sustained.
In both of our studies, the incidences of adverse
events, notably infectious adverse events, were higher
in the secukinumab groups than in the placebo
group during the induction period. The incidences
of adverse events in the secukinumab groups during
induction and the entire 52-week treatment period
in the FIXTURE study were similar to the incidence
with etanercept.
SUNDAY, MAY 3
Psoriasis Symposium
Sun. May 3, 15:30-17:00
SCIENTIFIC SESSIONS
123
PS3 Fresh Perspectives on Maximizing
Psoriasis Patient
Speaker HUANG, Yu-Huei (黃毓惠) MD
Moderator TSAI, Tsen-Fang (蔡呈芳) MD
HUANG, Po-Han (黃柏翰) MD
Psoriasis is a chronic inflammatory disease that impairs
patients' physical and social functioning. The advance
in medicine had equipped clinical dermatologists
plenty of treatment choices to treat psoriasis. However,
the complexity and variety of psoriasis brought so
much severe impact from patient perspectives that
physicians shall take into consideration to provide the
holistic patient care. Thus, what exactly are the unmet
needs from the patients? How we may improve the
outcome and patient wellbeing remained unanswered.
The assessment of health-related quality of life
(HRQoL) provides a comprehensive insight into the
actual disease burden that are not captured by the
traditional clinical parameters. Recently published in
Journal of Dermatology in Feb., Our Taiwan study
aimed to identify factors that may impact patients'
HRQoL. A cross-sectional study, recruiting a total of
414 psoriasis vulgaris patients between January 2008
and December 2011, has been conducted. Our study
found no significant correlation between disease
severity or duration of psoriasis with HRQoL. Female
patients have poorer HRQoL. Psoriatic arthritis, nail
involvement, burning and itching sensation have a
detrimental effect on HRQoL. This study highlighted
that specific disease-associated symptoms such as
itching and burning sensation, nail involvement and/or
concomitant arthritis were important factors that may
impact patients' HRQoL devoid of clinical severity.
Revicki et al. indicated that improvement in PASI
reduction of >75% corresponded to improvements
in HRQOL outcome measures for patients with
moderate to severe psoriasis. PASI 90 or 100
responders had greater improvements in DLQI
total score than PASI 75 responders. Following
review from Mattei et al. also indicated that in the
13 RCT analyzed, the mean percent PASI reduction
of >75%, had a mean DLQI reduction of 9.36, a
mean movement from DLQI band 3 to DLQI band
1. Physicians should carefully consider these factors
when treating psoriasis patients .
SCIENTIFIC SESSIONS 124
SUNDAY, MAY 3
診所經營管理者論壇
Sun. May 3, 15:30-17:00
診所及聯合診所之設立---功能規劃與管理
Speaker 白佳原 院長
Moderator 曾忠仁 醫師
林政賢 醫師
I.座向、環境之規劃（Location & Environment
Planning）
01.位址評估與選擇 Location Evaluation &
Selection
02.停車規劃
03.Rent or Buy of the Building
II.開幕之規劃
01.Time Schedule
02.License
03.Financial
04.招牌
05.設立之科別
06.門面 Layout Planning
07.櫃檯之設計
08.叫號之設計
09.預約掛號 VS 遲到之編號
10.藥局之設計：獨立門戶否？藥架之高度、每格
之高度、易拿取 VS 藥師身高、藥瓶之開罐？
磨藥台之高度、自動包藥機、預包
11.病歷室之規畫
12.資訊、電腦系統之選擇
13.安全系統之規畫
14.現金及支票之安全控管
15.員工之招募＆人事管理
16.公關 Public Relationship
17.年節之處理
18.廣告＆宣傳
19.藝術品裝潢
20.藥品之管理
21.清潔與醫療廢棄物
22.感染控制
23.緊急發電機
Room 304A
Moderator 曾忠仁 醫師
林政賢 醫師
診所經營管理者論壇
論壇1 診所及聯合診所之設立---功能規劃與
管理
15:30 / 白佳原 院長
論壇2 診所的財務
16:00 / 高永浩 會計師
論壇3 診所經營管理者座談
16:30 / 白佳原 院長
/ 高永浩會計師
/ 曾忠仁醫師
/ 林政賢醫師
SCIENTIFIC SESSIONS
125
診所的財務
Speaker 高永浩會計師
Moderator 曾忠仁 醫師
林政賢 醫師
65/10/22稅捐稽徵法完成立法迄今實務上國稅局
面對未依法設置帳簿或不依規定記載者，不曾祭出
稅捐稽徵法第45條之適用，僅依查得資料及財政部
頒費用標準核定其所得額。然而102年9月26日起各
區國稅局紛紛發表稅務新聞稿重申執行業務者如未
依法設置帳簿或不依規定記載，將依稅捐稽徵法第
45條規定祭出罰鍰甚至停業的聲明，其涵義為何？
醫師所得依開業性質區分之類別及查稅問題。
以聯合執業方式經營之節稅效益與注意事項。
醫師所得查稅類型及行政救濟敗訴之關鍵因
素。
診所經營管理者座談
Speaker 白佳原 院長
高永浩 會計師
曾忠仁 醫師
林政賢 醫師
Moderator 曾忠仁 醫師
林政賢 醫師
20
SCIENTIFIC SESSIONS 126
SUNDAY, MAY 3
Body Contouring (II) and Injectables
Sun. May 3, 15:30-17:00
Room 304B
Moderator CHENG, Kuo Liang (鄭國良) MD
SS21 Non-invasive Fat Reduction
of the Outer Thighs by Using
Cryolipolysis –Introduction of the
new Coolsmooth Applicator
15:30 / LU, Ching -I (盧靜怡) MD
Moderator HU, Sindy (胡倩婷) MD
SS22 What’s New in Cryolipolysis -
The Trend of Non-invasive Body
Contouring
16:00 / WANG, Cheng-Kun (王正坤) MD, EMBA
Moderator LU, Ching -I (盧靜怡) MD
SS23 Clinical Applications of A Novel
Polycaprolactone Based Dermal
Filler
16:30 / DE MELO, Francisco MD.
SS21 Non-invasive Fat Reduction
of the Outer Thighs by Using
Cryolipolysis –Introduction of the
new Coolsmooth Applicator
Speaker LU, Ching-I (盧靜怡) MD
Moderator CHENG, Kuo Liang (鄭國良) MD
CryolipolysisTM is developed according to the concept:
the fat cells are more susceptible to cold than the
skin, nerve and muscle. The efficacy and safety of
CryolipolysisTM depends on the suitable temperature
and treatment duration. CryolipolysisTM had been
proved that it is effective to reduce the fat of the
abdomen, back and inner thigh, but it was restricted to
treat the areas of enough pinchable fat.
The CoolsmoothTM is a new, flat, non-vacuum
applicator, which is developed to treat the areas of
non-pinchable fat including the saddle-bag areas of
outer thighs and also the inner thighs and central
abdomen. Since the CoolsmoothTM applicator does not
rely on the suction to reduce fat, CryolipolysisTM can
now freeze the fat of almost all areas of the body, only
if the treated areas can fit the size of the applicator.
SCIENTIFIC SESSIONS
127
SS22 What’s New in Cryolipolysis -
The Trend of Non-invasive Body
Contouring
Speaker WANG, Cheng-Kun (王正坤) MD, EMBA
Moderator HU, Sindy (胡倩婷) MD
Various cosmetic procedures and devices have been
developed to remove or reduce unwanted local
subcutaneous fat. Conventional fat removal is
achieved surgically by liposuction.
To date, there are several devices for noninvasive body
contouring: such as RF(radiofrequencies), LLLT(Low
Level Laser Therapy), Cryolipolysis, ultrasound and
HIFU(High Intensity Focused Ultrasound).
Cryolipolysis whereby fat layer reduction is produced
by selective destruction of fat cells by programmed
death (apoptosis). This technique uses controlled
cold exposure to obtain a gradual reduction of the
subcutaneous fat layer without damage to other
tissues. Studies shows that fat cells, in fact, are much
more sensitive to cold-induced apoptosis than other
anatomic structures such as skin, dermis, vessels,
nerves, and muscles. Cryolipolysis therefore is a safe,
effective, and well-tolerated noninvasive procedure for
body contouring.
This study is conducted by utilizing Icelipolysis, and
the optimal result can be seen from 2 to 3 months
after treatment. The results show that the procedure
significantly reduces the circumference and fat
thickness in the treated areas. The mean reduction in
fat thickness after treatments is 4.5 cm in abdomen.
Circumference is reduced by a mean of 6.86 cm in
abdomen. Weight is unchanged during the treatment,
and no effects on lipid or liver marker levels in the
bloodstream are observed. For patients, Icelipolysis
appears to be a technology offering an effective
procedure performed in a safe and gradual manner.
SS23 Clinical Applications of A Novel
Polycaprolactone Based Dermal
Filler
Speaker DE MELO, Francisco MD
Moderator LU, Ching -I (盧靜怡) MD
The actual knowledge of the aging process has
underlined the importance of volume changes caused
by loss of soft tissue and bone. Primarily, we observe
a decrease in the volume of the subcutaneous fat.
Although this loss of volume is not the only factor
involved, its correction can improve the overall look,
and overcome the need for other interventions.A
novel polycaprolactone based biostimulatory dermal
filler (Ellansé), restores lost volume by inducing
neocollagenesis, improving the soft tissue density and
skin quality. Polycaprolactone is a total resorbable
synthetic medical polymer which has been used for
several decades in medical devices. The longevity of
this dermal filler can be tuned from 12 to 48 months,
still maintaining a high safety standard. It has different
clinical applications, such as facial treatments,
hand rejuvenation and also body treatments, with
long-lasting and consistent results, which we will
demonstrate using 3D photo-technology. This lecture
will also focus on the importance of proper anatomic
knowledge, and clinical techniques to prevent
complications and obtaining predictable results.
130
131
SPEAKERS
132
ACQUILLA, Raj MBChB MRCGP MBCAM
Cosmetic Dermatologist, United Kingdom
CEO, Cheshire Cosmetic Ltd (UK), Cheshire
Cosmetic Ltd (UK)
North West Regional Chair, British College of
Aesthetic Medicine
Faculty Member, The European College of Aesthetic
Medicine & Surgery
AN, Kyung-Chun MD
Aesthetic Surgeon, South Korea
President, The Seroi Clinic
Founder and Director, 5D Liposculpture Academy
Clinical Professor, Korea University
Professor, Korean College of Cosmetic Surgery
President, Natural Beuty Network
Director, HiDef liposculpture, Korea
ASCHER, Benjamin MD
Plastic Surgeon, France
Chairman and Head of the Clinique of Aesthetic
Surgery IENA in Paris, France
Founder and Scientific Director of IMCAS congresses
(Paris, Shanghai, Hong Kong, and Delhi)
Co-director of the first French & European University
XII, Hopital Tarnier. France
Section editor of the Aesthetic Plastic Surgery Journal;
Editorial board, Journal of Cosmetic and Laser
Therapy
AVRAM, Marc R. MD
Dermatologist, United States
Clinical Professor, Dermatology,Department of
Dermatology,Weill Cornell Medical College/New
York Presbyterian Hospital
Associate Editor: Dermatologic Surgery,
Journal of Cosmetic and Laser Therapy &
Journal of Cosmetic Dermatology
International Speakers
133
International Speakers
BEN-NERIAH, Yinon MD., Ph D.
Israel
Professor, The Lautenberg Center for Immunology,
Hebrew University-Hadassah Medical School
President, ILANIT congress of all the societies of
experimental biology in Israel
Chair, Scientific Advisory Board, BIOSS Center of
Excellence, Freiburg University
George and Eva Klein Prize in Cancer Research, Israel
CASSUTO, Daniel MD
Plastic Surgeon, Italy
Plastic and Aesthetic Surgery, private practice in
Milano, Italy
Professor, Plastic, Reconstructive and Aesthetic
Surgery, Plastic Surgery Department, University of
Catania, Italy.
A well-known speaker at meetings throughout the
world. He has delivered more than 150 scientific
presentations on a wide variety of aesthetic topics.
CHAN, Hau-Ngai (陳厚毅) MD
Dermatologist, Hong Kong
Honorary Consultant Dermatologist, Kowloon
Central Cluster, the Hong Kong Hospital Authority
Specialist, Dermamier Skin & Laser Centre
CHAN, Henry M.B.B.S., MD, M Sc, PhD.,
MRCP, FRCP, FRCP, FRCP RCPS, FHKCP, FHKAM
Dermatologist, Hong Kong
Honorary Clinical Professor, Department of Medicine,
The University of Hong Kong
Visiting Scientist, Wellman Center for Photomedicine,
Massachusetts General Hospital, Boston, USA.
Honorary Consultant Dermatologist, Hong Kong
Hospital Authority.
Ellet H. Dr.ake Lectureship Award, American Society
for Laser Medicine and Surgery (ASLMS)
134
CHAN, Samson Chi-Fai (陳智輝) MB. ,
B Ch., FRCSE, FHKAM, FHKCOS
Orthopaedic Surgeon, Hong Kong
President,The Hong Kong Society for Diabetic Limb
Care
Honorary Clinical Associate Professor, Department of
Orthopaedics Surgery, University of Hong Kong.
Honorary Clinical Associate Professor, The Chinese
University of Hong Kong.
CHANG, Geun-Uck MD
Rhinoplastic Surgeon, South Korea
Director, Shimmian Rhinoplasty Clinic
Vice-president, Korean College of Cosmetic Surgery
(KCCS)
Member of KAFPRS (Korean Association of Facial
Plastic and Reconstructive Surgery)
CHEN, Wen-Chieh (陳文杰) MD
Dermatologist, Germany
Clinical Professor, Department of Dermatology and
Allergy, Technische Universität München, Munich
Germany
Member, German Dermatological Society
Member, German Society of Allergology and Clinical
Immunology
CHEONG, Wai-Kwong MD
Dermatologist, Singapore
Medical Director, Specialist Skin Clinic and
Associates, Singapore
Chairman, 1st Asian Expert Forum on the Diagnosis
and Management of Seborrhoeic Dermatitis
Member, 4th Asia Pacific Acne Leaders’ Summit
Member, P&G Olay Pro-X Global Dermatologist
Alliance
Member, International Advisory Committee, 8th
World Congress for Hair Research 2014, Korea
President, Dermatological Society of Singapore
Councilor, International Psoriasis Council
Medical Advisor, Psoriasis Association of Singapore
International Speakers
135
International Speakers
DE MELO, Francisco MD
Plastic Surgeon, United Arab Emirates
Consultant Plastic Surgeon, Aesthetica Clinic
has delivered a wide range of CME accredited training
courses in aesthetic medicine using the most advanced
techniques.
FISHER, David MD, PhD
Researcher, clinician and academic, United States
Ch a i r m a n , D e p a r t m e n t o f Der m a t o l o g y,
Massachusetts General Hospital at Harvard Medical
School
Director, Cutaneous Biology Research Center,
Massachusetts General Hospital
Edward Wigglesworth Professor of Dermatology,
Harvard Medical School
Professor of Pediatrics, Harvard Medical School
Presidential Citation, American Academy of
Dermatology, 2011
Lifetime Achievement Award, Society for Melanoma
Research
FOLEY, Peter BMedSc, MB BS,MD,FACD
Dermatologist, Australia
Head of Dermatology Research, Department of
Dermatology, St Vincent’s Hospital Melboume
Associate Investigator, Probity Medical Research,
Dermatology - Waterloo, Ontario, Canada
Director, Research, Skin & Cancer Foundation Inc.,
Carlton, Victoria
Co-concenor, the Australasian Psoriasis Registry
With over 70 publications in peer-reviewed journal’s.
FREVERT, Jürgen PhD
Biochemist, Germany
Senior Director, Head of Botulinum Research, Merz
Pharmaceuticals GmbH, Germany
Project Manager for biochemical projects, BioteCon
Therapeutics GmbH
Section Manager Molecular and Cellular Biology,
Battelle Europe Institute, Frankfurt
136
FUJIMOTO, Takahiro(藤本幸弘) MD, MBA, PhD
(Surgical Science), PhD (Engineering)
Specialist in Laser Dermatology , Japan
Director, Clinic F Laser & Skin Center
Clinical Associate, The Institution of medical research
of the University of Tokyo
PhD in Medicine (Surgical science) in the University
of Tokyo
PhD in Engineering (Laser : Electromagnetic field) in
Tokai University
Visiting Professor, Buckinghamshire New MBA
Program in Tokyo
Fellow ASLMS (American laser society of medicine
and surgery)
has been actively presenting his lectures at conferences
worldwide such as ASLMS, EADV, AAD, SPIE,
CLEO.
HAYASHI, Nobukazu MD, PhD
Dermatologist, Japan
Director, Department of Dermatology, Toranomon
Hospital
Adjunct Professor, Department of Dermatology, Tokyo
Women’s Medical University
Permanent Director, Japan Organization of Clinical
Dermatologists
Board Member, Japanese Society of Aesthetic
Dermatology
Chairman, Japan Acne Research Society
Section Editor, The Journal of Dermatology
Editor, Aesthetic Dermatology
Editor, Rinsho Derma (Tokyo)
IN, Sung-Il MD
Dermatologist, South Korea
Director, Charm Skin Clinic
Member, Korean Dermatological Association
Member, Korean Academy of Aesthetic medicine
Member, Korean Academy of Obesity Treatment
Member, Korean Society for the Study of Obesity
JUNG, Wonsug MD, PhD
Anatomists, South Korea
Assistant Professor in Gachon University College of
Medicine
Associate Vice Dean of Student Affairs in Gachon
University College of Medicine
Head, Department of Medicine in Gachon University
Graduate School
Member, Asian Association of Clinical Anatomists
Member, Korean Medical Associaion
International Speakers
137
International Speakers
KIM, Beom-Joon M.D, PhD
Dermatologist, South Korea
Head of Professor & Chairman, Department of
Dermatology, Chung-Ang University College of
Medicine, Seoul, Korea
Dr. Paul Janssen Award, Korean Dermatological
Association
Presidential Award, Korea Government
Editorial Board: Journal of the American Academy of
Dermatology; International Journal of Dermatology;
The Journal of Neural Regeneration Research
KULTHANAN, Kanokvalai MD
Dermatologist, Thailand
Chair, Department of Dermatology, Faculty of
Medicine Siriraj Hospital, Mahidol University,
Bangkok, Thailand
Secretary General, Dermatological Society of Thailand
Allergy and Immunology Unit, Department of
Dermatology, Faculty of Medicine Siriraj Hospital,
Mahidol University, Bangkok, Thailand
Member, The American Academy of Dermatology
Member, European Academy of Allergy and
Immunology
Chair, Thailand committee for clinical practice
guideline for urticaria
LEYDEN, James MD
Dermatologist, United States
Senior Consultant KGL Skin Study Center LLC
Professor Emeritus of Dermatology at the Hospital of
the University of Pennsylvania in Philadelphia
Honorary Member, Society of Investigative
Dermatology
American Academy of Dermatology Clarence
Livingood, M.D. Lectureship Award
Director, the American academy of Dermatology
Honorary Member, Society of Investigative
Dermatology
Clarence Livingood, M.D. Lectureship Award,
American Academy of Dermatology
MEDINA-LAVADIA, Angela MD
Dermatologist, Philippines
Chairman, Department of Dermatology, East Avenue
Medical Center
Attending Staff Dermatologsit and Active Consultant,
Department of Dermatology, St. Luke's Medical
Center, Cathedral Heights, Quezon City
Vice President, Philippine Dermatological Society
138
MOON, Hyoung-Jin MD
Facial Plastic Surgeon, South Korea
President, Dr. Moon’s Asthetic Plastic Surgery Clinic
Clinical Professor, Yosein University Medical College
Vice President, KAFPRS (Korean Academy of Facial
Plastic and Reconstructive Surgery)
Chief Faculty, International Microplastic Surgery
Academy
PAK, Chang-Sik MD
Plastic Surgeon, South Korea
Physician, Department of Plastic and Reconstructive
Surgery, Seoul National University Bundang Hospital
PRASETYO, Adri Dwi MD
Dermatologic Surgeon, Indonesia
Director, REJUVA Clinic, Surabaya, Indonesia
Board Certified Dermatologist, Airlangga University,
Surabaya
Scientific Board, International Master Course on
Aging Skin (IMCAS) Asia
National Trainer, Indonesian Society of Dermatology
and Venereology
Inventor and trainer of various aesthetic and surgical
procedures in Indonesia
RAPPL, Thomas MD
Plastic Surgeon, Austria
Reconstructive and Aesthetic Surgeon, Medical
University Hospital Graz, Austria
Director, Aesthetic Clinic (Schwarzl Klinik)
Member, ÖGPÄRC, ISAPS, SOFCPRE.
WAKO medical board member
International Speakers
139
International Speakers
ROHNER Sonja Andrea eidg. dipl. pharm.,
dipl. pharm. med. SwAPP
Medical Therapeutic Specialist, Switzerland
Medical Therapeutic Area Specialist, Spirig Pharma
AG, Egerkingen
Medical Advisor Diabetes, Boehringer Ingelheim
(Schweiz) GmbH, Basel 2012-2014
Field Medical Manager, Novo Nordisk Pharma AG,
Küsnacht ZH 2010-2011
SATO, Kiyoshi M Agr Sc
Research Scientist, Japan
Group Leader, Cutaneous Research Group, Shiseido
Research Scientist, Departments of Dermatology &
Cell Biology, New York University Medical Center
Master of Agriculture, Department of Agricultural
Science, The University of Tokyo
SCHMID-GRENDELMEIER, Peter MD, PhD
Dermatologist, Switzerland
Head, Allergy Unit, Department of Dermatology,
University Hospital of Zürich, Switzerland
Professor, Allergy and Dermatology, University of
Zürich, Switzerland
President, Swiss Society for Allergy and Clinical
Immunology
SCHWARZ, Thomas MD, PhD
Dermatologist, Germany
Professor and Chairman, Departent of Dermatology,
University Kiel
Vice-Dean, Medical Faculty, University Kiel
President, European Society for Dermatologic
Research (ESDR), 2005 -2006
Editorial Board: The Journal of
Investigative Dermatology; Photochemistry
Photobiology; Photodermatology Photoimmunology
Photomedicine; International Archives of Allergology
and Immunology
140
SUNDARAM, Hema MD, FAAD
Dermatologist, United States
Director, Sundaram Dermatology, Cosmetic & Laser
Surgery Center
Visiting Professor, American Society of Dermatologic
Surgery (ASDS)
Board of Directors, International Society for
Dermatologic Surgery (ISDS)
Associate Editor, Journal of Drugs in Dermatology
TAN, Jun (譚軍) MD
Plastic Surgeon, China
Director, Surgery and Laser Beauty Department,
Hunan Provincial People's Hospital
Professor and Master Instructor, Hunan Normal
University and NanHua University
National Committee, Chinese Medical Association of
Aesthetics and Cosmetology
National Committee, Laser Medical Branch of
Chinese Medical Doctor, Association of Plastic
Surgery
TSE, Ian Chi-Tat (謝志達)
MBBS,MRCP,FHKCP,FHKAM,FRCP
Dermatologist, Hong Kong
Consultant Dermatologist, Novo Medical Group
Honrary Assistant Professor, Chinese University of
Hong Kong
Managing Editor, Hong Kong Journal of Dermatology
and Venereology
Fellow, Royal College of Physicians of Edinburgh
Fellow, Royal College of Physicians of Glasgow (2013)
YU, Jonathan Nevin MD
Dermatologist, Philippines
Instructor, Skin and Cancer Foundation, Inc
Editorial Advisory Board, Asian Aesthtic Guide
Advisory Board, Allergan Philippines
Fellow, Philippine Dermatological Society
Fellow, American Academy of Dermatology
Fellow, American Society of Laser Surgery and
Medicine.
International Speakers
141
Domestic Speakers
CHANG, Kao-Jung (張高榮) MD
Plastic Surgeon, Taiwan
Chief Medical director, Ithaca Aesthetic and Antiging
Union clinic, Taipei
Membership of Taiwan Plastic and Reconstructive
Surgical Association and Taiwan Surgical Association
Attending Staff, Division of Plastic and Reconstructive
Surgery, Chang-Gung Memorial Hospital
Member, Taiwan Plastic and Reconstructive Surgical
Association
CHANG, Shyue-Luen (張學倫) MD
Dermatologist, Taiwan
Attending Physician, Department of Dermatology,
Taipei and Taoyuan Chang Gung Memorial Hospital
Membership, American Academy of Dermatology.
Membership, International Society for Hair
Restoration Surgery
Membership, American College of Phlebology
CHAO, Yates Yen-Yu (趙彥宇) MD
Dermatologist, Taiwan
Director, Chao and Chiu Institute of Dermatology
Director, L1 Cosmetic Surgery and Laser Center
A well-known expert of injectable fillers and lots of
Aesthetic devices and an advisory boards of leading
filler, cosmeceutical and device companies.
Attending Staff, Department of Dermatology, Chang-
Gung Memorial Hospital
He is an active lecturer and trainer of fillers across the
world
CHEN, Ya-Hui ( 陳雅惠) MD
Dermatologist, Taiwan
Director, Ya-Skin Dermatology and Aesthetics
Fellow, Department of Dermatology, Boston
University Hospital, MA., USA
Outstanding poster award and outstanding research
paper award from the Taiwanese Dermatological
Association
Outstanding scholarship award from Takeda Science
Foundation
142
Domestic Speakers
CHENG, Kuo Liang (鄭國良) MD
Dermatologist, Taiwan
Director, Haute Beaute Skin & Vein Clinic
Attending Physician, Department of Dermatology,
Taipei Medical University Hospital
Member, Taiwanese Dermatological Association
Fellow member, American Academy of Dermatologic
Surgery
Member, American society for Phlebology
has been invited to present at international associations
such as world congress of dermatology, ASLMS and
IMCAS
CHOU, Chun-Hsu (周俊旭) M.D, PhD
Facial Plastic Surgeon, Taiwan
Director, Dr.JOU Beauty Clinic
CEO, Dr.MORITA Cosmetic Brand
Member, Taiwan Academy of Facial Plastic and
Reconstructive Surgery
Member, Taiwan Otolaryngological Society
CHOU, Erh-Kang (周爾康) MD
Plastic Surgeon, Taiwan
Director, E.K Plastic Surgery Clinic
Attending doctor, Plastic and Reconstructive Surgery,
Burn Center, Chang-Gung Memorial Hospital, Lin-
Kou, Taiwan
Attending doctor, Plastic Surgery, China Medical
University Hospital, Taichung, Taiwan
Reviewer, the Journal of Hand and Microsurgery
CHU, Chia-Yu (朱家瑜) MD, PhD.
Dermatologist, Taiwan
Associate Professor, Department of Dermatology,
College of Medicine, National Taiwan University
CEO, International Medical Service Center, National
Taiwan University Hospital
Clinical Research Fellow, Department of Dermatology,
Henri Mondor Hospital, Paris
Editor-in-Chief, Dermatologica Sinica, Taipei, Taiwan
Published more than 130 articles about chronic
urticaria, chemokines /cytokines and cancer
progression, drug eruption, contact dermatitis, and
atopic dermatitis
143
Domestic Speakers
HSU, Nai-Jen (許乃仁) MD
Dermatologist, Taiwan
Director, Hsu Nai-Jen Dermatologic Clinic, Tainan
Secretary-Treasurer, 3rd Taiwan Dermatology
Aesthetic Conference (TDAC)
Member, Society of Dermatology R.O.C., Taiwan
Member, Society of Dermatoallergology and Contact
Dermatitis Japan
HUANG, Chi-Ching (黃奇卿) DDS
Dentist, Taiwan
Dean, Sun Ring Dentofacial Esthetic Clinic
Taiwan beauty medical specialist
Clinical Lecturer Taipei Medical University
National Taiwan University Hospital, Department of
Cosmetic Dentistry Lecture
Expertise:Oral maxillofacial reconstruction aesthetics
Achievements: 20l3 Archimedes Russia Exhibition of
Inventions, Poland Exhibition of Inventions, Ukraine
Exhibition of Inventions
HUANG, Po-Han (黃柏翰) MD
Dermatologist, Taiwan
Medical Director, Huang P.H. Dermatology and
Aesthetics
Founder, Taiwan Dermatology Aesthetic Conference
(TDAC)
Executive Director, Taiwanese Dermatological
Association (TDA)
Scientific Secretary, International Master Course on
Aging Skin (IMCAS) Asia
Member, Society for Pediatric Dermatology, USA
(SPD)
Reviewer, Journal of Cosmetic Dermatology
HUANG, Yu-Huei (黃毓惠) MD
Dermatologist, Taiwan
Attending Physician, Department of Dermatology ,
Chang Gung Memorial Hospital, Taipei
Assistant professor, Chang Gung University
Deputy Secretary General, Taiwanese Dermatological
Association
Member, Chinese Dermatology Society, Taipei
Member, American Academy of Dermatology
144
HUI, Rosaline Chung-Yee (許仲瑤) MD, PhD
Dermatologist, Taiwan
Attending Physician, Department of Dermatology,
Chang Gung Memorial Hospital at Taipei & Linkou
Assistant Professor, Chang Gung University
LEE, Chaw Ning (李兆甯) MD
Dermatologist, Taiwan
Resident, Department of Dermatology, National
Cheng Kung University, Tainan Taiwan
LEE, Julia Yu-Yun (李玉雲) MD
Dermatologist and Pathologist, Taiwan
Professor, Department of Dermatology, National
Cheng Kung University and Hospital
Chair, Department of Pathology, National Cheng
Kung University and Hospital, 2007-208
Assistant Professor, Departments of Pathology and
Dermatology, University of Pittsburgh, 1986-1988
Fellow, Dermatopathology, New York University
Medical Center, 1984-1986
LI, Kuan-Ying (李冠穎) MD
Plastic Surgeon, Taiwan
Superintendent of Mybest Cosmetic Surgery Clinic
Visiting Staff, Department of Aesthetic Unit,
Kaohsiung Veterans General Hospital
Director, Department of Aesthetic Unit, Feng Yuan
Hospital
Member, International Society of Aesthetic Plastic
Surgery
Member, Academy of Anti-Aging and Regenerative
Domestic Speakers
145
Domestic Speakers
LIN, Tsai-Ming (林才民) M.D, PhD
Plastic Surgeon, Taiwan
Director, Charming Institute of Aesthetic &
Regenerative Surgery
Assistant Professor, Kaohsiung Medical University
Attending Plastic Surgeon, Department of Plastic
Surgery, Kaohsiung Medical University
Director, Surgical Skill Center, Kaohsiung Medical
University Hospital
LU, Ching-I (盧靜怡) MD
Dermatologist, Taiwan
Superintendent, iSkin Laser and Skin Care Center,
Taiwan
Attending physician, Department of Dermatology,
Chang Gung Memorial Hospital, Taipei , Taiwan
Membership, the American Academy of Dermatology
Membership, the American Society of Cosmetic
Dermatology & Aesthetic Surgery
Membership, the American Academy of Anti-Aging
Medicine
PAN, Shin-Chen (潘信誠) MD, PhD
Plastic Surgeon, Taiwan
Assistant Professor, Plastic and Reconstruction
Surgeon, National Cheng Kung University Hospital
Chief, Hyperbaric Oxygen Therapy Center, National
Cheng Kung University Hospital
Research Fellow, University of Washington, Seattle,
USA
PENG, Hsien-Li (彭賢禮) MD
Dermatologist, Taiwan
Director, P-Skin professional Clinic
Editorial Advisory Board of The Asian Aesthetic
Guide
has been invited to speak in more than 100 events
about his experiences in injectables, devices or
combination therapy
146
SHIH, I-Hsin (施一新) MD
Dermatologist, Taiwan
Attending Physician, Department of Dermatology,
Chang Gung Memorial Hospital, Taipei
Director, Department of Pediatric Dermatology,
Chang Gung Memorial Hospital, Taipei
Member of the Board of Supervision, Taiwanese
Dermatological Association
Editor-in-Chief, Taiwanese Dermatological
Association Bulletin
SU, Chen-Wei (蘇承偉) MD
Dermatologist, Taiwan
Director, Chen Chih Dermatological, Cosmetic and
Laser Clinic, Taichung
Member of Taiwan Academy of Facial Plastic and
Reconstructive Surgery
Staff Attending, Department of Dermatology, Veterans
General Hospital Taichung & Laser and Aesthetic
TSENG, Fang-Wen (曾繁聞) MD
Dermatologist, Taiwan
Medical Director, Milano Aesthetic Clinic Taoyuan
Attending Physician, Department of Dermatology &
Aesthetic Medical Center, Chang-Gung Memorial
Hospital, Taipei, Taiwan
TSENG, Jonathan Te-Peng (曾德朋) MD
Dermatologist, Taiwan
Attending Physician, Department of Dermatology,
Taipei Medical University-Shuang Ho Hospital
Lecturer, School of Medicine, Taipei Medical
University
Research Fellow, Keio University and Toranomon
Hospital, Japan
Domestic Speakers
147
Domestic Speakers
WANG, Chao-Huei (王朝輝) MD
Dermatologist, Taiwan
President and CEO, Dr.Shine Medical Cosmetology
Center
Attending Doctor, Tongyen Dermatology Clinic
Attending Doctor, Department of Dermatology,
Mackay Hospital
Clinical Instructor, Department of Dermatology, Tzu
Chi Hospital
Has over 30,000 successful patients in liposuction
WANG, Cheng-Kun (王正坤) MD, EMBA
Dermatologist, Taiwan
Director, E-Champ Dermatology Clinic
Fellow, Asian Academy of Dermatology and
Venereology
Standing Director, Taiwan Medical Association
Standing Director, Taiwanese Dermatological
Association
WANG, Shiou-Han (王修含) MD, MSEE
Dermatologist, Taiwan
Director, Skin168 Institute of Dermatology, Taipei,
Taiwan
Adjunct Staff, Department of Dermatology, National
Taiwan University Hospital,Taipei, Taiwan
Certificate for special competence in Cosmetic
Dermatology
Awarded Best Annual Paper Award from Taiwanese
Society of Biomedical Engineering and Enginnering
Paper Award from Chinese Institute of Engineers
YANG,Chia-Yi (楊佳懿) MD
Dermatologist, Taiwan
Medical Director, Da An Dermatology and Aesthetics
Chair, Department of Dermatology, Cathay General
Hospital
Chair, Department of Dermatology, Taipei Municipal
Ren-Ai Hospital
Lecturer, Department of Medicine, National Yang-
Ming University
Deputy Secretary General, Taiwan Dermatological
Association
Adjunctive Attending Physician, Department of
Dermatology, National Taiwan University Hospital
148
YANG, Chih-Hsun (楊志勛) MD
Dermatologist, Taiwan
Director, Department of Dermatology, Chang Gung
Memorial Hospital, Taipei, Taiwan
Director, Cosmetic Center, Chang Gung Memorial
Hospital, Taipei, Taiwan
Associate Professor, Chang Gung Memorial Hospital,
Taipei, Taiwan
President, Taiwanese Dermatological Association
has authored more than a hundred publications mainly
focusing on the treatment of varicose vein, cutaneous
melanoma and dermatologic surgery
白佳原院長
Taiwan
中山醫學大學醫學人文暨社會學院院長
中華民國醫療精算學會理事長（ 2009/11 ～迄今）
愛恩佳醫療科技研發顧問(2010/1/1~迄今)
中華民國醫療精算學會理事長（ 2009/11 ～迄今）
中山醫學院附設醫院國際標準組織委員會執行長
行政院中部聯合服務中心衛生醫療組諮詢委員
考試院命題委員及閱卷委員編號
中山醫學大學／醫療產業科技管理學系（所）主任
高永浩會計師
Taiwan
元展聯合會計師事務所主持會計師
台灣省會計師公會會計審計委員會執行長
會計師公會全國聯合會中小企業會計審計委員會副
主任委員
會計師公會全國聯合會會計審計委員會委員
會計師公會全國聯合會稅制稅務委員會委員
台灣省會計師公會稅制稅務委員會委員
台北市會計師公會工商服務委員會委員
葉孟宜科長
Taiwan
衛生福利部食品藥物管理署醫療器材及化粧品組化
粧品管理科 科長
經濟部工業局民生化工組 技正
台北榮民總醫院藥劑部 公職藥師
Domestic Speakers
149
Domestic Speakers
MEMO
演講主題：以雷射治療活躍性的青春痘(痤瘡)
演講日期：2015年5月3日
主辦單位：臺灣皮膚科醫學會Taiwanese Dermatological Association
(註：本次演講會議語言為英語，現場有中文同步口譯，請詳見下列資訊)
3rd Taiwan Dermatology Aesthetic Conference
Taiwanese Dermatological Association Spring Meeting 2015
2 May- 3 May 2015, Kaohsiung Exhibition Center
第三屆臺灣皮膚科美容醫學學術研討會
2015年臺灣皮膚科醫學會春季學術研討會
2 May- 3 May 2015, 高雄展覽館
Title, Speaker & Moderators
How I Treat Active Acne Lesion with LasersSpeaker: WANG, Shiou-Han (王修含) MD
Moderators:
YANG, Li-Cheng (楊麗珍) MD
HUANG, Po-Han (黃柏翰) MD
Abstract
Acne treatment is an important issue for the daily practice of dermatologist. Topical and oral agents are essential in traditional medical therapy. Laser and energy based methods can provide adjuvant therapeutic effects. In several studies, light-emitting diode (LED), intense pulsed light (IPL), lasers and radiofrequency (RF) are advocated to take into consideration for the treatment of acne. For most modalities, such as infrared/KTP lasers, blue/red lights, IPL and RF, they can kill Propionibacterium acnes, the causitive bacteria of acne and destruct the sebaceous glands with either or both photochemical and photothermal effects. Besides suppression of sebaceous glands and bactericidal activity, pulsed dye laser (PDL) can induce keratinocyte growth arrest and have anti-inflammatory property. Although both IPL and PDL can treat acne effectively, PDL has a more sustained effect. TGF-beta is an substantial anti-inflammatory cytokine related to PDL. Combination therapy can get the most significant result if several laser modalities are combined with traditional medical treatment.Information of the Speaker
WANG, Shiou-Han (王修含) MDCurrent Position
Director, Skin168 Institute of Dermatology(王修含皮膚科診所), Taipei, TaiwanAdjunct Staff, Department of Dermatology, NTUH(台大醫院), Taipei, Taiwan
Curriculum Vitae
Dermatologist Dr. Shiou-Han Wang(皮膚科醫生：王修含醫師)EDUCATION
Doctor of Medicine (MD), College of Medicine, National Taiwan University
Master of Science in Electrical Engineering (MSEE), Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University
Bachelor of Science in Mechanical Engineering (BSME), College of Engineering, National Taiwan University
PROFESSIONAL CERTIFICATE & LICENSE
Medical License of the National Examination for Physician
Board Certification of the National Specialist Examination for Specialist of Dermatology
Certificate for special competence in Cosmetic Dermatology
POSTGRADUATE TRAINING & OCCUPATIONAL HISTORY
Resident, Department of Surgery, National Taiwan University Hospital(NTUH), Taipei, Taiwan
Resident, Department of Dermatology, NTUH, Taipei, Taiwan
Chief Resident, Department of Dermatology, NTUH, Taipei, Taiwan
Adjunct Staff, Department of Dermatology, NTUH, Taipei, Taiwan
Specialist in Dermatological Surgery & Laser, Department of Dermatology, NTUH, Taipei, Taiwan
Specialist in Acne & Scar Treatment, Department of Dermatology, NTUH, Taipei, Taiwan
Specialist in Dermatologic Ultrasound, Department of Dermatology, NTUH, Taipei, Taiwan
Autobiography
Doctor Shiou-Han Wang(王修含), MD MSEE is the Director of Skin168 Institute of Dermatology(王修含皮膚科診所) and on the Adjunct Staff at National Taiwan University Hospital(台大醫院) in Taipei.
He graduated with Academic Excellence Award from Department of Mechanical Engineering and received his MD degree from College of Medicine of National Taiwan University. He also received his MSEE from National Taiwan University Graduate Institute of Biomedical Electronics and Bioinformatics.
Dr. Shiou-Han Wang's area of research interest in biomedical engineering (laser, radiofrequency and ultrasound) and aesthetic dermatology. He has served as a specialist in Dermatological Surgery & Laser, Acne & Scar Treatment, and High-Frequency Ultrasound in Department of Dermatology, NTUH, Taipei, Taiwan.
Dr. Wang was awarded Best Annual Paper Award(年度最佳論文獎) from Taiwanese Society of Biomedical Engineering(中華民國生物醫學工程學會) and Enginnering Paper Award (工程論文獎) from Chinese Institute of Engineers(中國工程師學會). He serves a reviewer for Archives of Dermatology and International Journal of Dermatology. He delivered professional oral presentations and has been invited to speak at national and international aesthetic and dermatologic conferences, including International Conference on Behçet's Disease (ICBD), The International Society for Optical. Engineering (SPIE), International Master Course on Aging Skin (IMCAS), Asian Dermatological Congress (ADC), Global Chinese Dermatologist Summit (GCDS) and Minimal invasive plastic and aesthetic and dermatology (MIPASD).
附錄：
以下會議相關資訊，由台灣皮膚科醫學會提供，歡迎有興趣者報名參與盛會。
會議手冊資料引用自 http://www.tdmt.org/TDAC2015/AgendaInfo/?AgendaInfoSID=11
3rd Taiwan Dermatology Aesthetic Conference
Taiwanese Dermatological Association Spring Meeting 2015
2 May- 3 May 2015, Kaohsiung Exhibition Center
第三屆臺灣皮膚科美容醫學學術研討會
2015年臺灣皮膚科醫學會春季學術研討會
2 May- 3 May 2015, 高雄展覽館
SCIENTIFIC PROGRAM
理事長的話 WELCOME MESSAGE
會長、各位貴賓、先進、同仁：
「Glocalization」全球在地化，是全球化 (globalization)與在地化 (localization)兩字的結合，具有「思考全球化，行動在地化」的意涵。醫學的領域，與「人」息息相關，必須因地制宜，配合在地的風土民情，適情適性。
2015年台灣皮膚科醫學會春季學術研討會暨第三屆台灣皮膚科美容醫學學術研討會，承襲前兩屆傳統，結合皮膚科學與美容醫學，提供一個台灣與國際交流的平台，在皮膚科學部份：「痤瘡、酒糟性皮膚炎、異位性皮膚炎、蕁麻疹」，在美容醫學部份：「針劑注射、溶脂與自體脂肪移植、多汗症治療」，是本屆研討會的重點。每場研討會，都有一位國際與台灣代表，台上講者與台下會員共同參與，群策群力，以示本次會議「全球在地化」之宗旨。
感謝遠道而來的貴賓，以及籌辦委員會，與所有幕後工作人員的辛勞。
最後敬祝 大會圓滿成功!
各位貴賓、先進、同仁 身體健康、萬事如意!
臺灣皮膚科醫學會理事長
楊志勛
Distinguished Guests and Fellow Colleagues:
"Glocalization" is a combination of globalization and localization, which implies "globalized thinking and localized action." Medical practice should be customized to accommodate local culture to achieve better outcomes.
Adopting tradition from previous meetings, the 3rd Taiwan Dermatology Aesthetic Conference (TDAC) and the Taiwanese Dermatological Association (TDA) Spring Meeting 2015, integrates Dermatology Science and Aesthetic medicine, meanwhile, offers a platform for ideas exchange between Taiwan and the world. The key discussion to this meeting features "acne, rosacea, atopic dermatitis, urticaria"for dermatology, and "injectables, liposuction and fat autograft, hyperhydrosis/osmidrosis"for aesthetic medicine. Both International and Taiwanese representatives will be allocated in each sessions, while audience were encouraged to fully participate in the discussion to demonstrate the objective of "Glocalization".
We value and appreciate the attendance of all participants and I wish to thank the organizers, and the staff who has dedicated their hard work for this event.
Finally, best wishes for a successful meeting.
President of Taiwanese Dermatological Association
Chih-Hsun Yang, M.D.
TABLE OF CONTENTS
即時口譯服務
大會禮聘蔣希敏老師之專業團隊全程即時口譯 請在會議室入口處索取耳機
01
理事長的話 WELCOME MESSAGE
籌備委員會 ORGANIZING COMMITTEE
編輯室報告 EDITORIAL
會議緣由 ABOUT TDAC
贊助單位 SPONSORS & EXHIBITORS
報到需知 GENERAL INFORMATION
免費接駁巴士 FREE SHUTTLE BUS
交通資訊 TRANSPORTATION
高雄展覽館 MEETING VENUE
平面圖 3F FLOOR PLAN
議程一覽 PROGRAM AT A GLANCE
演講摘要 SCIENTIFIC SESSIONS
SATURDAY, MAY 2
10:00-12:00 MERZ Forum (Preconference Meeting)
13:30-15:00 Toxins Forum (I)
UV, inflammation and Cancer Forum
Hair Forum
Cosmeceuticals Symposium
15:30-18:00
Toxin Forum (II)
Wound Care Forum
Face Sculpting and Lifting Symposium
IMCAS Session
Satellite Speeches
18:00-19:30
Welcome Reception and Gala Dinner
19:30-21:00
Injectable Workshop:
Liposculpting Symposium
Satellite Speeches: HIFU
SUNDAY, MAY 3
08:30-10:00
Anatomy Workshop
Acne and Rosacea Symposium (I)
Non-invasive Body Contouring
Skin Tumor Experts Meeting
Satellite Speeches: Intense Pulse Light and Pulsed Dye Laser
10:30-12:00
Injectable Workshop: How to Make an Elegant Nose
Acne and Rosacea Symposium (II)
Emerging Energy Based Devices Symposium:
Satellite Speeches: Body Contouring (I)
12:00-13:30
Lunch Symposia
13:30-15:00
Injectable Workshop: How to Make Charming Eyes
Urticaria Symposium
Osmidrosis Workshop
Special Lecture
Satellite Speeches
Pearl of Injectable Treatment -Tips and Tricks
Dye Laser and Picosecond laser
Toxin Forum (II)
Wound Care Forum
Face Sculpting and Lifting Symposium
IMCAS Session
Satellite Speeches
18:00-19:30
Welcome Reception and Gala Dinner
19:30-21:00
Injectable Workshop:
Liposculpting Symposium
Satellite Speeches: HIFU
SUNDAY, MAY 3
08:30-10:00
Anatomy Workshop
Acne and Rosacea Symposium (I)
Non-invasive Body Contouring
Skin Tumor Experts Meeting
Satellite Speeches: Intense Pulse Light and Pulsed Dye Laser
10:30-12:00
Injectable Workshop: How to Make an Elegant Nose
Acne and Rosacea Symposium (II)
Emerging Energy Based Devices Symposium:
Satellite Speeches: Body Contouring (I)
12:00-13:30
Lunch Symposia
13:30-15:00
Injectable Workshop: How to Make Charming Eyes
Urticaria Symposium
Osmidrosis Workshop
Special Lecture
Satellite Speeches
15:30-17:00
Injectable Workshop: How to Make Sexy Lips
Psoriasis Symposium
診所經營管理者論壇
Satellite Speeches: Body Contouring (II) and Injectable
特邀嘉賓 Invited Faculty
Pearl of Injectable Treatment -Tips and Tricks
Dye Laser and Picosecond laser
TABLE OF CONTENTS
8
ORGANIZING COMMITTEE
臺灣有超過半數的皮膚科專科醫師在基層執業，他們不但提供了舉世最佳的基層皮膚醫療服務，也運用最新的醫療技術，造福具有美容醫學需求的民眾。
這將是臺灣再次由基層皮膚科醫師，根據第一線醫師的臨床需求，設計議程與邀請國外貴賓，共同為提升臺灣臨床醫療品質而舉辦。我們期望在會議籌辦的過程，各位皮膚科先進能不吝提出建議，讓這次會議能因為專題演講、示範教學與會場展覽，更加提升臺灣皮膚科醫師執業能力。
我們選擇由高雄出發，結合許多本地的基層執業醫師的想法與力量，呈現臨床與美容皮膚醫學的最新學術新知。
謹代表籌備委員會，我們期待並歡迎您在2015年初夏到訪高雄。
臺灣皮膚科醫學會2015年春季學術研討會
第三屆臺灣皮膚科美容醫學學術研討會
籌備委員會 曾忠仁 許乃仁 王昭欽 王銘燦 黃柏翰 蔡仁雨
敬 邀
籌備委員會：
主辦單位：臺灣皮膚科醫學會
委員：王銘燦、黃柏翰、曾忠仁、蔡仁雨
秘書長兼財務長：許乃仁
副秘書長：王昭欽
編輯委員會：王昭欽、林尚宏、謝其娟
晚會主持：李建儀、高珮菡
醫學會理事長：楊志勛
醫學會秘書長：王偉銘
顧問：王正坤、王德華、朱家瑜、吳介山、吳育弘、李婉若、林長熙、張英睿、張雅菁、張雲亭、陳怡如、陳國熏、黃禎憲、彭賢禮、楊國材、趙曉秋、蔡呈芳、蔡秀欣、 蔡高頌
會務秘書：林佳蓉、羅敏君、邵盈嘉、鄭雅方
ORGANIZING COMMITTEE
Organizing Committee
Organizer: Taiwanese Dermatological Association
Chair: Ming-Tsan Wang MD MOH, Po-Han Huang MD, Chung-Jen Tseng MD, Ren-Yeu Tsai MD
Secretary-Treasurer: Nai-Jen Hsu MD
Deputy Secretary General: Chao-Chin Wang MD
Program Editors: Chao-Chin Wang MD, Shang-Hong Lin MD, Chi-Chuan Hsieh MD
Gala Dinner Hostess: Jennifer C.Lee MD, Pei-Han Kao MD
President of TDA: Chih-Hsun Yang MD
Secretary General of TDA: Wei-Ming Wang MD PhD
Consultants: Cheng-Kun Wang MD, Tak-Wah Wong MD, Chia-Yu Chu MD PhD, Chieh-Shan Wu MD, Yu-Hung Wu
MD, Woan-Ruoh Lee MD PhD, Chrang-Shi Lin MD, Ying-Jui Chang MD PhD, Ya-Ching Chang MD,
Yun-Ting Chang MD PhD, Yi-Ju Chen MD PhD, Gwo-Shing Chen MD PhD, Jhen-Sian Huang MD,
Hsien-Li Peng MD, Kuo-Chia Yang MD, Sheau- Chiou Chao MD, Tsen-Fang Tsai MD, Hsiou-Hsin
Tsai MD,Kao Sung Tsai MD
Conference Secretaries: Chia-Jung Lin, Min-Jyun Luo, Yin-Chia Shao,Ya-Fang Cheng
There has been more than half of dermatologists running their own clinics in Taiwan. They offer one of the best dermatology care services in the world for local community. In addition, they are also practicing with newest techniques for patients with aesthetic demands.
Local practicing dermatologists are proud to support Kaohsiung to act as host city for the staging of the Taiwanese Dermatological Association Spring Meeting in 2015 and the 3rd Taiwan Dermatology Aesthetic Conference (TDAC) to present the latest information on medical and aesthetic dermatology.
On behalf of the Organizing committee, we look forward to welcoming you to Kaohsiung in 2015.
TDA Spring Meeting 2015 and the 3rd TDAC Organizing Committee:
Chung-Jen Tseng MD, Director, Beautyland Medical Cosmetic Center
Nai-Jen Hsu MD, Director, Hsu Nai-Jen Dermatological Clinic
Chao-Chin Wang MD, Director, Tainan Vigor Dermatological Clinic
Ming-Tsan Wang MD MOH, Director, Taiwanese Dermatological Association
Po-Han Huang MD, Executive Director, Taiwanese Dermatological Association
Ren-Yeu Tsai MD, Associate Professor, Taipei Medical University
ORGANIZING COMMITTEE
10
EDITORIAL
自己的會議，自己打造！
一本去年的初衷，我們堅信一個成功的會議，不該是單方面的聽講，而是由各方與會精英一同成就的。
大會提供最頂尖的講者、最深入的主題、最高水準的場地，另一方面還需要更多與會者的加入，讓知識成為真正的力量。今年大會更向前邁進一步，提出「「自己的會議，自己打造」的概念，在大會臉書粉絲團與討論區中廣徵各方意見，希望透過與會者好的想法、腦力激盪，一起打造一個屬於大家的理想會議。
籌備委員會廣邀國際級講者來台，今年共有68位國內外講者，近百場專題演講，為台灣醫界帶來最尖端的醫學新知。希望這個會議在作為一個知識傳遞的媒介之外，還能作為台灣醫界跨科別的交流、與國際專家接軌、與業界共存共榮的平台。本次大會手冊有充分的留白，讓它同時成為您的筆記本。會議期間還是會有不同的驚喜活動與大獎，敬請期待，也歡迎您的參與。會後全課程的線上評量讓您為台上的講者打分數；您會後的心得可以讓更多的朋友一起分享感動，還有機會把大獎贏回家。
「...會議曲終人散時，我們不只行囊滿滿，資訊滿滿，心中的暖意也和高雄的氣溫一樣，溫熱融融。」我們很開心去年與會的鄭愷平醫師為她去年的參與留下了這一段註腳。您可以用各種不同的角度來看待這場春季的盛宴：是學術的交會、是老友情感的交流、是業界資訊的匯集，甚至可以是闔家出遊的機會。
我們堅信這場國際級的會議讓您在學術上不需要捨近求遠。至於享用這場春季盛宴的方式，由您來決定。在溫暖的南臺灣，我們期待您的參與，激起更璀璨的火花。
It is not the speakers but the attendees who play the leading role of a conference. The organizing committee works hard to organize the world-class faculty and to create the best harmony between science and art, academics and professionals. And we believe that the faculty will bring up the most cutting-edge knowledge of their specialties for all the attendees. However, the conference won’t succeed without you taking part. We invite you to join us for the lively events during the conference and meet the experts and colleagues through the networking opportunity. You may also follow us on Facebook for the most updated news. Wish you a fantastic meeting experience in Kaohsiung.
Facebook page: https://www.facebook.com/tdacmeeting for all the ongoing events of TDAC Facebook group: http://goo.gl/ZR9b5T join for all the prize-winning opportunities
Chao-Chin Wang MD, Chi-Chuan Hsieh MD, Shang-Hong Lin MD
Editors, 3rd TDAC Publishing
Chih-Hsun Yang MD
President of Taiwanese Dermatological Association
Conference Secretary: Yin-Chia Shao
EDITORIAL
臉書粉絲團 https://www.facebook.com/tdacmeeting
好康好玩的都在這裡，記得按讚
臉書討論區 http://goo.gl/ZR9b5T
想拿大獎，加入就對了
第三屆臺灣皮膚科美容醫學學術研討會
編輯委員 王昭欽 謝其娟 林尚宏
理事長 楊志勛
會務秘書 邵盈嘉 謹識
11
EDITORIAL
12
美容皮膚醫學，乃是植基於皮膚生理學、皮膚病理學、臨床診斷學、皮膚治療學、皮膚外科學，將科學與美學結合的產物。由於嚴格的專科醫師訓練制度，讓皮膚科醫師能輕易地診斷皮膚的狀態，再利用最新的治療技術，完美地與型態美學結合，讓皮膚科專科醫師擁有與其他科別醫師更全面而獨特的增進皮膚的健康與美感的能力。
然而隨著醫療科技的進展，更精確的評估方法、創新的生物醫材與先進的治療儀器的發明，皮膚科醫師雖早已能善用自己對於皮膚狀態診治的優勢，提供更好的醫療服務，但臺灣皮膚科醫學會身為國內最大美容醫學領域之署定專科醫學會，有責無旁貸的義務，提供除了皮膚科醫師以外有志於美容醫學領域的醫界同仁進修的管道，全面提升臺灣美容醫學水準。除將提升國人皮膚健康與型態美學醫療水準外，也希望導正國內非專業當道的"醫美亂象"，因此舉辦臺灣皮膚科美容醫學學術研討會，讓有志於此新興領域的各界同好能齊聚一堂進行研習與討論。
臺灣皮膚科美容醫學學術研討會將提供國際頂尖專家互動交流、現場示範教學、臨床醫學美容醫學兼具的自由選擇多元教育課程，以提升國內與區域國家皮膚美容醫學水準，貢獻醫學繼續教育，提供臨床研究與專家經驗的交流園地。
About TDAC
Aesthetic dermatology is a combination of skin physiology, skin pathology, clinical diagnosis, skin therapeutics and skin surgery. It is a marriage of science and aesthetics. Doctors can easily diagnose the status of skin and its problems due to the intensive and strict training programs for specialized dermatologists. By combining the most advanced
therapeutic technique with precise aesthetic concept it allows dermatologists to enhance the health of skin and its beauty.
A dermatologist can achieve his/her best skin care medical practice by combining the progress of medical technology along with more precise diagnostic methods, innovative biological medical device and invention of advanced therapeutic equipment. However, Taiwanese Dermatological Association, the largest and prestigious aesthetic
medical society in Taiwan, has the obligation to provide the physicians other than dermatologists to pursuit the knowledge of the aesthetic medicine in order to enhance the quality of care to a higher level. Not only do we hope to elevate the health of skin and the aesthetic standard of our people but we also hope to correct the chaos of other
non-specialized doctors who are taking charge of most of the aesthetic medicine in Taiwan.
Therefore, conducting a Taiwan Dermatology Aesthetic Conference (TDAC) will allow physicians who are interested in this new medical field further learning and discussion. This symposium will provide the best international experts with interactions, live demonstrations and varies choices of clinical aesthetic dermatology learning courses. It is our goal to enhance the standard of our national aesthetic dermatology as well as to contribute
to the continuation and the growth of medical education and to become an exchange corner of clinical researches and expert experiences.
ABOUT TDAC
About TDAC
13
LOGO Designer
Prof Wang I-Hsuan Cindy
TDAC Logo Design Concept
Line : 線條 代表臺灣各地皮膚專科精英
Red Dot : 紅點 臺灣皮膚科美容醫學學術研討會
Vision : 科技 / 美學 / 提升臺灣美容醫學水準
Vision is positioned ourselves as the market leader for aesthetic dermatology
and cosmetic procedures. It's characterized as a simple and humble solution to
maintaining good health; hopes to bring joy and improve lifestyle.
School of Art, Design and Media, College of Humanities, Arts, & Social Sciences, Nanyang Technological
University, Singapore
1.2010年獲7項國際最具指標性視覺設計競賽類大獎
2.亞洲最具影響力設計金獎
3.美國ADC
4.One Show Design
5.德國紅點Reddot
6.德國 iF
7.台灣金蝶獎
Prof Cindy Wang is currently in the School of Art, Design and Media; she joined as an Assistant Professor of Visual Communication in 2007. Cindy holds a BFA from the School of Visual Art and a MA in New York University (NYU), Dept. of Graphic Communication Management & Technology.
Cindy's research focuses on use various principles and elements of graphic design, and combining with modern printing techniques to enhance visual communications. One of the key findings of her research was how to use illusions to further stimulate the visual expression of an artwork. The research revolves around the utilization of illusions and modern printing technologies to create new, innovative and unique illustration of visual presentation.
On the other hand, Cindy also research on type forms that combines elements of Asia and Western typography is innovative from as Asian perspective and meaningful as bridge between East and West. This fusion typography is gathering tremendous interest across the globe and her work in this area establishes her as a pioneer in this exciting
new area of design research. She has been successful in securing research grants to support her work.
Cindy's reputation is more and more well known on both international and national level. She has been prolific in publishing five books on her research themes, won numerous international awards and with numerous of exhibitions locally and internationally. All these awards are only honored to highly talented designer from Hong Kong, New York, and Germany. This explains that Cindy's creativity, talents, and ability are recognized throughout
the continents of Asia, North America, and Europe.
About TDAC
14
鑽石級贊助商
新加坡商莫氏亞太有限公司台灣分公司
法國高德美大藥廠
台灣諾華股份有限公司
博而美國際股份有限公司
沃醫學有限公司
德瑪凱股份有限公司
白金級贊助商
海喬國際股份有限公司
新加坡商美納里尼醫藥有限公司台灣分公司
裕利股份有限公司
欣美生醫股份有限公司
曜亞國際股份有限公司
友華生技醫藥股份有限公司
博士倫股份有限公司
慶安生醫科技股份有限公司
聯發生技美學有限公司
金級贊助商
臺灣萊雅股份有限公司
愛迪亞生醫股份有限公司
森田生醫股份有限公司
八億實業股份有限公司
萊亞實業股份有限公司
優擎科技有限公司
億鑫國際股份有限公司
恆旺國際有限公司
綺麗生技有限公司
妮傲絲翠股份有限公司
傑出美國際有限公司
泰合生技藥品股份有限公司
美商思爾提克 Zeltiq
永信藥品工業股份有限公司
惠民製藥股份有限公司
澳洲意高大藥廠
巴爾桑波有限公司
美商亞培股份有限公司台灣分公司
嬌生股份有限公司
一般贊助商
膠原科技股份有限公司
杏輝藥品工業股份有限公司
德實科技有限公司
德星有限公司
奇瑩國際有限公司
傳羚國際貿易有限公司
晨欣國際有限公司
長杏股份有限公司
美科實業有限公司
呈汝生物科技有限公司
衡奕精密工業股份有限公司
可若夫生物科技有限公司
力大圖書有限公司
高一藥品股份有限公司
IMCAS
台灣資生堂股份有限公司
科懋生物科技股份有限公司
歐強國際有限公司
SPONSORS & EXHIBITORS
報名截止日:
1.優先註冊費：即日起至4/19
2.4/19線上報名截止，請至大會現場報名。
報到作業事項:
1.請持使用身份證, 健保卡或其他有相片之證件進行
報到作業。
5/2報到時間 : 09:00~19:00
5/3報到時間 : 08:00~13:30
2.報到地點：高雄展覽館(806高雄市前鎮區成功二
路39號)一樓大會報到櫃檯。
出入管制:
出入會場一律配掛識別證。 與會者依身份別與是否
預訂活動，於進入各講堂或活動地點前，以識別證
確認身份，始得進入。
各項繼續教育學分：
參加證明需於會後上網填寫課後問卷完成後，得自
行列印。
皮膚科專科繼續教育積分：二十四點
台灣整形外科醫學會積分：B類積分15分
公務人員終身學習護照：十二小時
美容醫學教育訓練聯合委員會認證時數：申請中
用餐須知:
大會迎賓晚宴訂於5/2星期六下午18:00-19:30，地點
位於三樓301B會議室。 晚宴後仍有學術演講緊接著
登場。
5/3星期日午餐時間，除了有四場學術午餐活動同時
進行外(詳情請見會議議程)，本次特於大會會場三
樓增設用餐交誼專區。
費用:
1.因辦理會議之必要成本，若為個人因素不克前往
會議者，恕不退費。
2.若因天災等不可抗力因素取消會議，已繳費之與
會者，將由主辦單位臺灣皮膚科醫學會辦理全額
退費。
大會禁止事項:
演講進行時，全程禁止錄影、攝影、錄音。
會議設備:
會議期間，開放Wi-Fi免費無線上網。
17
General Information
Welcome to TDA Spring Meeting 2015 and 3rd TDAC!
Here are some important notices for you.
Please keep your badge at hand throughout the conference.
Attendees without registration badges will not be granted entry.
Pre-registration is strongly recommended as space is limited.
Those who have not completed advanced registration online may proceed to the On-Site Registration Desk at KEC
for registration.
The On-Site Registration Desk locate on the first floor of KEC (near the East Gate).
Office hour:
May 2 (Sat): 09:00~19:00
May 3 (Sun): 08:00~13:30
Photo identification will be required for registration.
Official Language
The official languages of TDAC 2015 are English and Mandarin. All seminars are in English unless otherwise
specified.
Simultaneous interpretation is available for all but satellite sessions.
Lunch and Dinner
The Gala Dinner will be held in Room 301B from 18:00 to 19:30 on May 2. Night sessions ensue after the Gala
Dinner. In addition to the luncheon symposia from 12:00-13:30 on May 3, the attendees who do not attend the
luncheon symposia may enjoy Chinese lunch boxes in the dining area. Vegetarian lunch boxes are also available.
Please specify your lunch option during registration.
Speaker Ready Room
The Speaker Ready Room will be open during the meeting.
Free Wi-Fi Service
Complimentary Wi-Fi service is available at KEC during the meeting.
No Photo Policy
Any form of photographing, video or audio recording is prohibited during the lectures.
Staff
The conference is organized by Taiwan Dermatological Association. For further information, please feel free to
contact the Office of TDA by
Phone at +886-2-25185127
Email at derma.email@msa.hinet.net
18
免費接駁專車（20人座中巴）
上車地點:展覽館東門入口
接駁路線
高雄展覽館 →捷運三多商圈站3號出口（靠中山路）（停５分鐘） → 漢來飯店 （新田路側門）
→ 國賓飯店 （大門慢車道處）→ 高雄展覽館（停５分鐘）
Route：Meeting Venue (KEC) → MRT R8 Sanduo Shopping District (Exit No 3) (stop 5 mins)
→ Grand Hi-Lai Hotel → Ambassador Hotel Kaohsiungl → Meeting Venue (KEC) (stop 5 mins)
FREE SHUTTLE BUS
Free Shuttle Bus
日期接駁時間發車頻率
末班車21:30
(高雄展覽館發車)
每15分鐘
每20-30分鐘
5/2 (六)
尖峰時段
離峰時段
5/3 (日)
09:30-21:30
09:30-11:30
13:00-15:00
19:30-21:30
末班車18:00
(高雄展覽館發車)
每15分鐘
每20-30分鐘
尖峰時段
離峰時段
07:30-18:00
07:30-09:30
11:30-13:30
15:00-18:00
Date / Day
May 2, Sat
Peak
Off-peak
May 3, Sun
Hours of Service Frequency
Last departure
from KEC at 21:30
15 min
20-30 min
Peak
Off-peak
Last departure
from KEC at 18:00
15 min
20-30 min
09:30-21:30
09:30-11:30
13:00-15:00
19:30-21:30
07:30-18:00
07:30-09:30
11:30-13:30
15:00-18:00
19
FREE SHUTTLE BUS
Free Shuttle Bus
KEC
展覽館
R8 MRT
Hi-Lai
Ambassador
漢
國
20
高雄展覽館座落亞洲新灣區樞紐位置，交通便捷，四通八達。
飛機-高雄小港國際機場
小港國際機場 → 轉乘捷運至三多商圈站 → 步行約10分鐘即可抵達
高鐵
台北至高雄僅需 1.5 小時
1.自左營高鐵站開車約20分鐘即可抵達
2.自左營高鐵站轉乘捷運至三多商圈站(15分鐘) → 步行約10分鐘即可抵達
火車
高雄火車站轉乘捷運至三多商圈站 (5分鐘) → 步行約10分鐘即可抵達
捷運
三多商圈站.3 號出口→步行約10分鐘即可抵達
自行開車-中山高速公路
北上：中山高國道一號→中正交流道下→沿中正路直行至中華路左轉→中華四路直行至四維路右轉→
四維四路直行至成功路左轉→直行成功二路→抵達
南下：中山高國道一號→高雄端/中山路出口下交流道→右轉中山四路直行至新光路左轉→成功二路左轉→抵達
市區公車
1. 168(環狀幹線) 至高雄展覽館站
2. 紅21(建軍站←→新光路口) 至高雄展覽館站
停車資訊
高雄展覽館B1停車場：汽車：40元 / 小時 機車：40元 / 每次
新光公有停車場：小型車30元 / 小時、大型車 60 元 / 小時
大會接駁車
三多捷運站→漢來飯店→國賓飯店→高雄展覽館 (定時循迴接駁)
KEC is located at the hub of the Kaohsiung Asian New Bay Zone and is easily reachable by air, sea, and land
transportation, including high-speed rail from Taipei and other cities in North Taiwan. Free shuttle transportation
will be provided during the meeting.
Kaohsiung International Airport
Direct flights from over 40 major Asian cities.
High Speed Rail
High Speed Rail connects from Taipei in 1 and half hour. Terminal stop is Kaohsiung is Zuoying Station:
(1) Taxi ride: 20 min to KEC
(2) Kaohsiung Rapid Transit to Sanduo Shopping District: 10 min walk to KEC
Kaohsiung Rapid Transit
Sanduo Shopping District Station (Exit No.3) : 10 min walk to KEC
National Freeway
10 minutes drive from National Freeway No.1.
Kaohsiung Buses
1. 168
2. Red 21
Shuttle
MRT R8 Sanduo Shopping District→ Grand Hi-Lai Hotel→ Ambassador Hotel Kaohsiung→Meeting Venue (KEC)
TRANSPORTATION
TRANSPORTATION
21
MEETING VENUE
高雄展覽館
806高雄市前鎮區成功二路39號
於2014年4月全新落成的高雄展覽館(KEC)位於高雄港亞洲新灣區中心，交通位置優越，氣候舒適怡人。
展覽館的整體造型設計結合了河流、海洋、船帆與港灣的意象，塑造波浪的屋頂造型，與城市的自然美景緊
密相容，表現出高雄特有的水色山光、優雅的港灣和海洋的波浪，是高雄水岸的新地標。
展覽空間包含室內與戶外展場，會議空間大小皆備，最多可容納4,000人，約1,500個標準攤位。
Kaohsiung Exhibition Center (KEC)
No.39, Chenggong 2nd Rd, Qianzhen District, Kaohsiung 806, Taiwan
Kaohsiung Exhibition Center (KEC) is nestled in Kaohsiung, Taiwan. This business exhibition center opened
in April 2014. The center has a total floor area of 67,000m2, which can accommodate 1,424 exhibition booths
and different meeting room sizes suitable for up to 4,000 people. It provides a place for holding international
conferences and trade shows. The exhibition center boasts of its multifunctional and flexible areas and of its
capability to host different kinds of events, making it a perfect venue to host 3rd TDAC and TDA Spring Meeting
2015.
MEETING VENUE
Scientfic Program 22
3F FLOOR PLAN
3F FLOOR PLAN
Scientfic Program
23
Scientfic Program 24
SCIENTIFIC SESSIONS
SATURDAY, MAY 2
10:30-12:00
MERZ Forum (Preconference Meeting)
Physician Only
Lecturing in English
Lecturing in Chinese
Simultaneous Interpreting
Medical Dermatology
Dermatological Surgery
Engergy-based Devices
Injectables
Staff Training
SCIENTIFIC SESSIONS 28
MF1 Pharmacology and Immunlogy of
Botulinum Toxin
Speakers FREVERT, Jürgen PhD
Moderator CHANG, Li-Yen (張立言) MD
TSENG, Chung-Jen (曾忠仁) MD
Botulinum neurotoxin injections are a valuable
treatment modality for many therapeutic indications
and have revolutionized the field of aesthetic
medicine so that they are the leading cosmetic
procedure performed worldwide. Studies show that
onabotulinumtoxinA (Botox), abobotulinumtoxinA
(Dysport) and incobotulinumtoxinA (Xeomin)
are comparable in terms of clinical efficacy and
safety. Differences between the products relate to
the botulinum neurotoxin protein composition
(complexes), specific biological potency, and their
immunogenicity. Protein complex size and molecular
weight have no effect on biological activity, stability,
spread of the neurotoxin in the body or side effect
profile. Complexing proteins can activate dendritic
cells and increase the risk of neutralizing antibody
formation, which can cause secondary treatment
failure. These attributes could lead to differences in
therapeutic outcomes, and given their widespread
aesthetic use physicians should be aware of how the
three neurotoxin products differ to ensure their safe
and effective use.
SATURDAY, MAY 2
MERZ Forum
Sat. May 2, 10:00~12:00
Room 301A
Moderator CHANG, Li-Yen (張立言) MD
TSENG, Chung-Jen (曾忠仁) MD
MF1 Pharmacology and Immunlogy of
Botulinum Toxin
10:00 / FREVERT, Jürgen PhD
MF2 Crafting Predictable Aesthetic
Outcomes with HA Filler Technology
10:35 / PRASETYO, Adri Dwi MD
MF3 Combination Therapy Using
Ulthera and Radiesse
11:10 / CHAO, Yates Yen-Yu (趙彥宇) MD
11:45 Discussion
SCIENTIFIC SESSIONS
29
MF2 Crafting Predictable Aesthetic
Outcomes with HA Filler Technology
Speaker PRASETYO, Adri Dwi MD
Moderator CHANG, Li-Yen (張立言) MD
TSENG, Chung-Jen (曾忠仁) MD
The use of injectable fillers for soft tissue
augmentation has gain worldwide popularity. With
regards of the value of volumetric enhancement in
achieving a more aesthetic appearance, as well as the
minimal downtime and predictable results, a new
hyaluronic acid (HA) filler technology is introduced.
As there is no single injectable filler that has all of the
desired characteristics, understanding the advantages
and disadvantages of one filler over another is
extremely helpful in guiding the patient to an informed
decision. Knowledge of the specific properties of HA
fillers may help physicians in choosing the appropriate
HA filler for facial rejuvenation and beautification.
This, together with appropriate injection training and
experience, should lead to results that ultimately will
benefit patients.
MF3 Combination Therapy Using Ulthera
and Radiesse
Speaker CHAO, Yates Yen-Yu (趙彥宇) MD
Moderator CHANG, Li-Yen (張立言) MD
TSENG, Chung-Jen (曾忠仁) MD
This section of lecture covers the subjects of
1.Principles of facial reshaping.
2.Advanced Ultherapy treatment technique.
3.Noval concepts of Radiesse skin boosting.
4.Different roles of Radiesse filler and Ulthera for
rejuvenation.
5.Different roles of Radiesse filler and Ulthera for
recontouring.
6.Practical combination of Radiesse and Ultherapy.
Coffee Break
Coffee Break
May 2, Sat 15:00-15:30
May 3, Sun 10:00-10:30
May 3, Sun 15:00-15:30
RM305
and Exhibit Hallway
14
SCIENTIFIC SESSIONS SCIENTIFIC SESSIONS
SATURDAY, MAY 2
Physician Only
Lecturing in English
Lecturing in Chinese
Simultaneous Interpreting
Medical Dermatology
Dermatological Surgery
Engergy-based Devices
Injectables
Staff Training
13:30-15:00
Toxin Forum (I)
UV, inflammation and Cancer Forum
Hair Forum
Cosmeceuticals Symposium
15:30-18:00
Toxin Forum (II)
Wound Care Forum
Face Sculpting and Lifting Symposium
IMCAS Session
Satellite Speeches
SCIENTIFIC SESSIONS
31
SATURDAY, MAY 2
Toxin Forum (I)
Sat. May 2, 13:30-15:00
Room 301A
Moderator HUANG, Po-Han (黃柏翰) MD
CASSUTO, Daniel MD
TF1 Facial Danger Zones During Toxin
Injection
13:30 / JUNG, Wonsug MD, PhD
/ MOON, Hyoung-Jin MD
TF2 The Solution of Dilemma Injection
in Toxin Treatments
14:30 / CASSUTO, Daniel MD
TF1 Facial Danger Zones During Toxin
Injection
Speaker JUNG, Wonsug MD, PhD
MOON, Hyoung-Jin MD
Moderator HUANG, Po-Han (黃柏翰) MD
CASSUTO, Daniel MD
Botulinum toxin, which has seen increasing popularity
in the field of esthetic surgery over the years, is a
neurotoxin secreted by bacteria called Clostridium
botulinum and is found in canned foods. Botulinum
toxin paralyzes the muscle by blocking the secretion of
a neurotransmitter called acetylcholine at the terminal
part of neuromuscular synapse. There are many types
of botulinum toxin such as A, B, C, D, E, F, G etc.,
but the ones for medical use are types A and B, and in
particular, type A is most commonly used. Botulinum
toxin is used for the treatment of muscular diseases
such as torticollis, strabismus, spastic dysphonia etc
but it is also widely used for esthetic purposes such as
treatment of wrinkles and square jaw. Botulinum toxin
can only be successfully performed if the surgeon has
a good understanding of facial anatomy and is able to
select the appropriate product for his purposes.
Anatomically, the face is the most complicated
structure of the human body. Especially, the structure
of facial muscles including nerves and vessels is very
variable and has the racial differences. Recently,
the importance on the facial anatomy has been
reconsidered as the interest on the facial aesthetics is
increasing. The aesthetic physicians should understand
the anatomy of the facial musculature. So I want
to introduce the anatomy oriented technique with
botulinum injection.
SCIENTIFIC SESSIONS 32
TF2 The Solution of Dilemma Injection
in Toxin Treatments
Speaker CASSUTO, Daniel MD
Moderator HUANG, Po-Han (黃柏翰) MD
CASSUTO, Daniel MD
.
高爾夫球賽
SATURDAY, MAY 2
GOLF Tournament
Time：Registration： 9：10 AM Tee-off：9:30 AM
Venue: Kaohsiung Golf Course
270, Qiu-Chang Rd. Da-Hua Li, Niao-Song District, Kaohsiung City
Tel：07-370-1101
Fee：Green fee and caddy fee on own.
Qualification：Members of TDA, and the attendee of 3rd TDAC
Registration：(Due April 25th, 2015)
Organizer：Mark Ming-Long Hsu
Tel：+886 921-290-364
E-mail：molly19790829@gmail.com (黃小姐 Miss Huang)
比賽時間：上午9時10分報到 9時30分開球（四人一組）
地點：高雄高爾夫球場(高雄市鳥松區大華里球場路270號 )
召集人：許明隆醫師
08
SATURDAY, MAY 2
Toxin Forum (I)
Sat. May 2, 13:30-15:00
SCIENTIFIC SESSIONS
33
SATURDAY, MAY 2
UV, Inflammation and Cancer Forum
Sat. May 2, 13:30-15:00
Room 301B
Moderator CHANG, Chung-Hsing (張中興) MD, PhD
LIU, Fu-Tong (劉扶東) MD, PhD
UV1 UV Pathways and Responses in Skin
Physiology and Carcinogenesis
13:30 / FISHER, David MD, PhD
UV2 At the Crossroad of Inflammation,
Senescence and Cancer
14:15 / BEN-NERIAH, Yinon MD, PhD
UV1 UV Pathways and Responses in Skin
Physiology and Carcinogenesis
Speaker FISHER, David MD, PhD
Moderator CHANG, Chung-Hsing (張中興) MD, PhD
LIU, Fu-Tong (劉扶東) MD, PhD
Skin cells are notable for their extensive intercellular
communication, which regulates numerous
physiologic aspects of skin as an organ. The control
of pigmentation represents one of the most important
regulators of skin carcinogenesis as well as photoaging.
Recent studies have helped to elucidate fundamental
processes which regulate melanocyte development
as well as molecular pathways controlling adaptive
pigmentary responses. The induction of pigment by
UV radiation (“tanning”) has been found to involve
cross-talk between keratinocytes and melanocytes.
This pathway involves the induced synthesis of
multiple biologically active peptides, some of which
appear to stimulate behavioral effects, such as sunseeking
(UV-seeking) behaviors via cutaneous
synthesis of beta-endorphin. Additionally, the roles of
certain pigments, particularly red/blond pheomelanins,
has suggested several mechanisms through which
they increase skin cancer risk. Pathways regulating
their synthesis as well as the molecular mechanisms
through which they modulate melanoma risk, will be
discussed.
SCIENTIFIC SESSIONS 34
UV2 At the Crossroad of Inflammation,
Senescence and Cancer
Speaker BEN-NERIAH, Yinon MD, PhD
Moderator CHANG, Chung-Hsing (張中興) MD, PhD
LIU, Fu-Tong (劉扶東) MD, PhD
Inflammation has many faces, most commonly
observed as an acute reaction in response to pathogen
or another insult, or a chronic phase, accompanying
chronic infection and chronic remittent inflammatory
disease, such as inflammatory bowel disease. Yet,
there is another type of smoldering inflammation,
which is harder to notice or monitor; it is called
parainflammation and appears to underlie some
of the major human diseases, cancer, diabetes type
2 and certain neurodegenerative diseases1. We
have developed mouse models of cancer based on
inducible CKI knockout, which exhibit smoldering
inflammation, and demonstrate how a low grade,
infiltrate-free inflammatory reaction to persistent
DNA damage response translates to an aberrant
growth2. To that end we determined the inflammatory
repertoire of the knockout mice, demonstrated its
association with cellular senescence and showed how
in the absence of p53, a senescence-inflammatory
response (SIR) is converted from a growth inhibitory
to growth promoting mechanism, both in vitro
and in vivo3. Anti-inflammatory reagents capable
of blocking SIR prevent carcinogenesis in mutant
mice. Our studies may explain the anti-carcinogenic
effects of non-steroidal anti-inflammatory drugs in
human cancer patients4. We will discuss mechanisms
and potential therapeutic effect of inducing
parainflammation in cancer, including melanoma.
1.Medzhitov, R. Origin and physiological roles of
inflammation. Nature 454, 428-35 (2008).
2.Elyada, E. et al. CKIalpha ablation highlights a
critical role for p53 in invasiveness control. Nature
470, 409-13 (2011).
3.Pribluda, A. et al. A senescence-inflammatory
switch from cancer-inhibitory to cancer-promoting
mechanism. Cancer Cell 24, 242-56 (2013).
4.Chan, A.T., Ogino, S. & Fuchs, C.S. Aspirin use and
survival after diagnosis of colorectal cancer. JAMA
302, 649-58 (2009).
SATURDAY, MAY 2
UV, Inflammation and Cancer Forum
Sat. May 2, 13:30-15:00
SCIENTIFIC SESSIONS
35
SATURDAY, MAY 2
Hair Forum
Sat. May 2, 13:30~15:00
Room 304A
Moderator CHEN, Chien-Hsun (陳建勳) MD
TSAI, Ren-Yeu (蔡仁雨) MD
HF1 Patient Selection for Hair
Transplantation and Training a Hair
Transplant Team
13:30 / AVRAM, Marc R. MD
HF2 Robotic Follicular Unit Extraction
14:15 / AVRAM, Marc R. MD
HF1 Patient Selection for Hair
Transplantation and Training a Hair
Transplant Team
Speaker AVRAM, Marc R. MD
Moderator CHEN, Chien-Hsun (陳建勳) MD
TSAI, Ren-Yeu (蔡仁雨) MD
The risk/benefit of elliptical donor harvesting vs.
robotic follicular unit extraction will be discussed and
reviewed. Appropriate candidate selection, anesthesia,
hairline design for men and women, instrumentation,
corrective surgery and future trends will be discussed.
Pre-conference: MERZ Forum May 2, Sat 10:00-12:00
Perhaps You Missed the Special Events!
03(2014手冊P.104是海喬的廣告)
SCIENTIFIC SESSIONS 36
HF2 Robotic Follicular Unit Extraction
Speaker AVRAM, Marc R. MD
Moderator CHEN, Chien-Hsun (陳建勳) MD
TSAI, Ren-Yeu (蔡仁雨) MD
Over the past twenty years, there has been
revolutionary changes in techniques in hair
transplantation. Men and women should consistently
receive naturally appearing transplanted hair. This
session will provide an overview of state of the art
techniques.
SATURDAY, MAY 2
Hair Forum
Sat. May 2, 13:30~15:00
SCIENTIFIC SESSIONS
37
SATURDAY, MAY 2
Cosmeceuticals Symposium
Sat. May 2, 13:30-15:00
Room 304B
Moderator CHIU,Pin-Chi (邱品齊) MD, MBA
SCHWARZ, Thomas MD, PhD
CS1 Whitening Cosmetic Development
and Claim Substantiation
13:30 / SATO, Kyoshi M Agr Sc
CS2 Claim Substantiation within Sun
Protection Products
14:00 / SCHWARZ, Thomas MD, PhD
CS3 我國化粧品管理現況與未來方向
14:30 / Yie, Mon-I (葉孟宜) Phar D
CS1 Whitening Cosmetic Development
and Claim Substantiation
Speaker SATO, Kyoshi M Agr Sc
Moderator CHIU,Pin-Chi (邱品齊) MD, MBA
SCHWARZ, Thomas MD, PhD
Skin lightening products which give lighter skin tone
or an even skin complexion are very popular especially
in Asian countries. In Japan, skin lightening products
are categorized in quasi-drugs which are defined as
cosmetic products that have moderate pharmacological
activity and contain active ingredients approved by
Japanese Ministry of Health, Labor and Welfare. Now
approximately twenty ingredients are used as active
skin lightening ingredients in Japanese cosmetic
market.
Skin lightening ingredients having different types of
mechanisms exist. The most common target of skin
lightening ingredients is tyrosinase in melanocytes.
Arbutin is known as a tyrosinase inhibitor. It inhibits
tyrosinase by competing with L-tyrosine, which
is a substrate of tyrosinase, at the active biding site
of tyrosinase. Kojic acid, which is also known as
a tyrosinase inhibitor, chelates copper needed for
tyrosinase to exert its activity. Magnolignan controls
tyrosinase activity inside melanocytes in a different
way. It inhibits the maturation of tyrosinase and
reduces the amount of tyrosinase in melanosomes.
Tranexiamic acid and chamomilla extract are
the different type of skin lightening ingredients.
Melanogenesis in melanocytes is much influenced by
mediators released from keratinocytes. The ingredients
reduce melanogenesis by controlling keratinocytederived
mediators to stimulate melanogenesis.
In my presenation, active skin lightening ingredients
approved in Japan will be introduced and their results
of human test will be shown.
SCIENTIFIC SESSIONS 38
CS2 Claim Substantiation within Sun
Protection Products
Speaker SCHWARZ, Thomas MD, PhD
Moderator CHIU,Pin-Chi (邱品齊) MD, MBA
There is no doubt about the benefit of sun protection.
Sunscreens are not the only but certainly a very
important tool to limit the adverse effects of UV rays.
The major aim of UV protection is the prevention
of DNA damage since DNA damage is the major
molecular mediator of chronic sun damage which
includes development of skin cancer, premature skin
ageing and pigment disorders. The most frequently
used method to measure the UVB filtering capacity
is the determination of the minimal erythema dose.
This method is quite well standardized (application
volume: 2 mg/cm²). UVB-induced erythema is
used as a surrogate marker for UVB-induced DNA
damage, since the erythema action spectrum and
the DNA damage action spectrum are quite similar.
However, they are not identical. Hence, methods are
developed which allow the direct measurement of
DNA damage. This, however, cannot be done in vivo
since biopsies would be required. An alternative is
the in vitro exposure of cultured keratinocytes or skin
equivalents to UV radiation in the absence or presence
of filter substances. In this setting DNA damage can
be directly measured. In addition, with this method
other read out systems can be utilized which includes
immunofluorescence, FACS analysis, multiplex
ELISA and PCR. P53 is another read-out candidate
since the increase in the expression of p53 correlates
quite well with the amount of DNA damage. P53
has been recently shown to play a crucial role in UVinduced
pigmentation by inducing the release of alpha
melanocyte stimulating hormone in keratinocytes
which activates melanocytes in a paracrine fashion to
produce melanin. However, with this method also
reactive oxygen species which are mostly induced by
UVA can be measured. The same applies for matrix
metalloproteinases which contribute to premature
skin aging. There is some evidence the infrared
irradiation also induces reactive oxygen species and
matrix metalloproteinases. Although the biologic
relevance of these findings is not yet clear, there are
substances available which absorb infrared radiation.
The respective capacity can also be measured with
these in vitro methods which certainly will contribute
to improve the quality and the accurate labeling of
filter substances. However, one has to be aware that a
filter substance can only be as good in daily practice as
it is applied. The major mistake by the vast majority
of consumers is the application of too small amounts.
The filtering capacity correlates strongly with the
amounts, however not in a linear but exponential
regression. Repeated application of sunscreens is
beneficial but cannot replace the application of the
required amounts. Hence, the consumers have to
better informed how to use sunscreens correctly.
大會花藝設計15
SATURDAY, MAY 2
Cosmeceuticals Symposium
Sat. May 2, 13:30-15:00
SCIENTIFIC SESSIONS
39
CS3 我國化粧品管理現況與未來方向
Speaker Yie, Mon-I (葉孟宜) Phar D
Moderator CHIU,Pin-Chi (邱品齊) MD, MBA
SCHWARZ, Thomas MD, PhD
簡報內容主要是說明目前國內化粧品主管機關重要
之管理規定及未來修法後之管理方向及重點。
籌備委員會製作海報
至IMCAS PARIS and IMCAS ASIA
我們努力讓
台灣看見世界
更希望
世界看見台灣
18
SCIENTIFIC SESSIONS 40
Room 301A
Moderator HUANG, Po-Han (黃柏翰) MD
SUNDARAM, Hema MD
TF3 Functional Facial Rebalancing
and Reshaping by Toxin-Concept,
Diagnosis and Advanced Approach
15:30 / HUANG, Chi-Ching DDS
TF4 Image Changing: Lifting Techniques
& Facial Reshaping Using Botulinum
Toxin and Fillers
16:20 / AN, Kyung-Chun MD
TF3 Functional Facial Rebalancing and
Reshaping by Toxin-Concept,
Diagnosis and Advanced Approach
Speaker HUANG, Chi-Ching (黃奇卿) DDS
Moderator HUANG, Po-Han (黃柏翰) MD
SUNDARAM, Hema MD
Functional facial rebalancing and reshaping by toxinconcept,
diagnosis and advanced approach.
Orofacial myofunctional disorders (OMD) refer to
abnormal resting posture of the orofacial musculature,
atypical chewing and swallowing patterns, dental
malocclusions, blocked nasal airways, and speech
problems (Hanson,1988). OMD are patterns involving
oral and/orofacial musculature that interferes
with normal growth, development, or function of
structures, or calls attention to itself (ASHA, 1993).[1]
OMD are found in both children and adults.
Mouth breathing is the most common problem of
OMD.
Open mouth posture
The adaptation from nasal to mouth breathing
takes pace when changes such as chronic middle ear
infections, sinusitis, allergic rhinitis, upper airway
infections, and sleep disturbances (e.g., snoring) take
place. In addition, mouth breathing is often associated
with a decrease in oxygen intake into the lungs.
Mouth breathing can particularly affect the growing
face, as the abnormal pull of these muscle groups
on facial bones slowly deforms these bones, causing
misalignment. The earlier in life these changes take
place, the greater the alterations in facial growth, and
ultimately an open mouth posture is created where the
upper lip is raised and the lower jaw is maintained in
an open posture.
Causes
1. Upper airway constrictions (e.g., deviated nasal
septum) or obstructions (e.g., enlarged tonsils) or
infections (e.g., rhinitis)
2. Imbalance in dental growth
3. Inadequate development of facial and cranial bones,
Long face, short face, wide face, narrow face or jaw
reduction, chin is too long, the flat of midface
4. Inappropriate development of muscles in the head
and neck areas
5. Facial asymmetry
Toxin-concept, diagnosis and advanced approach
SATURDAY, MAY 2
Toxin Forum (II)
Sat. May 2, 15:30-16:50
SCIENTIFIC SESSIONS
41
Goals/benefits of therapy
In accordance with Functional matrix theory, muscles
tend to dominate and determine the skeletal form
and function. This is the Toxin concept to reduce the
muscle strength to change the muscle function and
form in functional reconstruction & muscle training.
TF4 Image Changing: Lifting Techniques
& Facial Reshaping Using Botulinum
Toxin and Fillers
Speaker AN, Kyung-Chun MD
Moderator HUANG, Po-Han (黃柏翰) MD
Botulinum toxin and fillers have been friends for many
doctors and patients around the world for more than
15 years. Many techniques have been discussed by
the experts. Various techniques concerning injection
of the botulinum toxin concerns with the paralysing
target muscles of the face alone and injection of
the toxin is usually somewhat deep directly to the
muscles. In ‘lifting botulinum toxin technique,’ The
target for injection varies from epidermal area to deep
muscles. Very diluted solutions are used in small
amounts and the main purpose of this technique is
to achieve natural lookin appearance after the toxin
injection. This technique provides changes of image
of the patients. Serial procedures, 7 to 10 days apart
for 3-6 sessions will change the facial contours and
acquire desired look.
Using this technique will be very useful procedure in
outpatient clinics with short down time or almost no
down time.
SCIENTIFIC SESSIONS 42
SATURDAY, MAY 2
Wound Care Forum
Sat. May 2, 15:30~16:20
Room 301B
Moderator CWONG, Tak-Wah (王德華) MD
LEE, Chih-Hung (李志宏) MD, PhD
WC1 The Role of Hyperbaric Oxygen
Therapy in Chronic Wound
Management
15:55 / PAN, Shin-Chen (潘信誠) MD, PhD
WC2 Diabetic Wound Care Education in
Asia – Perspective of an Orthopaedic
Surgeon and Foot & Ankle Specialist
15:55 / CHAN, Samson Chi-Fai (陳智輝) MB,
B Ch, FRCSE, FHKAM, FHKCOS
WC1 The Role of Hyperbaric Oxygen
Therapy in Chronic Wound
Management
Speaker PAN, Shin-Chen (潘信誠) MD, PhD
Moderator CWONG, Tak-Wah (王德華) MD
LEE, Chih-Hung (李志宏) MD, PhD
Chronic wounds included diabetic foot ulcers and
others are still extremely difficult to heal. Therefore,
therapeutic options to improve healing rates are
continuously being explored. Optimal management
of chronic wounds is best offered by multidisciplinary
clinics. Revascularization to restore adequate blood
flow as needed and aggressive infection control are the
cornerstones of treatment. Other emerging therapy
such as systemic hyperbaric oxygen (HBO) may also
be helpful for improvement of healing of wounds.
HBO has been used in addition to standard
treatment of difficult wounds foot for more than
20 years. Evidence suggests that HBO reduces
amputation rates and increases the likelihood of
healing in infected diabetic foot ulcers, in association
with improved tissue oxygenation, resulting in better
quality of life. HBO therapy is a medical treatment
in which a patient breathes 100% oxygen (O2) inside
a pressurized treatment chamber. Intermittent HBO
may help in salvaging marginally perfused tissues. It
also improves (a) infection control due to enhanced
mobility and bacteria killing ability of leukocytes, (b)
granulation tissue formation due to stimulation of
fibroblast proliferation and collagen synthesis, and
(c) microcirculation due to edema reduction and
angiogenesis. We present our experience about the role
of HBO in management of chronic wounds.
SCIENTIFIC SESSIONS
43
WC2 Diabetic Wound Care Education
in Asia – Perspective of an
Orthopaedic Surgeon and Foot &
Ankle Specialist
Speaker CHAN, Samson Chi-Fai (陳智輝) MB,
B Ch, FRCSE, FHKAM, FHKCOS
Moderator CWONG, Tak-Wah (王德華) MD
LEE, Chih-Hung (李志宏) MD, PhD
Diabetes has an increasing proportion in health care
cost worldwide, due to its increasing prevalence
and persistence complications, countries in Asia
are battered with increasing incidence in younger
population and longer survival. The impact of diabetic
wound care drives wound care worker searching for
better and more effective wound healing technologies
and advances. Diabetic wound burdens the
orthopaedic care for the limbs and especially for the
Foot and Ankle specialist. We in Hong Kong formed
the Hong Kong Society of Diabetic Limb Care about
ten years ago and missioned to improve the Diabetic
Wound Care, education, research, and coordination
among wound care workers, including wound
specialist, wound nurses, podiatrist, and prosthetist
and orthotist. We have organized local health care
worker conference, public education, community
care activities, as well as regional and international
conferences, and have fostered and networked with the
Asia Pacific Association for Diabetic Limb Problems,
the World Union of Wound Healing Societies, and the
Asian Academy of Wound Technology collaboration.
The impact of our activities historically have aroused
awareness of the problem and importance of diabetic
limb care for the public, also disseminate knowledge
to health professionals and ancillary medical personnel
through medical seminars, various types of symposia
and educational exhibits, as well as attracted attention
of the health administrators and health care budgetholders,
political ministers in our local community
have been our strong support of our activities, after
all we are non-profit making, professional voluntary
group.
We can share some of our experience in success in
educating a mixed audience in this area of difficult
common clinical problems when so many advances
are made in recent years, in the coming future we shall
strive to provide practitioner who have a dedicated
interest in diabetic limbs care with new knowledge,
skill and techniques to optimize patient care.
SCIENTIFIC SESSIONS 44
SATURDAY, MAY 2
Face Sculpting and Lifting Symposium
Sat. May 2, 15:30-18:00
Room 304A
Moderator CHANG, Li-Yen (張立言) MD
WANG, Chao-Chin (王昭欽) MD
FSL1 Cog Thread Lifting Using ‘Curved
Cannula Technique’ for Easy and
Parallel Insertion of the Thread,
and ‘Temporal Loop Technique’ for
Strong Anchoring of the Threads
15:30 / AN, Kyung-Chun MD
FSL2 Combination Therapy of Fillers and
Noninvasive Face-Lift Modalities
with Monopolar RF and HIFU for
Facial Rejuvenation
16:00 / CHANG, Kao-Jung (張高榮) MD
FSL3 Facial Sculpting with Injectables and
Energy-Based Devices
16:30 / CHAO, Yates Yen-Yu (趙彥宇) MD
FSL4 The Application of
Micro-Autologous Fat
Transplantation(MAFT)
with Thread Lifting in Facial
Rejuvenation
17:00 / LIN, Tsai-Ming (林才民) M.D, Ph.D
FSL5 Minimally Invasive Face Lift with
Cone Sutures-Personal Experience
17:30 / LI, Kuan-Ying (李冠穎) MD
FSL1 Face Sculpting and Lifting: Cog
Thread Lifting Using ‘Curved
Cannula Technique’ for Easy and
Parallel Insertion of the Thread,
and ‘Temporal Loop Technique’ for
Strong Anchoring of the Threads
Speaker AN, Kyung-Chun MD
Moderator CHANG, Li-Yen (張立言) MD
WANG, Chao-Chin (王昭欽) MD
Cog thread lifting has been replacing the face lifting
surgeries because they are convinient and simple. Cog
threads not only elevates the drooping middle and
lower face but also stimulates the colagen production
around the inserted threads.
The ‘curved cannula technique ‘ keeps the thread in
parallel with the skin. Thus, preventing the ends of
the threads coming out near the perioral areas. With
proper execution of this technique, one can easily
place the threads in parallel with the curved facial skin.
The pulling force distributed among the entire cogs
of the thread will be dispersed through out the whole
length of the thread, thus sustaining length of period
by the PDO threads will be longer because lesser
force will be added at each cogs. This helps to prevent
unwanted dimpling effects by the cog threads.
In many procedures for uplifting the middle and
lower face, temporal fascia has been used. However,
the thread which also bites the temporal muscle
produces trigger points which makes unbarable pain
in many patients, for many months. ‘Temporal loop
technique’ utilizes the properties of the cogs which
will be embeded at the dermis of the temporal area in
figure of ‘U’ or ‘O’ loop form. This technique will
hold the threads, strongly, the lower face, especially.
However, this technique will be well utilized only if
the threads have good cogs, and the threads should be
long enough to make the loops.
SCIENTIFIC SESSIONS
45
FSL2 Combination Therapy of Fillers and
Noninvasive Face-Lift Modalities
with Monopolar RF and HIFU for
Facial Rejuvenation
Speaker CHANG, Kao-Jung (張高榮) MD
Moderator CHANG, Li-Yen (張立言) MD
WANG, Chao-Chin (王昭欽) MD
Nowadays, the rapid evolution and advance of
machines with radiofrequency and highly-intensified
focused ultrasound makes it easier for rejuvenation
of face without much downtime and much suffering
than the surgical intervention. In addition to the above
mentioned, any kind of fillers can also provide the
possibility of the volumizing effect and augument the
lift. We use these two combination therapy for years
and share these experience to all .
FSL3 Facial Sculpting with Injectables and
Energy-Based Devices
Speaker CHAO, Yates Yen-Yu (趙彥宇) MD
Moderator CHANG, Li-Yen (張立言) MD
WANG, Chao-Chin (王昭欽) MD
This section of lecture covers the subjects of
1.Principles of facial reshaping.
2.Intensive focused ultrasound in facial reshaping.
3.Radiofrequency devices in facial reshaping.
4.Volumizing fillers in facial reshaping.
5.Activating fillers in facial reshaping.
6.Practical combination of different modalities for
facial sculpting.
SCIENTIFIC SESSIONS 46
FSL4 The Application of Micro-Autologous
Fat Transplantation(MAFT) with
Thread Lifting in Facial Rejuvenation
Speaker LIN, Tsai-Ming (林才民) MD, PhD
Moderator CHANG, Li-Yen (張立言) MD
WANG, Chao-Chin (王昭欽) MD
Introduction
Aging process oN human face involves not only
the ptosis of skin (sagging or redundancy) but also
the deficiency of soft tissue under-beneath the skin.
Therefore both lifting and filling procedures for
rejuvenation of face are equally important. To evaluate
the effect of the thread-lift procedure with fat graft for,
we retrospectively reviewed our experience in applying
the concept of micro- autologous fat transplantation
(MAFT) to re-contour the deficient tissues combined
with simultaneous lifting with barbed suture.
Materials and Methods
The autologous fat was harvested from lower abdomen
then refined and processed at 3 min 3000 rpm by
centrifuge. There were 88 patients (79 female/9 male)
with average age 47.5 receiving micro- autologous fat
transplantation (MAFT) as a primary strategy for aging
face from Jan 2009 to Dec. 2014. Immediate after fat
grafting, barbed sutures were applied as an adjunctive
lifting procedure. An averaged 0.9 ml (ranging from 0.5
to 2.3 ml) of refined fat graft was micro-transplanted
evenly and precisely for each thread limb and related
uneven appearance with the MAFT-Gun®.
Results
Total procedural time of applying MAFT and placing
thread lift in was 28.5 minutes. Mild swelling and
ecchymosis but no other major morbidities were
noted. The final touch-up MAFT after thread-lift
alleviated the dimpling of the barbed suture and
avoided the temporal stretching line or plane should
the sutures placed superficially. In follow-up period,
patients all were satisfied with the result and longterm
(>6 months) outcome was appreciated as well.
Conclusion
MAFT concept has been introduced by Lin et al., and
applied for facial rejuvenation since 2006. Clinical
results for facial rejuvenation are satisfactory in longterm
follow up. By application of the innovative
medical device, surgeons seem to turn a used-to-be
inaccurate, labor demanding, and unpredictable fat
grafting into a micro-, precise, reliable, and confident
procedure. The consistency of each delived parcel
from 1/60 ~1/240 mL has also demonstrated its
reliable feasibility clinically.
More documents have also demonstrated the longterm
effect of barbed suture lifting in facial areas.
However, the immediately morbidities and most
embarrassed complications such as superficial
stretching marks and exit-dimple often frustrated both
surgeons and patients. With the immediate applying of
MAFT after thread-lifting, the embarrassed situations
have been effectively diminished. Therefore, thread
lift with micro- autologous fat transplantation (MAFT)
might be a better strategy for facial rejuvenation.
SATURDAY, MAY 2
Face Sculpting and Lifting Symposium
Sat. May 2, 15:30-18:00
SCIENTIFIC SESSIONS
47
FSL5 Minimally Invasive Face Lift with
Cone Sutures-Personal Experience
Speaker LI, Kuan-Ying (李冠穎) MD
Moderator
Surgical management of the aging face has
incorporated a wide range of new techniques over
thepast few years. Traditional face-lifting procedures
have employed historically more aggressive methods.
Because of the recent shift in the population’s interest
in less invasive procedures, the newer surgical
techniques have approached the reversal of senescent
changes of the face in a different fashion. Ultimately,
patients are seeking out procedures that
have little downtime coupled with longer-lasting
results and a favorable side-effect profile. For this
reason, facial plastic surgeons are continually adapting
newer and safer approaches to reversing ptotic changes
of the maturing face
Suture lifting over the early aging face are now
adaptive method and are better alternative to the
less invasive methods, such as toxin, fillers and
radiofrequence device.
My suture material is cones suture that have better
suspension effect and evenly hold the tissue. Limited
period and experience of the suture lifting for facial
rejuvenation in early aging, I also combined with some
rejuvenation techniques for whole face to get better
result.
SATURDAY, MAY 2
Satellite Speeches
Sat. May 2, 17:30-18:00
Position / 卡麥拉攝影咖啡館商業企劃攝影師 photographer
Website / http://www.wretch.cc/blog/wangdavid
http://www.flickr.com/photos/cameracoffee
WORKING EXPERIENCE /
Grand Hi Lai Hotel 漢來大飯店
Kaohsiung Howard hotel 高雄福華大飯店
CHATEAU de CHINE 翰品高雄
Dream mall 夢時代購物中心
BOZEN SANITARYWARE &
KITCHENWARE BOUTIQUE, Kaohsiung 柏正衛廚
David Wang is devoted to the integration of
photography with different aspects of life and the
promotion of esthetic sensibilities among the
general public. He established Camera Coffee in
2006,which is the first theme coffee shop that
focuses on photographic imaging. He is
currently a commercial project photographer.
PHOTOGRAPHER
王大衛
大會攝影師
致力於影像生活化並積極推廣市民美學的提升，
2006年創辦高雄第一間以生活攝影為主題的影像
咖啡館CAMERA COFFEE，並擔任CAMERA
COFFEE 商業企劃攝影師。
05
SCIENTIFIC SESSIONS 48
Room 304A
Moderator ASCHER, Benjamin MD
IS1 Presentation of IMCAS
17:00 / ASCHER, Benjamin MD
IS2 What's New in Anatomy- Injection
on Cadaver? Avoiding Face
Complications
17:05 / ASCHER, Benjamin MD
IS3 What's New in Anatomy- Injection
on Cadaver? Injectables
17:17 / PRASETYO, Adri Dwi MD
IS4 The New Science of Fillers and
Asian Aesthetics
17:29 / SUNDARAM, Hema MD
IS5 What's New in Lasers for Scars and
Pigmentation?
17:41 / CASSUTO, Daniel MD
Questions and Answers
17:53 / All
SATURDAY, MAY 2
IMCAS Session
Sat. May 2, 17:00-18:00
IS1 The Application of Micro-Autologous
Fat Tranvenation
Speaker ASCHER, Benjamin MD
Moderator ASCHER, Benjamin MD
SCIENTIFIC SESSIONS
49
IS2 What's New in Anatomy- Injection
on Cadaver? Avoiding Face
Complications
Speaker ASCHER, Benjamin MD
Moderator ASCHER, Benjamin MD
IS3 What's New in Anatomy- Injection
on Cadaver? Injectables
Speaker PRASETYO, Adri Dwi MD
Moderator ASCHER, Benjamin MD
學會在會議籌備期間發文至
國際知名會議組織IMCAS，
告知會議資訊，併邀請參加本次盛會。
台灣與
國際組織的合作
SCIENTIFIC SESSIONS 50
IS4 The New Science of Fillers and Asian
Aesthetics
Speaker SUNDARAM, Hema MD
Moderator ASCHER, Benjamin MD
IS5 What's New in Lasers for Scars and
Pigmentation?
Speaker CASSUTO, Daniel MD
Moderator ASCHER, Benjamin MD
SATURDAY, MAY 2
IMCAS Session
Sat. May 2, 17:00-18:00
SCIENTIFIC SESSIONS
51
SATURDAY, MAY 2
Satellite Speeches
Sat. May 2, 15:30-18:00
Room 304B
Moderator WU, Ching-Ying (吳青穎) MD
SS1 New Perspective for Skin Barrier
Repairer
15:30 / MEDINA-LAVADIA, Angela MD
Moderator LEE, Woan-Ruoh (李婉若) MD, PhD
SS2 A New Trend in Laser Treatment:
Mixed Technology. Combined CO2
10600nm and GaAs 1540nm for
Fractional Skin Resurfacing
16:00 / LU, Ching-I (盧靜怡) MD
Moderator Tseng, Chung-Ren (曾忠仁) MD
SS3 eTWO : Advanced Fractional
Radiofrequency for Rejuvenation
and Scar Treatment in Asian and
Other Pigmented Skin
16:30 / SUNDARAM, Hema MD
Moderator TSENG, Ming-Yi (曾銘儀) MD
SS4 Clinical Experiences of the Next
Generation Sculpturing System-
Maximus
17:00 / YU, Jonathan Nevin MD
Moderator Tseng, Chung-Ren (曾忠仁) MD
SS5 Evaluation of RF v.s. HIFU in Skin
Tightening: A Split Face Study
17:30 / TSENG, Fang-Wen (曾繁聞) MD
SS1 New Perspective for Skin Barrier
Repairer
Speaker MEDINA-LAVADIA, Angela MD
Moderator WU, Ching-Ying (吳青穎) MD
SCIENTIFIC SESSIONS 52
SS2 A New Trend in Laser Treatment:
Mixed Technology. Combined CO2
10600nm and GaAs 1540nm for
Fractional Skin Resurfacing-
Speaker LU, Ching-I (盧靜怡) MD
Moderator LEE, Woan-Ruoh (李婉若) MD, PhD
Fractional ablative and non-ablative lasers are useful
tools for facial rejuvenation and to treat acne scars.
However, each laser has its own advantages and
limitations. The ablative laser requires a period of
downtime during re-epithelialization and has a higher
risk of PIH, esp. on Asian skin. The non-ablative laser
needs more sessions to show the result and has less
fading-out effect for the scar border. A procedure that
combines both ablative and non-ablative fractional
lasers, which I had used for 6 more years, can deliver
good cosmetic results and reduce some side effects
of only using each one laser. Now, a novel technique
can deliver these two kinds of lasers at the same time.
We will discuss about the advantages of this technique
over the past and the possible side effects in this
session.
S S 3 e Two: Advanced Fr a c t i o n a l
Radiofrequency for Rejuvenation
and Scar Treatment in Asian and
Other Pigmented Skin
Speaker SUNDARAM, Hema MD
Moderator Tseng, Chung-Ren (曾忠仁) MD
Asian patients have individual patterns of aging,
and may also express different treatment aims
and objectives. Selection of laser and light energy
technologies for enhancement and rejuvenation of
Asian skin is based on the balance between treatment
needs, safety and efficacy. Each patient's tolerance
for post-procedural recovery time must also be
considered. The trend for patients in Asia and globally
is a preference for treatments that offer as little
recovery time as possible.
In this lecture, Dr. Hema will discuss the science
and clinical applications of eTwo, an advanced,
light energy device that combines fractionated
bipolar radiofrequency resurfacing (Sublative)
with bipolar radiofrequency plus broad band light
(Sublime). Because the light energies of eTwo are
non-chromophore-specific and therefore “colorblind”,
they offer excellent safety and efficacy for
all Fitzpatrick skin phototypes, including skin types
III and above. Dr. Hema will present the results she
has achieved with eTwo on Asian patients, and other
patients with pigmented skin. She will also discuss her
study data, which demonstrate the safety, efficacy and
tolerability of eTwo and the minimal recovery time.
The eTwo technology is well-suited to Asian
skin because it diminishes epidermal ablation to
sufficient extent that the risk of post-inflammatory
hyperpigmentation or hypopigmentation is minimized
or eliminated. The combined light energies of eTwo
target both superficial and deep tissue planes below the
epidermis, to achieve multi-level energy delivery. This
provides improvement in hyperpigmentation, skin
reflectance and rhytides, and volumetric improvement
in skin laxity and facial contours.
Since facial aging is recognized as a multi-level
pathology, layered rejuvenation with lasers and light
energy technologies such as eTwpo is logical and can
deliver optimal results.
SATURDAY, MAY 2
Satellite Speeches
Sat. May 2, 15:30-18:00
SCIENTIFIC SESSIONS
53
SS4 Clinical Experiences of the Next
Generation Sculpturing System-
Maximus
Speaker YU, Jonathan Nevin MD
Moderator TSENG, Ming-Yi (曾銘儀) MD
Non-invasive aesthetic procedures for body shaping
are constantly demanded worldwide. Currently
existing non- invasive procedures are limited in term
of efficacy and safety and practitioners often tend
to combine a few technologies and complementary
treatment modalities in order to improve results.
The Maximus platform is a unique device which
uses Tripolar RF to stimulate the release of fat with
collagen remodeling of the dermal layer. At the same
time it synergistically uses low frequency pulsed
current to stimulate muscle to remove the fat via
enhanced lymphatic drainage.
Clinical evaluations of the technology demonstrated
safety and efficacy of the Maximus treatment in
circumference reduction, improvement of cellulite
appearance and skin tightening.
Patients and practitioners benefit from the use of
multiple technologies at once, in a significantly shorter
treatment time as compared to other commonly used
combination protocols applying separate devices or
technologies.
Aside from body contouring, other treatment
modalities like facial tightening, acne and acne scar
treatments using the Maximus will be presented.
SS5 Evaluation of RF v.s. HIFU in Skin
Tightening: A Split Face Study
Speaker TSENG, Fang-Wen (曾繁聞) MD
Moderator Tseng, Chung-Ren (曾忠仁) MD
Monopolar radiofrequency (RF) and high-intensity
focused ultrasound (HIFU) are two of the moststudied
non-invasive skin tightening procedures. Both
technologies deliver heat to the dermis and deeper
layers of skin, causing thermally induced collagen
contraction, remodeling, and later neocollagenesis.
Although the effectiveness and safety of RF and HIFU
had been demonstrated separately in the literature,
there is controversy about direct comparison of
these two procedures. In order to improve our
understanding of patient selection for non-invasive
skin tightening procedures, we conducted a splitface
study on patients with different degree of facial
sagging and soft tissue volume. Monopolar RF with a
“total tip” (Thermage CPT Inc., Hayward, CA) was
used on one side of the face and neck of each patient,
while HIFU (Ulthera LLC, Mesa, AZ) was used on
the other. Clinical results and adverse events will be
presented.
May 2, Sat, 18:00-19:30
RM 301B
Gala Dinner, Opening and
Networking
Extensive Banquet-style Dining with
Self-select Buffet
雞尾酒會式精緻自助餐點
大會晚宴
13
SCIENTIFIC SESSIONS 54
SCIENTIFIC SESSIONS
SATURDAY, MAY 2
Physician Only
Lecturing in English
Lecturing in Chinese
Simultaneous Interpreting
Medical Dermatology
Dermatological Surgery
Engergy-based Devices
Injectables
Staff Training
19:30-21:00
Injectable Workshop: Pearl of Injectable Treatment -Tips and Tricks
Liposculpting Symposium
Satellite Speeches: HIFU
SCIENTIFIC SESSIONS
55
SATURDAY, MAY 2
Injectable Workshop: Pearl of Injectable Treatment-Tips and Tricks
Sat. May 2, 19:30-21:00
Room 301A
Moderator CHAO, Yates Yen-Yu (趙彥宇) MD
CASSUTO, Daniel MD
PIT1 To Treat Tear Trough with
Confidence
19:30 / MOON, Hyoung-Jin MD
PIT2 Upper and Lower Asian Eyelid
Volumetry to Achieve Holistic
Periorbital Augmentation
19:45 / PRASETYO, Adri Dwi MD
PIT3 Treatment of Skin Necrosis After
Filler Injection
20:00 / CHANG, Geun-Uck MD
PIT4 How can Science Predict and Perfect
our Filler Results?
20:15 / SUNDARAM, Hema MD
PIT5 Tips and Tricks of Injectables
20:30 / CASSUTO, Daniel MD.
PIT1 To Treat Tear Trough with Confidence
Speaker MOON, Hyoung-Jin MD
Moderator CHAO, Yates Yen-Yu (趙彥宇) MD
CASSUTO, Daniel MD
The deflated infraorbital hollow gives an impression
of tiredness, age, and depression. It is one of the
most challenging areas of the face to treat, with
far less tissue between bone and skin than in the
cheek. Recently, the use of dermal fillers to correct
infraorbital hollows has evolved as a rapid nonsurgical
option. Overcorrection, too-superficial injections,
and choice of an inappropriate filler may lead to
unacceptable aesthetic results. By placing the filler at
the deepest
level of the hollow, the filler is covered by multilayer.
This multilayer covering
the product, allows for ease of manipulation if there
are irregularities detected.
Selection of appropriate patients, filler material,
and injection techniques are critical for successful
treatment outcomes. Three-dimensional volume
augmentation is an essential to correct the infraorbital
hollow. Doctors must thoroughly understand threedimensional
facial anatomy. And also requires
knowledge of the properties of each filler , as well
as an understanding of the patient's major aesthetic
concerns.
SCIENTIFIC SESSIONS 56
PIT2 Upper and Lower Asian Eyelid
Volumetry to Achieve Holistic
Periorbital Augmentation
Speaker PRASETYO, Adri Dwi MD
Moderator CHAO, Yates Yen-Yu (趙彥宇) MD
CASSUTO, Daniel MD
The typical characteristics of an aging periorbital
region are complex 3-dimensional volume loss, change
of contours, and thin skin with laxity. Rejuvenation
treatment is based on these holistic understandings.
The volumetric injection using hyaluronic acid (HA)
fillers brings substantial enhancement to both upper
and lower eyelid. To achieve smooth contours, a
layered, diffuse feathered threading technique was
used, placing the filler deep and superficial to the
orbicularis oculi muscle. Despite the relatively small
volume required, the upper and lower periorbital
aesthetics are significantly improved. Thin skin in
aging periorbital requires volumetric under laxitybased
sequential sessions, which is safer, less risk
of over-correction, and effectively integrate to
produce a more natural appearance of rejuvenation.
Individualized planning and evaluation during
procedural injection are essential in patients with very
thin skin, preexisting color problems, or preexisting
fat bulge for periorbital augmentation with hyaluronic
acid fillers.
PIT3 Treatment of Skin Necrosis After
Filler Injection
Speaker CHANG, Geun-Uck MD
Moderator CHAO, Yates Yen-Yu (趙彥宇) MD
CASSUTO, Daniel MD
The use of fillers in the face for augmentation is
a popular procedure in aesthetic practice. In nose
case, it can be used for augmentation of the radix,
dorsum, and tip. Although generally safe, disastrous
complications can occur if filler is inadvertently
injected into a terminal artery, resulting in
thromboembolism, skin ischemia, and necrosis. This
occurs most commonly in the region of the nasal
tip, columella, and alar region. Injections in these
sitesshould be avoided.
In the event of skin ischemia, initial treatment
consists of regular dressing, hyperbaric oxygen therapy,
and prostaglandin injections. If skin necrosis occurs
despite initial attempts at salvage, reconstruction
must be performed. Local flap and regional flapssuch
as the subnasal flap, nasolabial flap, and paramedian
forehead flaps can be used, often in conjunction with
autologous cartilage.
The paramedian forehead flap remains a workhorse
for nasal reconstruction. Based on the supratrochlear
artery, it can be designed for soft tissue cover of the
nasal dorsum, tip and alar regions, with good skin
matching. Closure of the donor site can usually be
performed primarily.
SATURDAY, MAY 2
Injectable Workshop: Pearl of Injectable Treatment-Tips and Tricks
Sat. May 2, 19:30-21:00
SCIENTIFIC SESSIONS
57
PIT4 How can Science Predict and Perfect
our Filler Results?
Speaker SUNDARAM, Hema MD
Moderator CHAO, Yates Yen-Yu (趙彥宇) MD
CASSUTO, Daniel MD
Hyaluronic acid (HA) fillers products that are
currently available for aesthetic use including Belotero
(Esthélis, Fortélis and Modélis), Juvéderm, Voluma,
Restylane and Teosyal. Another commonly used filler
is calcium hydroxylapatite (CaHA) which is known
as Radiesse. All are safe, efficacious and predictable.
In recent years, interest has focused on the rheology
(flow-related properties) of these products and
how they are relevant to clinical behavior. In this
lecture, Dr. Hema will provide an overview of the
physical properties of HA and CaHA fillers, some key
rheologic studies including important methodological
considerations, and a discussion of how the results can
guide the use of different filler products. The primary
rheologic parameters that have been investigated are
cohesivity, elastic modulus (G prime), and viscosity.
Recently, a new 5-point scale for HA filler cohesivity
has been developed and validated. Previous studies of
HA and CaHA fillers reveal that they can be broadly
divided into three groups based on their G prime
and viscosity and their resultant physical properties.
Group 1 fillers have high elasticity and high viscosity
and therefore are firm and non-spreading. Group 2
fillers have medium to high elasticity and viscosity
and are intermediate in firmness and tendency to
spread. Group 3 fillers are soft, spreading fillers. Filler
rheology is an exciting and rapidly advancing field.
It is of value in selecting the most appropriate filler
products and injection techniques to achieve the best
outcomes. The lecture concludes with a look into the
future – at new scientific investigations, and how they
will shape our future use of fillers.
REFERENCES
Sundaram H, Rohrich R, Liew S et al. Cohesivity
of hyaluronic acid fillers: Development and clinical
implications of a novel assay, pilot validation with a
5-point grading scale, and evaluation of six US FDAapproved
fillers Plast Reconstr Surg – in press.
Sundaram H, Cassuto D. Biophysical characteristics
of hyaluronic acid soft tissue fillers and their relevance
to aesthetic applications. Plast Reconstr Surg. (2013)
Ascher B, Rzany B, Sundaram H. (Chairs). “Fillers:
From Characteristics to Recommendations.”
Consensus panel discussion, IMCAS 2013 Annual
Meeting, Paris, France.
Stocks D, Sundaram H, et al. Rheological evaluation
of the physical properties of hyaluronic acid dermal
fillers. J Drugs Dermatol. (2011).
Sundaram H, Voigts B et al. Comparison of the
rheological properties of viscosity and elasticity in two
categories of soft tissue fillers: calcium hydroxylapatite
and hyaluronic acid. Dermatol Surg. (2010).
Kablik J, Monheit GD et al. Comparative physical
properties of hyaluronic acid dermal fillers. Dermatol
Surg. (2009).
SCIENTIFIC SESSIONS 58
PIT5 Tips and Tricks of Injectables
Speaker CASSUTO, Daniel MD
Moderator CHAO, Yates Yen-Yu (趙彥宇) MD
SATURDAY, MAY 2
Injectable Workshop: Pearl of Injectable Treatment-Tips and Tricks
Sat. May 2, 19:30-21:00
SCIENTIFIC SESSIONS
59
SATURDAY, MAY 2
Liposculpting Symposium
Sat. May 2, 19:30-21:00
Room 304A
Moderator YANG, Hung-Hsu (楊弘旭) MD
WANG, Chao-Huei (王朝輝) MD
LS1 Comprehensive Surgeries of the
Trunk for ‘Trunk Contouring’ vs.
Regional Liposuction
19:30 / AN, Kyung-Chun MD
LS2 How to Become a Successful
Liposuctionist Detailed Techniques
20:00 / WANG, Chao-Huei (王朝輝) MD
LS3 Body Sculpture : Surgical and Nonsurgical
Choices
20:30 / CHOU, Erh-Kang (周爾康) MD
LS1 Comprehensive Surgeries of the
Trunk for ‘Trunk Contouring’ vs.
Regional Liposuction
Speaker AN, Kyung-Chun MD
Moderator YANG, Hung-Hsu (楊弘旭) MD
WANG, Chao-Huei (王朝輝) MD
A massive number of patients are looking for
liposuction. Their need for liposuction used to be
to discard unwanted fatty tissue around their belly,
arms, and thighs, mostly. However, the expectations of
patients seeking for liposuction are high. They want
to become healthy looking with perfect body contour.
They don’t want to have any loose skin around their
waist with many stretch marks.
When designing the patients before liposuction, who
want to have perfect body like the celebrities, the
whole problem has to be taken into consideration
for the surgeons. Laxity of the skin and abdominal
muscles, stretch marks on the abdomen, diastasis of
the rectus abdominis, hernias, etc. must be taken into
consideration. Likewise the smooth contour between
the suctioned area and the area without liposuction
must also be harmonized. The whole figure of the
body should coninside with the look of other parts.
Thus, giving perfect shape of the patients. As the
technologies of the surgical devices advance, shaping
of the fatty tissue is more precisely done. Devices
using radiofrequencies, ultrasound, LASERs, and
vibration are helpful aids for sculpting the fatty tissues
and for skin retraction. The shape of the abdominal
muscles are emphasized on the surface of the
abdomen, thus acquiring a much wanted athletic look
for both male and female patients.
SCIENTIFIC SESSIONS 60
LS2 How to Become a Successful
Liposuctionist Detailed Techniques
Speaker WANG, Chao-Huei (王朝輝) MD
Moderator YANG, Hung-Hsu (楊弘旭) MD
The liposuction had developed since 1970. Too much
complications and incredible high mortalities were
noted. The wetting methods improved with time. Till
tumescent solution by Dr Klein had greatly success.
The complication rate and mortality rate lower down
thereafter. The concepts included with vascular
constriction, swellen fat tissue, diluted lidocaine,
controlled systemic toxicity of lidocaine. So we can
avoid bleeding, fat emboli, thumbus and lidocaine
toxicity. The evolution of techniques developed with
time as well. According to different equipement and
machine, different kinds of liposuction style marked.
There were SAL, UAL, PAL, LAL, WAL and RFAL.
Each technique contained different function and
benefit, so did the complications and drawbacks.
Basically, from skin to muscle, there contained
different layers, including epidermis, dermis, apical
layer, superficial fat, superficial fascia, deep fat and
deep fascia. Acknowledging the structure, we are able
to draw more fat, naming ultratumescent liposuction,
than before without skin complication. With event
wetting distribution, we can expect smooth skin
performance.
For satisfactory success, multiple factories must
be considered. Such as proper custom selection,
anethesia, positions, incisions, techniques and skills,
we should take more into consideration. Patient
complained with localized or refractory fat part.
Neither major comorbidity nor unrealistic expectation
should be taken place. Unlike foreign sugery
performance with multiple entries, we try to hide the
entry point in fold and hair. For the different purpose,
we use different techniques and skills. To draw out
the fat or to shaping the muscular texture was totally
different thinking process and doing.
With proceeding from tumescent liposuction by
Dr Klein, we revised something to improve the
performance. At very beginning, drawing fat safely was
the first consideration and stage. In the tumescent era,
the total complication lowered to acceptable result.
The mortality became extremely rare at a large-scaled
study for decades. Then, by knowing the structure,
we drawed more fat than before. Following stage, to
persuing excent result, we shaping and contouring
the muscular texture. At final stage, we shall devote
our knowledge and skills to treat the complication. By
learning and teaching, the liposuction performance
can achieve more satisfactory boundary.
SATURDAY, MAY 2
Liposculpting Symposium
Sat. May 2, 19:30-21:00
SCIENTIFIC SESSIONS
61
LS3 Body Sculpture : Surgical and Nonsurgical
Choices
Speaker CHOU, Erh-Kang (周爾康) MD
Moderator YANG, Hung-Hsu (楊弘旭) MD
WANG, Chao-Huei (王朝輝) MD
In recent years, body contouring project is receiving
increasing attention in the medical beauty items.
Plastic items inside the United States, liposuction and
breast augmentation surgery is the highest ranking in
the top three. Generalized body contouring surgery
also includes lifting surgery after massive weight
loss. Several years before, autologous fat graft as one
method for breast augmentation bring the liposuction
surgery to another peak in cosmetic market. Today we
will talk about the body curve beauty, from the ancient
standard, evolution of body pretty, then latest scientific
selection appreciate treatment tools for better results.
國內會議宣傳
FB粉絲專頁
https://www.facebook.com/tdacmeeting
11
SCIENTIFIC SESSIONS 62
Room 304B
Moderator HSU, Nai-Jen (許乃仁) MD
SS7 Safety and Efficacy of Ulthera in
the Rejuvenation of Aging Lower
Eyelids: A Pivotal Clinical Trial
19:30 / PAK, Chang-Sik MD
Moderator CHAO, Sheau-Chiou (趙曉秋) MD
SS8 Double Micro Focused Ultrasound
System for Non Invasive Skin Lifting
20:00 / CHEN, Ya-Hui (陳雅惠) MD
Moderator LIN, Chrang-Shi (林長熙) MD
SS9 My Experience for Combined
Therapy in HIFU Treatment with
Toxin, Derma Filler and PDO
Thread
20:30 / KIM, Beom-Joon MD, PhD
SS10 The Potential Risk of Combined
Therapy in HIFU Treatment and
how to Handle it
20:40 / SU, Chen-Wei (蘇承偉) MD
SS11 HIFU for skin tightening and lifting
using Ultraformer
20:50 / ASCHER, Benjamin MD
SS7 Safety and Efficacy of Ulthera in
the Rejuvenation of Aging Lower
Eyelids: A Pivotal Clinical Trial
Speaker PAK, Chang-Sik MD
Moderator HSU, Nai-Jen (許乃仁) MD
The changes in the periorbital region are among the
most prominent features of the aging process in the
lower eyelids. Intense focused ultrasound (IFUS),
known as the Ulthera System, was designed to correct
this process. The current study assessed the safety and
efficacy of the Ulthera System. This study enrolled
seven adult patients who presented from March 2011
to May 2012 for correction of lower eyelid aging by
Ulthera. The subjects were treated using Ulthera
1.5 and 3.0 mm probes. The 1.5 mm probe is used
to tighten of loose eyelid skin and the deep dermis,
whereas the 3.0 mm probe is used to tighten the
orbicularis oculi muscle and the orbital septum. The
patients were evaluated for allergic reactions and other
side effects. The subjects' satisfaction with clinical
photographs and the degree of pain were evaluated.
Moreover, orbital computed tomography (CT) and
ophthalmologic examinations were performed. The
study used CT both as a research tool and as a clinical
score system for evaluating aging lower eyelids and
performed statistical analysis. Based on the CT images,
the difference between the pre- and postoperative
distances from the baseline (line between the most
inferior point of the supraorbital rim and the most
superior point of the infraorbital rim) to the most
protruding point of the orbital septum was 0.51 +/- A
0.23 for the right eye (p < 0.001) and 0.54 +/- A 0.17
for the left eye (p < 0.001). The subjective score for
patient satisfaction was 3.85 +/- A 0.69. The objective
satisfaction scores reported by two blinded researchers
were respectively 3.45 +/- A 1.69 and 3.25 +/- A
1.43. During the study period, no adverse events and
no suspected serious adverse reactions were noted.
Tightening of infraorbital laxity and skin can be
achieved using the Ulthera System. Patients showed
a minimal pain level during treatment, and topical
analgesic cream was able to manage pain during the
procedure.
SATURDAY, MAY 2
Satellite Speeches: HIFU
Sat. May 2, 19:30-21:00
SCIENTIFIC SESSIONS
63
SS8 Double Micro Focused Ultrasound
System for Non Invasive Skin
Lifting
Speaker CHEN, Ya-Hui (陳雅惠) MD
Moderator CHAO, Sheau-Chiou (趙曉秋) MD
Skin laxity is a common complaint from patients who
request a skin rejuvenation procedure.
Microfocused ultrasound (MFU), a novel treatment
modality for skin laxity, produces thermal effects at
various depths while sparing overlying epidermis.
The transducer can concentrate ultrasound energy
with very high intensity at specific locations below
the epidermis and specifically target the dermis or
superficial musculoaponeurotic system, a fibrous
network consisting of collagen fibers, elastic fibers,
and fat cells that connects the facial muscles with the
dermis, which is supposed to be tightened during a
facelift. The goal is to produce a deeper wound healing
response at multiple levels with robust collagen
remodeling and thus a more durable clinical response.
MFU combined with visual monitoring can be
applied to the skin with higher degree of precision
to lift and tighten the dermis and subdermal tissues
noninvasively. Common adverse events include
momentary discomfort during the treatment session,
transient erythema and edema, and occasional
bruising.
The patients in our institute were first treated with a
4.5-mm, 4-MHz HIFU probe, from 1.5 to 1.8J/cm2,
followed by a 3.0-mm, 7-MHz HIFU probe, from
0.7 to 0.9J/cm2. The improvement after treatment as
compared to the pre-treatment photography, patient
satisfaction and adverse events will be presented and
discussed in our report.
In conclusion, MFU is a useful nonablative method
for lifting lax facial and neck skin.
SS9 My Experience for Combined Therapy
in HIFU Treatment with Toxin,
Derma Filler and PDO Thread
Speaker KIM, Beom-Joon M.D, PhD
Moderator LIN, Chrang-Shi (林長熙) MD
The demand for noninvasive techniques of facial
contouring has experienced exponential growth over
the last decade because younger looking face raises
one's competitiveness. Moreover, there is a particular
interest in safe and effective ways to decrease skin
laxity and smooth irregular contours and texture
without downtime. Also, aesthetic clinicians have
a constantly expanding range of treatment options
in facial contoruing and tightening at their disposal.
In addition to surgical interventions, cosmetic
rejuvenation procedures may involve injectable fillers,
botulinum toxin, ablative and nonablative resurfacing,
phototherapy, and radiofrequency treatments. Over
the past decade, radiofrequency and infrared laser
devices have been popularized owing to their ability
to deliver controlled heat to the dermis, stimulate
neocollagenesis, and effect modest tissue tightening
with minimal recovery. However, these less invasive
approaches are historically associated with inferior
efficacy so that surgery still remains the treatment of
choice to address moderate to severe tissue laxity.
High intensity focused ultrasound (HIFU) has
recently been evaluated as a method for transcutaneous
heat delivery that reaches the deeper subdermal
connective tissue in tightly focused zones at consistent
programmed depths and selective destruction of
adipose tissue. HIFU has been adapted specifically for
skin tightening and contouring with little recovery or
risk of complications.
This topic covers the principles and clinical
applications of HIFU to facial contouring for
enhanced efficacy and consistency of clinical
improvement.
SCIENTIFIC SESSIONS 64
SS10 The Potential Risk of Combined
Therapy in HIFU Treatment and
how to Handle
Speaker SU, Chen-Wei (蘇承偉) MD
Moderator LIN, Chrang-Shi (林長熙) MD
High intensity focused ultrasound (HIFU) is a one
of noninvasive treatments for facelift, it directly
delivers heat energy to skin and subcutaneous tissue
that can stimulate and renew the skin's collagen
and thus consequently improving the texture and
reducing sagging of the skin. There are still some
common and severe complications which need serious
consideration. Skin burns and pain in the treatment
region; the next common complication was severe
edema or neurapraxia of the designated area to variable
degrees.
Injectable soft tissue fillers/toxin and HIFU
treatments are frequently combined or performed
soon after one another to literally achieves the great
results. The treating physician should keep in mind
that the potential exists for injection complications.
Fortunately, most complications are minor and
transient in nature, although the patient may consider
them aesthetically displeasing and unacceptable.
Major complications are rare, but they can produce
permanent, disfiguring damage.
Skin thickness varies among facial areas, which affects
optimal injection or targeting depth. The appropriate
depth of placement is dependent on the combined
product selected and strongly influences the end
result. In order of depth, hyaluronic acid products,
calcium hydroxyapatite (Radiesse) and poly-L-lactic
acid (Sculptra) should be injected into the different
depth. In addition, the areas have minimal collateral
circulation and are at increased risk of vascular
compromise.
Complications are best prevented with careful
planning. Thorough knowledge of both pertinent
facial anatomy and the specific characteristics of each
filler/HIFU machine is critical. In addition, managing
patient expectations is an important element in the
pretreatment preparation.
SS11 HIFU for skin tightening and lifting
using Ultraformer
Speaker ASCHER, Benjamin MD
Moderator LIN, Chrang-Shi (林長熙) MD
SATURDAY, MAY 2
Satellite Speeches: HIFU
Sat. May 2, 19:30-21:00
SCIENTIFIC SESSIONS
65
SCIENTIFIC SESSIONS
MEMO
SCIENTIFIC SESSIONS 68
SCIENTIFIC SESSIONS
69
SCIENTIFIC SESSIONS
SUNDAY, MAY 3
08:30-10:00
Anatomy Workshop
Acne and Rosacea Symposium (I)
Non-invasive Body Contouring
Satellite Speeches: Intense Pulse Light and Pulsed Dye Laser
Physician Only
Lecturing in English
Lecturing in Chinese
Simultaneous Interpreting
Medical Dermatology
Dermatological Surgery
Engergy-based Devices
Injectables
Staff Training
SCIENTIFIC SESSIONS 70
SUNDAY, MAY 3
Anatomy Workshop
Sun. May 3, 8:30-10:00
Room 301A
Moderator TSENG, Chung-Jen (曾忠仁) MD
SUNDARAM, Hema MD
CASSUTO, Daniel MD
AW1 Overview of Key Anatomical
Structures - An Asian Perspective
(video demo)
8:30 / JUNG, Wonsug MD, Ph.D
/ MOON, Hyoung-Jin MD
AW1 Overview of Key Anatomical
Structures - An Asian Perspective
(video demo)
Speaker JUNG, Wonsug MD, PhD
MOON, Hyoung-Jin MD
Moderator TSENG, Chung-Jen (曾忠仁) MD
SUNDARAM, Hema MD
CASSUTO, Daniel MD
It has already been passed 10 years since cosmetic
surgical procedures, using fillers has been introduced
to Asia. The concept itself of ‘filler’ was unfamiliar,
but the advantage that it is safer and effective gradually
became well-known. Thus, it has recently become a
representative procedure in the cosmetic surgery area.
Filler is any material that can augment volume when
injected into the body, and is usually an injectable
material. Well-known fillers include hyaluronic acid
products, collagen, paraffin, liquid silicon etc. Fillers
are usually classified by their components. Fillers can
be classified by their longevity, fillers with duration of
less than 2 years are called temporary fillers, those with
duration of 2 to 5 years are called semi-permanent
fillers, and those lasting no less than 5 years after
injection are called permanent fillers. Fillers can also
be divided based on the mechanism of action, such as
volumizing fillers and stimulatory fillers. Collagen
and hyaluronic fillers in which the injected material
itself constitute the augmented volume are classified as
volumizing fillers, and those which augment volume
by stimulating fibroblasts to synthesize collagen or
depositing fibrous tissues through inflammatory
response are called stimulatory fillers.
Most of the fillers introduced in Asia have a good
safety profile. However, serious side effects such
as granuloma formation or inflammation due to
tissue reaction have been reported with several filler
products, so it is necessary to select the desirable filler
by understanding the characteristics of each product.
The ideal filler should have no tissue reaction, is longlasting,
safe and easy to use, be, and have no intratissue
migration or allergic reaction.
Facial cosmetic surgery using filler can only be
successfully performed if the surgeon has a good
understanding of anatomy and is able to select the
appropriate product for his purposes.
Anatomically, the face is the most complicated
structure of the human body. Especially, the structure
SCIENTIFIC SESSIONS
71
of facial muscles including nerves and vessels is very
variable and has the racial differences. Recently,
the importance on the facial anatomy has been
reconsidered as the interest on the facial aesthetics is
increasing. The aesthetic physicians should understand
the anatomy of the facial musculature. Through
this lecture, I would like to show the anatomical
characteristics and the individual variations of the face
related to the filler injection for the safe and efficient
clinical applications.
Meet and Dine with Experts
SUNDAY, MAY 3 18:30~20:30
與大師有約
Dr. ACQUILLA, Raj
Dr. CHAN,Samson Chi-Fai (陳智輝)
Dr. PRASETYO, Adri
Dr. SATO, Kiyoshi
Dr. SUNDARAM, Hema
會員/準會員限定！
與大師共進晚餐的難得經驗
若您尚未登記與大師見面的機會，
請速洽大會秘書處預約繳費(1500元/人)
高雄漢來飯店12F東方樓
19
SCIENTIFIC SESSIONS 72
Room 301B
Moderator YANG, Li-Cheng (楊麗珍) MD
HUANG, Po-Han (黃柏翰) MD
AR1 Taiwan Acne Consensus Report
8:30 / HUI, Rosaline Chung-Yao (許仲瑤) MD, PhD
AR2 What does 30 years of Isotretinoin
Usage Tell Us?
8:40 / YANG,Chia-Yi (楊佳懿) MD
AR3 How I Treat Active Lesion with
Lasers
9:00 / WANG, Shiou-Han (王修含) MD
AR4 How I Treat Acne Scars?
9:20 / CHAO, Yates Yen-Yu (趙彥宇) MD
AR5 Evidence for Treating Early to
Prevent Scar
9:40 / HAYASHI, Nobukazu MD, PhD
10:00 Discussion
AR1 Taiwan Acne Consensus Report
Speaker HUI, Rosaline Chung-Yao (許仲瑤) MD, PhD
Moderator YANG, Li-Cheng (楊麗珍) MD
HUANG, Po-Han (黃柏翰) MD
I will present the conclusion from consensus meeting
on treatment of Acne vulgaris, which covers patient
education and recommendation on the use of topical
and systemic antibiotics, hormone, and isotretinoin;
as well as adjuvant physical therapies and laser/ light
treatment. Special highlight is on the use of topical
maintenance therapy and agreement on limiting the
use of antibiotics.
SUNDAY, MAY 3
Acne and Rosacea Symposium (I)
Sun. May 3, 8:30-10:00
SCIENTIFIC SESSIONS
73
AR2 What does 30 years of Isotretinoin
Usage Tell Us?
Speaker YANG,Chia-Yi (楊佳懿) MD
Moderator YANG, Li-Cheng (楊麗珍) MD
HUANG, Po-Han (黃柏翰) MD
With 30 years of clinical use, it is appropriate to review
the use of isotretinoin. We now understand that
retinoids influence cellular growth, differentiation,
morphogenesis and apoptosis, inhibit tumour
promotion and malignant cell growth, exert immunomodulatory
actions and alter cellular cohesiveness.
This has expanded the indications of isotretinoin from
just acne and rosacea to a wide range of inflammatory
and malignant skin disorders. While the standard dose
has served us well in the management of acne vulgaris,
there is emerging evidence that much lower dosages
are just as effective but have significantly fewer adverse
effects. Important changes in the use of isotretinoin
include using a lower daily dose for a longer period of
time. The frequency of depressive disorders during
isotretinoin treatment varies in different studies, and it
is unclear whether this is a consequence of isotretinoin
therapy. Teratogenicity however,remains a very
significant concern. Relapse of acne vulgaris continues
to be a problem but we are beginning to recognise
that this is related less to the cumulative dose and
more to the length of sebaceous gland suppression.
New indications continue to emerge, particularly as
a potential treatment for both intrinsic and extrinsic
(photo) aging.
AR3 How I Treat Active Lesion with
Lasers
Speaker WANG, Shiou-Han (王修含) MD
Moderator YANG, Li-Cheng (楊麗珍) MD
HUANG, Po-Han (黃柏翰) MD
Acne treatment is an important issue for the daily
practice of dermatologist. Topical and oral agents
are essential in traditional medical therapy. Laser
and energy based methods can provide adjuvant
therapeutic effects. In several studies, light-emitting
diode (LED), intense pulsed light (IPL), lasers and
radiofrequency (RF) are advocated to take into
consideration for the treatment of acne. For most
modalities, such as infrared/KTP lasers, blue/red
lights, IPL and RF, they can kill Propionibacterium
acnes, the causitive bacteria of acne and destruct the
sebaceous glands with either or both photochemical
and photothermal effects. Besides suppression of
sebaceous glands and bactericidal activity, pulsed dye
laser (PDL) can induce keratinocyte growth arrest
and have anti-inflammatory property. Although both
IPL and PDL can treat acne effectively, PDL has a
more sustained effect. TGF-beta is an substantial antiinflammatory
cytokine related to PDL. Combination
therapy can get the most significant result if several
laser modalities are combined with traditional medical
treatment.
SCIENTIFIC SESSIONS 74
AR4 How I Treat Acne Scars?
Speaker CHAO, Yates Yen-Yu (趙彥宇) MD
Moderator YANG, Li-Cheng (楊麗珍) MD
HUANG, Po-Han (黃柏翰) MD
The section of lecture covers the subjects of
1.Review of present environments of acne scar
treatment.
2.The good, the bad and the ugly of what we do.
3.The mechanism of acne scar formation.
4.The principle of acne scar treatment.
5.Operational acne scar treatment.
6.The combination with light-based procedures.
7.Prevention is better than cure.
AR5 Evidence for Treating Early to
Prevent Scar
Speaker HAYASHI, Nobukazu MD, PhD
Moderator YANG, Li-Cheng (楊麗珍) MD
HUANG, Po-Han (黃柏翰) MD
Prevention of scar is one of the most important
concern for acne patients, but classification of acne
scars has not yet been established, and there have been
very few studies on the prevalence and severity of acne
scars. We investigated the prevalence of acne scars and
their impact on the quality of life (QOL) in Japanese
acne patients with our classification for acne scars.
Acne scars were classified as mini-scars (atrophic
scars 0.5-2 mm in diameter), atrophic scars (≥2 mm
in diameter), and hypertrophic scars. The severity of
acne and acne scars were evaluated. The background
of patients and their QOL in relation to acne were
assessed. Of 240 subjects, 90.8% had scars. All patients
with scars had mini-scars; 61.2% and 14.2% of 240
had atrophic scars and hypertrophic scars, respectively.
Severe scarring was found in patients who had
experienced severe acne symptoms, although 15.0%
of patients with scars had experienced only mild acne
symptoms. The total Dermatology Life Quality Index
score was significantly higher in patients with scars
than in patients without scars (5.9 ± 4.4 vs. 4.2 ± 4.1)
.The onset age of acne was similar but acne patients
with scar got initial treatment at the significantly elder
age than ones without acne scar. (19.9±6.4 and 16.8
±4.3 years, respectively; P < 0.01).
Our results confessed that approximately 90% of
patients who visited dermatologists have some scars,
and mild acne symptoms may cause acne scar which
had a negative inpact on patients’ QOL. Comparison
of the background between acne patients with scar
and without scar suggested that earlier treatments by
dermatologists may avoid scar formation.
In conclusion, early intervention by dermatologists is
recommended to prevent acne scar.
SUNDAY, MAY 3
Acne and Rosacea Symposium (I)
Sun. May 3, 8:30-10:00
SCIENTIFIC SESSIONS
75
SUNDAY, MAY 3
Non invasive Body Contouring Devices
Sun. May 3, 8:30-10:00
Room 304A
Moderator CHEN, Yi-Ju (陳怡如) MD
CHENG, Teh-Yang (莊德揚) MD
NB1 Monopolar Radiofrequency for Body
Contouring
8:30 / PENG, Hsien-Li (彭賢禮) MD
NB2 Side Effects and Adipocytic Changes
after Cryolipolysis
8:42 / WANG, Cheng-Kun (王正坤) M.D., EMBA
NB3 Non-invasive Fat Reduction by
Using Cryolipolysis
8:54 / LU, Ching-I (盧靜怡) MD
NB4 Thermal Effect Focused Ultrasound
for Body Contouring
9:06 / IN, Sung-il MD
NB5 Non-thermal Effect Focused
Ultrasound for Body Contouring
9:18 / CHANG, Shyue-Luen (張學倫) MD
NB6 Combined Techniques of
Radiofrequency and Dynamic
muscle Activation in Body
Contouring
9:30 / YU, Jonathan Nevin MD
NB7 Selective Radiofrequency Therapy
As A Non-Invasive Approach For
Contactless Body Contouring
9:42 / FUJIMOTO, Takahiro MD, PhD, MBA
NB1 Monopolar Radiofrequency for Body
Contouring
Speaker PENG, Hsien-Li (彭賢禮) MD
Moderator CHEN, Yi-Ju (陳怡如) MD
CHENG, Teh-Yang (莊德揚) MD
Body contouring is one of the fastest growing
treatments of the global aesthetic field. Monopolar
radiofrequency uses volumetric bulk heating to induce
new collagen formation and tighten skin. It not only
treats the facial and neck skins, but also that of the
hands and the body. In this session, I will present
clinical experience using monopolar RF for body
contouring and tightening.
SCIENTIFIC SESSIONS 76
NB2 Side Effects and Adipocytic Changes
after Cryolipolysis
Speaker WANG, Cheng-Kun (王正坤) M.D., EMBA
Moderator CHEN, Yi-Ju (陳怡如) MD
CHENG, Teh-Yang (莊德揚) MD
Cryolipolysis is a contemporary method for localized
natural fat reduction while sparing injury to skin
and other structures. The proposed mechanisms,
which result in immediate fat cell demise and gradual
apoptosis, are associated with lipid-ice crystallization,
inflammatory panniculitis, phagocytic process, and
then gradual clearance.
Most adipocytes cooled to 7°C demonstrated necrotic
injury and some apoptotic injury. Adipocytes cooled to
temperatures of 14°C, 21°C, and 28°C resulted in no
necrotic injury but had the same degree of apoptotic
injury after 48 hours as those cooled to 7°C. There
is supportive evidence that intracellular “lipid ice” is
formed at around 10.0°C (compared to water ice at
0°C). The presence of lipid ice may contribute to the
immediate death or delayed apoptosis of fat cells.
The side effects of cryolipolysis includes cold injury
and blister formation. The wound may present with
blisters that do not appear to be deep. There is often
progression of the wounds over days because of injury
to the microvasculature.
NB3 Cryolipolysis for Body Contouring
Speaker LU, Ching-I (盧靜怡) MD
Moderator CHEN, Yi-Ju (陳怡如) MD
CHENG, Teh-Yang (莊德揚) MD
CryolipolysisTM is developed according to the
concept: the fat cells are more susceptible to cold
than the skin, nerve and muscle. The efficacy and
safety of CryolipolysisTM depends on the suitable
temperature and treatment duration. Here, we will
discuss about the advantages of this technique over the
other noninvasive treatment of fat reduction and the
advantages of “DualSculpting”.
SUNDAY, MAY 3
Non invasive Body Contouring Devices
Sun. May 3, 8:30-10:00
SCIENTIFIC SESSIONS
77
NB4 Thermal Effect Focused Ultrasound
for Body Contouring
Speaker IN, Sung-il MD
Moderator CHEN, Yi-Ju (陳怡如) MD
CHENG, Teh-Yang (莊德揚) MD
Non-invasive body contouring is often challenging
topic in aesthetic dermatology field. There have been
various non-invasive methods to reduce body fat,
including radiofrequency, laser/light, cryolipolysis,
ultrasound and etc.
HIFU is a one of the cutting edge technology that
passing through skin and superficial tissue without
causing injury. Liposonix® is a significant advance
in non-invasive body contouring that patients are
looking for. Liposonix® automatically aims transducer
to create continuous thermal lesion lines at focal
depth, and produce predictable, reproducible, uniform
lesion matrix. The temperature within the focal zone
causes rapid cell death. It reduces fat and provides
tightening of collagen within the subcutaneous layer.
Average circumferential waist reduction after a single
Liposonix treatment is at least 2.5 cm.
NB5 Non-thermal Effect Focused
Ultrasound for Body Contouring
Speaker CHANG, Shyue-Luen (張學倫) MD
Moderator CHEN, Yi-Ju (陳怡如) MD
CHENG, Teh-Yang (莊德揚) MD
Wider social acceptances of cosmetic procedures
have resulted in increased demands for procedures
that will improve body image and the quality of life.
Current available options for body contouring do not
necessarily satisfy all of the patient’s needs.A novel
non-invasive therapeutic ultrasound system that uses
non-thermal focused ultrasound to reduce adipose
tissue has been developed to improve the removal
of unwanted fat deposits without the drawbacks of
invasive techniques. Previous studies have shown
that single or multiple treatments by this device are
effective and safe.
We conduct a study that include thirty-two Asian
patients receiving 3 sequential treatments every
2 weeks in the abdominal region. Two patients
underwent MRI study randomly. There was a mean
reduction in circumference of 3.91±1.8 cm (p≤0.001).
In MRI measurement, the average in fat thickness
reduction was 21.4 and 25 % on the upper and lower
abdomen, respectively. There were three mild and
self-limited localized adverse events. Although the
change is minor compared to traditional surgical
procedure, it is real and effective.
SCIENTIFIC SESSIONS 78
NB6 Combined Techniques of
Radiofrequency and Dynamic
muscle Activation in Body
Contouring
Speaker YU, Jonathan Nevin MD
Moderator CHEN, Yi-Ju (陳怡如) MD
CHENG, Teh-Yang (莊德揚) MD
Non-invasive aesthetic procedures for body shaping
are constantly demanded worldwide. Currently
existing non- invasive procedures are limited in term
of efficacy and safety and practitioners often tend
to combine a few technologies and complementary
treatment modalities in order to improve results.
The Maximus platform is a unique device which uses
Tripolar RF to stimulate the release of fat with collagen
remodeling of the dermal layer. At the same time it
synergistically uses low frequency pulsed current
to stimulate muscle to remove the fat via enhanced
lymphatic drainage.
Clinical evaluations of the technology demonstrated
safety and efficacy of the Maximus treatment in
circumference reduction, improvement of cellulite
appearance and skin tightening.
Patients and practitioners benefit from the use of
multiple technologies at once, in a significantly shorter
treatment time as compared to other commonly used
combination protocols applying separate devices or
technologies.
Aside from body contouring, other treatment
modalities like facial tightening, acne and acne scar
treatments using the Maximus will be presented.
NB7 Selective Radiofrequency Therapy
As A Non-Invasive Approach For
Contactless Body Contouring
Speaker FUJIMOTO, Takahiro MD, PhD, MBA
Moderator CHEN, Yi-Ju (陳怡如) MD
CHENG, Teh-Yang (莊德揚) MD
Noninvasive body contouring treatment is an everexpanding
category in aesthetics, and today there is
an array of technologies that promise to help freeze,
emulsify, or damage fat cells and tame trouble spots.
Vanquish from BTL Aesthetics utilizes a Selective
RF™ field system designed for no contact deep tissue
energy application. This system automatically tunes
the tissue-applicator generator circuitry to selectively
deliver RF energy to adipose tissue layer with specific
impedance, shaping the energy field to optimize
penetration and maximize the treatment area. The
adipose tissue layer is heated faster than other tissue
layers such as skin and muscle. However, these layers
cool down much more rapidly than adipose tissue
because of the circulating blood. In addition, skin
can be cooled by air circulation due to the no contact
applicator.
Vanquish provides a safe and effective procedure that
treats a large surface area with virtually no patient
discomfort and no consumables. Numerous published
studies confirm that the clinical end point of body
contouring is to achieve adipocyte apoptosis.This has
been documented to occur when the temperature
of fat cells rises above 44C. Vanquish emits highfrequency
radio waves that penetrate through
the tissue layers to heat the fat cells to 46C with
extraordinary selectivity due to its software.
During the procedure, the client lies down in a
comfortable position and the Vanquish panel is
positioned over the intended areas of the body. Sensors
within the device will almost instantaneously measure
the impedance and adjust the energy delivery. Patients
describe a feeling of warmth that is similar to a heating
pad. They often use the 30-minute treatment time to
relax, nap, or listen to music because of the easy and
pain-free nature of treatment.
The average patient typically undergoes one treatment
a week for approximately 4 to 6 weeks. Most of
our patients report a visible change after the third
SUNDAY, MAY 3
Non invasive Body Contouring Devices
Sun. May 3, 8:30-10:00
SCIENTIFIC SESSIONS
79
treatment.
Patients can return to their normal routines and
activities immediately after the treatment. To ensure
the proper elimination of the fat cells, patients
are advised to drink lots of water before and after
Vanquish treatment, as well as to stay active by walking
or exercising.
SCIENTIFIC SESSIONS 80
SUNDAY, MAY 3
Skin Tumor Experts Meeting
Sun. May 3, 9:20-10:20
Room 303B
Moderator CHANG, Chun-Hsing (張中興) MD PhD
C HENG, Shih-Tsung (鄭詩宗) MD
ST1 The Melanoma Revolution:
Breakthroughs in Therapeutics
and Understanding Molecular
Pathogenesis
8:30 / FISHER, David MD, PhD
Discussion
10:00 / All
ST1 The Me l anoma R e v o l u t i o n :
Breakthroughs in Therapeutics
and Understanding Molecular
Pathogenesis
Speaker FISHER, David MD, PhD
Moderator CHANG, Chun-Hsing (張中興) MD PhD
C HENG, Shih-Tsung (鄭詩宗) MD
Melanoma has emerged as a malignancy whose
molecu l a r underpinnings and thera p e u t i c
opportunities stand at the forefront of recent progress
in the world of oncology. Several key oncogenic driver
events were identified through genomic analyses,
one of which (BRAF(V600E)) provides a drugable
opportunity. In deed small molecule targeting of the
BRAF/MEK/MAPK pathway has produced a high
fraction of significant clinical responses in patients
harboring mutant BRAF. Emergence of treatment
resistance, however, is a common event, and represents
a key challenge to ultimate success of this therapeutic
approach. Simultaneously, major breakthroughs have
occurred in the application of immunotherapies to
the treatment of advanced melanoma. Most successful
among these are the “immune checkpoint” blockade
therapies. These treatments consist of humanized
“blocking” antibodies which prevent “tolerance”
receptors from functioning, thereby triggering
reactivation and anti-tumor immunity. This lecture
will review these important treatment paradigms as
well as molecular aspects of melanoma which are
thought to underlie both the successes and limitations
of these new therapeutic approaches.
SCIENTIFIC SESSIONS
81
SUNDAY, MAY 3
Satellite Speeches: Intense Pulse Light and Pulsed Dye Laser
Sun. May 3, 8:30- 10: 00
Room 304B
Moderator CHEN, Po-Hung (陳柏宏) MD
SS12 Clinical Applications on Optimal
Pulse Technology (OPT) and
Fractional Non-Ablative Skin
Resurfacing
8:30 / CHAN, Hau-Ngai (陳厚毅) MD
Moderator CHEN,Chien-Hsun (陳建勳) MD
SS13 Novel Treatment of Acne Vulgaris
(Biostimulation)
9:00 / TSE, Ian Chi-Tat (謝志達)
MBBS,MRCP,FHKCP,FHKAM,FRCP
Moderator WU, Chwen-Huey (吳純慧) MD
SS14 Versatile Clinical Application of
Cynergy MPX Laser
9:30 / PENG, Hsien-Li (彭賢禮) MD
SS12 Clinical Applications on Optimal
Pulse Technology (OPT) and
Fractional Non-Ablative Skin
Resurfacing
Speaker HAN, Hau-Ngai (陳厚毅) MD
Moderator CHEN, Po-Hung (陳柏宏) MD
SCIENTIFIC SESSIONS 82
SS13 Novel Treatment of Acne Vulgaris
(Biostimulation)
Speaker TSE, Ian Chi-Tat (謝志達)
MBBS,MRCP,FHKCP,FHKAM,FRCP
Moderator CHEN,Chien-Hsun (陳建勳) MD
Pulsed dye laser is one of the standard treatment
modalities for vascular lesions. A novel use of the
pulsed dye laser, biostimulation, is achieved by
585nm-pulsed dye laser with pulse duration 0.35ms.
The microcapillaries of diameter <15micron are
injured rather than damaged. This up-regulates TGFbeta
(transforming growth factor) by up to 15 times
in 24 hours following a single treatment. Fibroblast
activity is stimulated and dermal collagen is enhanced.
This presentation will examine the evidence of
biostimulation in treatment of inflammatory acne
lesion, acne scar and facial rhytides.
SS14 Versatile Clinical Application of
Cynergy MPX Laser
Speaker PENG, Hsien-Li (彭賢禮) MD
Moderator WU, Chwen-Huey (吳純慧) MD
Dye lasers have long been the gold standard of
vascular lesion treatment such as port wine stain (PWS)
and telangiectasia (up to about 2 mm in diameter),
while Long pulsed Nd Yag laser showed success in
hair removal and dilated vessels (up to 3-4mm in
diameter).Cynergy laser combines dye laser and long
pulsed Nd Yag laser on the same station. Sequential
firing of dye laser and long pulsed Nd Yag can induce
methemoglobin formation, and allow the physician
to use lower energies when targeting different sizes
of unwanted vessels.Aside from vascular implications,
there are many conditions reported to be treatable
by Cynergy MPX laser, such as rosacea, acne scars
,psoriasis and dark circles.In this session, I will
present and review the versatile clinical applications of
Cynergy MPX laser treatments.
SUNDAY, MAY 3
Satellite Speeches: Intense Pulse Light and Pulsed Dye Laser
Sun. May 3, 8:30- 10: 00
SCIENTIFIC SESSIONS
83
SUNDAY, MAY 3
Satellite Speeches
Sun. May 3, 10:00-10:30
Room 303A
Moderator LIN, Cythia (林亭如)
SS15 經營診所如何擴大非醫療的毛利效益
10:00 / LIN, Cythia (林亭如)
SS15 經營診所如何擴大非醫療的毛利效益
Speaker CHOU, Chunhsu (周俊旭) MD
Moderator LIN, Cythia (林亭如)
消費者對於美容需求概分為手術、注射整形、
鐳射以及美容保養，醫療美容院所（醫院附設醫美
中心、醫美診所）競爭亦日趨激烈，如何在既有營
業項目下擴大營業額，最重要是擴大毛利，將外在
市場既有消費行為導入院所，是未來醫療美容院所
所必須思考的方向。
SCIENTIFIC SESSIONS 84
SCIENTIFIC SESSIONS
SUNDAY, MAY 3
10:30-12:00
Injectable Workshop: How to Make an Elegant Nose
Acne and Rosacea Symposium (II)
Emerging Energy Based Devices Symposium:
Dye Laser and Picosecond laser
Satellite Speeches: Body Contouring (I)
Physician Only
Lecturing in English
Lecturing in Chinese
Simultaneous Interpreting
Medical Dermatology
Dermatological Surgery
Engergy-based Devices
Injectables
Staff Training
SCIENTIFIC SESSIONS
85
Room 301A
Moderator MOON, Hyoung-Jin MD
CHAO, Yates Yen-Yu (趙彥宇) MD
SW1 Asian Rhinoplasty and Preference of
Asian Nasal Aesthetics
10:30 / CHANG, Geun-Uck MD
SW2 Dual Anatomic Layer Concept of
Nasal Augmentation
11:00 / PRASETYO, Adri Dwi MD
SW3 Surgical Removal and Aestheic
Restoration of Nasal Granulomatosis
after Filler Injection (Surgical
Treatment of Paraffinoma)
11:30 / CHANG, Geun-Uck MD
SW1 Asian Rhinoplasty and Preference of
Asian Nasal Aesthetics
Speaker CHANG, Geun-Uck MD
Moderator MOON, Hyoung-Jin MD
CHAO, Yates Yen-Yu (趙彥宇) MD
Cosmetic doctors should have knowledges of standard
aesthetics and features of Asian nose for the best result
when they consult with patients.
Ideal nasal shape is important, but most of all,
harmony with face is more important.
Asian nose vs Western nose
Many Asians have poorly projected tip with weak
support and somewhat bulbous nasal tip with little
definition. The weak lower lateral cartilages and the
caudal septum as well as thick skin and soft tissues
contribute to this phenomenon.
Ideal nasal shape
1. Nasion area
Nasofrontal angle is the most important element in
deciding the nasal height. the ideal nasofrontal angle
for Westerns is 134 degrees(woman) and 130(man),
but 135 degrees was preferred by Asians. The nasion
is the lowest part of the nose. Generally, nasal height
at nasion in the lateral view is about 6mm visible
from the cornea to the nasion was recommended,
but the elevation and shape of the forehead should be
considered.
2. Nasal dorsum
It's ideal if there are 2 parallel lines as a pair on the
nasal dorsum when seen from the front. The ideal
width between the lines in Westerns resulted as
6-8mm(woman), 8-10mm(man). But 8-10mm is ideal
for Asians; however, the shape of the face, distance
between the eyes, and the patient's preference should
be considered in this numerical value. In lateral face
view, the nasal dorsal line from nasion to nasal tip is
more natural when the line is little bit curved rather
than going straight.
3. Nasal tip
The beauty of the nasal tip decides the entire nose's
beauty. In case of Asians, the cartilage is weak and the
SUNDAY, MAY 3
Injectable Workshop: How to Make an Elegant Nose
Sun. May 3, 10:30-12:00
SCIENTIFIC SESSIONS 86
skin is thick so the nasal tip does not get defined too
well, however, the tip defining point should be visible
if possible. In lateral view, 90-95 degrees is appropriate
for Asian nasolabial angle. The doctor should be able
to present the ideal aesthetic standard for the patient
before procedues or operation.
SW2 Dual Anatomic Layer Concept of
Nasal Augmentation
Speaker PRASETYO, Adri Dwi MD
Moderator MOON, Hyoung-Jin MD
CHAO, Yates Yen-Yu (趙彥宇) MD
The nose is a central feature of the face and in
contemporer socio-psychology is highly rewarded
aesthet i c a l l y. Des c r iption of nasal anatomy
corresponds to various skin lining thickness,
specific subcutaneous adipose tissue, layers of
superficial musculoaponeurotic system (SMAS),
dermocartilaginous ligaments, bone and cartilage.
Skin quality with various thickness supported by
underneath tissues creates the border outline and
three-dimensional contour. Interdomal fat pad
and other specific subcutaneous adipose tissue
provides useful space for augmentation. The nasal
SMAS consists of unique layers and has medial
and lateral components. The dermocartilaginous
ligament corresponds to the deep medial expansion.
Supraperiosteum and supraperichondrium provide the
deep spacial place for safe and volumic filler injection.
These detailed anatomy provide rational for dual
anatomic layers of safe and effective augmentation to
establish the aesthetic trends of the nose.
SUNDAY, MAY 3
Injectable Workshop: How to Make an Elegant Nose
Sun. May 3, 10:30-12:00
SCIENTIFIC SESSIONS
87
SW3 Surgical Removal and Aestheic
Restoration of Nasal Granulomatosis
after Filler Injection (Surgical
Treatment of Paraffinoma)
Speaker CHANG, Geun-Uck MD
Moderator MOON, Hyoung-Jin MD
CHAO, Yates Yen-Yu (趙彥宇) MD
Injection of foreign materials, such as paraffin oil, is
an old and obsolete procedure used since the 19th
century to fill anatomic or surgical cavities or to
improve body appearance aesthetically. Some of the
more commonly used liquids are paraffin (mineral
oil), and polydimethyl siloxane (injectable silicone).
Direct injection of liquid paraffin has been used for
soft tissue augmentation throughout the world during
the first half of the 20th century. The use of injectable
liquids for nasal augmentation has been described
by numerous clinicians informing the public of its
destructive consequences. Many patients are suffering
from complications such as paraffinoma, or sclerosing
lipogranulomatosis defined as a granulomatous foreign
body reaction, a well-recognized late complication of
foreign material injection. Although this practice was
abandoned in many countries because of numerous
complications, it continued to be performed by
unqualified practitioners. Most patients are initially
asymptomatic after injection. Gradually, however,
complications such as foreign body granulomatous
reaction develop. It usually manifest as irregular
plaque-like indurations of the skin. Microscopically,
there is granulomatous inflammation with multiple
clear vacuoles.
The goal in treating patients with nasal sclerosing
lipogranulomatosis after injection is radical
debridement of affected areas preserving nasal skin,
and dermofat grafting. Affected soft tissue and foreign
material can be excised between nasal skin and nasal
bone. Only thin skin can be remained after removal,
so blood supply could be poor. That’s why dermofat
graft can be recommended, and hard implants cannot
be used for dorsal augmentation. Dermofat can be
harvested from buttocks area, epidermis is removed,
and inserted into nasal dorsum. If patients don’t want
skin scar or dermofat harvest is not available due to
other reasons, donated dermis such as Alloderm® can
be used. Complete surgical excision is desired because
it can reduce the incidence of recurrence. Surgeons
should be careful not to perforate skin during removal.
SCIENTIFIC SESSIONS 88
SUNDAY, MAY 3
Acne and Rosacea Symposium (II)
Sun. May 3, 10:30-12:30
Room 301B
Moderator CHEN, Wen-Chieh (陳文杰) MD
AR6 Antibiotic Resistance in Asia
Antibiotic Stewardship in Acne
10:30 / LEYDEN, James MD
Moderator LEE, Julia Yu-Yun (李玉雲) MD
AR7 Facial Flushing: Update on
Pathogenesis and Treatment
11:20 / CHEN, Wen-Chieh (陳文杰) MD
Moderator LEE, Woan-Ruoh (李婉若) MD, PhD
AR8 Topical Brimonidine Gel
Introduction
11:50 / TSENG, Jonathan Te-Peng (曾德朋) MD
Moderator LEE, Julia Yu-Yun (李玉雲) MD
AR9 Therapeutic Effects of Topical
Brimonidine Gel on Facial Erythema
of Rosacea - A Preliminary
Observation on Taiwanese Patients
12:10 / LEE, Chaw Ning (李兆甯) MD
/ LEE, Julia Yu-Yun (李玉雲) MD
AR6 Antibiotic Resistance in Asia
Antibiotic Stewardship in Acne
Speaker LEYDEN, James MD
Moderator CHEN, Wen-Chieh (陳文杰) MD
Antimicrobial resistance is a major health issue.
Good antibiotic stewardship is a commitment to help
reduce the spread of antibiotic resistance by using
the right dose of the right antibiotic at the right time
and for the right duration. In many Asian countries,
the consumption of antibiotics is high and antibiotic
resistance is rising so a review of current practice is
urgently needed.
The sensitivity of Propionibacterium acnes (P. acnes)
to antibiotics has decreased rapidly, resulting in less
sensitive strains of P. acnes being found worldwide.
Decreased sensitivity can affect clinical outcomes.
Topical clindamycin is prescribed based on in-vitro
data demonstrating its anti-inflammatory properties,
not in-vivo studies. Two in three patients will have
P. acnes strains for which clindamycin will not work
as an antibiotic. P. acnes sensitivity is greatest to
minocycline.
The Global Alliance to Improve Outcomes in Acne
group recommends the combination of a topical
retinoid with an antimicrobial agent as first-line
therapy for almost all patients with acne. If the
addition of an antibiotic to this regimen is required, its
use should be limited in duration and co-prescribed
with benzoyl peroxide (BPO). Antibiotics should not
be used as monotherapy.
Treatment of acne with adapalene/BPO, a retinoid/
antimicrobial combination, provides both shortterm
efficacy and long-term control. In addition,
clinical improvements resulting from the use of this
combination product with an oral antibiotic for 12
weeks are maintained without continued antibiotic
use.
BPO, the most potent bactericidal agent against P.
acnes, reduces the likelihood of antibiotic resistant P.
acnes emerging. In addition, clinical data demonstrate
that treatment with adapalene/BPO effectively reduces
skin colonization by both antibiotic-sensitive and
antibiotic-resistant P. acnes strains.
SCIENTIFIC SESSIONS
89
AR7 Fa c i a l F l u s h i n g : U p d a t e o n
Pathogenesis and Treatment
Speaker CHEN, Wen-Chieh (陳文杰) MD
Moderator LEE, Julia Yu-Yun (李玉雲) MD
Flush/flash can be defined as transient recurrent
erythema of rapid onset due to paroxismal arteriolar
dilatation localized to face and anterior chest. Clinical
variations may include behavior-dependent flushes
(alcohol consumption, sport or emotional stress),
menopausal hot flushes, hypersentivity reactionmediated
flushes, neoplasm-associated flushes,
drug-induced flushes and rosacea. Menopausal hot
flush is an exaggerated heat dissipation response,
accompanied with profuse sweating, peripheral
vasodilation and feelings of intense internal heat.
Flushes can occur in the presence of tumors, such as
neuroendocrine tumors, medullary thyroid cancer,
renal cell carcinoma, pheochromocytoma or mast
cell activation disorders. Drugs inducing flushes may
include androgen or estrogen deprivation therapy,
niacin, prostacyclin analogues, phosphodiesterase
type 5 inhibitors, dimethyl fumarate, pentoxyfylline,
and infusions with steroid, adenosine or intravenous
immunoglobulin.
The pathophysiologic mechanisms of different
flushes are incompletely understood. Cutaneous
circulation is controlled by a complex interplay of
reflex thermoregulatory control and local heating/
cooling control involving vascular endothelia,
adrenergic and sensory systems. The arterioles
constitute the major resistance in vessels and play a
key role in regulating regional blood flows. Factors
that can influence neurogenic constriction of vascular
beds include the density of sympathetic innervation,
density and subtype of adrenergic receptors,
differences in norepinephrine kinetics, release of
cotransmitters, and local factors such as the degree
of basal tone, the concentrations of vasoactive tissue
metabolites, as well as vessel size and structure. The
sympathetic nerves innervating the vasculature, like
the autonomic nerves innervating the heart, also
display tonic activity, which sets a background level
of vasoconstriction. Withdrawing sympathetic tone
causes less vasoconstriction, resulting in vasodilation.
Understanding of the sympathetic control of blood
vessels in modulating arteriolar resistance and
venous capacitance is expanded upon molecular
characterization of nine subtypes of adrenergic
receptors ( 1A, 1B, 1D, 2A/D, 2B, 2C, 1, 2, and 3)
located on vascular smooth muscles. Whereas both
postjunctional 1- and 2-adrenergic receptors (
1A-, 1D-, 2A/D-, and 2B- subtypes) have been implicated
in sympathetic vasoconstriction, activation of
prejunctional neural adrenergic receptors (mainly
2A/D- and 2C- receptor subtypes) reduces sympathetic
vasoconstriction. In many blood vessels expressing
-adrenergic receptors, - is the predominant
subtype and is activated mainly by circulating
catecholamines to cause vasodilation. Binding of
norepinephrine to adrenergic receptors increases
intracellular Ca2+ leading to contraction of the smooth
muscle.
Elevations in core body temperature occur prior to
menopausal hot flushes, which acts within a greatly
narrowing thermoneutral zone mainly due to estrogen
withdrawl and elevated brain norepinephrine. The
precise etiopathogenesis of rosacea is still unclear. A
progressive central facial erythema is the hallmark,
which usually begins at the age between 20s and 40s.
An increased size of blood and lymphatic vessels has
been demonstrated but the existence of angiogenesis
and/or lymphangiogenesis is debating. Involvement
and activation of mast cells is observed in flushes
associated with hypersensitivity reactions, certain drug
side effects and rosacea.
Topical use of selective -adrenergic receptor agonists
has been demonstrated to be an effective symptomatic
treatment for facial erythema of rosacea. Brimonidine
is highly selective for the 2A-, whereas oxymetazoline
highly selective for the 1A- and partially selective
for 2A- receptor. Brimonidine tartrate 0.33% gel,
approved by the US FDA in August 2013, is indicated
for persistent facial erythema of rosacea. Effect on
erythema severity is observed within 30 minutes of
application after the first application in 1/3 of the
treated patients. The durability of the effect can
be maintained at month 12, with no tachyphylaxis
observed. Rebound erythema can be observed in
approximately 10 to 20% of the patients treated.
Systemic administration of carvedilol, a nonselective
-adrenergic blocker, at 3.125-6.25 mg twice daily
has also been demonstrated to be effective in a small
series of patients. Whether these drugs also possess
an intrinsic anti-inflammatory capacity remains to be
determined.
SCIENTIFIC SESSIONS 90
Systemic hormone therapy with low-dose estrogen
(< 0.5 mg/day) or estrogen plus progestin is the
most effective treatment for menopausal vasomotor
symptoms including hot flushes. Conjugated
estrogens/bazedoxifene (selective estrogen receptor
modulator) represents a new, progestin-free treatment.
Paroxetine mesylate is the first non-hormonal therapy
approved by FDA. Gabapentin and venlafaxine
demonstrate significant efficacy in improving hot
flushes in patients of breast cancer or prostate cancer
undertaking estrogen or androgen-deprivation
therapies. Clonidine can reduce hot flushes associated
with menopause or hormone-deprivation therapy, but
its efficacy in rosacea is weakly evidenced.
AR8 Topical Brimonidine Gel Introduction
Speaker TSENG, Jonathan Te-Peng (曾德朋) MD
Moderator LEE, Woan-Ruoh (李婉若) MD, PhD
Rosacea is a common inflammatory skin disorder
affecting a significant amount of population. Persistent
erythema is the primary feature of rosacea, in addition,
other cutaneous signs such as telangiectasia, papules,
and pustules may also be present. Several medications
are currently approved for the treatment of rosacea
in papules and pustules forms, however, treatment
of erythema is limited. Brimonidine tartrate, a highly
selective alpha2-adrenergic receptor agonist, was
recently shown to be an effective medication in
reducing the erythema of Rosacea with good safety
profile. (J Drugs Dermatol. 2014;13(1):56-61)
SUNDAY, MAY 3
Acne and Rosacea Symposium (II)
Sun. May 3, 10:30-12:30
SCIENTIFIC SESSIONS
91
AR9 Therapeutic Effects of Topical
Brimonidine Gel on Facial
Erythema of Rosacea - A
Preliminary Observation on
Taiwanese Patients
Speaker LEE, Chaw Ning (李兆甯) MD
LEE, Julia Yu-Yun (李玉雲) MD
Moderator LEE, Julia Yu-Yun (李玉雲) MD
Rosacea is a common, chronic inflammatory
skin condition worldwide, including Taiwan.
It has a significant negatively impacts patients'
quality of life. Treatment of moderate to severe
erythematotelangiectatic rosacea (ETR) subtype is
often not satisfactory. Brimonidine is a α2 adrenergic
receptor agonist. Topical brimonidine tartrate gel (TB)
is newly approved for treating moderate to severe
erythema of rosacea. Recent studies showed that oncedaily
application resulted in a 2-grade improvement
of facial erythema in 22% patients at 12h on day 29,
and that BT is safe and consistently effective for longterm
treatment, even in the presence of concomitant
therapies for the inflammatory lesions of rosacea.
(Moore et al JDD 2014).
TB has just become available to a small number of our
patients with ETR in March this year. We shall report
our preliminary clinical observation of the treatment
effects in these patients.
SCIENTIFIC SESSIONS 92
SUNDAY, MAY 3
Emerging Energy Based Devices Symposium Dye Laser and Picosecond Laser
Sun. May 3, 10:30-12:00
Room 304A
Moderator YANG, Chia-Yi (楊佳懿) MD
CHUANG, Shyh-Dyi (莊士迪) MD
EE1 New Applications of Pulsed-dye
Laser: “Biostimulation”
10:30 / TSE, Ian Chi-Tat MBBS, MRCP, FHKCP,
FHKAM, FRCP
EE2 Versatile Clinical Applications of
MPX Pulsed Dye Laser
10:45 / PENG, Hsien-Li (彭賢禮) MD
EE3 Picoseconed Laser
Picosure: From Science to Clinical
Applications
11:00 / PENG, Hsien-Li (彭賢禮) MD
EE4 Dual Wavelength Picosecond Laser
11:15 / CHAN, Henry MD, PhD.
EE5 The Therapeutic Strategy and
Clinical Experiences in Scar
Remodeling by Laser Treatment
11:30 / TAN, Jun (譚軍) MD
EE6 Combination of Infrared Light and
Bi-polar Radio Frequency Energies
for Facial Rejuvenation
11:45 / SUNDARAM, Hema MD
EE1 New Applications of Pulsed-dye
Laser: “Biostimulation”
Speaker TSE, Ian Chi-Tat MBBS, MRCP, FHKCP,
FHKAM, FRCP
Moderator YANG, Chia-Yi (楊佳懿) MD
CHUANG, Shyh-Dyi (莊士迪) MD
Pulsed dye laser is one of the standard treatment
modalities for vascular lesions. A novel use of the
pulsed dye laser, biostimulation, is achieved by
585nm-pulsed dye laser with pulse duration 0.35ms.
The microcapillaries of diameter <15micron are
injured rather than damaged. This up-regulates TGFbeta
(transforming growth factor) by up to 15 times
in 24 hours following a single treatment. Fibroblast
activity is stimulated and dermal collagen is enhanced.
This presentation will examine the evidence of
biostimulation in treatment of inflammatory acne
lesion, acne scar and facial rhytides.
SCIENTIFIC SESSIONS
93
EE2 Versatile Clinical Applications of
MPX Pulsed Dye Laser
Speaker PENG, Hsien-Li (彭賢禮) MD
Moderator YANG, Chia-Yi (楊佳懿) MD
CHUANG, Shyh-Dyi (莊士迪) MD
Dye lasers have long been the gold standard of
vascular lesion treatment such as port wine stain (PWS)
and telangiectasia (up to about 2 mm in diameter),
while Long pulsed Nd Yag laser showed success in
hair removal and dilated vessels (up to 3-4mm in
diameter).
Cynergy laser combines dye laser and long pulsed
Nd Yag laser on the same station. Sequential firing
of dye laser and long pulsed Nd Yag can induce
methemoglobin formation, and allow the physician
to use lower energies when targeting different sizes of
unwanted vessels.
Aside from vascular implications, there are many
codition which the Cynergy laser can treat, such as
rosacea and dark circles.
In this session, I will present clinical experience
on Cynergy laser treatments for different clinical
conditions.
EE3 Picosure: From Science to Clinical
Applications
Speaker PENG, Hsien-Li (彭賢禮) MD
Moderator YANG, Chia-Yi (楊佳懿) MD
CHUANG, Shyh-Dyi (莊士迪) MD
The use of Q-switching lasers in the 1980s
revolutionized the way tattoos and pigmented
lesions were treated and became the gold standard
for tattoo removal. However, treatments and results
remain far from perfect, and doctors are looking
for new technologies to reduce the pain during
treatments and get better results. To achieve selective
photothermolysis, sufficient energy to damage the
target needs to be delivered with a pulse duration that
is less than the thermal relaxation time (TRT) of the
target, which is itself defined by the size and shape of
the target. The TRT of tattoo pigment particles and
melanocyte is less than 10 nanoseconds, suggesting
that energy delivery in the picosecond range (10−12
seconds) should be effective. Picosecond laser
treatments cause significant photomechanical effects
and lead to mechanical breakup of the ink or pigment
particles. Using picosecond pulses allows lower
laser fluences to be used, which should decrease
adverse side effects that are typically produced with
nanosecond QS lasers. Using the Picosecond laser we
can break up smaller particles of tattoo and pigmented
lesions, and less treatments are needed to achieve
better results.
The new picosecond 755 / 532 nm laser ranging from
550 to 750 picosecond is avalible on the aesthetic
market. 755nm provides better photoselective effect in
malanin, while 532nm provides better tattoo clearance
in red and yellow tatoo ink.
Furthermore, an innovative optical focus lens has
been developed that gauges distribution of energy to
the treatment area. The focus lens can enhance focal
fluence up to 20 times energetically campared to the
standard handpiece, and only less than 10% of the
tissue is exposed to ultra high fluence. When using
the fractional focus lens, the epidermis will experience
damage called laser induced optical breakdown
(LIOB). By using this special focus lens, removal of
pigmentation, pore size reduction, and improvement
of wrinkles can be done at the same time.
SCIENTIFIC SESSIONS 94
EE4 Dual Wavelength Picosecond Laser
Speaker CHAN, Henry MD, PhD.
Moderator YANG, Chia-Yi (楊佳懿) MD
CHUANG, Shyh-Dyi (莊士迪) MD
EE5 The Therapeutic Strategy and Clinical
Experiences in Scar Remodeling by
Laser Treatment
Speaker TAN, Jun (譚軍) MD
Moderator YANG, Chia-Yi (楊佳懿) MD
CHUANG, Shyh-Dyi (莊士迪) MD
傳統的疤痕修復技術，總是無法有效的幫助病人消
除疤痕。隨著雷射技術的成熟發展，譚軍教授利用
二氧化碳飛梭雷射技術在整形外科、美容及燒燙傷
領域建立了多個全新的治療理論：疤痕原位再生皮
膚理論、疤痕早期干預治療概念與雷射聯合治療疤
痕概念。而譚軍教授發明的「人工點陣技術」及
「雷射穿孔技術與濕式醫療技術結合的皮膚原位再
生技術」更是突破了傳統疤痕修復的技術限制，有
效幫助病人重獲美麗的肌膚。
SUNDAY, MAY 3
Emerging Energy Based Devices Symposium Dye Laser and Picosecond Laser
Sun. May 3, 10:30-12:00
SCIENTIFIC SESSIONS
95
EE6 Combination of Infrared Light and
Bi-polar Radio Frequency Energies
for Facial Rejuvenation
Speaker SUNDARAM, Hema MD
Moderator YANG, Chia-Yi (楊佳懿) MD
CHUANG, Shyh-Dyi (莊士迪) MD
SCIENTIFIC SESSIONS 96
Room 304B
Moderator WANG, Chao-Huei (王朝輝) MD
SS15 Vanquish: Selective Radiofrequency
Therapy As A Non-Invasive
Approach For Contactless Body
Contouring
10:30 / FUJIMOTO, Takahiro MD,PhD, MBA
Moderator CHANG, Kao-Jung (張高榮) MD
SS16 A Review of Non-Invasive Fat
Reduction Treatments in Korea-
Focusing on High Intensity Focused
Ultrasound
11:00 / IN, Sung-Il MD
Moderator CHIU,Pin-Chi (邱品齊) MD, MBA
SS17 Managing Seborrheic Dermatitis
with Herbal Cosmeceuticals
11:30 / HUANG, Po-Han (黃柏翰) MD
SUNDAY, MAY 3
Satellite Speeches: Body Contouring I
Sun. May 3, 10:30-12:00
SS15 Vanquish: Selective Radiofrequency
Therapy As A Non-Invasive
Approach For Contactless Body
Contouring
Speaker FUJIMOTO, Takahiro MD,PhD, MBA
Moderator WANG, Chao-Huei (王朝輝) MD
Noninvasive body contouring treatment is an everexpanding
category in aesthetics, and today there is
an array of technologies that promise to help freeze,
emulsify, or damage fat cells and tame trouble spots.
Vanquish from BTL Aesthetics utilizes a Selective
RF™ field system designed for no contact deep tissue
energy application. This system automatically tunes
the tissue-applicator generator circuitry to selectively
deliver RF energy to adipose tissue layer with specific
impedance, shaping the energy field to optimize
penetration and maximize the treatment area. The
adipose tissue layer is heated faster than other tissue
layers such as skin and muscle. However, these layers
cool down much more rapidly than adipose tissue
because of the circulating blood. In addition, skin
can be cooled by air circulation due to the no contact
applicator.
Vanquish provides a safe and effective procedure that
treats a large surface area with virtually no patient
discomfort and no consumables. Numerous published
studies confirm that the clinical end point of body
contouring is to achieve adipocyte apoptosis.This has
been documented to occur when the temperature
of fat cells rises above 44C. Vanquish emits highfrequency
radio waves that penetrate through
the tissue layers to heat the fat cells to 46C with
extraordinary selectivity due to its software.
During the procedure, the client lies down in a
comfortable position and the Vanquish panel is
positioned over the intended areas of the body. Sensors
within the device will almost instantaneously measure
the impedance and adjust the energy delivery. Patients
describe a feeling of warmth that is similar to a heating
pad. They often use the 30-minute treatment time to
relax, nap, or listen to music because of the easy and
pain-free nature of treatment.
The average patient typically undergoes one treatment
a week for approximately 4 to 6 weeks. Most of
our patients report a visible change after the third
treatment.
SCIENTIFIC SESSIONS
97
Patients can return to their normal routines and
activities immediately after the treatment. To ensure
the proper elimination of the fat cells, patients
are advised to drink lots of water before and after
Vanquish treatment, as well as to stay active by walking
or exercising.
SS16 A Review of Non-Invasive Fat
Reduction Treatments in Korea –
Focusing on High Intensity Focused
Ultrasound
Speaker IN, Sung-Il MD
Moderator CHANG, Kao-Jung (張高榮) MD
Non-invasive body contouring is often challenging
topic in aesthetic dermatology field. There have been
various non-invasive methods to reduce body fat,
including radiofrequency, laser/light, cryolipolysis,
ultrasound and etc.
HIFU is a one of the cutting edge technology that
passing through skin and superficial tissue without
causing injury. Liposonix® is a significant advance
in non-invasive body contouring that patients are
looking for. Liposonix® automatically aims transducer
to create continuous thermal lesion lines at focal
depth, and produce predictable, reproducible, uniform
lesion matrix. The temperature within the focal zone
causes rapid cell death. It reduces fat and provides
tightening of collagen within the subcutaneous layer.
Average circumferential waist reduction after a single
Liposonix treatment is at least 2.5 cm.
SCIENTIFIC SESSIONS 98
SS17 Body Contouring I: Managing
Seborrheic Dermatitis with Herbal
Cosmeceuticals
Speaker HUANG, Po-Han (黃柏翰) MD
Moderator CHIU,Pin-Chi (邱品齊) MD, MBA
Dandruff and seborrheic dermatitis are common and
troublesome scalp conditions with the primary signs
and symptoms being presence of skin flakes, pruritus,
and sometimes erythema. The first line treatment for
patients with mild severity consists of prescription
and cosmeceutical products, such as zinc pyrithione,
ketoconazole and tar shampoo. Herbal medicine is
traditionally used in many diseases by most Asian
population. The botanical agents reported to be useful
in seborrheic dermatitis are extracts of herbs with antiinflammatory
and anti-fungal effects.
However, p r e p a r a t i o n o f b o t a n i c a l - b a s ed
cosmeceuticals is complex. Very few of these products
are supported by evidence-based science. Therefore,
we conducted a clinical observation using a novel
bio-herbal scalp lotion containing Rheum Palmatum
Extract (Da Huang), Portulaca Oleracea Extract (Ma
Chi Xian), Phellodendron Amurense Bark Extract
(Huang Bai), Angelica Polymorpha Sinensis Root
Extract (Dang Gui), Sapindus Mukorossi Fruit Extract
(You Huang Zi) and Indigofera Tinctoria Extract (Qing
Dai) once daily. Patients also used semi-herbal antidandruff
shampoo containing zinc pyrithione, salicylic
acid and Sapindus Mukorossi Fruit Extract every other
day. Patients who were not satisfied with previously
used shampoo were enrolled in this observation.
Based on Global Severity Score of Scalp, Scalp Surface
Area, Patient and Physician Global Assessments of
Severity, we found the bio-herbal skin treatment is a
safe, well-tolerated and efficacious option in managing
patients with mild seborrheic dermatitis. For those who
have poor response to ketoconazole or zinc pyrithione
shampoo, this herbal cosmeceutical combination will
be one of the options before dermatologists prescribe
topical steroid preparations. In addition, since more
and more botanicals are marketed in cosmeceutical
formulations, dermatologists need to obtain working
knowledge of the major botanicals.
SUNDAY, MAY 3
Satellite Speeches: Body Contouring I
Sun. May 3, 10:00- 17: 00
SCIENTIFIC SESSIONS
99
SCIENTIFIC SESSIONS
SUNDAY, MAY 3
12:00-13:30
Lunch Symposia
Physician Only
Lecturing in English
Lecturing in Chinese
Simultaneous Interpreting
Medical Dermatology
Dermatological Surgery
Engergy-based Devices
Injectables
Staff Training
SCIENTIFIC SESSIONS 100
SUNDAY, MAY 3
Lunch Symposium: MERZ
Sun. May 3, 12:00- 13:30
Room 301A
Moderator WU, Ying-Chin (吳英俊) MD
LS1 From Complex to Neurotoxin : the
Development of Incobotulinum
Toxin A
12:00 / FREVERT, Jürgen MD
LS2 The Science of Total Facial
Rejuvenation with New Generation
HA Filler Technology
12:40 / PRASETYO, Adri Dwi MD
13:20 Discussion
LS1 From Complex to Neurotoxin : the
Development of Incobotulinum
Toxin A
Speaker FREVERT, Jürgen MD
Moderator WU, Ying-Chin (吳英俊) MD
SCIENTIFIC SESSIONS
101
LS2 The Science of Total Fa c i a l
Rejuvenation with New Generation
HA Filler Technology
Speaker PRASETYO, Adri Dwi MD
Moderator WU, Ying-Chin (吳英俊) MD
Aging process decrease facial aesthetics by ongoing
soft-tissue and structural remodeling. The objective
of aesthetic treatments is to challenge this process and
create a more youthful and appearance. Most injectable
fillers are indicated for the reduction of facial folds,
but the current aesthetic paradygm is toward volume
replacement, structural support and beautification
in multiple areas, known as total facial approach.
Successful outcomes incorporate artistic principles,
anatomically rational techniques, and modern
hyaluronic acid filler technology. A novel technology
comprising cohesivity, elasticity, and plasticity provides
complete restoration and structural augmentation
in multilayers fashion, from supraperiosteal deep
injections of volume-depleted fat pads to subdermal
injections for panfacial treatment. The combination of
these new generation fillers helps to forestall the facial
aging process, to beautify, and provide more natural
outcome.
SCIENTIFIC SESSIONS 102
SUNDAY, MAY 3
Lunch Symposium: Galderma
Sun. May 3, 12:30- 13:30
Room 301B
Moderator CHIU,Pin-Chi (邱品齊) MD, MBA
LS3 Innovation in Sun Protection :
Daylong
12:30 / SCHWARZ, Thomas MD, PhD
/ ROHNER, Sonja Andrea eidg. dipl. pharm., dipl.
pharm. med. SwAPP
LS3 Innovation in Sun Protection :
Daylong Lunch Symposium
Speaker SCHWARZ, Thomas MD, PhD
Moderator CHIU,Pin-Chi (邱品齊) MD, MBA
SCIENTIFIC SESSIONS
103
LS3 Innovation in Sun Protection :
Daylong Lunch Symposium
Speaker ROHNER, Sonja Andrea eidg. dipl. pharm., dipl.
pharm. med. SwAPP
Moderator CHIU,Pin-Chi (邱品齊) MD, MBA
Sun protection is the central most powerful tool
available to prevent the development of skin cancer
and avoid premature skin aging. .
However, optimal sun protection is dependent on
multiple factors including the amount of sunscreen
applied, the frequency of application, and the type of
sunscreen utilized. Without consideration of these
critical measures, even the most effective sunscreen
will provide inadequate protection, and result in poor
consumer compliance.
Innovative galenic formulations are the solution
to achieve these critical measures in optimal sun
protection. By creating formulations that have superior
photoprotection, offer application convenience, and
reach high cosmetic acceptance will ultimately support
compliant, frequent, and recommended application
amounts.
Daylong’s passion is to stay at the forefront of
innovation in sun protection, applying the latest
scientific findings to deliver the best sun protection
solutions possible:
-A combination of high quality ingredients in an
innovative galenic formulation.
SCIENTIFIC SESSIONS 104
SUNDAY, MAY 3
Lunch Symposium: TBMS
Sun. May 3, 12:10- 13:30
Room 304A
Moderator PENG, Hsien-Li (彭賢禮) MD
CHENG, Kuo Liang (鄭國良) MD
LS5 The Picosecond Revolution
12:10 / PENG, Hsien-Li (彭賢禮) MD
LS6 New Revolutionary Revitalization
Technique with Improvement of
Pigmentation, Pore Size and Fine
Wrinkle Simultaneously by 755 nm
Picosecond Laser with Focus Lens
Array in Asia Skin—A Preliminary
Report
12:50 / CHENG, Kuo Liang (鄭國良) MD
LS5 The Picosecond Revolution
Speaker PENG, Hsien-Li (彭賢禮) MD
Moderator CHENG, Kuo Liang (鄭國良) MD
Picosecond laser is one of the most important
advances in laser technology in recent years. Picosure,
the first commercially available picosecond laser, has
a pulse length 90 times shorter than the nanosecond
Alexandrite 755nm .
Picosure sees success in treating tattoos of different
colors, pigmented lesions, and the revitalizing of skin.
Through the unique focus lens design, the picosecond
755 laser can also treat fine wrinkles, melasma,
reduced pore size and atrophic acne scars, etc.
In this session, I will present clinical experience about
the picosecond 755nm laser.
SCIENTIFIC SESSIONS
105
LS6 New Revolutionary Revitalization
Technique with Improvement of
Pigmentation, Pore Size and Fine
Wrinkle Simultaneously by 755 nm
Picosecond Laser with Focus Lens
Array in Asia Skin—A Preliminary
Report
Speaker CHENG, Kuo Liang (鄭國良) MD
Moderator PENG, Hsien-Li (彭賢禮) MD
New breakingthrough laser technology with much
shorter pulse width of 755 nm ranged from 550 to 750
picosecond was recently introduced in the aesthetic
market. With picosecond pulse duration, theoretically
more photomechanical effect was involved to destroy
targets with less thermal damage, fluence and sessions
of treatment compared to covnentional photothermal
effect by nanosecond system. We report a new method
of revitalization in treating aging skin for 3 months
with 755 nm picosecond laser.
SCIENTIFIC SESSIONS 106
SUNDAY, MAY 3
Lunch Symposium: Menarini
Sun. May 3, 12:00- 13:30
Room 304B
Moderator HO, Ji-Chen (何宜承) MD
LS7 A Novel Topical Therapy for
Seborrheic Dermatitis
12:00 / CHEONG, Wai-Kwong MD
LS8 Handling Seborrheic Dermatitis
with a Non-Steroid Topical Agent –
Patient Experience Sharing
12:40 / SHIH, I-Hsin (施一新) MD
13:20 Questions & Answers
L S 7 A Novel Topical Therapy for
Seborrheic Dermatitis
Speaker CHEONG, Wai-Kwong MD
Moderator HO, Ji-Chen (何宜承) MD
Seborrhoeic dermatitis (SD) affects 1 – 5% of the
overall population. Infants and adults between the
ages of 30 and 60 years are most commonly affected.
In Asian skin, SD presents in a similar manner to
that seen in Western skin. However, milder forms of
the clinical lesions are often not recognized by the
patient as SD, but regarded as dry skin and therefore
left untreated. SD is a multifactorial skin disease that
is dependent on 3 factors: sebaceous gland secretions,
Malassezia infection and genetic susceptibility; M.
restricta appears to be the predominant species seen in
Korean patients.
It has been observed that patients in Asia tend to selftreat
SD. This could be related to lack of awareness
among the public that SD is a chronic skin condition
that can worsen without effective medical treatment.
This situation is compounded by a limitation in
effective treatments available to physicians. The most
commonly prescribed topical treatments contain
corticosteroids which are associated with potential
side effects with prolonged usage. Steroid-free topical
agents include calcineurin inhibitors and anti-fungals
such as ketoconazole.
A new non-steroidal cream, Sebclair™ has been
proven to be an effective SD treatment with superior
relapse prevention rates. It has anti-inflammatory and
anti-fungal activities, the latter attributed to Piroctone
olamine. The presentation will discuss this novel
therapy in SD
SCIENTIFIC SESSIONS
107
LS8 Handling Seborrheic Dermatitis with
a Non-Steroid Topical Agent –
Patient Experience Sharing
Speaker SHIH, I-Hsin (施一新) MD
Moderator HO, Ji-Chen (何宜承) MD
Seborrheic dermatitis (SD) is a very common skin
problem and dermatologists encounter SD in their
practice almost everyday. Since SD is a chronic,
relapsing, inflammatory skin disease, It bothers many
patients. We tried to use a non-steroid topical agent on
SD patient and observe its clinical response.
We have conducted an open label clinical study on SD:
Inclusion criteria:
1.Age > 12 years of age
2.Diagosed SD patient for at least 3 months
3.Willing to participate and follow-up at weeks 2 and 4
sfter first consultation
4.Agreeable to patient consent/release form
Exclusion criteria:
1.Age < 12 years of age
2.Pregnant or lactaing patients
3.Using SD preparations from either physicians
(prescribed) or from pharmacies
4.Frequent, unavoidable sun exposure over majority of
skin
5.Non-compliance
Clincal pictures taken at week 0, week 2 and week 4
for assessment.
SCIENTIFIC SESSIONS 108
SCIENTIFIC SESSIONS
SUNDAY, MAY 3
13:30-15:00
Injectable Workshop: How to Make Charming Eyes
Urticaria Symposium
Osmidrosis Workshop
Special Lecture
Satellite Speeches
Physician Only
Lecturing in English
Lecturing in Chinese
Simultaneous Interpreting
Medical Dermatology
Dermatological Surgery
Engergy-based Devices
Injectables
Staff Training
SCIENTIFIC SESSIONS
109
SUNDAY, MAY 3
Injectable Workshop: How to Make Charming Eyes
Sun. May 3, 13:30-15:00
Room 301A
Moderator PENG, Hsien-Li (彭賢禮) MD
ACQUILLA, Raj MBChB MRCGP MBCAM
HM4 Peri-orbital Beautification – a 6
Point Approach Using HA Filler
13:30 / ACQUILLA, Raj MBChB MRCGP MBCAM
HM5 The Ideal Shapes and Positions of
Eyebrows
14:00 / HSU, Nai-Jen (許乃仁) MD
HM6 Restorative Approach to the
Periorbital Region
14:30 / SUNDARAM, Hema MD
HM4 Peri-orbital Beautification – a 6 Point
Approach Using HA Filler
Speaker ACQUILLA, Raj MBChB MRCGP MBCAM
Moderator PENG, Hsien-Li (彭賢禮) MD
Peri-orbital beautification
The eye and peri-orbital area is the aesthetic centre of
the face and the first area to show the signs of ageing.
It is often perceived as the area through which people
estimate age and mood. This region is a 360 degree
complex which deteriorates through ageing and can be
summarised as follows:
1) Frontal elongation and brow ptosis
2) Fat accumulation and skin excess in the upper
eyelid
3) Crows feet lines
4) Lateral lower lid cheek junction
5) Infraorbital fat prolapse
6) Tear trough
After treating the upper face with Botulinum toxin we
can optimise the peri-orbital region by injecting low
molecular weight HA in the following 6 points:
1) Zygomatic arch - to lift the lateral cheek
2) Beautification point - to optimise the Ogee curve
3) Malar groove - to correct concavity in the cheek
and tear trough
4) Anatomical tear trough
5) Lateral lid cheek junction
6) Temple, brow and forehead to support the eyebrow
Sequential treatment in low to high risk areas allows
safe injection using low volumes and optimising
aesthetic outcomes in this sensitive and delicate
anatomical region.
SCIENTIFIC SESSIONS 110
HM5 The Ideal Shapes and Positions of
Eyebrows
Speaker HSU, Nai-Jen (許乃仁) MD
Moderator PENG, Hsien-Li (彭賢禮) MD
ACQUILLA, Raj MBChB MRCGP MBCAM
Eyebrows are the important frames of the eyes. Their
main function is hypothesized to prevent sweat, water,
and other debris from falling down into the eye socket,
but they are also important to human communication
and facial expression.The popular shapes and positions
of eyebrows changed in different times.In this leture,
I will talk about the ideal position of eyebrows; the
aging process of eyebrows and the methods which can
change the shapes and positions of eyebrows.
HM6 Restorative Approach to the
Periorbital Region
Speaker SUNDARAM, Hema MD
Moderator PENG, Hsien-Li (彭賢禮) MD
ACQUILLA, Raj MBChB MRCGP MBCAM
If the eyes are the window to the soul, as the poets
say, then the periorbital area is the all-important
frame for that window. When periorbital rejuvenation
is performed well, it can profoundly improve the
appearance of the eyes, and also positively impact the
whole face by restoring prominence to the upper face
in comparison to the lower face and re-establishing
more youthful facial proportions.
This lecture discusses the rationale for combined
nonsurgical treatments to the "periorbital frame" and
presents some novel paradigms for rejuvenating it
by combining fractional bipolar radiofrequency (RF)
and infrared (IR) energy with soft tissue fillers and
botulinum toxin neuromodulators. These treatments
can be applied directly within the periorbital frame.
They can also be applied outside the frame for
secondary vectoring effects. These two approaches
will be compared and contrasted. The combination
of volumetric RF and IR technologies that stimulate
collagenesis and elastogenesis with fillers results in
a restorative approach to periorbital rejuvenation
via synergistic improvement of tissue quality. This
approach is well-suited to Asian patients because RF
and IR are non-chromophore-specific (“color-blind)
and thus can be used safely for pigmented skin.
References
Sundaram H and Kiripolsky M. Clinics in Plastic
Surgery (2013)
Sundaram H and Carruthers J. in Procedures in
Cosmetic Dermatology: Soft Tissue Augmentation
(2013)
SUNDAY, MAY 3
Injectable Workshop: How to Make Charming Eyes
Sun. May 3, 13:30-15:00
SCIENTIFIC SESSIONS
111
SUNDAY, MAY 3
Urticaria Symposium
Sun. May 3, 13:30-15:00
Room 301B
Moderator LEE, Woan-Ruoh (李婉若) MD, PhD
SCHMID-GRENDELMEIER, Peter MD, PhD
UT1 Classification, Diagnosis, Disease
Burden of Chronic Spontaneous
Urticaria (CSU)
13:30 / KULTHANAN, Kanokvalai MD
UT2 Chronic Urticarial and Its
Management: The Humanized IgE
Antibody Omalizumab as a Novel
Treatment of Chronic Spontaneous
Urticaria: MoA and Phase III Data
14:00 / SCHMID-GRENDELMEIER, Peter MD, PhD
UT3 Overview of International and Local
CSU Treatment Guideline, and
Clinical Experience
14:30 / CHU, Chia-Yu (朱家瑜) MD, PhD.
UT1 Classification, Diagnosis, Disease
Burden of Chronic Spontaneous
Urticaria (CSU)
Speaker KULTHANAN, Kanokvalai MD
Moderator LEE, Woan-Ruoh (李婉若) MD, PhD
SCHMID-GRENDELMEIER, Peter MD, PhD
Urticaria is defined by the occurrence of transient
pruritic wheals and/or angioedema. Episodes lasting for
longer than 6 weeks are regarded as chronic urticaria.
The current classification distinguishes spontaneous
from inducible urticarial forms. Symptoms of chronic
spontaneous urticaria (CSU) appear spontaneously. In
most cases, there is no identifiable exogenous stimulus
for hive production.
Diagnostic approach in patients with CSU requires a
thorough history, including possible eliciting factors
and comorbid disorders. Routine laboratory testing
in the absence of a clinical history is rarely helpful
in determining an etiology. The extended diagnostic
procedures should be considered on an individual
basis in patients with long-standing, severe or
persistent urticaria.
The quality of life (QoL) impairment of CSU
patients is comparable with that of patients with
ischemic heart disease. The common impact issues are
pruritus, wheals, embarrassment from urticarial sighs
on body, feeling nervous, swelling of eyes and lips,
embarrassment in going to public places, bad mood,
interfere with sleep, eating, work and spot activities.
CSU poses a high socioeconomic burden for patients.
It is burdensome in terms of both direct medical
costs and indirect costs to society. Dealing with
CSU patients who have a frustrating, unpredictable
condition is challenging and time consuming for
physicians. The patients often have impaired QoL, a
significant emotional burden and high expectations.
SCIENTIFIC SESSIONS 112
UT2 Chroni c U r t i c a r i a l a n d I t s
Management: The Humanized IgE
Antibody Omalizumab as a Novel
Treatment of Chronic Spontaneous
Urticaria: MoA and Phase III Data
Speaker SCHMID-GRENDELMEIER, Peter MD, PhD
Moderator Woan-Ruoh (李婉若) MD, PhD
Urticaria is a very common skin disease with
heterogenous background of causes. A diagnostic
approach is based on the duration of the disease and
a variety of other aspects such angioedeme, duration
of wheals and possible inducing factors such as
physical factors. The diagnsotic algorhytm suggested
revised Urticaria guidelines 2014 elaborated by
EAACI/WAO/GA2LEN will be discussed. Also the
suggested sequentilal therapeutic management by
increased doses of H1-blockers up to fourfold doses
and as a new 3rd step the use of omalizumab will be
presented. Data from the several phase III studies with
Omalizumab will be presented. Also indication and
practical use of Omalizumab in chronic spontaneous
urticaria willl be extensively shwon, based onn the
litarature and experience with mor than 40 own cases.
UT3 Overview of International and Local
CSU Treatment Guideline, and
Clinical Experience
Speaker CHU, Chia-Yu (朱家瑜) MD, PhD
Moderator LEE, Woan-Ruoh (李婉若) MD, PhD
SCHMID-GRENDELMEIER, Peter MD, PhD
Chronic idiopathic urticaria (also called chronic
spontaneous urticarial; CSU) is defined as itchy
hives that last for at least 6 weeks, with or without
angioedema, and that have no apparent external
trigger. CSU has a significant effect on patients’
quality of life both physically and psychologically.
CSU is a common dermatosis, with a prevalence of
1% and a peak incidence between 20 and 40 years of
age. This disease affects women more frequently than
men and it may persist for 3-5 years in 50% of patients
and for over 10 years in 20%. The EAACI/GA2LEN/
EDF/WAO/ guideline provides recommendations for
diagnostic and therapeutic approaches in urticaria.
This guideline recommended first-line treatment
is monotherapy with a second-generation H1-
antihistamine. If symptoms persist after 2 weeks,
recommended second-line therapy is a secondgeneration
H1-antihistmamine at up to four times the
licensed dose. If symptoms persist after one to four
further weeks, the third-line add-on therapies would
be omalizumab, cyclosporine A, or montelukast. The
international EAACI/GA2LEN/EDF/WAO/ guideline
states that the aim of therapy for urticarial should
be complete symptom control. The presentation
will cover the 2014 Taiwanese Dermatological
Association (TDA) consensus regarding the definition,
classification, diagnosis, and management of urticaria.
TDA urticaria treatment consensus recommended
the Urticaria Activity Score (UAS) system or UAS7
(Urticaria Activity Score for 7 days) system to be the
method for assessing disease activity in spontaneous
urticaria. With regard to the treatment algorithm,
it should be noted that the time between each line
of defense was shortened from the original EAACI
guidelines upon which the TDA consensus is based.
Clinicians should also be aware that H1 antihistamines
and omalizumab are the only medications licensed for
treating chronic urticaria by the FDA (US Food and
Drug Administration) and EMA (European Medicines
Agency). Finally, the practical use of omalizumab in
chronic spontaneous urticaria will be shown based on
my own experience.
SUNDAY, MAY 3
Urticaria Symposium
Sun. May 3, 13:30-15:00
SCIENTIFIC SESSIONS
113
SUNDAY, MAY 3
Osmidrosis Workshop
Sun. May 3, 13:30-15:00
Room 304A
Moderator TSAI, Ren-Yeu (蔡仁雨) MD
OW1 Toxin for Hyperhidrosis
13:30 / CASSUTO, Daniel MD
OW2 Noninvasive Treatment of
Bromidrosis by Microwave-based
Device --the Correlation between
clinical and Histologic Study
14:00 / YANG, Chih-Hsun (楊志勛) MD
OW1 Toxin for Hyperhidrosis
Speaker CASSUTO, Daniel MD
Moderator TSAI, Ren-Yeu (蔡仁雨) MD
SCIENTIFIC SESSIONS 114
OW2 Noninvasive Treatment of Bromidrosis
by Microwave-based Device --the
Correlation between clinical and
Histologic Study
Speaker YANG, Chih-Hsun (楊志勛) MD
Moderator TSAI, Ren-Yeu (蔡仁雨) MD
Microwave-based devices target sweat glands through
energy delivery at the dermal-subcutaneous interface.
These devices have been approved by the Food and
Drug Administration as a noninvasive treatment for
axillary hyperhidrosis. We conducted a prospective
study using miraDry® system in treating axillary
osmidrosis. Seven patients with axillary osmidrosis
were recruited and received two consecutive treatment
sessions with a 3-month interval. Overall, six out
of seven (85.7%) participants were satisfied with
the procedure. Skin biopsy specimens reveled 93%
reduction of apocrine glands. Histopathological
changes include dermal fibrosis, necrosis of sweat
glands, and subcutaneous fat necrosis. Transient
swelling, bruise, numbness, lumps, and hypotrichosis
were observed, but no patient reported disabling side
effects. Microwave-based devices are noninvasive and
a potential alternative therapeutic modality for axillary
osmidrosis treatment.
SUNDAY, MAY 3
Osmidrosis Workshop
Sun. May 3, 13:30-15:00
SCIENTIFIC SESSIONS
115
SUNDAY, MAY 3
Special Lecture
Sun. May 3, 14:20-15:00
Room 304A
Moderator HUANG, Po-Han (黃柏翰) MD
CL1 What's Hot in Aesthetic Procedures
Concerning: Lipolysis, Morphotypes
and Neck Rejuvenation
14:20 / ASCHER, Benjamin MD
CL1 What's Hot in Aesthetic Procedures
Concerning: Lipolysis, Morphotypes
and Neck Rejuvenation
Speaker ASCHER, Benjamin MD
Moderator HUANG, Po-Han (黃柏翰) MD
SCIENTIFIC SESSIONS 116
SUNDAY, MAY 3
Satellite Speeches
Sun. May 3, 13:30-15:00
Room 304B
Moderator TSENG, Chung-Jen (曾忠仁) MD
SS18 The Efficacy of a 532nm & 1064nm
Picoseconds Laser for the Treatment
of Tattoo Removal and Benign
Pigmented Lesions
13:30 / CHAN, Henry MD, PhD
Moderator CHAO, Yates Yen-Yu (趙彥宇) MD
SS19 Nonsurgical Modalities to Treat the
Aging Face with Princess ha -based
Fillers
14:00 / RAPPL, Thomas MD
Moderator WANG, Chao-Chin (王昭欽) MD
SS20 EnerJet: Dermal remodeling system
for immediate and long lasting
aesthetic results, by incorporating
Jet Volumetric Remodeling (JVR)
Technology.
14:30 / CASSUTO, Daniel MD
SS18 The Efficacy of a 532nm & 1064nm
Picoseconds Laser for the Treatment
of Tattoo Removal and Benign
Pigmented Lesions
Speaker CHAN, Henry MD, PhD
Moderator TSENG, Chung-Jen (曾忠仁) MD
Improved tattoo clearance by picosecond pulses in
humans was first reported in the literature in 1998.
The study treated designated parts of the same tattoo
with 35-picosecond and 10-nanosecond pulses
from 2 neodymium:YAG lasers and reported that
picosecond pulses are more efficient than nanosecond
pulses in clearing black tattoos. Recently, commercial
picosecond lasers were introduced.
A new (2014) mult i - c e n t e r s t u dy u s ing a
450-picosecond pulses dual-wavelength picosecond
laser to treat 60 patients at 3 sites (Tina Alster, MD,
Arielle Kauvar, MD, & Eric Bernstein, MD) had
interim results which reported that 89% of the subjects
had at least 50% clearance, and 54% of the subjects had
at least 75% clearance of the tattoo. For patients who
had at least 75% clearance, the clearance was achieved
in an average of 4 treatments.
Laser treatment of benign pigmented lesions have
been studied widely. Q-switched laser for pigmented
lesions in Asians reported a 25% post inflammatory
hyperpigmentation risk. Long pulsed Nd:YAG was
reported to have a lower PIH risk.
We recently conducted a study using the dualwavelength
picosecond device to assess the safety
and efficacy of picosecond laser for the treatment
of benign pigmented lesions among Asian. Interim
result reported that 72.7% of subjects had at least 50%
clearance after 3-month follow-up and 3.2% of blister
and PIH.
Preliminary results support the effectiveness and
safety. Updated data from the study will be presented.
SCIENTIFIC SESSIONS
117
SS19 Nonsurgical Modalities to Treat the
Aging Face with Princess HA -based
Fillers
Speaker RAPPL, Thomas MD
Moderator CHAO, Yates Yen-Yu (趙彥宇) MD
Over the past two decades, soft tissue augmentation
using injectable fillers, has become a standard clinical
approach for correcting age-related facial defects.
HA-based fillers appear to be ideal due to their low
immunogenic potential and relatively long-lasting
effect.
The Princess® family (Princess® FILLER, Princess®
VOLUME, Princess® RICH) of dermal fillers,
based on bio fermentative HA, was introduced to the
European market in 2009. It is indicated to correct
deeper wrinkles and folds, increase or restore facial
volume to the face and remodel facial contours.
SS20 EnerJet: Dermal remodeling system
for immediate and long lasting
aesthetic results, by incorporating
Jet Volumetric Remodeling (JVR)
Technology. .
Speaker CASSUTO, Daniel MD
Moderator WANG, Chao-Chin (王昭欽) MD
Using non-thermal kinetic energy to deliver
hyaluronic acid (or other beneficial solutions) for
immediate skin hydration and long term effect which
initiate wound healing process resulting in collagen
regeneration. The treatment is painless and with
minimum downtime. The EnerJet offers various
treatments such as lifting, acne scars, stretch marks
and overall skin regeneration. Improvement can be
seen as early as 1 month and as long as 18 months after
the treatment series.
I have been using the technology since 2009.It’s the
most effective treatment I can provide to my patients
for old stretch marks. It’s also the first line treatment
for deep acne scars, that would not show such an
improvement with any other kind of technology.
In both cases, the atrophic areas are regenerated
without any risk of side effects.
SCIENTIFIC SESSIONS 118
SCIENTIFIC SESSIONS
SUNDAY, MAY 3
15:30-17:00
Injectable Workshop: How to Make Sexy Lips
Psoriasis Symposium
診所經營管理者論壇
Satellite Speeches: Body Contouring (II) and Injectable
Physician Only
Lecturing in English
Lecturing in Chinese
Simultaneous Interpreting
Medical Dermatology
Dermatological Surgery
Engergy-based Devices
Injectables
Staff Training
SCIENTIFIC SESSIONS
119
SUNDAY, MAY 3
Injectable Workshop: How to Make Sexy Lips
Sun. May 3, 15:30-17:00
Room 301A
Moderator PENG, Hsien-Li (彭賢禮) MD
ACQUILLA, Raj MBChB MRCGP MBCAM
IW7 Lip & Peri-oral Rejuvenation – A 6
Point Technique Using HA Filler
15:30 / ACQUILLA, Raj MBChB MRCGP
MBCAM
IW8 Lips Sculpture in Asian
16:00 / PENG, Hsien-Li (彭賢禮) MD
IW9 Anatomic Subdivision Unit Concept
of Lip Augmentation
16:30 / PRASETYO, Adri Dwi MD
IW7 Lip & Peri-oral Rejuvenation – A 6
Point Technique Using HA Filler
Speaker ACQUILLA, Raj MBChB MRCGP MBCAM
Moderator PENG, Hsien-Li (彭賢禮) MD
Peri-oral rejuvenation
The lips are the most dynamic, sensitive and sensual
part of the face. During ageing the lip tissue inverts
causing loss of vertical height and projection, the
philtrum flattens and elongates whilst peri-oral rhytids
deepen. Meanwhile the oral commisure descends
giving the mouth a sad appearance. Injecting in a
sequential manner over 6 points from lateral to medial
can optimise the beauty of the lips and peri-oral
region:
1)Oral commisure – to promote a positive mouth
2)Vermillion border – to enhance eversion and
musocal show
3)Glogau-Klein points – to sharpen the cupids bow
4)Philtral columns – to strengthen the peri-oral frame
5) Peri-oral rhytids – injected superficially and
perpendicularly
6)Volumetry – to achieve the harmony and balance of
PHI
Injection methodology of HA filler at specific depths
allows restoration of the anatomical detail of the lip
and conformity towards the aesthetic ideal.
SCIENTIFIC SESSIONS 120
IW8 Lips Sculpture in Asian
Speaker PENG, Hsien-Li (彭賢禮) MD
Moderator ACQUILLA, Raj MBChB MRCGP MBCAM
The lips is very important for feminine beauty. The
aging signs in lips may include volume loss, wrinkles
on the lips or the perioral skin, dryness, dark color,
and a downturn at the corners of the mouth. A full
pair of beautiful lips makes a face young and attractive.
Just as Asian skin differs from Caucasian skin, so do
the lips. Asian lips are generally fuller than Caucasian
ones, with thicker upper vermilion lips. As a result, lip
sculpting for Asians may differ from in Caucasians.
In this presentation, I will introduce my way to do
aesthetic lip sculpting in Asians .
IW9 Anatomic Subdivision Unit Concept
of Lip Augmentation
Speaker PRASETYO, Adri Dwi MD
Moderator PENG, Hsien-Li (彭賢禮) MD
ACQUILLA, Raj MBChB MRCGP MBCAM
Lip filler augmentation is performed to achieve the
goals of universally accepted standards for ‘ideal’
shapes and proportions, trends, and harmony
with the patient’s overall facial structure. These
objectives lead to specific technical implications in
filler injection by using the concept of anatomic
subdivision unit. Sixteen anatomic subdivision
units for lip augmentation are defined. Videos of
injection technique using this concept are displayed
and practical cases are explained. Lip shapes and
proportions vary between individuals. Aesthetic goals
have to be addressed by using universally accepted
standards, trends regarding attractiveness, and how
it can be applied aesthetically to the patient’s overall
facial structure. These objectives have the implication
of injecting specific target of augmentation in the
anatomic subdivision units of the lips. Regarding lip
augmentation, there are overlapping rules of aesthetic
proportions and trends. Anatomic subdivision unit
concept of lip augmentation is important for achieving
specific results guided by the patient's aesthetic
indication and demand.
SUNDAY, MAY 3
Injectable Workshop: How to Make Sexy Lips
Sun. May 3, 15:30-17:00
SCIENTIFIC SESSIONS
121
SUNDAY, MAY 3
Psoriasis Symposium
Sun. May 3, 15:30-17:00
Room 301B
Moderator TSAI, Tsen-Fang (蔡呈芳) MD
HUANG, Po-Han (黃柏翰) MD
PS1 Selective Targeting of IL-17 in
Psoriasis: the State of the Art
15:30 / FOLEY, Peter BMedSc, MB BS,MD,FACD
PS2 Challenging the Standard of Care
with IL 17 Inhibition: the Evidence
16:00 / FOLEY, Peter BMedSc, MB BS,MD,FACD
PS3 Fresh Perspectives on Maximizing
Psoriasis Patient
16:30 / HUANG, Yu-Huei (黃毓惠) MD
PS1 Selective Targeting of IL-17 in
Psoriasis: the State of the Art
Speaker FOLEY, Peter BMedSc, MB BS,MD,FACD
Moderator TSAI, Tsen-Fang (蔡呈芳) MD
HUANG, Po-Han (黃柏翰) MD
Psoriasis is a chronic relapsing disease of the skin
characterized by variable clinical features. The lesions
are classified as erythrosquamous, which indicates that
both the vasculature (erythema) and the epidermis
(increased scale formation) are involved. Infiltration
of T-helper Type 1 (Th1) cells into regions of affected
skin has long been recognised as a major component
of the immunopathogenesis of psoriasis. More
recently, the Th17 cell was identified; so named
because IL-17 is the key cytokine it produces. The
identification of IL-17 inhibition could be important
in the management of psoriasis. Current treatments,
such as ustekinumab (a IL-23 inhibitor), act upstream
to the generation of IL-17.
In synergy with other cytokines such as TNFα and
IFNγ, IL-17A directly activates keratinocytes and
dermal fibroblasts to produce cytokines (e.g. IL-6,
TNFα, IL-1β) and chemokines. This leads to the
recruitment of inflammatory cells such as neutrophils
and lymphocytes (e.g. Th17 cells) into the psoriatic
lesion thereby maintaining and amplifying local
inflammation. Furthermore, IL-17A released from
Th17 cells induces keratinocyte hyperproliferation.
IL-17A is highly expressed in psoriatic skin lesions. To
target IL-17 effectively, it should be recognised that its
expression in psoriatic skin does not depend entirely
on the activation of Th17 cells, and that mast cells
and neutrophils also release IL-17. Thus, IL-17A is a
rational target for inhibition as therapy for psoriasis.
SCIENTIFIC SESSIONS 122
PS2 Challenging the Standard of Care
with IL 17 Inhibition: the Evidence
Speaker FOLEY, Peter BMedSc, MB BS,MD,FACD
Moderator TSAI, Tsen-Fang (蔡呈芳) MD
HUANG, Po-Han (黃柏翰) MD
Wi th the development of treatments such as
adalimumab (an antitumour necrosis factor
alpha mAb) and ustekinumab (anti-IL-12/23),
dermatologists began to be able to achieve higher %
of PASI 75 and further explore possibility of PASI 90
response in psoriasis patients. Psoriasis treatments are
now at a stage where it is possible to extend treatment
expectations further using the new generation of anti-
IL-17 medications. Secukinumab is the first of the IL-
17 agents that has been assessed in several 52-week
Phase III studies, of which the two pivotal trials were
recently reported in the New England Journal of
Medicine.
Secukinumab at 150 mg and 300 mg (administered at
Baseline, Weeks 1, 2, 3 and then every 4 weeks starting
from Week 4) was compared with placebo in the
ERASURE trial, or etanercept (at the indicated dose of
50 mg twice weekly, followed by 50 mg once weekly)
in the FIXTURE trial. The proportion of patients who
met the criterion for PASI 75 at week 12 was higher
with each secukinumab dose than with placebo or
etanercept: in the ERASURE study, the rates were
81.6% with 300 mg of secukinumab, 71.6% with 150
mg of secukinumab, and 4.5% with placebo; in the
FIXTURE study, the rates were 77.1% with 300 mg
of secukinumab, 67.0% with 150 mg of secukinumab,
44.0% with etanercept, and 4.9% with placebo. At 16
weeks the benefit was even greater, with 76% (150
mg) and 87% (300 mg) of patients achieving PASI 75.
Furthermore, Clinical response (i.e., a 50% reduction
in the mean PASI score) occurred more rapidly with
each secukinumab dose (median, 3.0 weeks with 300
mg and 3.9 weeks with 150 mg) than with etanercept
(median, 7.0 weeks) in the FIXTURE study. Most
importantly, the improvements seen at 16 weeks were
maintained throughout the full 52 weeks of the study,
suggesting that the efficacy of secukinumab is both
rapid and sustained.
In both of our studies, the incidences of adverse
events, notably infectious adverse events, were higher
in the secukinumab groups than in the placebo
group during the induction period. The incidences
of adverse events in the secukinumab groups during
induction and the entire 52-week treatment period
in the FIXTURE study were similar to the incidence
with etanercept.
SUNDAY, MAY 3
Psoriasis Symposium
Sun. May 3, 15:30-17:00
SCIENTIFIC SESSIONS
123
PS3 Fresh Perspectives on Maximizing
Psoriasis Patient
Speaker HUANG, Yu-Huei (黃毓惠) MD
Moderator TSAI, Tsen-Fang (蔡呈芳) MD
HUANG, Po-Han (黃柏翰) MD
Psoriasis is a chronic inflammatory disease that impairs
patients' physical and social functioning. The advance
in medicine had equipped clinical dermatologists
plenty of treatment choices to treat psoriasis. However,
the complexity and variety of psoriasis brought so
much severe impact from patient perspectives that
physicians shall take into consideration to provide the
holistic patient care. Thus, what exactly are the unmet
needs from the patients? How we may improve the
outcome and patient wellbeing remained unanswered.
The assessment of health-related quality of life
(HRQoL) provides a comprehensive insight into the
actual disease burden that are not captured by the
traditional clinical parameters. Recently published in
Journal of Dermatology in Feb., Our Taiwan study
aimed to identify factors that may impact patients'
HRQoL. A cross-sectional study, recruiting a total of
414 psoriasis vulgaris patients between January 2008
and December 2011, has been conducted. Our study
found no significant correlation between disease
severity or duration of psoriasis with HRQoL. Female
patients have poorer HRQoL. Psoriatic arthritis, nail
involvement, burning and itching sensation have a
detrimental effect on HRQoL. This study highlighted
that specific disease-associated symptoms such as
itching and burning sensation, nail involvement and/or
concomitant arthritis were important factors that may
impact patients' HRQoL devoid of clinical severity.
Revicki et al. indicated that improvement in PASI
reduction of >75% corresponded to improvements
in HRQOL outcome measures for patients with
moderate to severe psoriasis. PASI 90 or 100
responders had greater improvements in DLQI
total score than PASI 75 responders. Following
review from Mattei et al. also indicated that in the
13 RCT analyzed, the mean percent PASI reduction
of >75%, had a mean DLQI reduction of 9.36, a
mean movement from DLQI band 3 to DLQI band
1. Physicians should carefully consider these factors
when treating psoriasis patients .
SCIENTIFIC SESSIONS 124
SUNDAY, MAY 3
診所經營管理者論壇
Sun. May 3, 15:30-17:00
診所及聯合診所之設立---功能規劃與管理
Speaker 白佳原 院長
Moderator 曾忠仁 醫師
林政賢 醫師
I.座向、環境之規劃（Location & Environment
Planning）
01.位址評估與選擇 Location Evaluation &
Selection
02.停車規劃
03.Rent or Buy of the Building
II.開幕之規劃
01.Time Schedule
02.License
03.Financial
04.招牌
05.設立之科別
06.門面 Layout Planning
07.櫃檯之設計
08.叫號之設計
09.預約掛號 VS 遲到之編號
10.藥局之設計：獨立門戶否？藥架之高度、每格
之高度、易拿取 VS 藥師身高、藥瓶之開罐？
磨藥台之高度、自動包藥機、預包
11.病歷室之規畫
12.資訊、電腦系統之選擇
13.安全系統之規畫
14.現金及支票之安全控管
15.員工之招募＆人事管理
16.公關 Public Relationship
17.年節之處理
18.廣告＆宣傳
19.藝術品裝潢
20.藥品之管理
21.清潔與醫療廢棄物
22.感染控制
23.緊急發電機
Room 304A
Moderator 曾忠仁 醫師
林政賢 醫師
診所經營管理者論壇
論壇1 診所及聯合診所之設立---功能規劃與
管理
15:30 / 白佳原 院長
論壇2 診所的財務
16:00 / 高永浩 會計師
論壇3 診所經營管理者座談
16:30 / 白佳原 院長
/ 高永浩會計師
/ 曾忠仁醫師
/ 林政賢醫師
SCIENTIFIC SESSIONS
125
診所的財務
Speaker 高永浩會計師
Moderator 曾忠仁 醫師
林政賢 醫師
65/10/22稅捐稽徵法完成立法迄今實務上國稅局
面對未依法設置帳簿或不依規定記載者，不曾祭出
稅捐稽徵法第45條之適用，僅依查得資料及財政部
頒費用標準核定其所得額。然而102年9月26日起各
區國稅局紛紛發表稅務新聞稿重申執行業務者如未
依法設置帳簿或不依規定記載，將依稅捐稽徵法第
45條規定祭出罰鍰甚至停業的聲明，其涵義為何？
醫師所得依開業性質區分之類別及查稅問題。
以聯合執業方式經營之節稅效益與注意事項。
醫師所得查稅類型及行政救濟敗訴之關鍵因
素。
診所經營管理者座談
Speaker 白佳原 院長
高永浩 會計師
曾忠仁 醫師
林政賢 醫師
Moderator 曾忠仁 醫師
林政賢 醫師
20
SCIENTIFIC SESSIONS 126
SUNDAY, MAY 3
Body Contouring (II) and Injectables
Sun. May 3, 15:30-17:00
Room 304B
Moderator CHENG, Kuo Liang (鄭國良) MD
SS21 Non-invasive Fat Reduction
of the Outer Thighs by Using
Cryolipolysis –Introduction of the
new Coolsmooth Applicator
15:30 / LU, Ching -I (盧靜怡) MD
Moderator HU, Sindy (胡倩婷) MD
SS22 What’s New in Cryolipolysis -
The Trend of Non-invasive Body
Contouring
16:00 / WANG, Cheng-Kun (王正坤) MD, EMBA
Moderator LU, Ching -I (盧靜怡) MD
SS23 Clinical Applications of A Novel
Polycaprolactone Based Dermal
Filler
16:30 / DE MELO, Francisco MD.
SS21 Non-invasive Fat Reduction
of the Outer Thighs by Using
Cryolipolysis –Introduction of the
new Coolsmooth Applicator
Speaker LU, Ching-I (盧靜怡) MD
Moderator CHENG, Kuo Liang (鄭國良) MD
CryolipolysisTM is developed according to the concept:
the fat cells are more susceptible to cold than the
skin, nerve and muscle. The efficacy and safety of
CryolipolysisTM depends on the suitable temperature
and treatment duration. CryolipolysisTM had been
proved that it is effective to reduce the fat of the
abdomen, back and inner thigh, but it was restricted to
treat the areas of enough pinchable fat.
The CoolsmoothTM is a new, flat, non-vacuum
applicator, which is developed to treat the areas of
non-pinchable fat including the saddle-bag areas of
outer thighs and also the inner thighs and central
abdomen. Since the CoolsmoothTM applicator does not
rely on the suction to reduce fat, CryolipolysisTM can
now freeze the fat of almost all areas of the body, only
if the treated areas can fit the size of the applicator.
SCIENTIFIC SESSIONS
127
SS22 What’s New in Cryolipolysis -
The Trend of Non-invasive Body
Contouring
Speaker WANG, Cheng-Kun (王正坤) MD, EMBA
Moderator HU, Sindy (胡倩婷) MD
Various cosmetic procedures and devices have been
developed to remove or reduce unwanted local
subcutaneous fat. Conventional fat removal is
achieved surgically by liposuction.
To date, there are several devices for noninvasive body
contouring: such as RF(radiofrequencies), LLLT(Low
Level Laser Therapy), Cryolipolysis, ultrasound and
HIFU(High Intensity Focused Ultrasound).
Cryolipolysis whereby fat layer reduction is produced
by selective destruction of fat cells by programmed
death (apoptosis). This technique uses controlled
cold exposure to obtain a gradual reduction of the
subcutaneous fat layer without damage to other
tissues. Studies shows that fat cells, in fact, are much
more sensitive to cold-induced apoptosis than other
anatomic structures such as skin, dermis, vessels,
nerves, and muscles. Cryolipolysis therefore is a safe,
effective, and well-tolerated noninvasive procedure for
body contouring.
This study is conducted by utilizing Icelipolysis, and
the optimal result can be seen from 2 to 3 months
after treatment. The results show that the procedure
significantly reduces the circumference and fat
thickness in the treated areas. The mean reduction in
fat thickness after treatments is 4.5 cm in abdomen.
Circumference is reduced by a mean of 6.86 cm in
abdomen. Weight is unchanged during the treatment,
and no effects on lipid or liver marker levels in the
bloodstream are observed. For patients, Icelipolysis
appears to be a technology offering an effective
procedure performed in a safe and gradual manner.
SS23 Clinical Applications of A Novel
Polycaprolactone Based Dermal
Filler
Speaker DE MELO, Francisco MD
Moderator LU, Ching -I (盧靜怡) MD
The actual knowledge of the aging process has
underlined the importance of volume changes caused
by loss of soft tissue and bone. Primarily, we observe
a decrease in the volume of the subcutaneous fat.
Although this loss of volume is not the only factor
involved, its correction can improve the overall look,
and overcome the need for other interventions.A
novel polycaprolactone based biostimulatory dermal
filler (Ellansé), restores lost volume by inducing
neocollagenesis, improving the soft tissue density and
skin quality. Polycaprolactone is a total resorbable
synthetic medical polymer which has been used for
several decades in medical devices. The longevity of
this dermal filler can be tuned from 12 to 48 months,
still maintaining a high safety standard. It has different
clinical applications, such as facial treatments,
hand rejuvenation and also body treatments, with
long-lasting and consistent results, which we will
demonstrate using 3D photo-technology. This lecture
will also focus on the importance of proper anatomic
knowledge, and clinical techniques to prevent
complications and obtaining predictable results.
130
131
SPEAKERS
132
ACQUILLA, Raj MBChB MRCGP MBCAM
Cosmetic Dermatologist, United Kingdom
CEO, Cheshire Cosmetic Ltd (UK), Cheshire
Cosmetic Ltd (UK)
North West Regional Chair, British College of
Aesthetic Medicine
Faculty Member, The European College of Aesthetic
Medicine & Surgery
AN, Kyung-Chun MD
Aesthetic Surgeon, South Korea
President, The Seroi Clinic
Founder and Director, 5D Liposculpture Academy
Clinical Professor, Korea University
Professor, Korean College of Cosmetic Surgery
President, Natural Beuty Network
Director, HiDef liposculpture, Korea
ASCHER, Benjamin MD
Plastic Surgeon, France
Chairman and Head of the Clinique of Aesthetic
Surgery IENA in Paris, France
Founder and Scientific Director of IMCAS congresses
(Paris, Shanghai, Hong Kong, and Delhi)
Co-director of the first French & European University
XII, Hopital Tarnier. France
Section editor of the Aesthetic Plastic Surgery Journal;
Editorial board, Journal of Cosmetic and Laser
Therapy
AVRAM, Marc R. MD
Dermatologist, United States
Clinical Professor, Dermatology,Department of
Dermatology,Weill Cornell Medical College/New
York Presbyterian Hospital
Associate Editor: Dermatologic Surgery,
Journal of Cosmetic and Laser Therapy &
Journal of Cosmetic Dermatology
International Speakers
133
International Speakers
BEN-NERIAH, Yinon MD., Ph D.
Israel
Professor, The Lautenberg Center for Immunology,
Hebrew University-Hadassah Medical School
President, ILANIT congress of all the societies of
experimental biology in Israel
Chair, Scientific Advisory Board, BIOSS Center of
Excellence, Freiburg University
George and Eva Klein Prize in Cancer Research, Israel
CASSUTO, Daniel MD
Plastic Surgeon, Italy
Plastic and Aesthetic Surgery, private practice in
Milano, Italy
Professor, Plastic, Reconstructive and Aesthetic
Surgery, Plastic Surgery Department, University of
Catania, Italy.
A well-known speaker at meetings throughout the
world. He has delivered more than 150 scientific
presentations on a wide variety of aesthetic topics.
CHAN, Hau-Ngai (陳厚毅) MD
Dermatologist, Hong Kong
Honorary Consultant Dermatologist, Kowloon
Central Cluster, the Hong Kong Hospital Authority
Specialist, Dermamier Skin & Laser Centre
CHAN, Henry M.B.B.S., MD, M Sc, PhD.,
MRCP, FRCP, FRCP, FRCP RCPS, FHKCP, FHKAM
Dermatologist, Hong Kong
Honorary Clinical Professor, Department of Medicine,
The University of Hong Kong
Visiting Scientist, Wellman Center for Photomedicine,
Massachusetts General Hospital, Boston, USA.
Honorary Consultant Dermatologist, Hong Kong
Hospital Authority.
Ellet H. Dr.ake Lectureship Award, American Society
for Laser Medicine and Surgery (ASLMS)
134
CHAN, Samson Chi-Fai (陳智輝) MB. ,
B Ch., FRCSE, FHKAM, FHKCOS
Orthopaedic Surgeon, Hong Kong
President,The Hong Kong Society for Diabetic Limb
Care
Honorary Clinical Associate Professor, Department of
Orthopaedics Surgery, University of Hong Kong.
Honorary Clinical Associate Professor, The Chinese
University of Hong Kong.
CHANG, Geun-Uck MD
Rhinoplastic Surgeon, South Korea
Director, Shimmian Rhinoplasty Clinic
Vice-president, Korean College of Cosmetic Surgery
(KCCS)
Member of KAFPRS (Korean Association of Facial
Plastic and Reconstructive Surgery)
CHEN, Wen-Chieh (陳文杰) MD
Dermatologist, Germany
Clinical Professor, Department of Dermatology and
Allergy, Technische Universität München, Munich
Germany
Member, German Dermatological Society
Member, German Society of Allergology and Clinical
Immunology
CHEONG, Wai-Kwong MD
Dermatologist, Singapore
Medical Director, Specialist Skin Clinic and
Associates, Singapore
Chairman, 1st Asian Expert Forum on the Diagnosis
and Management of Seborrhoeic Dermatitis
Member, 4th Asia Pacific Acne Leaders’ Summit
Member, P&G Olay Pro-X Global Dermatologist
Alliance
Member, International Advisory Committee, 8th
World Congress for Hair Research 2014, Korea
President, Dermatological Society of Singapore
Councilor, International Psoriasis Council
Medical Advisor, Psoriasis Association of Singapore
International Speakers
135
International Speakers
DE MELO, Francisco MD
Plastic Surgeon, United Arab Emirates
Consultant Plastic Surgeon, Aesthetica Clinic
has delivered a wide range of CME accredited training
courses in aesthetic medicine using the most advanced
techniques.
FISHER, David MD, PhD
Researcher, clinician and academic, United States
Ch a i r m a n , D e p a r t m e n t o f Der m a t o l o g y,
Massachusetts General Hospital at Harvard Medical
School
Director, Cutaneous Biology Research Center,
Massachusetts General Hospital
Edward Wigglesworth Professor of Dermatology,
Harvard Medical School
Professor of Pediatrics, Harvard Medical School
Presidential Citation, American Academy of
Dermatology, 2011
Lifetime Achievement Award, Society for Melanoma
Research
FOLEY, Peter BMedSc, MB BS,MD,FACD
Dermatologist, Australia
Head of Dermatology Research, Department of
Dermatology, St Vincent’s Hospital Melboume
Associate Investigator, Probity Medical Research,
Dermatology - Waterloo, Ontario, Canada
Director, Research, Skin & Cancer Foundation Inc.,
Carlton, Victoria
Co-concenor, the Australasian Psoriasis Registry
With over 70 publications in peer-reviewed journal’s.
FREVERT, Jürgen PhD
Biochemist, Germany
Senior Director, Head of Botulinum Research, Merz
Pharmaceuticals GmbH, Germany
Project Manager for biochemical projects, BioteCon
Therapeutics GmbH
Section Manager Molecular and Cellular Biology,
Battelle Europe Institute, Frankfurt
136
FUJIMOTO, Takahiro(藤本幸弘) MD, MBA, PhD
(Surgical Science), PhD (Engineering)
Specialist in Laser Dermatology , Japan
Director, Clinic F Laser & Skin Center
Clinical Associate, The Institution of medical research
of the University of Tokyo
PhD in Medicine (Surgical science) in the University
of Tokyo
PhD in Engineering (Laser : Electromagnetic field) in
Tokai University
Visiting Professor, Buckinghamshire New MBA
Program in Tokyo
Fellow ASLMS (American laser society of medicine
and surgery)
has been actively presenting his lectures at conferences
worldwide such as ASLMS, EADV, AAD, SPIE,
CLEO.
HAYASHI, Nobukazu MD, PhD
Dermatologist, Japan
Director, Department of Dermatology, Toranomon
Hospital
Adjunct Professor, Department of Dermatology, Tokyo
Women’s Medical University
Permanent Director, Japan Organization of Clinical
Dermatologists
Board Member, Japanese Society of Aesthetic
Dermatology
Chairman, Japan Acne Research Society
Section Editor, The Journal of Dermatology
Editor, Aesthetic Dermatology
Editor, Rinsho Derma (Tokyo)
IN, Sung-Il MD
Dermatologist, South Korea
Director, Charm Skin Clinic
Member, Korean Dermatological Association
Member, Korean Academy of Aesthetic medicine
Member, Korean Academy of Obesity Treatment
Member, Korean Society for the Study of Obesity
JUNG, Wonsug MD, PhD
Anatomists, South Korea
Assistant Professor in Gachon University College of
Medicine
Associate Vice Dean of Student Affairs in Gachon
University College of Medicine
Head, Department of Medicine in Gachon University
Graduate School
Member, Asian Association of Clinical Anatomists
Member, Korean Medical Associaion
International Speakers
137
International Speakers
KIM, Beom-Joon M.D, PhD
Dermatologist, South Korea
Head of Professor & Chairman, Department of
Dermatology, Chung-Ang University College of
Medicine, Seoul, Korea
Dr. Paul Janssen Award, Korean Dermatological
Association
Presidential Award, Korea Government
Editorial Board: Journal of the American Academy of
Dermatology; International Journal of Dermatology;
The Journal of Neural Regeneration Research
KULTHANAN, Kanokvalai MD
Dermatologist, Thailand
Chair, Department of Dermatology, Faculty of
Medicine Siriraj Hospital, Mahidol University,
Bangkok, Thailand
Secretary General, Dermatological Society of Thailand
Allergy and Immunology Unit, Department of
Dermatology, Faculty of Medicine Siriraj Hospital,
Mahidol University, Bangkok, Thailand
Member, The American Academy of Dermatology
Member, European Academy of Allergy and
Immunology
Chair, Thailand committee for clinical practice
guideline for urticaria
LEYDEN, James MD
Dermatologist, United States
Senior Consultant KGL Skin Study Center LLC
Professor Emeritus of Dermatology at the Hospital of
the University of Pennsylvania in Philadelphia
Honorary Member, Society of Investigative
Dermatology
American Academy of Dermatology Clarence
Livingood, M.D. Lectureship Award
Director, the American academy of Dermatology
Honorary Member, Society of Investigative
Dermatology
Clarence Livingood, M.D. Lectureship Award,
American Academy of Dermatology
MEDINA-LAVADIA, Angela MD
Dermatologist, Philippines
Chairman, Department of Dermatology, East Avenue
Medical Center
Attending Staff Dermatologsit and Active Consultant,
Department of Dermatology, St. Luke's Medical
Center, Cathedral Heights, Quezon City
Vice President, Philippine Dermatological Society
138
MOON, Hyoung-Jin MD
Facial Plastic Surgeon, South Korea
President, Dr. Moon’s Asthetic Plastic Surgery Clinic
Clinical Professor, Yosein University Medical College
Vice President, KAFPRS (Korean Academy of Facial
Plastic and Reconstructive Surgery)
Chief Faculty, International Microplastic Surgery
Academy
PAK, Chang-Sik MD
Plastic Surgeon, South Korea
Physician, Department of Plastic and Reconstructive
Surgery, Seoul National University Bundang Hospital
PRASETYO, Adri Dwi MD
Dermatologic Surgeon, Indonesia
Director, REJUVA Clinic, Surabaya, Indonesia
Board Certified Dermatologist, Airlangga University,
Surabaya
Scientific Board, International Master Course on
Aging Skin (IMCAS) Asia
National Trainer, Indonesian Society of Dermatology
and Venereology
Inventor and trainer of various aesthetic and surgical
procedures in Indonesia
RAPPL, Thomas MD
Plastic Surgeon, Austria
Reconstructive and Aesthetic Surgeon, Medical
University Hospital Graz, Austria
Director, Aesthetic Clinic (Schwarzl Klinik)
Member, ÖGPÄRC, ISAPS, SOFCPRE.
WAKO medical board member
International Speakers
139
International Speakers
ROHNER Sonja Andrea eidg. dipl. pharm.,
dipl. pharm. med. SwAPP
Medical Therapeutic Specialist, Switzerland
Medical Therapeutic Area Specialist, Spirig Pharma
AG, Egerkingen
Medical Advisor Diabetes, Boehringer Ingelheim
(Schweiz) GmbH, Basel 2012-2014
Field Medical Manager, Novo Nordisk Pharma AG,
Küsnacht ZH 2010-2011
SATO, Kiyoshi M Agr Sc
Research Scientist, Japan
Group Leader, Cutaneous Research Group, Shiseido
Research Scientist, Departments of Dermatology &
Cell Biology, New York University Medical Center
Master of Agriculture, Department of Agricultural
Science, The University of Tokyo
SCHMID-GRENDELMEIER, Peter MD, PhD
Dermatologist, Switzerland
Head, Allergy Unit, Department of Dermatology,
University Hospital of Zürich, Switzerland
Professor, Allergy and Dermatology, University of
Zürich, Switzerland
President, Swiss Society for Allergy and Clinical
Immunology
SCHWARZ, Thomas MD, PhD
Dermatologist, Germany
Professor and Chairman, Departent of Dermatology,
University Kiel
Vice-Dean, Medical Faculty, University Kiel
President, European Society for Dermatologic
Research (ESDR), 2005 -2006
Editorial Board: The Journal of
Investigative Dermatology; Photochemistry
Photobiology; Photodermatology Photoimmunology
Photomedicine; International Archives of Allergology
and Immunology
140
SUNDARAM, Hema MD, FAAD
Dermatologist, United States
Director, Sundaram Dermatology, Cosmetic & Laser
Surgery Center
Visiting Professor, American Society of Dermatologic
Surgery (ASDS)
Board of Directors, International Society for
Dermatologic Surgery (ISDS)
Associate Editor, Journal of Drugs in Dermatology
TAN, Jun (譚軍) MD
Plastic Surgeon, China
Director, Surgery and Laser Beauty Department,
Hunan Provincial People's Hospital
Professor and Master Instructor, Hunan Normal
University and NanHua University
National Committee, Chinese Medical Association of
Aesthetics and Cosmetology
National Committee, Laser Medical Branch of
Chinese Medical Doctor, Association of Plastic
Surgery
TSE, Ian Chi-Tat (謝志達)
MBBS,MRCP,FHKCP,FHKAM,FRCP
Dermatologist, Hong Kong
Consultant Dermatologist, Novo Medical Group
Honrary Assistant Professor, Chinese University of
Hong Kong
Managing Editor, Hong Kong Journal of Dermatology
and Venereology
Fellow, Royal College of Physicians of Edinburgh
Fellow, Royal College of Physicians of Glasgow (2013)
YU, Jonathan Nevin MD
Dermatologist, Philippines
Instructor, Skin and Cancer Foundation, Inc
Editorial Advisory Board, Asian Aesthtic Guide
Advisory Board, Allergan Philippines
Fellow, Philippine Dermatological Society
Fellow, American Academy of Dermatology
Fellow, American Society of Laser Surgery and
Medicine.
International Speakers
141
Domestic Speakers
CHANG, Kao-Jung (張高榮) MD
Plastic Surgeon, Taiwan
Chief Medical director, Ithaca Aesthetic and Antiging
Union clinic, Taipei
Membership of Taiwan Plastic and Reconstructive
Surgical Association and Taiwan Surgical Association
Attending Staff, Division of Plastic and Reconstructive
Surgery, Chang-Gung Memorial Hospital
Member, Taiwan Plastic and Reconstructive Surgical
Association
CHANG, Shyue-Luen (張學倫) MD
Dermatologist, Taiwan
Attending Physician, Department of Dermatology,
Taipei and Taoyuan Chang Gung Memorial Hospital
Membership, American Academy of Dermatology.
Membership, International Society for Hair
Restoration Surgery
Membership, American College of Phlebology
CHAO, Yates Yen-Yu (趙彥宇) MD
Dermatologist, Taiwan
Director, Chao and Chiu Institute of Dermatology
Director, L1 Cosmetic Surgery and Laser Center
A well-known expert of injectable fillers and lots of
Aesthetic devices and an advisory boards of leading
filler, cosmeceutical and device companies.
Attending Staff, Department of Dermatology, Chang-
Gung Memorial Hospital
He is an active lecturer and trainer of fillers across the
world
CHEN, Ya-Hui ( 陳雅惠) MD
Dermatologist, Taiwan
Director, Ya-Skin Dermatology and Aesthetics
Fellow, Department of Dermatology, Boston
University Hospital, MA., USA
Outstanding poster award and outstanding research
paper award from the Taiwanese Dermatological
Association
Outstanding scholarship award from Takeda Science
Foundation
142
Domestic Speakers
CHENG, Kuo Liang (鄭國良) MD
Dermatologist, Taiwan
Director, Haute Beaute Skin & Vein Clinic
Attending Physician, Department of Dermatology,
Taipei Medical University Hospital
Member, Taiwanese Dermatological Association
Fellow member, American Academy of Dermatologic
Surgery
Member, American society for Phlebology
has been invited to present at international associations
such as world congress of dermatology, ASLMS and
IMCAS
CHOU, Chun-Hsu (周俊旭) M.D, PhD
Facial Plastic Surgeon, Taiwan
Director, Dr.JOU Beauty Clinic
CEO, Dr.MORITA Cosmetic Brand
Member, Taiwan Academy of Facial Plastic and
Reconstructive Surgery
Member, Taiwan Otolaryngological Society
CHOU, Erh-Kang (周爾康) MD
Plastic Surgeon, Taiwan
Director, E.K Plastic Surgery Clinic
Attending doctor, Plastic and Reconstructive Surgery,
Burn Center, Chang-Gung Memorial Hospital, Lin-
Kou, Taiwan
Attending doctor, Plastic Surgery, China Medical
University Hospital, Taichung, Taiwan
Reviewer, the Journal of Hand and Microsurgery
CHU, Chia-Yu (朱家瑜) MD, PhD.
Dermatologist, Taiwan
Associate Professor, Department of Dermatology,
College of Medicine, National Taiwan University
CEO, International Medical Service Center, National
Taiwan University Hospital
Clinical Research Fellow, Department of Dermatology,
Henri Mondor Hospital, Paris
Editor-in-Chief, Dermatologica Sinica, Taipei, Taiwan
Published more than 130 articles about chronic
urticaria, chemokines /cytokines and cancer
progression, drug eruption, contact dermatitis, and
atopic dermatitis
143
Domestic Speakers
HSU, Nai-Jen (許乃仁) MD
Dermatologist, Taiwan
Director, Hsu Nai-Jen Dermatologic Clinic, Tainan
Secretary-Treasurer, 3rd Taiwan Dermatology
Aesthetic Conference (TDAC)
Member, Society of Dermatology R.O.C., Taiwan
Member, Society of Dermatoallergology and Contact
Dermatitis Japan
HUANG, Chi-Ching (黃奇卿) DDS
Dentist, Taiwan
Dean, Sun Ring Dentofacial Esthetic Clinic
Taiwan beauty medical specialist
Clinical Lecturer Taipei Medical University
National Taiwan University Hospital, Department of
Cosmetic Dentistry Lecture
Expertise:Oral maxillofacial reconstruction aesthetics
Achievements: 20l3 Archimedes Russia Exhibition of
Inventions, Poland Exhibition of Inventions, Ukraine
Exhibition of Inventions
HUANG, Po-Han (黃柏翰) MD
Dermatologist, Taiwan
Medical Director, Huang P.H. Dermatology and
Aesthetics
Founder, Taiwan Dermatology Aesthetic Conference
(TDAC)
Executive Director, Taiwanese Dermatological
Association (TDA)
Scientific Secretary, International Master Course on
Aging Skin (IMCAS) Asia
Member, Society for Pediatric Dermatology, USA
(SPD)
Reviewer, Journal of Cosmetic Dermatology
HUANG, Yu-Huei (黃毓惠) MD
Dermatologist, Taiwan
Attending Physician, Department of Dermatology ,
Chang Gung Memorial Hospital, Taipei
Assistant professor, Chang Gung University
Deputy Secretary General, Taiwanese Dermatological
Association
Member, Chinese Dermatology Society, Taipei
Member, American Academy of Dermatology
144
HUI, Rosaline Chung-Yee (許仲瑤) MD, PhD
Dermatologist, Taiwan
Attending Physician, Department of Dermatology,
Chang Gung Memorial Hospital at Taipei & Linkou
Assistant Professor, Chang Gung University
LEE, Chaw Ning (李兆甯) MD
Dermatologist, Taiwan
Resident, Department of Dermatology, National
Cheng Kung University, Tainan Taiwan
LEE, Julia Yu-Yun (李玉雲) MD
Dermatologist and Pathologist, Taiwan
Professor, Department of Dermatology, National
Cheng Kung University and Hospital
Chair, Department of Pathology, National Cheng
Kung University and Hospital, 2007-208
Assistant Professor, Departments of Pathology and
Dermatology, University of Pittsburgh, 1986-1988
Fellow, Dermatopathology, New York University
Medical Center, 1984-1986
LI, Kuan-Ying (李冠穎) MD
Plastic Surgeon, Taiwan
Superintendent of Mybest Cosmetic Surgery Clinic
Visiting Staff, Department of Aesthetic Unit,
Kaohsiung Veterans General Hospital
Director, Department of Aesthetic Unit, Feng Yuan
Hospital
Member, International Society of Aesthetic Plastic
Surgery
Member, Academy of Anti-Aging and Regenerative
Domestic Speakers
145
Domestic Speakers
LIN, Tsai-Ming (林才民) M.D, PhD
Plastic Surgeon, Taiwan
Director, Charming Institute of Aesthetic &
Regenerative Surgery
Assistant Professor, Kaohsiung Medical University
Attending Plastic Surgeon, Department of Plastic
Surgery, Kaohsiung Medical University
Director, Surgical Skill Center, Kaohsiung Medical
University Hospital
LU, Ching-I (盧靜怡) MD
Dermatologist, Taiwan
Superintendent, iSkin Laser and Skin Care Center,
Taiwan
Attending physician, Department of Dermatology,
Chang Gung Memorial Hospital, Taipei , Taiwan
Membership, the American Academy of Dermatology
Membership, the American Society of Cosmetic
Dermatology & Aesthetic Surgery
Membership, the American Academy of Anti-Aging
Medicine
PAN, Shin-Chen (潘信誠) MD, PhD
Plastic Surgeon, Taiwan
Assistant Professor, Plastic and Reconstruction
Surgeon, National Cheng Kung University Hospital
Chief, Hyperbaric Oxygen Therapy Center, National
Cheng Kung University Hospital
Research Fellow, University of Washington, Seattle,
USA
PENG, Hsien-Li (彭賢禮) MD
Dermatologist, Taiwan
Director, P-Skin professional Clinic
Editorial Advisory Board of The Asian Aesthetic
Guide
has been invited to speak in more than 100 events
about his experiences in injectables, devices or
combination therapy
146
SHIH, I-Hsin (施一新) MD
Dermatologist, Taiwan
Attending Physician, Department of Dermatology,
Chang Gung Memorial Hospital, Taipei
Director, Department of Pediatric Dermatology,
Chang Gung Memorial Hospital, Taipei
Member of the Board of Supervision, Taiwanese
Dermatological Association
Editor-in-Chief, Taiwanese Dermatological
Association Bulletin
SU, Chen-Wei (蘇承偉) MD
Dermatologist, Taiwan
Director, Chen Chih Dermatological, Cosmetic and
Laser Clinic, Taichung
Member of Taiwan Academy of Facial Plastic and
Reconstructive Surgery
Staff Attending, Department of Dermatology, Veterans
General Hospital Taichung & Laser and Aesthetic
TSENG, Fang-Wen (曾繁聞) MD
Dermatologist, Taiwan
Medical Director, Milano Aesthetic Clinic Taoyuan
Attending Physician, Department of Dermatology &
Aesthetic Medical Center, Chang-Gung Memorial
Hospital, Taipei, Taiwan
TSENG, Jonathan Te-Peng (曾德朋) MD
Dermatologist, Taiwan
Attending Physician, Department of Dermatology,
Taipei Medical University-Shuang Ho Hospital
Lecturer, School of Medicine, Taipei Medical
University
Research Fellow, Keio University and Toranomon
Hospital, Japan
Domestic Speakers
147
Domestic Speakers
WANG, Chao-Huei (王朝輝) MD
Dermatologist, Taiwan
President and CEO, Dr.Shine Medical Cosmetology
Center
Attending Doctor, Tongyen Dermatology Clinic
Attending Doctor, Department of Dermatology,
Mackay Hospital
Clinical Instructor, Department of Dermatology, Tzu
Chi Hospital
Has over 30,000 successful patients in liposuction
WANG, Cheng-Kun (王正坤) MD, EMBA
Dermatologist, Taiwan
Director, E-Champ Dermatology Clinic
Fellow, Asian Academy of Dermatology and
Venereology
Standing Director, Taiwan Medical Association
Standing Director, Taiwanese Dermatological
Association
WANG, Shiou-Han (王修含) MD, MSEE
Dermatologist, Taiwan
Director, Skin168 Institute of Dermatology, Taipei,
Taiwan
Adjunct Staff, Department of Dermatology, National
Taiwan University Hospital,Taipei, Taiwan
Certificate for special competence in Cosmetic
Dermatology
Awarded Best Annual Paper Award from Taiwanese
Society of Biomedical Engineering and Enginnering
Paper Award from Chinese Institute of Engineers
YANG,Chia-Yi (楊佳懿) MD
Dermatologist, Taiwan
Medical Director, Da An Dermatology and Aesthetics
Chair, Department of Dermatology, Cathay General
Hospital
Chair, Department of Dermatology, Taipei Municipal
Ren-Ai Hospital
Lecturer, Department of Medicine, National Yang-
Ming University
Deputy Secretary General, Taiwan Dermatological
Association
Adjunctive Attending Physician, Department of
Dermatology, National Taiwan University Hospital
148
YANG, Chih-Hsun (楊志勛) MD
Dermatologist, Taiwan
Director, Department of Dermatology, Chang Gung
Memorial Hospital, Taipei, Taiwan
Director, Cosmetic Center, Chang Gung Memorial
Hospital, Taipei, Taiwan
Associate Professor, Chang Gung Memorial Hospital,
Taipei, Taiwan
President, Taiwanese Dermatological Association
has authored more than a hundred publications mainly
focusing on the treatment of varicose vein, cutaneous
melanoma and dermatologic surgery
白佳原院長
Taiwan
中山醫學大學醫學人文暨社會學院院長
中華民國醫療精算學會理事長（ 2009/11 ～迄今）
愛恩佳醫療科技研發顧問(2010/1/1~迄今)
中華民國醫療精算學會理事長（ 2009/11 ～迄今）
中山醫學院附設醫院國際標準組織委員會執行長
行政院中部聯合服務中心衛生醫療組諮詢委員
考試院命題委員及閱卷委員編號
中山醫學大學／醫療產業科技管理學系（所）主任
高永浩會計師
Taiwan
元展聯合會計師事務所主持會計師
台灣省會計師公會會計審計委員會執行長
會計師公會全國聯合會中小企業會計審計委員會副
主任委員
會計師公會全國聯合會會計審計委員會委員
會計師公會全國聯合會稅制稅務委員會委員
台灣省會計師公會稅制稅務委員會委員
台北市會計師公會工商服務委員會委員
葉孟宜科長
Taiwan
衛生福利部食品藥物管理署醫療器材及化粧品組化
粧品管理科 科長
經濟部工業局民生化工組 技正
台北榮民總醫院藥劑部 公職藥師
Domestic Speakers
149
Domestic Speakers
MEMO
全站熱搜
留言列表
